{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "nP_YkzbPtnJt",
        "outputId": "31c99341-6338-4d77-b001-bb521340f06f"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting pdfplumber\n",
            "  Downloading pdfplumber-0.11.9-py3-none-any.whl.metadata (43 kB)\n",
            "\u001b[?25l     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m0.0/43.6 kB\u001b[0m \u001b[31m?\u001b[0m eta \u001b[36m-:--:--\u001b[0m\r",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m43.6/43.6 kB\u001b[0m \u001b[31m1.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting pdfminer.six==20251230 (from pdfplumber)\n",
            "  Downloading pdfminer_six-20251230-py3-none-any.whl.metadata (4.3 kB)\n",
            "Requirement already satisfied: Pillow>=9.1 in /usr/local/lib/python3.12/dist-packages (from pdfplumber) (11.3.0)\n",
            "Collecting pypdfium2>=4.18.0 (from pdfplumber)\n",
            "  Downloading pypdfium2-5.3.0-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (67 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m67.8/67.8 kB\u001b[0m \u001b[31m3.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.12/dist-packages (from pdfminer.six==20251230->pdfplumber) (3.4.4)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.12/dist-packages (from pdfminer.six==20251230->pdfplumber) (43.0.3)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.12/dist-packages (from cryptography>=36.0.0->pdfminer.six==20251230->pdfplumber) (2.0.0)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.12/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer.six==20251230->pdfplumber) (2.23)\n",
            "Downloading pdfplumber-0.11.9-py3-none-any.whl (60 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m60.0/60.0 kB\u001b[0m \u001b[31m3.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pdfminer_six-20251230-py3-none-any.whl (6.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.6/6.6 MB\u001b[0m \u001b[31m39.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pypdfium2-5.3.0-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (3.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.0/3.0 MB\u001b[0m \u001b[31m97.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pypdfium2, pdfminer.six, pdfplumber\n",
            "Successfully installed pdfminer.six-20251230 pdfplumber-0.11.9 pypdfium2-5.3.0\n"
          ]
        }
      ],
      "source": [
        "!pip install pdfplumber\n",
        "!pip install sentence-transformers faiss-cpu\n",
        "!pip install -U langchain langchain-community sentence-transformers faiss-cpu\n",
        "!pip install -U langchain langchain-openai\n",
        "!pip -q install ipywidgets\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "5XDOb45xugQb"
      },
      "source": [
        "## Подготовка данных"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "SINUr2ETkC0T"
      },
      "source": [
        "### Извлечение отчистка текста\n",
        "\n",
        "#### Импорты"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "xl0kns1sbH2R"
      },
      "outputs": [],
      "source": [
        "import re\n",
        "import pdfplumber\n",
        "from pathlib import Path\n",
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "import numpy as np\n",
        "import faiss\n",
        "from sentence_transformers import SentenceTransformer\n",
        "\n",
        "from dotenv import load_dotenv\n",
        "import os\n",
        "from langchain_openai import ChatOpenAI"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "G4rQBRHCbTwG"
      },
      "source": [
        "Функция загрузки pdf файлов"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Zob2efUrbZN5"
      },
      "outputs": [],
      "source": [
        "def extract_text_from_pdf(pdf_path: Path) -> str:\n",
        "    text = []\n",
        "    with pdfplumber.open(pdf_path) as pdf:\n",
        "        for page in pdf.pages:\n",
        "            page_text = page.extract_text()\n",
        "            if page_text:\n",
        "                text.append(page_text)\n",
        "    return \"\\n\".join(text)\n",
        "def extract_pdf_folder(folder: str | Path) -> dict[str, str]:\n",
        "    folder = Path(folder)\n",
        "    results = {}\n",
        "\n",
        "    for pdf_file in folder.glob(\"*.pdf\"):\n",
        "        print(f\"Processing: {pdf_file.name}\")\n",
        "        results[pdf_file.name] = extract_text_from_pdf(pdf_file)\n",
        "\n",
        "    return results\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "h9zdJgAad0m2",
        "outputId": "94a6a34f-38b0-4b2b-d50c-8ce09a358307"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Processing: 2025.10.17.683162v1.full.pdf\n",
            "Processing: 2023.06.05.543662v1.full.pdf\n",
            "Processing: 2025.11.07.687156v1.full.pdf\n",
            "Processing: 2023.04.20.537649v1.full.pdf\n",
            "Processing: 2025.10.16.682926v1.full.pdf\n",
            "Processing: 2022.09.16.508278v1.full.pdf\n",
            "Processing: 2025.01.26.634937v2.full.pdf\n",
            "Processing: 2025.10.06.680030v1.full.pdf\n",
            "Processing: 2025.12.09.692941v1.full.pdf\n",
            "Processing: 2025.12.04.692105v1.full.pdf\n",
            "Processing: 2025.11.27.690929v1.full.pdf\n",
            "Processing: 2025.12.03.692255v1.full.pdf\n",
            "Processing: 2025.11.04.686626v1.full.pdf\n",
            "Processing: 2025.07.11.659973v2.full.pdf\n",
            "Processing: 2025.08.18.670945v1.full.pdf\n",
            "Processing: 2025.06.09.658689v1.full.pdf\n",
            "Processing: 2025.01.17.633633v1.full.pdf\n",
            "Processing: 2025.01.10.632400v1.full.pdf\n",
            "Processing: 2024.08.29.610372v1.full.pdf\n",
            "Processing: 2024.02.16.578765v1.full.pdf\n",
            "Processing: 2023.06.15.545187v1.full.pdf\n",
            "Processing: 2023.03.28.534418v2.full.pdf\n",
            "Processing: 2020.12.10.419598v2.full.pdf\n",
            "Processing: 2022.05.14.491965v1.full.pdf\n",
            "Processing: 2025.12.30.697044v2.full.pdf\n",
            "Processing: 2025.06.15.659785v2.full.pdf\n",
            "Processing: 2023.07.28.550932v1.full.pdf\n",
            "bioRxiv preprint doi: https://doi.org/10.1101/2020.12.10.419598; this version posted September 6, 2022. The copyright holder for this preprint\n",
            "(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.\n",
            "The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network\n",
            "Milène Vandal 1, Adam Institoris 2*, Ben Korin 3*, Colin Gunn 1*, Suzie Lee 1, Jiyeon Lee 3,\n",
            "Philippe Bourassa 4,5, Ramesh C. Mishra 2, Govind Peringod 2, \n"
          ]
        }
      ],
      "source": [
        "texts = extract_pdf_folder('/content/drive/MyDrive/Colab Notebooks/resurse/articles')\n",
        "print(texts[\"2020.12.10.419598v2.full.pdf\"][:500])"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "UuU3_KL-bMBz"
      },
      "source": [
        "Функция очистки текста"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_BaNjZynLldL"
      },
      "outputs": [],
      "source": [
        "def clean_pdf(text: str) -> str:\n",
        "  text = re.sub(r'https?://\\S+', '', text)\n",
        "  text = re.sub(r'[^\\w\\s]', '', text)\n",
        "  text = re.sub(r'\\n+', '\\n', text)\n",
        "  text = re.sub(r'[ \\t]+', ' ', text)\n",
        "  text = re.sub(r'https?://\\S+', '', text)\n",
        "\n",
        "  return text.strip()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "WHu3281Zi0A2",
        "outputId": "47e2c268-1d47-4c4d-a37f-23f13e1a7d52"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "bioRxiv preprint doi this version posted September 6 2022 The copyright holder for this preprint\n",
            "which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\n",
            "The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network\n",
            "Milène Vandal 1 Adam Institoris 2 Ben Korin 3 Colin Gunn 1 Suzie Lee 1 Jiyeon Lee 3\n",
            "Philippe Bourassa 45 Ramesh C Mishra 2 Govind Peringod 2 Yulan Jiang 1 Sotaro Hirai 1\n",
            "Camille Belzil 1 Louise Reveret 45 Cy\n"
          ]
        }
      ],
      "source": [
        "cleaned_text = {}\n",
        "\n",
        "for name, text in texts.items():\n",
        "  cleaned_text[name] = clean_pdf(text)\n",
        "\n",
        "print(cleaned_text[\"2020.12.10.419598v2.full.pdf\"][:500])"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "SZVPc4JkoYsv"
      },
      "source": [
        "Извлечение Abstract, introduce, conclusion"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ElaRlpL3odtQ"
      },
      "outputs": [],
      "source": [
        "def extract_between(text: str, start: str, ends: list[str]) -> str | None:\n",
        "    # Учитываем варианты типа \"1 Introduction\", \"I. INTRODUCTION\", \"Abstract:\" и т.п.\n",
        "    start_pat = rf\"(?:^|\\n)\\s*(?:\\d+\\.?\\s*|[IVX]+\\.\\s*)?(?:{start})\\s*[:\\-]?\\s*\"\n",
        "    end_pat = \"|\".join([rf\"(?:\\d+\\.?\\s*|[IVX]+\\.\\s*)?{e}\" for e in ends])\n",
        "    pattern = rf\"(?is){start_pat}(.*?)(?=(?:^|\\n)\\s*(?:{end_pat})\\s*[:\\-]?\\s*|\\Z)\"\n",
        "\n",
        "    m = re.search(pattern, text)\n",
        "    return m.group(1).strip() if m else None\n",
        "\n",
        "\n",
        "def extract_aic(text: str) -> dict[str, str]:\n",
        "    # 1. Пытаемся найти секции по заголовкам\n",
        "    abstract = extract_between(\n",
        "        text,\n",
        "        start=r\"abstract\",\n",
        "        ends=[r\"keywords?\", r\"introduction\", r\"background\", r\"methods?\", r\"materials?\"]\n",
        "    )\n",
        "\n",
        "    introduction = extract_between(\n",
        "        text,\n",
        "        start=r\"introduction\",\n",
        "        ends=[r\"methods?\", r\"materials?\", r\"methodology\", r\"results?\", r\"experiments?\", r\"discussion\", r\"conclusions?\"]\n",
        "    )\n",
        "\n",
        "    conclusion = extract_between(\n",
        "        text,\n",
        "        start=r\"conclusions?\",\n",
        "        ends=[r\"references\", r\"bibliography\", r\"acknowledg(e)?ments\", r\"appendix\", r\"supplementary\", r\"funding\"]\n",
        "    )\n",
        "\n",
        "    # 2. Fallback: split по Introduction\n",
        "    m = re.search(r'(?is)\\b(?:\\d+\\.?\\s*|[IVX]+\\.\\s*)?introduction\\b', text)\n",
        "\n",
        "    if m:\n",
        "        before_intro = text[:m.start()].strip()\n",
        "        from_intro = text[m.start():].strip()\n",
        "    else:\n",
        "        before_intro = text.strip()\n",
        "        from_intro = \"\"\n",
        "\n",
        "    # 3. Применяем правила, которые ТЫ попросил\n",
        "    if not abstract:\n",
        "        abstract = before_intro if before_intro else None\n",
        "\n",
        "    if not conclusion:\n",
        "        conclusion = from_intro if from_intro else None\n",
        "\n",
        "    return {\n",
        "        \"abstract\": abstract,\n",
        "        \"introduction\": introduction,\n",
        "        \"conclusion\": conclusion\n",
        "    }"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "7Lzfwu5dzDu7",
        "outputId": "0390bcf3-0af3-4ba2-e582-2bfc8697154e"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "ABSTRACT: bioRxiv preprint doi this version posted September 6 2022 The copyright holder for this preprint\n",
            "which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\n",
            "The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network\n",
            "Milène \n",
            "INTRO: The brain vasculature is composed of a complex network of vessels with specialized segments\n",
            "presenting distinct cellular and molecular signatures Schaeffer and Iadecola 2021 Each type\n",
            "of vessels along the vascular tree plays unique and critical roles in regulating cerebral blood flow\n",
            "CBF that is ess\n",
            "CONCLUSION: Introduction\n",
            "The brain vasculature is composed of a complex network of vessels with specialized segments\n",
            "presenting distinct cellular and molecular signatures Schaeffer and Iadecola 2021 Each type\n",
            "of vessels along the vascular tree plays unique and critical roles in regulating cerebral blood flow\n",
            "CB\n"
          ]
        }
      ],
      "source": [
        "sections = extract_aic(cleaned_text[name])\n",
        "name = \"2020.12.10.419598v2.full.pdf\"\n",
        "secs = extract_aic(cleaned_text[name])\n",
        "\n",
        "print(\"ABSTRACT:\", secs[\"abstract\"][:300])\n",
        "print(\"INTRO:\", secs[\"introduction\"][:300] if secs[\"introduction\"] else \"None\")\n",
        "print(\"CONCLUSION:\", secs[\"conclusion\"][:300])\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "JygPJ4mTiz9A"
      },
      "source": [
        "Чистим текст при помощи регулярных выражений"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "KabHu-iyop_z"
      },
      "outputs": [],
      "source": [
        "def clean_section(text: str) -> str:\n",
        "    text = re.sub(r'https?://\\S+', '', text)\n",
        "    text = re.sub(r\"(?i)bioRxiv preprint doi:?.*\", \" \", text)\n",
        "    text = re.sub(r\"(?i)this version posted.*\", \" \", text)\n",
        "    text = re.sub(r\"(?i)the copyright holder.*\", \" \", text)\n",
        "    text = re.sub(r\"(?i)available under a\\s*cc-?by.*license\\.\", \" \", text)\n",
        "    text = re.sub(r'\\[(\\d+([,\\-]\\s*\\d+)*)\\]', ' ', text)\n",
        "    text = re.sub(r'\\s+', ' ', text)\n",
        "    return text.strip()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ORElOOARoxYD"
      },
      "outputs": [],
      "source": [
        "sections_by_pdf = {}\n",
        "\n",
        "for name, text in cleaned_text.items():\n",
        "    secs = extract_aic(text)\n",
        "    # чистим только найденные секции\n",
        "    secs = {k: (clean_section(v) if isinstance(v, str) and v.strip() else None) for k, v in secs.items()}\n",
        "    sections_by_pdf[name] = secs\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YqrUJQsoo-rn",
        "outputId": "848b0521-2ae7-46a8-c649-17cb47746282"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "ABSTRACT:\n",
            " which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network Milène Vandal 1 Adam Institoris 2 Ben Korin 3 Colin Gunn 1 Suzie Lee 1 Jiyeon Lee 3 Philippe Bourassa 45 Ramesh C Mishra 2 Govind Peringod 2 Yulan Jiang 1 Sotaro Hirai 1 Camille Belzil 1 Louise Reveret 45 Cyntia Tremblay 5 Mada Hashem 6 Esteban Elias 7 Bill Meilandt 3 Oded Foreman 3 Meron RouseGirma 3 D\n",
            "\n",
            "INTRODUCTION:\n",
            " The brain vasculature is composed of a complex network of vessels with specialized segments presenting distinct cellular and molecular signatures Schaeffer and Iadecola 2021 Each type of vessels along the vascular tree plays unique and critical roles in regulating cerebral blood flow CBF that is essential to supply oxygen and nutrients to the brain Cerebrovascular dysfunction that involves brain endothelial cells BECs and other cell types forming the neurovascular unit is amongst the earliest de\n",
            "\n",
            "CONCLUSION:\n",
            " Introduction The brain vasculature is composed of a complex network of vessels with specialized segments presenting distinct cellular and molecular signatures Schaeffer and Iadecola 2021 Each type of vessels along the vascular tree plays unique and critical roles in regulating cerebral blood flow CBF that is essential to supply oxygen and nutrients to the brain Cerebrovascular dysfunction that involves brain endothelial cells BECs and other cell types forming the neurovascular unit is amongst th\n"
          ]
        }
      ],
      "source": [
        "name = \"2020.12.10.419598v2.full.pdf\"\n",
        "\n",
        "print(\"ABSTRACT:\\n\", sections_by_pdf[name][\"abstract\"][:500] if sections_by_pdf[name][\"abstract\"] else \"NOT FOUND\")\n",
        "print(\"\\nINTRODUCTION:\\n\", sections_by_pdf[name][\"introduction\"][:500] if sections_by_pdf[name][\"introduction\"] else \"NOT FOUND\")\n",
        "print(\"\\nCONCLUSION:\\n\", sections_by_pdf[name][\"conclusion\"][:500] if sections_by_pdf[name][\"conclusion\"] else \"NOT FOUND\")\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "uYkaYTt-mymd"
      },
      "source": [
        "### Exploere data analys (EDA)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "#### Выведем первые 5 очищенных статей"
      ],
      "metadata": {
        "id": "SAzg2widULwm"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ihxymqsl_CF_",
        "outputId": "aa5e0d44-2f1f-498c-e1d9-b3e336ed749e"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "['bioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nModeling Alzheimers Disease with APOE4 NeuronGlial Brain Assembloids Reveals\\nIGFBPs as Therapeutic Targets\\nEliana Sherman12 Kevin Qiu3 Rebecca Roberts4 Lucille Shichman5 Sihan Li1 Huayu Sun6\\nLucie Ide1 Allison Tucker127 Seonjoo Lee8 Weronika Gniadzik127 JungBum Shin1 Katia\\nSolChurch9 Jaideep Kapur6 Aiying Zhang5 Alev Erisir4 Lulu Jiang127 and For the\\nAlzheimers Disease Neuroimaging Initiative\\n1Department of Neuroscience 2Center for Brain Immunology and Glia BIG University of\\nVirginia School of Medicine Charlottesville VA USA 22908\\n3Department of Medicine University of Virginia School of Medicine Charlottesville VA USA\\n22903\\n4Department of Psychology University of Virginia Charlottesville VA USA 22904\\n5School of Data Science University of Virginia Charlottesville VA USA 22903\\n6Department of Neurology Brain Institute University of Virginia Charlottesville VA USA\\n22903\\n7Neuroscience Graduate Program University of Virginia Charlottesville Virginia USA\\n8Department of Psychiatry Columbia University Irvine Medical Center NY 10032\\n9Genome Analysis Technology Core University of Virginia Charlottesville VA USA\\nA list of authors and their affiliations appears at \\nhow_to_applyADNI_Acknowledgement_Listpdf\\n Correspondence should be addressed to jiangluluvirginiaedu\\n1\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nSUMMARY\\nAlzheimers disease AD research has been hindered by the lack of models that faithfully\\nrecapitulate the full profile of disease progression in a human genetic background We developed\\na 3D assembloid model Masteroid using iPSCderived neurons astrocytes and microglia from\\nAPOE44 and isogenic control lines Neurons were seeded with tau oligomers then combined with\\nastrocytes and microglia to form mature 3D Masteroids followed by amyloidβ oligomer\\nexposure After four weeks ADMasteroids exhibited hallmark pathologies including\\nextracellular amyloidβ deposits intracellular tau aggregation neurodegeneration astrogliosis\\nand microglial activation with APOE4 exacerbating all phenotypes Singlecell RNA sequencing\\nfurther identified novel roles of IGFBP pathways in amyloidβ and taumediated pathology This\\ninnovative platform provides a robust system to dissect cellular and molecular mechanisms of AD\\nprogression and offers a powerful tool for therapeutic discovery\\nKeywords\\nAlzheimers disease Brain Assembloid Tau oligomers Amyloid Plaques APOE4\\nNeurodegeneration Microglia Astrocyte Oligodendrocyte IGFBP\\nHighlights\\n The 3D human neuronglia assembloid Masteroid composed of neurons astrocytes\\nmicroglia and oligodendrocytes faithfully recapitulates human brain ultrastructure and\\nintercellular interactions\\n Exposure to oligomeric tau and Aβ induced hallmark Alzheimers pathologies including\\namyloid deposition tau aggregation neurodegeneration and gliosis\\n The APOE4 genotype exacerbated all pathological features highlighting its role in driving\\nmulticellular interactions that accelerate disease progression\\n The IGF signaling axis was identified as a key mediator of Aβ and tauinduced pathology and\\na potential therapeutic target\\n2\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nGraphical Abstract\\nAbbreviations\\nAD Alzheimers Disease\\noTau Oligomeric tau\\nNC Normal Control\\nAβ Amyloid beta\\nAD oTau Oligomeric tau derived from diseased AD brains\\nAD Aβ Condition with both Aβ oligomers and AD oTau\\nUMAP Uniform manifold approximation and projection\\nGSEA Gene set enrichment analysis\\nCU Cognitively unimpaired\\nMCI Mild cognitive impairment\\nDEM Demented\\nADNI Alzheimers Disease Neuroimaging Initiative\\n3\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nINTRODUCTION\\nAlzheimers disease AD a leading cause of dementia worldwide is a progressive\\nneurodegenerative disorder that gradually impairs memory cognition behavior and executive\\nfunctions13 AD is defined by two primary pathological hallmarks the accumulation of\\nextracellular amyloidβ Aβ plaques and intracellular neurofibrillary tau tangles accompanied by\\ngliosis and neuronal loss Despite substantial advances in understanding AD pathology the\\ncomplex interplay of genetic cellular and environmental factors makes the mechanisms of the\\ndisease progression an enigma Among genetic risk factors carrying the ε4 allele of apolipoprotein\\nE APOE4 represents the strongest contributor to lateonset AD45 Accumulating evidence from\\nepidemiological and genomewide association studies GWAS has shown that APOE4\\nheterozygotes are two to three times more likely and homozygotes up to 12 to 15 times more\\nlikely to develop AD compared with APOE3 populations468 In this study we analyzed positron\\nemission tomography PET imaging data from nondemented preclinical individuals in the\\nAlzheimers Disease Neuroimaging Initiative ADNI cohort and found that even among\\ncognitively normal control participants both APOE4 heterozygotes and homozygotes show\\nsignificantly increased amyloidβ and tau burden compared with noncarriers demonstrating that\\nAPOE4 drives early pathological changes well before clinical symptoms emerge Figure 1\\nFurthermore APOE4 increases the risk of amyloidrelated imaging abnormalities during treatment\\nwith secondgeneration antiamyloid monoclonal antibodies and diminishes therapeutic efficacy\\n911 Despite its central role in AD pathogenesis the mechanisms by which APOE4 potentiates\\npathological amyloid and tau burden exacerbates disease severity and confers treatment\\nresistance remain elusive\\nProgress in understanding AD and APOE4 has been limited by the lack of models that\\naccurately capture human pathophysiology While animal models have provided critical insights\\ninto amyloid processing tau aggregation and neuroinflammation speciesspecific differences\\nprevent full recapitulation of the human brain and the complex interplay of AD pathologies This\\nlimitation is particularly pronounced for APOE4 as APOE exhibits speciesspecific differences in\\nits evolution structure and posttranslational modifications between rodents and humans1213\\nRodent models even those expressing humanized APOE encounter difficulty in reproducing the\\nphenotypes observed in human populations1416 Human induced pluripotent stem cell hiPSC\\nbased models have emerged as powerful tools to overcome these limitations1720 By\\n4\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nreprogramming patientderived cells into neurons astrocytes and other brain cell types hiPSC\\nmodels allow the study of AD mechanisms in a human genetic context21 Advances in stem cell\\nengineering have further enabled the generation of threedimensional 3D brain organoids or\\nassembloids selforganizing multicellular structures that recapitulate aspects of human brain\\ndevelopment cellular diversity and architecture2226 Organoids and assembloids provide unique\\nopportunities to investigate cellular interactions and disease processes in a physiologically relevant\\nenvironment that is difficult to achieve in conventional 2D cultures2732 However most current\\norganoid systems remain limited in cellular composition often lacking or exhibiting delayed\\ndevelopment of key nonneuronal cell types and rarely incorporate diseaserelevant stressors in a\\ncontrolled and systematic manner3336\\nTo overcome the challenges in understanding the pathophysiology of AD and recapitulate\\nhuman heterogeneity we built on our previously published Asteroid model37 to develop\\nMasteroids 3D cultures composed of hiPSCderived neurons astrocytes microglia and\\nendogenously generated oligodendrocytes In this study we established Masteroid models using\\nhiPSCs carrying APOE4 and their isogenic APOE3 controls combining tau and amyloid\\npathologies to more comprehensively model AD progression Our Masteroid system was\\nspecifically designed to capture both the proteopathic and genetic contributors to AD Neurons\\nwere initially seeded with tau oligomers to prime the system for pathological tau aggregation and\\nthen combined with astrocytes and microglia to form mature multicellular 3D Masteroids The\\ncultures were subsequently exposed to extracellular amyloidβ oligomers creating a\\ncomprehensive environment that models intermediate and advanced stages of neurodegeneration\\nAfter four weeks ADMasteroids faithfully recapitulated multiple hallmark features of AD\\npathology including Aβ deposition tau aggregation widespread neurodegeneration astrogliosis\\nand robust microglial activation Notably the presence of APOE4 markedly exacerbated all of\\nthese pathological phenotypes highlighting its critical role in disease progression Electron\\nmicroscopy revealed that Masteroids recapitulated ultrastructural features of the human brain\\nincluding neuronal synaptic structures neuronglial interactions glial phagocytic activity and\\nearly myelination development Electrophysiological recordings confirmed Masteroid neurons had\\nexcitation ability action potentials in response to current injection and synaptic events\\nLeveraging singlecell RNA sequencing we identified IGFBPs as distinct mediators and\\nhighlighted signaling pathways involved in amyloidβ and tauassociated cellular dysfunction\\n5\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nproviding new mechanistic insights Strikingly treatment of ADMasteroids with IGFBP inhibitor\\nNBI 31772 significantly reduced neurodegeneration astrogliosis and microglial activation\\ndemonstrating a direct role for IGFBP signaling in driving AD pathogenesis Together these\\nresults establish Masteroids as a powerful tool for highthroughput evaluation of therapeutic\\ninterventions bridging a critical gap between conventional cell cultures and in vivo models and\\nenabling the study of complex genotypepathology interactions in AD under a controlled\\nenvironment\\nRESULTS\\nDoseDependent Impact of APOE4 on Aβ Deposition and Tau Accumulation from\\nPreclinical to Prodromal Stages\\nAD is composed of three primary stages preclinical prodromal and clinical38 In the\\npreclinical stage patients are primarily asymptomatic and cognitively normal while bearing some\\npathological markers of AD In the prodromal stage patients experience mild cognitive\\nimpairment MCI ranging from early to late MCI with varying levels of AD pathology The\\nclinical stage is characterized by extensive AD pathology alongside severe cognitive impairment38\\nUsing the ADNI dataset3942 we analyzed the impact of APOE4 status on amyloid and tau burden\\nin human patients during the preclinical and prodromal stages of AD The ADNI study is composed\\nof three cohorts of varying severities determined by diagnostic criteria of both cognitive and\\npathological scores the Cognitively Unimpaired CU cohort the Mild Cognitive Impairment\\nMCI cohort and the EarlyStage Alzheimers Disease DEM cohort4344 The CU cohort consists\\nof both normal control participants with little to no positive AD pathology as well as cognitively\\nnormal participants with some AD pathological markers but little to no cognitive impairment For\\nour analysis we considered the CU cohort to be in the preclinical stage the MCI cohort to be in\\nthe prodromal stage and the DEM cohort to be in the clinical stage\\nWe began by analyzing the difference in amyloid burden in the preclinical and prodromal\\nstages of AD between APOE33 APOE34 and APOE44 individuals The amyloid burden was\\ndetermined by the proportion of a given population with a positive whole brain PET scan which\\nwas defined by a normalized Standardized Uptake Value Ratio SUVR 111 Figure 1A Even\\none APOE4 allele markedly increased amyloid positivity in preclinical and prodromal patients\\nwith homozygotes showing the highest rates indicating a dosedependent effect of APOE4 on\\n6\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\ndisease progression Figure 1B APOE34 in the CU group showed significantly higher amyloid\\npositivity than noncarriers though no difference was observed between APOE34 and APOE44\\ncarriers Figure S1A By MCI stage the APOE44 individuals had a significantly greater\\nproportion of amyloid positive scans than the APOE34 though this difference is not significant\\nin the DEM cohort as nearly all APOE34 and APOE44 patients had positive amyloid scans In\\nboth the MCI and DEM cohorts any instance of APOE4 APOE44 vs APOE43 vs APOE33 led\\nto a significantly greater proportion of amyloid positive scans than in noncarriers Figures S1B\\nand S1C Across all genotypes each additional APOE4 allele was associated with higher amyloid\\npositivity with APOE44 carriers showing the greatest amyloid burden Figure S1D\\nAmyloid accumulation typically marks early AD pathology while tau burden increases in\\nparallel with cognitive decline45 We therefore analyzed tau PET data in the same ADNI cohort by\\nAPOE status across disease stages focusing on the entorhinal cortex which is among the first\\nregions to show tau pathology4647 Tau burden was determined by the actual SUVR value instead\\nof a binary cutoff of positive or negative scan like amyloid prevalence Figure 1C Similarly to\\nobservations with amyloid burden APOE4 heterozygotes and homozygotes had significantly\\ngreater tau burden than noncarriers in both the left and right entorhinal cortex as early as in the\\npreclinical and prodromal stages of AD with APOE4 homozygotes exhibiting greater tau burden\\nthan APOE4 heterozygotes Figures 1D and 1E In the CU cohort tau burden in the left\\nentorhinal cortex did not differ significantly by APOE4 status though a strong trend was seen\\nbetween APOE33 and APOE44 In the right entorhinal cortex tau burden was significantly\\nhigher in APOE44 than APOE33 individuals with no difference between APOE33 and\\nAPOE34 Figure S1E By the prodromal stage of MCI APOE4 heterozygotes and homozygotes\\nshowed significantly greater tau burden in both the left and right entorhinal cortices compared to\\nnoncarriers Figure S1F Across all genotypes each additional APOE4 allele was linked to\\nhigher tau burden in both entorhinal cortices with APOE4 homozygotes showing the greatest\\nlevels Figure S1G\\nAltogether our analysis demonstrated a dosedependent effect of the APOE4 allele on disease\\nprogression influencing both Aβ deposition and tau accumulation from the earliest preclinical\\nand prodromal stages\\n7\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n8\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 1 DoseDependent Impact of APOE4 on Aβ Deposition and Tau Accumulation\\nfrom Preclinical to Prodromal Stages\\nA Examples of a negative top and positive bottom amyloid PET scan visualized sagittally\\nleft coronally center and axially right A positive scan is defined by a normalized SUVR \\n111 see methods\\nB Quantification of proportion of population with positive amyloid PET scan by APOE genotype\\nin preclinical and prodromal populations CU and MCI n 565 341 and 76 for APOE33\\nAPOE34 and APOE44 respectively\\nC Mean tau PET burden by brain region in the full cohort shown by APOE genotypes\\nD Quantification of normalized Tau PET SUVR in left entorhinal cortex by APOE genotypes in\\npreclinical and prodromal populations CU and MCI n 339 196 and 38 for APOE33\\nAPOE34 and APOE44 respectively\\nE Quantification of normalized Tau PET SUVR in right entorhinal cortex by APOE genotype in\\npreclinical and prodromal populations CU and MCI n 339 196 and 38 for APOE33\\nAPOE34 and APOE44 respectively\\n p 0001 p 00001 Amyloid PET statistical analysis was done by Chisquare Test\\nwith Yates correction B and Tau PET statistical analysis was done with KruskalWallis test D\\nand E with p values shown See also Figure S1\\n3D Masteroid culture system recapitulates human brain cell types and ultrastructure\\nTo establish a 3D neuronglial assembloid model that recapitulates the coordinated origin and\\nemergence of neurons astrocytes and microglia similar to human brain development we\\ndeveloped a 3D coculture system termed Masteroid for modeling neurodegenerative diseases\\nfollowing a modified neuronastrocyte AstTau assembloid protocol developed in our previous\\nwork 3748 In brief human iPSCs with a normal APOE33 genotype were initially differentiated\\ninto hematopoietic progenitor cells and neural progenitor cells hiNPCs where hiNPCs were also\\nfurther differentiated into astrocyte progenitor cells All three types of progenitor cells were\\nsubsequently differentiated into neuronal astrocytic and microglial lineages to generate human\\niPSCderived neurons hiNeurons astrocytes hiAstrocytes and microglia hiMicroglia These\\ncells were then combined into a 3D spherical culture termed Masteroids and allowed to mature\\nover the course of 5 weeks Figure 2A We also maintained individual hiNeurons hiAstrocytes\\nand hiMicroglia in 2D culture for 1 week alongside the creation of Masteroids to confirm proper\\ncell morphology and identity through immunolabeling Figure 2B Mature Masteroids exhibited\\nextensive neuronal and astrocytic processes with microglia distributed throughout the Masteroid\\nFigure 2C\\n9\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nThe final Masteroid cellular phenotypes were characterized using singlecell RNA sequencing\\nscRNAseq profiling 8000 cells per sample at a sequencing depth of 50000 read pairs per cell\\nVisualization by uniform manifold approximation and projection UMAP demonstrated the\\nseparation of cells into trajectory guided clusters The clusters were identified as astrocytes ASC\\nexcitatory neurons EX_NEU inhibitory neurons IN_NEU microglia Microglial\\noligodendrocytes Oligo and various progenitor and panneuronal cells Figure 2D Analysis of\\nscRNAseq clustering revealed an oligodendrocyte cluster which was confirmed by\\nimmunolabeling for Myelin Basic Protein MBPpositive myelinating oligodendrocytes in\\nMasteroids Figures 2D S2A and S2B To determine the origin of the oligodendrocytes the\\nastrocyte oligodendrocyte and progenitor clusters were isolated and redefined on a UMAP\\nfollowed by a pseudotime subclustering and trajectory analysis Figure S2C4951 This analysis\\ntraced gene expression trajectories and indicated that oligodendrocytes in Masteroids likely\\noriginate from astrocyte progenitor cells Previous studies showed that astrocytes and\\noligodendrocytes share a common glial precursor5254 and astrocytes can be reprogrammed into\\noligodendrocytes5556 Together with our pseudotime analysis this supports that the endogenously\\ngenerated oligodendrocytes within our Masteroids originate from astrocyte progenitor cells To\\ndetermine the number and probability of intercellular interactions between cell types we did\\nCellChat scRNAseq analysis which identified the differentially overexpressed ligands and\\nreceptors in each cluster57 Significant receptorligand interactions were present between all cell\\ntypes in the Masteroids noting the presence of extensive intercellular communication with the\\nstrongest interaction probability occurring between the neuronal clusters Figure 2E scRNAseq\\nprofiling of voltagegated channel expression in hiNeurons confirmed Masteroid functionality\\nshowing expression of hyperpolarization cyclicnucleotide gated HCN subunits for I currents\\nh\\nvoltagegated sodium and potassium channels for action potentials and calcium channel subunits\\nrequired for synaptic neurotransmitter release Figures S2D S2E S2F and S2G5860\\nTo further validate that Masteroids recapitulate the ultrastructure of human brain tissue we\\nperformed transmission electron microscopy EM Synapses were identified Figure 2F with\\npresynaptic terminals containing numerous vesicles adjacent to the synaptic cleft and a prominent\\npostsynaptic density features indicative of active synapses and supporting the biophysical\\nfunctionality of the Masteroid model 6162 EM also revealed the proper ultrastructural morphology\\nof mature neuronal and glial cells within Masteroids Figures S2H S2I and S2J Masteroid\\n10\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nneurons have abundant perinuclear cytoplasm with mitochondria endoplasmic reticulum Golgi\\nand numerous ribosomes and large round nuclei with lowcontrast unclustered chromatin and\\ndistinct nucleoli Figure S2H6364 Masteroid neurons often extend large neurites from the cell\\nbody Figure S2H64 Masteroid glial cells display irregularlyshaped and darker nuclei composed\\nof dense clumped chromatin with smaller and darker cytoplasm Figure S2I Cells with\\nintracellular space containing a full ensemble of cytoskeletal elements including microtubules and\\nneurofilaments were also found Figure S2J6165 Myelin whirls concentric membrane stacks\\nlacking a neuropil core were observed confirming myelinating oligodendrocyte development in\\nMasteroids Figure 2G63 Moreover wholecell patchclamp recordings further validated the\\nelectrophysiological functionality of whole Masteroids at day 35 of culture Figure S2K\\nMasteroid hiNeurons exhibited a resting membrane potential and action potentials were evoked\\nby current injection Figures S2L and 2H66 The hiNeurons also showed synaptic transmission\\nwith relatively infrequent but consistent and spontaneous excitatory postsynaptic currents EPSCs\\nobserved indicating the formation of synapses between hiNeurons within the Masteroids as was\\nalso observed by EM Figures S2M and 2F\\nTogether scRNAseq profiling EM ultrastructural analysis and electrophysiological\\nrecordings demonstrate the overall biophysical functionality cellular health and intercellular\\nconnectivity of Masteroids\\n11\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n12\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 2 3D Masteroid culture system recapitulates human brain cell types and\\nultrastructure\\nA Schematic illustrating experimental Masteroid culture system Created with BioRendercom\\nB Representative immunofluorescence images of iPSCderived neurons TUJ1 magenta\\nastrocytes GFAP green and microglia CD11b green P2RY12 red and IBA1 magenta with\\ndsDNA stain Dapi blue Scale bar 50µm\\nC Representative tile scanned and zstacked immunofluorescence images of 3D Masteroid with\\ncell type markers for astrocytes GFAP cyan microglia IBA1 red and neurons TUJ1\\nmagenta Scale bar 100µm\\nD UMAP of singlecell transcriptomic profiles by scRNAseq after filtration and cell type\\nidentification The following cell types were identified astrocytes ASC red excitatory neurons\\nEX_NEU lime green inhibitory neurons IN_NEU teal microglia Microglial blue\\noligodendrocytes Oligo pink and various progenitor and panneuronal cells ASC_P orange\\nCycling olive EX_NEU_P green IN_NEU_P cyan NEU_P purple NEU_X light pink\\nE Number and weight of significant ligandreceptor interactions between five major cell types\\nCircle sizes are proportional to the number of cells within a given cluster and line width is\\nproportional to the indicated number or strength of interactions Cell types included are\\nexcitatory neurons EX_NEU blue inhibitory neurons IN_NEU green astrocytes ASC red\\nmicroglia Microglial purple and oligodendrocytes Oligo orange\\nF Electron microscopy EM image of a synapse within a Masteroid Green arrows point to\\nmicrotubules purple arrow points to synaptic vesicles blue arrows point to ribosomes and \\nindicates postsynaptic density Scale bar 05µm\\nG EM image of a myelin whirl within a Masteroid Scale bar 1µm\\nH Single cell patchclamp Iclamp recording of an action potential in a Masteroid in response\\nto current injection 20 pA per step\\nFG m mitochondria t synaptic terminal d dendrite er endoplasmic reticulum and r\\nribosomes See also Figure S2\\nPropagation of oTau and Aβ oligomers in Masteroids mirrors key features of AD\\nWe next used our Masteroid system to build a model of sporadic AD by selectively\\npropagating human oligomeric tau oTau andor Aβ oligomers Figure S3A Oligomeric tau was\\nextracted from postmortem human brain tissue by centrifugation using a wellestablished\\nextraction method6770 Human oTau fractions were isolated from diseased Alzheimers brains AD\\noTau and age matched control brains NC and identified by Western blot with antiTau\\nantibodies total by Tau5 and PhosphoTau by pThr217 Figures S3B and S3C The dose\\nresponse of oTau toxicity was determined using LDH analysis at 24 and 96 hours after addition of\\noTau in 2D hiNeurons Figure S3D Based on the doseresponse 004mgmL of human oTau\\nwas seeded to hiNeurons 24 hours prior to their combination with hiAstrocytes and hiMicroglia\\n13\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nfor all ADMasteroids while the controls were treated with the same volume of NC fraction\\nPurified Aβ oligomers 05µMmL were spiked in at one week after the Masteroids were\\ntransferred to 96 well plates The proper size 10 kDa and identity of the purified Aβ oligomers\\nwas confirmed by western blot with antiAβ antibody 6E10 Figure S3E To dissect the\\ncontributions of amyloid and tau pathology to AD pathogenesis we established four Masteroid\\nconditions NC NC Aβ AD oTau and AD Aβ by selectively introducing NC or AD oTau together\\nwith either Aβ oligomers or a DMSO vehicle Figure 3A Subsequent analysis of these\\nMasteroids revealed significant development of ADassociated pathology in all diseased\\nconditions with the most pronounced effects observed in Masteroids treated with both AD oTau\\nand Aβ oligomers Figure 3\\nThe reactive astrogliosis marker GFAP showed significant increases in astrocytic reactivity\\nin both AD oTau and AD Aβ Masteroids with a more significant increase in the AD Aβ condition\\ncompared to AD oTau alone Figure 3B While AD oTau Masteroids exhibited some microglial\\nactivation as indicated by IBA1 only AD Aβ Masteroids showed significant increase Figure 3C\\nBoth Aβ and AD oTau treatments led to a significant decrease in neuronal TUJ1 immunolabeling\\ncompared to NC Masteroids with Aβ conditions showing greater neuronal loss than AD oTau\\nalone and the most severe loss observed in AD Aβ Masteroids Figure 3D Immunolabeling by\\n6E10 in whole Masteroids revealed that both NC Aβ and AD Aβ conditions formed Aβ plaques\\nFigures 3E and 3F While some plaques were more diffuse others exhibited the classic star\\nshape morphology with a dense core71 No Aβ plaques were observed in the NC or AD oTau\\nconditions In identifying the tau pathology we found that the AD oTau and AD Aβ Masteroids\\nshowed significant tau misfolding MC1 antibody with the AD Aβ Masteroids containing\\nsignificantly more misfolded tau than the AD oTau only condition Figures 3G and 3H This is\\nconsistent with the most pronounced glial activation and neuronal loss occurring in the AD Aβ\\ncondition highlighting the deleterious synergistic interaction between tauopathy and Aβ in\\nAD7273 Interestingly there were no significant differences in neuronal loss or Aβ burden between\\nNC Aβ and AD Aβ Masteroids Figures 3D 3E and 3F suggesting that tau may not directly\\ninduce or enhance amyloid pathology EM imaging also revealed extensive neurodegenerative and\\nAD pathology in NC Aβ AD oTau and AD Aβ Masteroids including abundant dystrophic\\nneurites degenerating myelin membrane sheath disintegration glial engulfment and lipofuscin\\naccumulation Figures 3I S3F S3G S3H S3I and S3J7476\\n14\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nTo further delineate cell typespecific responses to amyloid and tau pathology we\\ncompared scRNAseq profiles from NC AD oTau NC Aβ and AD Aβ Masteroids uncovering\\nboth shared and distinct transcriptional alterations induced by oTau and Aβ UMAP projections\\ndemonstrated successful integration of all scRNAseq datasets and visualized changes in the\\nrelative proportions of cell types across conditions Figures S4A S4B S4C and S4D\\nDifferential gene expression analysis of the IN_NEU and EX_NEU clusters revealed an overall\\nreduction in synaptic gene expression in AD Aβ Masteroids compared to NC Masteroids Figures\\nS3K and S3L and ASC clusters exhibited diseaseassociated astrocyte features such as extensive\\nupregulation of PLCG2 in AD Aβ Masteroids Figure S3M7778 Additionally the predicted\\ninteraction probability between EX_NEU and IN_NEU clusters was notably decreased in NC Aβ\\nand AD Aβ Masteroids relative to NC consistent with observed neuronal loss by immunolabeling\\nand the reduction in synaptic markers Figures S4I S4J S4K S4L S4Q S4R S4S and S4T\\nFunctional gene set enrichment analysis GSEA further revealed that AD Aβ Masteroids robustly\\nrecapitulate ADrelated pathway alterations Figure 3J They showed strong enrichment in\\nrespirasomal spliceosomal ribosomal neurodegenerative and stressresponse pathways\\nalongside marked dysregulation of histone and immune signaling79 Conversely pathways linked\\nto neuronal and glial morphology synaptic formation and function were substantially\\ndownregulated consistent with neuronal loss and impaired communication7980 Overall these\\nresults highlight the strong modeling of ADassociated cellular dysfunction in AD Aβ Masteroids\\n15\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n16\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 3 Propagation of oTau and Aβ oligomers in Masteroids mirrors key features of AD\\nA Tiled and zstacked immunofluorescence images of control NC Aꞵ oligomers only NC Aꞵ\\noTau only AD and Aꞵ oligomers and oTau AD Aꞵ Masteroids with dsDNA nuclei stain\\nDAPI cyan astrocytes GFAP green microglia IBA1 red and neurons TUJ1 magenta\\nScale bar 100µm\\nB Quantification of astrogliosis by GFAP raw integrated density normalized to Masteroid area\\nC Quantification of microglia activation by IBA1 raw integrated density normalized to TUJ1\\nD Quantification of neuronal loss by TUJ1 raw integrated density normalized to Masteroid\\narea\\nE Immunofluorescence images of Aꞵ plaques 6E10 yellow Scale bar 50µm\\nF Quantification of Aꞵ burden by 6E10 raw integrated density normalized to Masteroid area\\nG DAB staining images of misfolded tau MC1\\nH Quantification of misfolded tau by MC1 DAB staining normalized to Masteroid area\\nI Electron microscopic view of neurodegenerative pathology in AD oTau Masteroid dystrophic\\nneurite containing degenerated mitochondria red arrow multilamellar whorls and electron\\ndense granules green arrow Scale bar 1µm\\nJ Heatmap showing normalized enrichment scores NES of pathways in APOE3 AD Aβ\\nMasteroids versus APOE3 NC Masteroids by scRNAseq Positive NES indicates upregulation\\nin APOE3 AD Aβ Pathways include oxidative phosphorylation dark orange histone\\nmodifications pink ribosomal light orange spliceosomal yellow neurodegenerative green\\nstress response teal immune signaling blue synaptic purple and neuronalglial\\nmorphology burgundy\\nError bars indicate 95 of the standard error of the mean p 005 p 001 p \\n0001 p 00001 Statistical analysis was done using oneway ANOVA with Fishers LSD\\nB C D F and Tukeys multiple comparison test H See also Figures S3 and S4\\noTau and Aβ Oligomer Seeding in APOE44 Masteroids Reveals APOE4Genotypic AD\\nPathology\\nAPOE4 Masteroids were generated using hiNeurons hiAstrocytes and hiMicroglia derived\\nfrom homozygous APOE4 iPSCs and treated with the same selective seeding of oTau and Aβ\\noligomers as APOE33 Masteroids as described in Figure 3 Cell morphology and identity were\\nconfirmed through individual 2D cultures and immunostaining of whole Masteroids Figures 4A\\nand 4B Proper neuronal and glial ultrastructure within APOE4 Masteroids was validated by EM\\nimaging Figures S5A and S5B which revealed synaptic vesicles extensive cytoskeletal\\norganization with microtubules neurofilaments and dendritic branching Figures S5C S5D\\nS5E Extensive processes were also observed by both IF and EM imaging Figures 4B and S5F\\nCellular phenotypes of APOE4 Masteroids were further characterized by scRNAseq with UMAP\\n17\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nprojections demonstrating integration across experimental conditions and visualizing relative\\nproportional shifts in cell types between groups Figures S4E S4F S4G and S4H\\nPathological analyses were performed on APOE4 Masteroids to determine the impact of oTau\\nand Aβ in this deleterious genotype The reactive astrocyte marker GFAP showed a significant\\nincrease in astrogliosis between APOE4 NC and APOE4 AD Aβ Masteroids confirmed by both\\nimmunofluorescence labeling and immunoblotting Figures 4C S5G and S5I scRNAseq\\nanalysis revealed elevated reactive astrocyte gene expression in the APOE4 AD Aβ ASC\\npopulation compared to APOE4 NC ASC with significant upregulation of AD risk genes PLCG2\\nand CLU and enrichment of postmortem AD astrocyte signatures Figure S5M and S5N 8185\\nSignificant microglial activation was observed across all noncontrol APOE4 Masteroid\\nconditions with the strongest activation in APOE4 AD Aβ Masteroids Figures 4D S5H and\\nS5J scRNAseq analysis demonstrated robust enrichment of diseaseassociated microglial\\nDAM signatures with key genes including NEAT1 PICALM APOE MAPT CD44 PSEN1\\nSORL1 and GRN markedly upregulated in APOE4 AD Aβ Masteroids closely mirroring post\\nmortem AD brain profiles Figures S5O and S5P8487 Notably PLCG2 showed striking\\nupregulation and IGF1R emerged as one of the most prominently elevated transcripts in APOE4\\nAD Aβ Masteroids Figure S5O Neuronal analyses revealed significant loss in APOE4 NC Aβ\\nand AD Aβ Masteroids compared to both APOE4 NC and AD oTau conditions Figures 4E S5H\\nand S5K scRNAseq profiling further showed an increase in both inhibitory and excitatory\\nneurons carrying ADassociated transcriptional signatures in APOE4 AD Aβ Masteroids\\ncompared to APOE4 NC Figures S5Q S5R S5S and S5T82 Interestingly no differences were\\ndetected between APOE4 NC and AD oTau or between APOE4 NC Aβ and AD Aβ groups in\\nneuronal loss as indicated by TUJ1 intensity Figure 4E\\nWholeorganoid immunolabeling of APOE4 Masteroids with the 6E10 antibody revealed\\nextensive Aβ plaque accumulation in both NC Aβ and AD Aβ conditions Figures 4F and 4G\\nNotably despite the absence of exogenous Aβ oligomers 6E10positive plaques were detected in\\nnonAβ APOE4 Masteroids Although plaques were observed only in the APOE4 NC condition\\nand not in the APOE4 AD oTau condition by wholeorganoid labeling both NC and AD oTau\\nconditions exhibited plaque formation in 14μm cryosections Figures S5U and S5V indicating\\nthat the APOE4 genotype alone is sufficient to drive endogenous plaque formation APOE4\\nMasteroids also developed extensive tau pathology with significant increases in\\n18\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nhyperphosphorylated labeled by pThr217 pSer202 oligomeric labeled by TOMA2 and\\nmisfolded tau MC1 in AD oTau and AD Aβ conditions Figures 4H 4I S5G S5L S5W S5X\\nS5Y and S5Z The presence of Aβ did not further affect tau hyperphosphorylation on site\\npThr217 as NC and NC Aβ and AD oTau and AD Aβ groups showed comparable levels within\\neach category Figures S5G S5L S5W and S5X However tau oligomerization and misfolding\\nassessed with TOMA2 and MC1 antibodies followed a more severe pattern AD oTau and AD Aβ\\nMasteroids developed significantly greater pathology than NC and NC Aβ groups and the addition\\nof Aβ oligomers exacerbated these effects APOE4 AD Aβ Masteroids developed the highest\\nburden of oligomeric and misfolded tau surpassing AD oTau Masteroids Figures 4I S5Y and\\nS5Z Moreover ultrastructural analyses by EM revealed extensive neurodegenerative pathology\\nDystrophic neurites lipofuscin and degenerating myelin were detected across all conditions\\nincluding APOE4 NC Masteroids Figures 4K S5AA S5BB and S5CC Morphologically\\nabnormal mitochondria and pronounced vacuole accumulation were particularly evident in AD\\nand AD Aβ Masteroids Figures 4K S5CC and S5DD In addition APOE4 AD Aβ Masteroids\\ndisplayed striking glial engulfment with cytoplasmic inclusions containing phagocytosed\\nmaterial ranging from loose chromatin to dystrophic neurite fragments Figures 4J and S5EE\\nAltogether APOE4 Masteroids alone developed Aβ plaques mild gliosis and neuronal\\ndystrophy whereas addition of oTau and Aβ oligomers induced robust ADlike pathology\\nincluding reactive astrocyte and microglial activation neuronal loss Aβ plaques tau\\nhyperphosphorylation oligomerization and misfolding and ultrastructural neurodegeneration\\nwith the greatest severity observed in APOE4 AD Aβ Masteroids\\n19\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n20\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 4 oTau and Aβ Oligomer Seeding in APOE44 Masteroids Reveals APOE4\\nGenotypic AD Pathology\\nA Immunofluorescence images of APOE4 iPSC induced neurons TUJ1 magenta astrocytes\\nGFAP cyan and Microglia CD11b green P2RY12 red and IBA1 magenta with dsDNA\\nstain DAPI Scale bar 50µm\\nB Tile scanned and zstacked immunofluorescence images of control NC Aꞵ oligomer only\\nNC Aꞵ oTau only AD and Aꞵ oligomer and oTau AD Aꞵ APOE4 Masteroids with\\nastrocytes GFAP green microglia IBA1 red and neurons TUJ1 magenta Scale bar \\n100µm\\nC Quantification of astrogliosis by GFAP labeling raw integrated density normalized to\\nMasteroid area\\nD Quantification of microglial activation by IBA1 labeling raw integrated density normalized to\\nMasteroid area\\nE Quantification of neuronal loss by TUJ1 labeling raw integrated density normalized to\\nMasteroid area\\nF Immunofluorescence images of amyloid plaques 6E10 yellow within Masteroids Scale bar\\n 50µm\\nG Quantification of amyloid burden by 6E10 labeling raw integrated density normalized to\\nMasteroid area\\nH Immunofluorescence images of NC and AD Aꞵ APOE4 Masteroids with astrocytes GFAP\\ncyan microglia IBA1 red neurons TUJ1 magenta and oligomeric tau TOMA2 green\\nScale bar 50µm\\nI Quantitation of oligomeric tau labeled by TOMA2 antibody raw integrated density normalized\\nto neuronal area\\nJ Electron microscopy EM image of glial engulfment in an APOE4 AD Aꞵ Masteroid Green\\narrow points to loose chromatin engulfed while the red arrow points to engulfed dystrophic\\nneurites Scale bar 2µm\\nK EM images of neurodegeneration in APOE4 AD left and APOE4 AD Aꞵ right Masteroids\\nRed arrow points to dystrophic neurites and degenerating myelin m depicts deformed and\\nenlarged mitochondria cyan arrows depict lysosomes and magenta arrow points to filament\\nbundles Scale bars 1µm\\nJK n nucleus m mitochondria Error bars indicate 95 standard error of the mean p \\n005 p 001 p 0001 p 00001 Statistical analysis was done using one\\nway ANOVA with Fishers LSD C D E G and Tukeys multiple comparisons test I See also\\nFigures S4 and S5\\nAPOE44 significantly exacerbates AD pathology compared to APOE33\\nHaving determined the impact of AD pathology within genotypes we wanted to examine the\\nimpact of the APOE4 genotype on AD pathology in comparison to the APOE3 isogenic control\\nNotably APOE4 NC Masteroids develop Aβ plaques even in the absence of Aβ oligomer or AD\\noTau challenge which differs from APOE3 Masteroids Figures S5U and S5V In APOE4\\n21\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nMasteroids neuronal loss did not differ significantly between NC and AD oTau conditions\\nwhereas APOE3 AD oTau Masteroids exhibited a significant reduction relative to APOE3 NC\\nFigures 3D and 4E However when directly comparing between the genotypes APOE4\\nMasteroids exhibited significantly more neuronal loss compared to their APOE3 isogenic control\\nwith the most profound difference observed in the basal NC conditions Figures 5A and 5B This\\nsuggested that the lack of significant difference observed across the intermediate APOE4\\nconditions was due to an increase in severity at the basal level of APOE4 rather than a lack of\\nneuronal loss in APOE4 AD oTau Masteroids This is further evidenced by the significant increase\\nin neuronal loss in APOE4 AD oTau and AD Aβ Masteroids when directly compared to their\\nrespective APOE3 counterparts Figure 5B Additionally APOE4 Aβ Masteroids had\\nsignificantly greater Aβ burdens than APOE3 Aβ Masteroids and the plaques in APOE4 Aβ\\nMasteroids were generally larger and denser than those in APOE3 Aβ Masteroids Figures 5A\\nand 5C There was also a remarkable increase in misfolded tau in APOE4 Masteroids compared\\nto APOE3 Masteroids particularly in the NC and NC Aβ conditions Figures 5D and 5E\\nComparison of glial pathology between APOE4 and APOE3 Masteroids revealed that APOE4\\nMasteroids exhibit a more severe pathological baseline In APOE3 Masteroids significant\\nastrogliosis was observed under intermediate conditions and reached its peak in the AD Aβ\\ncondition By contrast in APOE4 Masteroids only the AD Aβ condition showed significantly\\ngreater astrogliosis relative to the APOE4 baseline Figures 3B and 4C This was further\\nsupported by scRNAseq profiling of several top DEGs LFC 3 between APOE3 NC and\\nAPOE4 NC astrocytic clusters Figure 5F APOE4 NC astrocytes showed reduced expression of\\nprotective and amyloidclearance genes NTRK2 C1QL2 GAD2 NMU LRP2 HAP1 and\\nupregulation of genes linked to Aβ accumulation and neuroinflammation CDH23 IFI168894\\nindicating a transcriptomic shift toward a more pathogenic state Figure 5F Notably many of\\nthe top 20 up and downregulated DEGs across major cell types in APOE3 NC versus APOE4 NC\\nMasteroids were linked to AD indicating widespread dysregulation of ADassociated genes driven\\nby the APOE4 genotype alone Figures S6A S6B S6C S6D and S6E84 In APOE3 Masteroids\\nonly the most severe condition combining AD oTau and Aβ oligomers induced significant\\nmicroglial inflammation However all noncontrol APOE4 conditions exhibited significant\\nmicroglial activation with the strongest response observed in the AD Aβ condition Figures 3C\\nand 4D This trend suggests that microglial activation required less pathology in APOE4\\n22\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nMasteroids than in APOE3 Masteroids indicating that APOE4 itself primes the Masteroids for an\\namplified inflammatory response scRNAseq profiling further highlighted genotype and cell\\ntypespecific dysregulation of ADassociated genes PLCG2 expression was elevated at baseline\\nin APOE4 NC and remained higher across all cell types under AD Aβ challenge consistent with\\na primed inflammatory state in APOE4 Masteroids Figure S6F CLU expression also diverged\\nby genotype APOE3 astrocytes and microglia upregulated CLU under AD Aβ whereas APOE4\\nmicroglia downregulated CLU and APOE4 neurons aberrantly increased it indicating a\\ndysregulated Clusterin response in APOE4 Masteroids Figure S6G9596\\nTo further determine the impact of APOE4 in pathologically challenged conditions we\\nnarrowed the scRNAseq analysis to compare between APOE4 AD Aβ and APOE3 AD Aβ which\\nrevealed widespread genotype and cell typespecific dysregulation of ADassociated genes\\nFigures 5G 5H 5I 5J and S6H In excitatory EX_NEU and inhibitory IN_NEU neurons\\nAPOE4 Masteroids showed strong upregulation of APP MAPT PICALM TMEM106B CLU\\nBACE1 and SORT1 while astrocytes ASC and microglia MG exhibited selective increases in\\nMAPT CLU APOE PSEN1 and PLCG2 and oligodendrocytes Oligo showed similar trends\\nfor PICALM MAPT PLCG2 and SORT1 Figures 5K 5L 5M 5N and 5O CellChat network\\nanalysis revealed enhanced neuronalglial interaction probabilities in APOE4 compared to APOE3\\nFigure S6I indicating a more reactive and pathologically engaged cellular network By cross\\nreferencing a scRNAseq atlas of the entorhinal cortex from AD brains our clusterlevel analyses\\nrevealed stronger ADassociated neuronal and microglial signatures in APOE4 AD Aβ Masteroids\\naccompanied by downregulation of protective A2 astrocyte signatures Figures S6J S6K S6L\\nand S6M8297 Collectively these results demonstrate that APOE4 amplifies ADrelevant\\ntranscriptional dysregulation and intercellular network alterations under Aβ and oTauinduced\\nstress producing a more severe genotypedependent pathology APOE4 drives stronger\\nnetworked AD pathology than APOE3 underscoring its central role in genotypedependent\\ndisease progression\\n23\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n24\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 5 APOE44 significantly exacerbates AD pathology compared to APOE33\\nA Immunofluorescence images of amyloid plaques 6E10 yellow within Aβ Masteroid\\nconditions Scale bar 50µm\\nB Quantification of neuronal loss by TUJ1 labeling raw integrated density normalized to\\nMasteroid area\\nC Quantification of Aβ plaques by 6E10 labeling raw integrated density normalized to\\nMasteroid area\\nD Representative images of MC1 in 14µm thin sections of APOE3 and APOE4 Masteroids\\nScale bar 50µm\\nE Quantification of misfolded tau in APOE3 and APOE4 Masteroids by MC1 raw integrated\\ndensity normalized to Masteroid area\\nF Expression of top DEGs LFC 3 of ADassociated genes in APOE3 NC and APOE4 NC\\nastrocytes ASC by scRNAseq Genes are colorcoded as follows downregulated in AD red\\nprotective against AD yellow involved in Aβ clearance green contributing to Aβ burden\\nblue or upregulated in AD purple\\nGJ Red dots indicate genes upregulated in APOE4 and those in blue are downregulated in\\nAPOE4 Log foldchange cutoffs are y 2 and 2 with a p value cutoff of 005 log10P 2\\nG Volcano plot of DEGs between APOE3 AD Aꞵ and APOE4 AD Aꞵ excitatory neurons\\nEX_NEU\\nH Volcano plot of DEGs between APOE3 AD Aꞵ and APOE4 AD Aꞵ inhibitory neurons\\nIN_NEU\\nI Volcano plot of DEGs between APOE3 AD Aꞵ and APOE4 AD Aꞵ astrocytes ASC\\nJ Volcano plot of DEGs between APOE3 AD Aꞵ and APOE4 AD Aꞵ microglia Microglial\\nK Expression of differentially expressed ADassociated genes in APOE3 AD Aβ and APOE4\\nAD Aβ excitatory neurons by scRNA EX_NEU\\nL Expression of differentially expressed ADassociated genes in APOE3 AD Aβ and APOE4\\nAD Aβ inhibitory neurons by scRNA IN_NEU\\nM Expression of differentially expressed ADassociated genes in APOE3 AD Aβ and APOE4\\nAD Aβ astrocytes by scRNA ASC\\nN Expression of differentially expressed ADassociated genes in APOE3 AD Aβ and APOE4\\nAD Aβ microglia by scRNA Microglial\\nO Expression of differentially expressed ADassociated genes in APOE3 AD Aβ and APOE4\\nAD Aβ oligodendrocytes by scRNA Oligo\\nError bars indicate 95 standard error of the mean p 005 p 001 p 0001\\n p 00001 Statistical analysis was done using twoway ANOVA with Fishers LSD B C\\nand E Blue bars are APOE3 conditions burgundy bars are APOE4 conditions See also\\nFigures S4 and S6\\nAPOE4 Aβ oligomers and oTau synergistically activate ADrelated pathways highlighting\\nIGF signaling as a key mediator\\nTo delineate how APOE4 interacts with Aβ and oTau to influence AD pathogenesis we\\n25\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nperformed Cytoscape STRING network analysis of differentially expressed genes DEGs across\\nall major cell types in APOE4 AD Aβ Masteroids relative to APOE3 NC Network analysis\\nrevealed extensive transcriptional reprogramming across cell types Excitatory neurons\\nEX_NEU and inhibitory neurons IN_NEU exhibited dysregulation of translational and\\nribosomal stress metabolic pathways synaptic activity chaperonemediated protein folding and\\ncytoskeletal signaling RHO GTPase in EX_NEU ubiquitination and proteolysis in IN_NEU\\nFigures 6A and 6B Inhibitory neurons IN_NEU showed further dysregulation in neurogenesis\\nand cholesterol biosynthesis Figures 6A Astrocytes ASC showed enrichment for translational\\nand ribosomal stress mitochondrial dysfunction neurodegenerationrelated pathways\\nmetabolism neurogenesis and development cellmatrix interactions and synaptic activity and\\nimmuneinflammatory responses Figures 6C Microglia Microglial exhibited transcriptional\\nchanges in translation immune and inflammatory responses proteolysis migration axon\\nguidance and Wnt signaling Figures 6D9899 Oligodendrocytes Oligo were enriched for\\nribosome and translation transcriptional signaling cell adhesion and synapse formation oxidative\\nphosphorylation and neurodegeneration pathways development and DNA damage responses\\nFigures 6E\\nNext analysis of top differentially expressed transcripts in APOE4 AD Aβ versus APOE3 NC\\nhighlights APOE4s broad impact on multicellular ADrelevant networks with IGFBP2 IGFBP5\\nand IGF1R key components of the IGF signaling pathway among the most significantly altered\\ngenes Figures 6F and S6N Across all cell types DEGs implicated in the IGF signaling axis\\nwere prominently altered suggesting APOE4 modulates neurotrophic and metabolic networks in\\nresponse to Aβ and oTau stress Figures 6G S6O S6P S6Q S6R and S6S100 Collectively\\nthese results demonstrate that APOE4 synergizes with Aβ and oTau to drive widespread cell type\\nspecific transcriptional networks that converge on protein homeostasis synaptic function\\nmetabolism and neuroinflammation reinforcing its central role in exacerbating AD pathology\\n26\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n27\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 6 APOE4 Aβ oligomers and oTau synergistically activate ADrelated pathways\\nhighlighting IGF signaling as a key mediator\\nAE MCL clustering of DEGs between APOE3 NC and APOE4 AD Aβ cell types see Methods\\np 005 with additive gene annotations Genes upregulated in APOE4 AD Aβ are shown in\\nred and those downregulated are shown in blue\\nA Gene interaction network of significant DEGs in inhibitory neurons IN_NEU\\nB Gene interaction network of significant DEGs in excitatory neurons EX_NEU\\nC Gene interaction network of significant DEGs in astrocytes ASC\\nD Gene interaction network of significant DEGs in microglia Microglial\\nE Gene interaction network of significant DEGs in oligodendrocytes Oligo\\nF scRNAseq heatmap of log fold changes of ADassociated genes between APOE3 NC and\\nAPOE4 AD Aβ Genes upregulated in APOE4 AD Aβ are shown in red and those\\ndownregulated are shown in blue\\nG scRNAseq comparison of IGF signaling gene expression in astrocytes ASC excitatory\\nneurons EX_NEU inhibitory neurons IN_NEU microglia Microglial and oligodendrocytes\\nOligo between APOE3 NC and APOE4 AD Aβ Masteroids\\n p 005 p 001 Statistical analysis was done using paired onesided Wilcoxon\\nsignedrank test G See also Figure S6\\nIGFBP inhibitor NBI 31772 ameliorates AD associated neuroinflammation\\nOur scRNAseq data suggested that Insulinlike Growth Factor Binding Proteins IGFBPs\\nand the Insulinlike Growth Factor IGF signaling pathway play a crucial role in the propagation\\nof AD pathology in the Masteroid model Figures 5G 5H 5I 5J S6H 6F and 6G The IGF\\naxis is a complex signaling pathway increasingly implicated in AD pathogenesis100108 IGFBPs\\nparticularly IGFBP2 and IGFBP5 have been shown to modulate IGF availability neuronal\\nsurvival and synaptic function101102109 To test the involvement of IGFBPs and the IGF axis in\\nAD pathological development we treated Masteroids with an IGFBP inhibitor a small molecule\\nnamed NBI 31772 that has been successfully applied in retinal organoids previously109 All eight\\nMasteroid conditions APOE4 oTau Aβ oligomers were treated with NBI 31772 at 05µM\\nfor 4 days to assess the role of IGF signaling in AD pathology Treatment markedly reduced\\nreactive astrogliosis neuronal loss and microglial inflammation in diseased Masteroids Figures\\n7 and S7 In APOE3 NC Aβ Masteroids NBI 31772 decreased astrogliosis but did not restore\\nneuronal loss whereas APOE3 AD oTau Masteroids showed no change in astrogliosis but\\nexhibited increased TUJ1 labeling indicating reduced neuronal loss Figures 7A 7B and 7C In\\nthe severe APOE3 AD Aβ condition NBI 31772 ameliorated both astrogliosis and neuronal loss\\n28\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigures 7B and 7C Similar effects were observed in APOE4 Masteroids treated NC Aβ AD\\noTau and AD Aβ Masteroids all showed significantly less neuronal loss than untreated controls\\nthough improvements in astrogliosis and microglial inflammation were limited to the severe\\nAPOE4 AD Aβ condition with intermediate conditions largely unaffected Figures 7B 7D 7E\\n7F S7A S7B S7C S7D S7E S7G and S7H While more APOE4 conditions showed partial\\nneuronal recovery upon NBI 31772 treatment the effect was more pronounced in APOE3\\nMasteroids Figure 7B This likely reflects the higher baseline neuronal loss in APOE4 NC\\nAPOE4 AD oTau and APOE4 AD Aβ Masteroids where immunolabeling was already\\nsubstantially reduced compared to APOE3 counterparts Figure 5B Nevertheless in all\\nconditions exhibiting neuronal recovery NBI 31772 restored neurons to the baseline levels typical\\nof their respective genotypes indicating that treatment effectively normalized neuronal capacity\\nrelative to the intrinsic genotypespecific baseline Figure 7B\\nSurprisingly despite the pronounced reduction in glial activation and neuronal loss NBI\\n31772 treatment led to an increase in tau phosphorylation and misfolding Figures 7G 7H S7F\\nS7H S7I and S7J Tau misfolding MC1 increased markedly in all APOE3 conditions\\nfollowing treatment whereas only APOE4 NC and NC Aβ Masteroids showed significant\\nincreases Consistent with the less pronounced neuronal recovery the increase in tau misfolding\\nwas less substantial in APOE4 Masteroids compared to APOE3 Masteroids Figures 7G and 7H\\nMoreover NBI 31772 treated APOE4 NC and NC Aβ Masteroids exhibited higher tau\\nhyperphosphorylation at pThr217 in 14µm sections while APOE4 NC and AD Aβ Masteroids\\nshowed increased pSer202 phosphorylation by immunoblot Figures S7F S7H S7I and S7J\\nOverall NBI 31772mediated inhibition of IGFBPs mitigates ADassociated\\nneuroinflammation and neuronal loss across APOE3 and APOE4 Masteroids while paradoxically\\nincreasing tau phosphorylation and misfolding highlighting a complex genotypedependent role\\nof IGF signaling in AD pathology\\n29\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n30\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nFigure 7 IGFBP inhibitor NBI 31772 ameliorates ADassociated neuroinflammation\\nA Immunofluorescence images of APOE3 Masteroids NBI 31772 treatment Neurons TUJ1\\nmagenta astrocytes GFAP cyan and microglia IBA1 red are shown Scale bar 50µm\\nB Quantification of neuronal loss in all conditions by TUJ1 raw integrated density normalized to\\nMasteroid area\\nC Quantification of astrogliosis in APOE3 Masteroids by GFAP raw integrated density\\nnormalized by Masteroid area\\nD Quantification of astrogliosis in APOE4 Masteroids by GFAP raw integrated density\\nnormalized by Masteroid area\\nE Western blot band of IBA1 and corresponding βactin\\nF Quantification of microglial activation in APOE4 Masteroids by IBA1 Western blot raw\\nintegrated density with background subtraction normalized by βactin\\nG DAB images of MC1 in 14µm thin APOE3 and APOE4 Masteroid sections NBI 31772\\ntreatment Scale bar 50µm\\nH Quantification of misfolded tau burden in Masteroids NBI 31772 treatment by MC1 raw\\nintegrated density normalized to Masteroid area\\nError bars indicate 95 standard error of the mean p 005 p 001 p 0001\\n p 00001 Statistical analysis was done using twoway ANOVA with Fishers LSD B C\\nD E and G Bars with stripes represent NBI 31772 treatment See also Figure S7\\nDISCUSSION\\nAlzheimers disease AD is a complex neurodegenerative disorder in which the interplay\\nbetween genetic risk factors and pathological hallmarks such as amyloidbeta Aβ and tau drives\\ndisease progression1110 Modeling these interactions in a humanrelevant system has remained\\nchallenging particularly in the preclinical and prodromal stages of AD Our APOE3 and APOE4\\nMasteroid model provides a robust platform to interrogate both individual components and their\\nsynergistic effects on AD pathology while also enabling functional studies of genotypespecific\\ncontributions and therapeutic interventions\\nConsistent with clinical observations our analysis with the pan ADNI PET scan imaging\\ndataset revealed that APOE4 markedly exacerbates amyloid deposition and tau pathology in\\npreclinical and prodromal stages with severity increasing with allele dosage111 Notably in our\\nMasteroid model APOE4 NC organoids developed Aβ plaques and tau hyperphosphorylation\\neven in the absence of exogenous seeding of Aβ oligomers or oTau highlighting the intrinsic\\npathogenic influence of the APOE4 genotype These findings recapitulate the early genotype\\ndriven disease processes that are nearly impossible to study in living humans By incorporating\\n31\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nexcitatory and inhibitory neurons astrocytes microglia and oligodendrocytes our Masteroid\\nbrain organoid system matures rapidly within five weeks while maintaining functional synapses\\nproper membrane potential action potential propagation and active ligandreceptor interactions\\nThe endogenously generated oligodendrocytes in the Masteroids further provides the potential to\\nstudy myelin dynamics neurodegeneration and other CNS disorders including multiple sclerosis\\nin a versatile and reproducible humanrelevant system112 The functional robustness of our\\nMasteroids is extensively underscored by electrophysiological recordings which demonstrate\\nhealthy wellformed neuronal networks capable of patchclamp analysis This confirms both the\\nbiophysical integrity and the intercellular connectivity necessary for modeling complex AD\\npathology Compared to traditional cerebral organoids or rodent models15282933 our system\\nachieves functional maturity and multilineage composition in a fraction of the time bridging a\\ncritical gap in translational research\\nAt the molecular level scRNAseq reveals that APOE4 significantly amplifies ADassociated\\ntranscriptional programs across neurons and glia By combining oTau and Aβ in our assembloids\\na feature largely absent in previous APOE4 organoid or spheroid models we provide the first\\nsystem capable of dissecting the combined impact of multiple pathological components in a human\\ngenotypespecific context Importantly our data demonstrates that APOE4 not only exacerbates\\nneurodegeneration and glial activation but also modulates critical pathways including the IGF\\nsignaling axis105 highlighting mechanisms that may underlie genotypespecific vulnerability\\nThe utility of this model extends to translational applications Treatment with the IGFBP\\ninhibitor NBI 31772 reduced astrogliosis microglial activation and neuronal loss particularly in\\nAPOE3 Masteroids but paradoxically increased tau phosphorylation and misfolding These results\\nmirror the differential efficacy and resistance observed among specific genotypic populations in\\nhuman clinical trials underscoring the predictive value of the Masteroid system for evaluating\\ngenotypedependent therapeutic responses By capturing both the protective and deleterious effects\\nof interventions our model provides a platform for optimizing drug candidates before clinical\\ntesting\\nOverall the Masteroid system demonstrates remarkable versatility allowing for the study of\\nindividual AD components genotypespecific effects and complex interactions between Aβ tau\\nand APOE4 It faithfully recapitulates key features of human AD including amyloid plaque\\n32\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nformation tau pathology neuroinflammation and neuronal loss while providing a rapid and\\nreproducible platform for mechanistic studies and therapeutic testing By bridging the gap between\\nin vitro and in vivo models Masteroids hold significant promise for advancing our understanding\\nof AD pathogenesis and for accelerating the development of genotypetailored therapies\\nLimitations of the study\\nWhile Masteroids capture key neuronal and glial components and recapitulate AD pathology\\nthey lack full cellular diversity vascularization and longrange brain connectivity\\nElectrophysiological and network properties may not fully reflect the adult human brain and the\\naccelerated in vitro disease timeline may not model slow chronic processes Systemic factors and\\nperipheral immune interactions are absent and therapeutic responses may not fully predict clinical\\noutcomes Despite these limitations Masteroids provide a reproducible manipulable human\\nrelevant platform for studying genotypespecific mechanisms and testing candidate interventions\\nResource availability\\nLead contact\\nFurther information and requests for resources and reagents should be directed to and will be\\nfulfilled by the lead contact Lulu Jiang jiangluluvirginiaedu\\nMaterials availability\\nThis study did not generate new unique reagents\\nData and code availability\\nSingle cell RNAseq data generated in this study will be deposited in the NCBI Gene\\nExpression Omnibus GEO and made publicly available upon publication\\nThis paper used existing R and STRING code packages and does not report original code\\nAny additional information required to reanalyze the data reported in this paper is available from\\nthe lead contact upon request\\nAcknowledgments\\nPostmortem human brain tissues were provided by the Emory University Goizueta\\nAlzheimers Disease Research Center P30 AG066511 We thank Dr Rakez Kayed and his lab\\n33\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nfor their generous support in providing the TOMA2 antibody We also acknowledge the late Dr\\nPeter Davies NorthwellHofstra and the Feinstein Institutes for Medical Research for providing\\nthe CP13 and MC1 antibodies Electron Microscopy sample preparation was performed using the\\nLeica UC7 at the Molecular Electron Microscopy Core supported by the University of Virginia\\nSchool of Medicine RRID SCR_019031 The RNA sequencing was conducted at the Genome\\nAnalysis and Bioinformatics Core at UVA RRIDSCR_018883 We are grateful for the following\\nfunding support to LJ UVA Provost Award UVA Health System Virginia Alzheimers disease\\nCenter 2023 Pitch and Catch funding UVA Brain Institute Transformative Neuroscience Pilot\\nGrant Jim and Bruce Eck Fund Strang Neuroscience Research Award NIHNIA\\nR01AG091577 Commonwealth Health Research Board Award Cure Alzheimers Fund\\nData collection and sharing for Figure 1 of this project was funded by the Alzheimers Disease\\nNeuroimaging Initiative ADNI National Institutes of Health Grant U01 AG024904 and DOD\\nADNI Department of Defense award number W81XWH1220012 ADNI is funded by the\\nNational Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and\\nthrough generous contributions from the following AbbVie Alzheimers Association\\nAlzheimers Drug Discovery Foundation Araclon Biotech BioClinica Inc Biogen Bristol\\nMyers Squibb Company CereSpir Inc Cogstate Eisai Inc Elan Pharmaceuticals Inc Eli Lilly\\nand Company EuroImmun F HoffmannLa Roche Ltd and its affiliated company Genentech\\nInc Fujirebio GE Healthcare IXICO Ltd Janssen Alzheimer Immunotherapy Research \\nDevelopment LLC Johnson Johnson Pharmaceutical Research Development LLC\\nLumosity Lundbeck Merck Co Inc Meso Scale Diagnostics LLC NeuroRx Research\\nNeurotrack Technologies Novartis Pharmaceuticals Corporation Pfizer Inc Piramal Imaging\\nServier Takeda Pharmaceutical Company and Transition Therapeutics The Canadian Institutes\\nof Health Research is providing funds to support ADNI clinical sites in Canada Private sector\\ncontributions are facilitated by the Foundation for the National Institutes of Health\\nwwwfnihorg The grantee organization is the Northern California Institute for Research and\\nEducation and the study is coordinated by the Alzheimers Therapeutic Research Institute at the\\nUniversity of Southern California ADNI data are disseminated by the Laboratory for Neuro\\nImaging at the University of Southern California\\nAuthor contributions\\n34\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nConceptualization LJ\\nInvestigation ES KQ RR AZ AE LJ LS SL HS LI WG KS\\nVisualization ES KQ RR LS HS AZ AE LJ\\nData analysis ES KQ LS SL AZ\\nWriting Editing ES LJ KQ RR LS SL HS AT AZ AE JK JS\\nSupervision LJ\\nDeclaration of interests\\nLJ and ES have filed a patent application related to the technology described in this\\nmanuscript The authors declare no other competing interests\\n35\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nSTAR METHODS\\nKEY RESOURCES TABLE in the supplemental material\\nLEAD CONTACT AND MATERIALS AVAILABILITY\\nFurther information and requests for resources should be directed to and will be fulfilled by\\nthe Lead Contact Lulu Jiang jiangluluvirginiaedu\\nEXPERIMENTAL MODEL AND SUBJECT DETAILS\\nCell Culture\\nCell maintenance\\nAll cell cultures were maintained at 37C with 5 CO2 All cell counts were performed in\\nduplicates using the C100 Automated Cell Counter RWD with trypan blue\\nHuman induced pluripotent stem cells iPSC\\nHuman iPSCs were obtained from Jackson Laboratory JIPSC001150 JIPSC001162 and\\nmaintained as a monolayer culture in StemFlex medium Thermo Fisher Scientific cat\\nA3349401 with 1 PenicillinStreptomycin Thermo Fisher Scientific cat 15070063 on\\nCorning Matrigel hESCqualified Matrix Corning cat 354277 coated tissue culture plates\\n1X RevitaCell Supplement Thermo Fisher Scientific cat A2644501 was added to the\\nmedium when thawing iPSCs were passaged at 80 confluency by Accutase Stemcell\\nTechnologies cat 07920 dissociation as necessary A full media change was performed every\\nother day iPSCs were cryopreserved in CryoStor CS10 Stemcell Technologies cat 07959\\nAll iPSCs used for experimentation were maintained at passage 10\\niPSC neuronal progenitor cell hiNPC\\nHuman iPSCs were passaged and plated at 50000 cellscm2 in STEMdiff SMADi Neural\\nInduction medium Stemcell Technologies cat 08581 with 10µM ROCK inhibitor Y27632\\nStemcell Technologies cat 72304 and 1 PenicillinStreptomycin on Corning Matrigel\\nhESCqualified Matrix coated tissue culture plates hiNPCs were maintained in monoculture and\\npassaged at 90 confluency by Accutase dissociation as necessary A full media change was\\nperformed every other day hiNPCs were cryopreserved STEMdiff Neural Progenitor Freezing\\nMedium Stemcell Technologies cat 05838\\n36\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\niPSC neuronal cell hiNeuron\\nAfter 18 days in STEMdiff SMADi Neural Induction medium hiNPCs were passaged and\\nplated at 50000 cellscm2 in STEMdiff Forebrain Neuron Differentiation Medium Stemcell\\nTechnologies cat 08600 with 10µM ROCK inhibitor Y27632 and 1 PenicillinStreptomycin\\non Corning Matrigel hESCqualified Matrix coated tissue culture plates and transduced with a\\nNEUROG2 lentivirus GeneCopoeia cat CLPHPRM50462LvPF02A00 at MOI 2 to induce\\niPSCderived neuronal cells hiNeurons After 48 hours the cells were again transduced using the\\nsame NEUROG2 lentivirus to ensure complete transduction A full media change was performed\\n24 hours after each transduction\\niPSC astrocytic cell hiAstrocyte\\niPSCderived astrocyte progenitor cells hiAPCs were differentiated from hiNPCs After 19\\ndays in STEMdiff SMADi Neural Induction Medium NPCs were passaged and plated at 50000\\ncellscm2 in STEMdiff Astrocyte Differentiation Medium Stemcell Technologies cat 100\\n0013 with 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated\\ntissue culture plates A full media change was performed daily for 5 days then every other day for\\n15 days passaging as needed with Accutase dissociation The differentiated hiAPCs were\\ncryopreserved in CryoStor CS10 At the time of experimentation hiAPCs were thawed in\\nSTEMdiff Astrocyte Maturation Medium Stemcell Technologies cat 1000016 with 1\\nPenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture\\nplates A full media change was performed every other day for 5 days with one passage by\\nAccutase at 90 confluency as necessary\\niPSC hematopoietic progenitor cell hiHPC\\niPSC derived hematopoietic progenitor cells hiHPCs were differentiated from iPSCs\\nHuman iPSCs were plated in StemFlex medium with 1 PenicillinStreptomycin as small\\naggregates on Corning Matrigel hESCqualified Matrix coated tissue culture plates The next\\nday the StemFlex medium was removed and replaced with STEMdiff Hematopoietic Basal\\nMedium containing Supplement A Stemcell Technologies cat 05310 and 1 Penicillin\\nStreptomycin After two days a half media change was performed The following day considered\\nday 3 the medium was changed to STEMdiff Hematopoietic Basal Medium containing\\nSupplement B and 1 PenicillinStreptomycin A half media change was performed on days 5 7\\n37\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nand 10 hiHPCs were harvested at day 12 and either directly differentiated into microglia or\\ncryopreserved in CryoStor CS10\\niPSC microglial cell hiMicroglia\\niPSC derived microglia hiMicroglia were derived from hiHPCs hiHPCs were plated in\\nSTEMdiff Microglia Differentiation Medium Stemcell Technologies cat 1000019 and 1\\nPenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture\\nplates 1mL of medium was added every 23 days After 12 days the cell suspension was collected\\nand replated in the same medium After 24 days in differentiation medium the hiMicroglia were\\ncryopreserved in CryoStor CS10 Four days prior to experimentation hiMicroglia were thawed\\nin STEMdiff Microglia Maturation Medium Stemcell Technologies cat 1000020 with 1\\nPenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture\\nplates 1mL of medium was added every other day\\nMasterioid generation and maintenance\\nA single cell suspension of hiNeurons and hiAstrocytes was prepared by Accutase\\ndissociation and washed once with DMEMF12 Stemcell Technologies cat 36254 to remove\\ndebris as described before37 A single cell suspension of hiMicroglia was prepared by collecting\\nthe floating cells and washing once with DMEMF12 hiNeurons hiAstrocytes and hiMicroglia\\nwere combined in a 454510 ratio in Masteroid medium DMEMF12 Stemcell Technologies\\ncat 36254 1 Glutamax Thermo Fisher Scientific cat 35050061 1 sodium pyruvate\\nThermo Fisher Scientific cat 11360070 1 N2 Supplement Thermo Fisher Scientific cat\\n17502048 1 B27 Supplement Thermo Fisher Scientific 17504044 10µM Y276321\\nPenicillinStreptomycin 1mgmL Heparin SigmaAldrich cat H3149250KU and 10\\nSTEMdiff Microglia Maturation Medium passed through a 40µm cell strainer and plated at\\n2000 cellsmicrowell in AggreWell800 microwells Stemcell Technologies cat 34815 coated\\nin AntiAdherence Rinsing Solution Stemcell Technologies cat 07010 The Aggrewell plate\\nwas immediately centrifuged at 100g for 3 minutes to capture the cells in the microwells and\\nincubated for 24 hours A halfmedia change was performed at 24 hours and then every other day\\nfor 1 week At 1 week when the spheroids displayed a smooth bright edge under the cell culture\\nmicroscope cultures were transferred to ultralowattachment roundbottom 96well plates\\n38\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nThermo Fisher Scientific cat 174929 and maintained in 200µL Masteroid media rotating at\\n65rpm\\nFor the generation of Masteroids with AD oTau seeding hiNeurons were exposed to 40ngmL\\noTau fraction extracted from postmortem AD brain tissues or agematched normal control by\\ndirect admission into cell culture media for 24 hours prior to their incorporation into Masteroid\\nThe concentration of oTau fraction to be added into the iNeurons was determined by doseresponse\\ntest For the Masteroids with Aβ oligomers conditions Masteroids were exposed to 05µM Aꞵ\\noligomers or vehicle control DMSO after 1 week when the Masteroids were transferred to 96\\nwell plates Anaspec cat AS6412905 The dose of Aβ oligomers were determined by a dose\\nresponse test in hiNeurons and hiAstrocyte\\nFor NBI 31772 treatment Masteroids were exposed to 05µM of NBI 31772\\nMedChemExpress cat HY110135 or vehicle control DMSO at 5 days before collection Half\\nmedia change was performed daily with 1µM NBI 31772 to maintain the 05µM concentration\\n2D neuron and glial culture treatment\\nAt the time point of creating the Masteroids individual cultures of hiNeurons hiAstrocytes\\nand hiMicroglia were passaged and plated in Masteroid media onto Corning Matrigel hESC\\nqualified Matrix coated tissue culture 8 well chambers Half media changes were performed every\\nother day\\nOligomer processing\\nGeneration of S1p oTau fraction\\nThe anonymous postmortem human brain tissues used in this study were sourced from the\\nbrain bank of the Emory Goizueta Alzheimers Disease Research Center ADRC funded by NIH\\nP30AG066511 All fresh frozen tissue samples 8 agematched control and 8 AD were de\\nidentified and obtained from the human prefrontal cortex tissues Brodmann Area 10 within the\\nsame patient cohort These brain regions were selected due to their consistent availability in the\\nbrain bank and previous research indicating high positive correlations between altered gene\\nexpression and disease severity measures regardless of the classification scheme for disease\\nseverity113 The generation of S1p oTau fractions was consistent with previous publications6870 In\\nbrief frozen sections were weighed 100250mg and put into polycarbonate thick wall 15mL\\n39\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\ntubes Beckman Coulter cat 357448 A 10x volume of homogenization buffer Hsaio TBS buffer\\n50mM Tris pH 80 274mM NaCl 5mM KCl supplemented with cOmplete Protease Inhibitor\\nCocktail Roche cat 05892791001 and the phosphatase inhibitor cocktail PhosSTOP Roche\\ncat 04906837001 was used to homogenize brain tissue The homogenate was centrifuged at\\n29800 x g for 20 minutes at 4C The supernatant was then centrifuged a second time at 150000\\nx g at 4C for 40 minutes The TBSextractable pellet S1p fraction was resuspended with 50uL\\nTE buffer 10mM Tris pH 80 1mM EDTA 5mM KCl supplemented with cOmplete Protease\\nInhibitor Cocktail and PhosSTOP relative to the starting weight of the tissue homogenized\\naliquoted and frozen at 80C Tau oligomerization was confirmed through running a western blot\\nand visualizing total misfolded and oligomerized tau with AntiTau Antibody clone Tau5\\nMillipore Sigma cat MAB361 and PhosphoTau Thr217 Polyclonal Antibody Thermo\\nFisher Scientific cat 44744\\nThe human brain tissue samples used in this study were all deidentified All studies included\\nboth sexes and results were integrated by covariate analysis as described below\\nPrimary\\nNeuropathologic Braak Age at Age at Duration\\nDiagnosis Stage Onset DeathBx years APOE Race Sex\\nAlzheimers disease AD VI 49 59 10 E33 w m\\nAD VI 59 69 10 E34 w m\\nAD VI 53 71 18 E34 w m\\nAD VI 65 80 15 E34 b f\\nAD V 77 83 6 NA w f\\nAD V 86 92 6 E34 w f\\nAD V 82 92 10 E33 w m\\nAD VI 80 93 13 E34 w f\\nNormal Control NC I NA 59 NA E23 b m\\nNC I NA 70 NA E33 b m\\nNC I NA 72 NA E33 w m\\nNC II NA 78 NA E33 w f\\nNC IV NA 84 NA E23 b f\\nNC III NA 91 NA E33 w f\\nNC III NA 92 NA E33 w f\\nNC II NA 94 NA E33 w m\\nPreparation of Aꞵ oligomers\\n40\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n05mg of human betaAmyloid 142 Anaspec cat AS6412905 was dissolved in 50µL of\\nfiltered DMSO then transferred to a 15mL Protein LoBind Eppendorf tube Eppendorf cat 022\\n431081 The dissolved Aβ was sonicated at a high power 550 Sonic Dismembrator machine\\noutput power 550W output frequency 20KHz on ice for 2 minutes then resuspended with 60µL\\nof neurobasal medium Thermo Fisher Scientific cat 21103049 for a final concentration of\\n1mM The resuspension was rotated at 4C for 24 hours to promote oligomerization\\nOligomerization was confirmed through running a nativepage gel and visualizing with Purified\\nantiβAmyloid 116 Antibody BioLegend cat 803001 Aꞵ oligomers were aliquoted and\\nstored at 80C\\nSample collection\\nMasteroid fixation for immunofluorescence\\nAt the time of collection Masteroids were transferred to a 15mL Protein LoBind Eppendorf\\ntube Eppendorf cat 022431081 and allowed to settle The supernatant was discarded and the\\nMasteroids were fixed in 4 PFA in 1x PBS for 15 minutes After fixation Masteroids were\\nwashed 3 times for 10 minutes each in 1x PBS Samples were stored in 1x PBS at 4C\\nMasteroid fixation for electron microscopy\\nAt the time of collection Masteriods were transferred to a 15mL tube and allowed to settle\\nThe supernatant was discarded and the Masteroids were fixed with 4 PFA and 25\\nglutaraldehyde Electron microscopy sciences cat 16316 in 1x PBS for 20 minutes After\\nfixation Masteroids were washed 2 times for 10 minutes each in 1x PBS Samples were stored in\\n4 PFA in 1x PBS at 4C\\n2D individual culture fixation for immunofluorescence\\nAfter 1 week in culture the individual cell types were washed once with 1x PBS then fixed in\\n4 PFA in 1x PBS for 15 minutes After fixation chambers were washed 3 times for 10 minutes\\neach in 1x PBS Samples were stored in 1x PBS at 4C\\nProtein lysate\\nAt the time of collection 16 pooled Masteroids per condition were transferred to a 15mL\\nProtein LoBind Eppendorf tube and allowed to settle The supernatant was discarded and the\\nMasteroids were washed once with PBS The PBS was discarded and the samples were flash\\n41\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nfrozen and stored at 80C Samples were subsequently lysed by mechanical homogenization in\\n40µL of Hsiao TBS buffer 50mM Tris pH 80 274mM NaCl 5mM KCl supplemented with\\ncOmplete Protease Inhibitor Cocktail Roche cat 05892791001 and the phosphatase inhibitor\\ncocktail PhosSTOP Roche cat 04906837001 200U of Benzonase SigmaAldrich cat\\nE101425KU with 1mM MgCl2 was added for removal of nucleic acids Lysate concentration\\nwas quantified by the Pierce BCA assay according to the manufacturers protocol Thermo Fisher\\nScientific cat 23225\\n14µm thin sectioning of Masteroids\\nMasteroids were pooled per condition and fixed in a freshly prepared solution of 4\\nparaformaldehyde and 01 glutaraldehyde in PBS for 5 minutes at room temperature After\\nfixation samples were washed three times in PBS for 10 minutes each A thin layer of a 3 agar\\nsolution maintained at 55C was poured into a 35mm petri dish Masteroids were carefully\\ntransferred to the petri dish and positioned on the same layer no more than 1cm apart and\\nadditional 3 agar solution was used to fully embed the Masteroids then cooled for 15 minutes to\\nsolidify The block containing the Masteroids was separated using a razor blade then carefully\\nextracted with a spatula To prevent freezing artifacts during cryosectioning Masteroids were\\nequilibrated in 30 sucrose for 24 hours at 4C Embedded samples were sectioned at 14µm\\nthickness using a lowprofile blade in a cryochamber at 30C and collected onto positively\\ncharged glass slides Slides with Masteroid sections were stored at 4C\\nConditioned media collection\\n60µL of conditioned cell culture media from replicate Masteroid wells were collected in flat\\nbottomed 96well plates and frozen at 20C\\nSample processing\\nImmunofluorescence labeling\\nSelected Masteroids from each condition were washed in 150µL PBS for 10 minutes in a U\\nbottom 96well plate and then permeabilized in 150µL PBS025 Triton X100 PBST for 30\\nminutes The Masteroids were blocked with 150µL PBST with 5 Bovine Serum Albumin BSA\\nand 5 Normal Goat Serum NGS for 1 hour at room temperature RT After blocking the\\nMasteroids were incubated in primary antibodies diluted in 5 BSA in PBST overnight at 4C\\n42\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nPlates were wrapped with parafilm and photobleached by an LED lamp The following day the\\nMasteroids were washed 3 times with PBST for 10 minutes each before being incubated in\\nsecondary antibodies diluted 11000 of Alexaconjugated antibodies made from goat purchased\\nfrom Thermo Fisher Scientific in PBST with 5 BSA for two hours The Masteroids were\\nprotected from light and washed 3 times with PBST for 10 minutes each followed by one 10\\nminute wash with PBS For Masteroids stained with DAPI Nucleic Acid Stain Thermo Fisher\\nScientific cat 62248 15000 of 1mgmL stock was diluted in PBST and incubated with\\nasteroids for 15 minutes followed by 2 washes with PBST then 1 with PBS 10 minutes each\\nMasteroids were then mounted onto microscope glass slides in Prolong Gold Antifade Mountant\\nThermo Fisher Scientific cat P36934 and protected from light All washing and incubated steps\\nwere done with agitation Primary antibodies used for Masteroid immunofluorescent labeling were\\nas follows Tuj1Anti BetaTubulin 3 Antibody chicken Aves Labs cat TUJ 1500 GFAP\\nMonoclonal Antibody rat Thermo Fisher Scientific cat 130300 1500 Anti Iba1 rabbit\\nFUJIFILM Wako Pure Chemical Corporation cat 01919741 1300 Anti Iba1 goat FUJIFILM\\nWako Pure Chemical Corporation cat 01127991 1300 Monoclonal antiTOMA2 mouse\\nprovided by Dr Rakez Kayed 1500 Myelin Basic Protein rabbit Cell Signaling Technology\\ncat 78896 1500 6E10Purified antiβAmyloid 116 Antibody mouse BioLegend cat\\n803001 1500 CD11b Antibody clone 5C6 rat BioRad cat MCA711G 1300 AntiP2Y12\\nAntibody rabbit Abcam cat ab300141 1500 and AntiMicrotubuleAssociated Protein\\nAntibody chicken Antibodies Incorporated cat MAP 1500 Secondary antibodies used for\\nMasteroid immunofluorescent labeling were as follows Goat antiRat IgG HL Alexa Fluor\\n405 Thermo Fisher Scientific cat A48261 Goat antiRat IgG HL Alexa Fluor 488 Thermo\\nFisher Scientific cat A11006 Goat antiRabbit IgG HL Alexa Fluor 488 Thermo Fisher\\nScientific cat A11008 Goat antiRabbit IgG HL Alexa Fluor 594 Thermo Fisher Scientific\\ncat A11012 Goat antiMouse IgG HL Alexa Fluor 405 Thermo Fisher Scientific cat\\nA48255 Goat antiMouse IgG HL Alexa Fluor 488 Thermo Fisher Scientific cat A28175\\nDonkey antiGoat IgG HL Alexa Fluor 647 Thermo Fisher Scientific cat A21447 and Goat\\nantiChicken IgG HL Alexa Fluor 647 Thermo Fisher Scientific cat A32933 More details\\nare available from the Key Research Table in the supplemental materials\\nImmunofluorescence staining of 14µm thin sections of Masteroids\\n43\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nMasteroids were sliced and collected onto slides as described in the 14µm thin sectioning of\\nMasteroids protocol Sections were outlined with a hydrophobic barrier using a PAP pen and air\\ndried before staining Immunofluorescence staining was performed as described in the\\nImmunofluorescence Staining protocol with the modification of using 01 Triton X100 in\\nPBS instead of 025\\nImmunohistochemistry single stain with DAB 33diaminobenzidine of 14µm thin sections of\\nMasteroids\\nMasteroids were sliced and collected onto slides as described in the 14µm thin sectioning of\\nMasteroids protocol All subsequent steps were performed at room temperature unless otherwise\\nspecified Sections were outlined with a hydrophobic barrier using a PAP pen and airdried before\\nstaining Sections were washed in PBS for 10 minutes then treated with 1 H O diluted in dH2O\\n2 2\\nfor 15 minutes Sections were rinsed twice in PBS for 15 minutes each then blocked with 04\\nTriton X100 with 1 BSA and 4 NGS in PBS for 30 minutes After blocking sections were\\nincubated overnight in 1 antibody diluted in DAKO antibody diluent 5 BSA in 025 TritonX\\n100PBS at 4C with photobleaching The following day sections were rinsed twice in PBS for\\n15 minutes then incubated for one hour in BTA solution 044 Biotinylated goat antirabbit \\nmouse depending on 1 antibody IgG diluted in 03 Triton X100PBS Sections were rinsed\\ntwice in PBS then treated with Avidin Biotin Complex ABC 088 Avidin 088 Biotin\\ndiluted in 03 Triton X100PBS prepared 30 minutes prior to use Vector Laboratories cat\\nPK6101 After ABC incubation sections were washed three times in PBS for 10 minutes each\\nDAB solution was prepared by adding 1 tablet DAB Millipore Sigma cat D42935SET and 1\\ntablet Urea SigmaAldrich cat D4193 to 5mL dH O and vortexed until fully dissolved DAB\\n2\\nsolution was added to sections individually for one to three minutes until section turned medium\\nbrown in color then were immediately placed in PBS Sections were washed twice with PBS for\\nfive minutes each then dried overnight at 37C The following day sections were dehydrated by\\nwashing in 70 EtOH 85 EtOH 95 EtOH and 100 EtOH for two minutes each followed\\nby washing in 100 EtOH for five minutes Slides were then cleared by washing twice in Xylene\\nfor five minutes followed by immediately dropping 50µL of Permount Mounting Medium\\nThermo Fisher Scientific cat SP15500 and covering with glass coverslips Slides were dried\\novernight in the fume hood and stored at 4C for long term storage All washing and incubated\\nsteps were done with agitation Primary antibodies used for Masteroid DAB labeling were as\\n44\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nfollows MC1 mouse Dr Peter Davies and the Feinstein Institutes for Medical Research 1300\\nand PhosphoTau Thr217 Polyclonal Antibody rabbit Thermo Fisher Scientific cat 44744\\n1500 Secondary antibodies used for Masteroid DAB labeling were as follows Goat antiRabbit\\nIgG Antibody HL Biotinylated Vector Laboratories cat BA1000 and Goat antiMouse IgG\\nAntibody HL Biotinylated Vector Laboratories cat BA9200 More details are available\\nfrom the Key Research Table in the supplemental materials\\nElectron microscopy\\nThe protocol for sample preparation is consistent with previous publications114 In brief\\nResin embedding for electron microscopy followed standard protocols Masteroids fixed with 4\\nPFA and 25 glutaraldehyde EMS cat 16316 were transferred to Beem Capsules EMS cat\\n70010B in 01M phosphate buffer PB and allowed to settle All subsequent steps were carried\\nout in the same Beem Capsules About half of the buffer was removed and replaced with 1\\nosmium tetroxide in 01M PB then once the Masteroids were visible all the buffer was removed\\nand replaced with the 1 osmium tetroxide solution for one hour The Masteroids were then\\ntransferred into 50 EM grade ethanol EMS cat 15055 for three minutes and counterstained\\nwith filtered 4 uranyl acetate in 70 ethanol overnight in the refrigerator The sections were\\ndehydrated through a series of ethanol and EM grade acetone EMS cat 10015 solutions and\\ninfiltrated with a 11 ratio of EPON EMbed 812 resin EMS cat 14121 and acetone overnight\\nThey were then transferred to 100 EPON resin overnight Capsules were then placed in a 60C\\noven for 48 hours until hardened the resin block is removed from the capsules the block face was\\ntrimmed to 1x2mm that contains multiple Masteroids and then cut into ultrathin 6070nm\\nsections using an ultramicrotome Leica Ultracut UCT7 The ultrathin sections were collected on\\n200 mesh copper grids EMS cat Cu G200TTCu and slot copper grids EMS cat FCF2010\\nCu50 in ultrapure water and allowed to dry before imaging\\nImmunoblot Western blot\\n10µg of Masteroid lysate was separated by denaturing gel electrophoresis SDSpage and\\ntransferred onto a nitrocellulose membrane The membrane was blocked for an hour in 5 non\\nfat milk in 01 Tween20 in 1x PBS PBST and incubated in primary antibody dilution\\nantibody dependent in 5 BSA PBST overnight at 4C The following day the membrane was\\nwashed with PBST for 3 times for 10 minutes each then incubated with secondary antibody\\n45\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n15000 conjugated with horseradish peroxidase Thermo Fisher Scientific cat G21040 cat\\nA16054 cat G21234 cat A16054 in 5 BSA PBST for 2 hours at RT The membrane was\\nwashed with PBST 3 times for 10 minutes before briefly being washed with PBS prior to\\nvisualization Antibody staining was visualized using SuperSignal West Pico PLUS\\nChemiluminescent Substrate Thermo Fisher Scientific cat 34578 and imaged by ChemiDoc\\nImaging System BioRad For reprobing membranes were incubated in Restore PLUS\\nWestern Blot Stripping Buffer Thermo Fisher Scientific cat 46430 for 15 minutes at RT Band\\nintensities were quantified using ImageJ Protein abundance was normalized to total Beta Actin\\nwith background subtraction Primary antibodies used for immunoblotting were as follows IBA1\\nPolyclonal Antibody rabbit Proteintech cat 109041AP 11000 GFAP Monoclonal Antibody\\nrat Thermo Fisher Scientific cat 130300 11000 6E10Purified antiβAmyloid 116\\nAntibody mouse BioLegend cat SIG39320 11000 Beta Actin Monoclonal Antibody\\nmouse Proteintech cat 660091Ig 12000 NeuN Polyclonal Antibody rabbit Thermo Fisher\\nScientific cat PA578499 11000 and CP13 mouse Dr Peter Davies and the Feinstein\\nInstitutes for Medical Research 11000 Secondary antibodies used for immunoblotting were as\\nfollows Goat antiRabbit IgG HL HRP Thermo Fisher Scientific cat G21234 12000 Goat\\nantiMouse IgG HL HRP Thermo Fisher Scientific cat G21040 12000 and Goat antiRat\\nIgG HL HRP Thermo Fisher Scientific cat A18865 12000 More details are available from\\nthe Key Research Table in the supplemental materials\\nLDH cytotoxicity assay\\nThe CyQUANT LDH Cytotoxicity Assay was performed as per manufacturers instructions\\nusing 50µL conditioned media replicates to measure lactate dehydrogenase LDH release\\nThermo Fisher Scientific cat C20301 The assay 490nm and 680nm absorbance readings were\\ntaken on an Epoch microplate spectrophotometer BioTek\\nSinglecell RNAsequencing sample preparation\\nThe protocol for Singlecell RNAsequencing sample preparation was consistent from our\\nprevious publication37 In brief for each condition 30 Masteroids were pooled in a 15mL Protein\\nLoBind Eppendorf tube and allowed to settle The supernatant was discarded and a singlecell\\nsuspension was produced by incubation in 500µL of digestion buffer Accutase with 80 UmL\\nProtector RNase Inhibitor Sigma Aldrich cat 3335399001 for 1 hour at 37C with gentle\\n46\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\npipette mixing every 10 minutes At the end of the incubation the singlecell suspension was\\nwashed with 500μL wash buffer 002 BSA in 1X PBS with 80 UmL Protector RNase Inhibitor\\nand passed through a 20μM filter Miltenyi Biotec cat 130101812 to a fresh 2mL Protein\\nLoBind Eppendorf After another centrifugation the supernatant was discarded and the single\\ncell pellet gently resuspended in 50μL of wash buffer Cells were counted in triplicate on the\\nNexcelom Cellometer Auto 2000 with trypan blue and processed through the singlecell RNA\\nsequencing pipeline from 10X Genomics 3 Version 3 10X Genomic Chromium\\nSinglecell RNAsequencing library preparation and sequencing\\nThe singlecell RNA library preparation and sequencing was done by the University of\\nVirginia School of Medicines Genome Analysis and Technology Core GATC\\nRRIDSCR_018883 cDNA library creation RNA samples were processed for singlecell\\nsequencing according to manufacturers instructions using the kit according to validated standard\\noperating procedures established by the GATC cDNA quality assessment cDNA quality was\\nassessed by the MiSeq Reagent Nano Kit v2 Illumina cat MS1022001 Singlecell libraries\\nwere sequenced using a p4100 kit Chromium Next GEM Single Cell 3 GEM Library Gel\\nBead Kit v31 16 rxns Illumina cat PN1000121 on the NextSeq2000 Sequencing System\\nIllumina\\nWholecell recording of Masteroids\\nNeuronal activity in whole neuronglial brain assembloid was recorded using a wholecell\\npatch clamp technique as described previously115 Wholecell patchclamp recordings were\\nperformed under infrared differential interference contrast microscopy Olympus a 40 water\\nimmersion objective was used to visually identify neurons in the brain assembloid The Masteroids\\nwere continuously perfused with ACSF solution that was saturated with 95 O2 and 5 CO2 at\\nroom temperature Patch electrodes final resistances 35 MΩ were pulled from borosilicate glass\\nSutter Instruments Novato CA USA on a horizontal FlamingBrown microelectrode puller\\nModel P97 Sutter Instruments For voltageclamp recordings the electrode tips were filled with\\na filtered internal recording solution that consisted of the following components in mM 100 Cs\\ngluconate 10 Hepes 06 EGTA 4 MgATP and 03 NaGTP 5 QX314 the pH was 73 with\\nCsOH and the osmolarity was 310 mosmol l1 For currentclamp recording the pipette solution\\ncontained the following in mm 135 potassium gluconate 25 NaCl 10 Hepes 05 EGTA 40\\n47\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nMgATP 04 NaGTP 01 CaCl2 the pH was 73 and the osmolarity was 310 mosmol l1\\nNeurons were voltage clamped at 60mV using a PC505B amplifier Warner Instruments\\nHamden CT USA Electrode capacitance was electronically compensated Access resistance was\\ncontinuously monitored and if the series resistance increased by 20 at any time the recording\\nwas terminated Currents were filtered at 2 kHz digitized using a Digidata 1322 digitizer\\nMolecular Devices Sunnyvale CA USA and acquired using Clampex 102 software Molecular\\nDevices Spontaneous excitatory postsynaptic currents sEPSCs were recorded from neurons\\nafter blocking the GABA\\nA\\nreceptors with the antagonist picrotoxin 50μm\\nQuantification and statistical analysis\\nFluorescent image analysis\\nFluorescent images were captured by STELLARIS 5 Confocal Microscope Leica\\nMicrosystems Stellaris 5 and LP8 Confocal Microscope Leica Microsystems SP8 using LAS\\nX Life Science Microscope Software Platform Leica Microsystems The staining intensities in\\nimmunofluorescencelabeled Masteroids were measured by ImageJ116\\nBrightfield image analysis\\nBrightfield images DAB were captured by Keyence BZX810 Microscope Keyence BZ\\nX810 using BZX800 Viewer Software Keyence The staining intensities in DABlabelled\\nMasteroids were measured by ImageJ116\\nElectron microscopy analysis\\nElectron microscopy EM images were captured on a JEOL 1010 EM with a 16megapixel\\nCCD camera SIA at magnifications ranging from 4kx to 20kx yielding nmpixel resolution\\nAdobe Photoshop was used to balance and annotate EM images Crosssections of dendrites were\\nidentified by the presence of microtubules and lack of neurotransmitter vesicles Axon terminals\\nmay display presynaptic zones and contain vesicles Glial and neuronal cells were identified based\\non established accepted criteria6165117118\\nSchematics\\nSchematics were created with BioRendercom\\nData analysis\\n48\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nStatistical analysis\\nStatistical analyses and figures artwork were performed using GraphPad Prism version 1000\\nfor Windows Pairwise data was compared using onetailed Wilcoxon matchedpairs signed rank\\ntest All group data are expressed as mean SEM Column means were compared using oneway\\nANOVA with treatment as the independent variable Group means were compared using twoway\\nANOVA using factors of genotype and fraction treatment respectively When ANOVA showed a\\nsignificant difference pairwise comparisons between group means were examined by Tukeys\\nDunnett or uncorrected Fishers LSD multiple comparison test Significance was defined when p\\n 005 Gene networks were visualized using the Cytoscape StringApp 220 STRING protein\\nquery through Cytoscape 3103\\nSinglecell RNAsequencing analysis\\nCellRanger pipeline\\nCellRanger version 310 10X Genomics was used to combine and process the raw Illumina\\nNextSeq 500 RNA and NOVAseq sequencing files First each sequencing library was\\ndemultiplexed by sample index to generate FASTQ files for pairedend reads using the CellRanger\\nmkfastq pipeline FASTQ files were then passed to the CellRanger count pipeline which used\\nSTAR aligner version 2 to align reads to the human reference genome GRCh38119 Genecell\\nbarcode matrices of each sample were further processed in R version 403\\nSeurat object filtration\\nDatasets were loaded into Seurat v503 for filtering normalization and data scaling120 Cells\\ncontaining fewer than 2000 and greater than 20000 RNA counts and greater than 25\\nmitochondrial RNA were filtered out using Seurats subset function Datasets were processed\\nusing SCTransform and integrated using Seurats CCA integration121 Clusters were determined\\nfrom the uniform manifold approximation and projection UMAP dimensional reduction graph\\nvia SLM algorithm using Seurats native FindClusters function at 15 resolution122\\nCluster celltype identification\\nIdentities of each cluster were labeled manually using the APOE3 NC condition through\\nvarious methods including comparing cluster marker genes to known human neuronalglial cell\\ntypes scoring each cluster enrichment of marker genes from our previous singlecell organoid\\n49\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\ndatasets using AddModuleScore37123 Clusters otherwise not found in APOE3 NC were matched\\nto the nearest normal cluster by querying the dataset containing all clusters to the annotated\\nAPOE3 NConly dataset Significantly upregulated genes in disease conditions were obtained\\nusing Wilcoxon rankedsum testing\\nDifferential expression analysis\\nDifferential expression analysis was performed within each cell type between different\\nconditions using the Wilcoxon ranksum test implemented in Seurat with a minpct of 01 a\\nlogfcthreshold of 025 and a pseudocount of 1 default A multiplecomparison correction was\\nperformed using the Benjamin Hochberg FDR method to produce an adjusted p value124\\nDifferentially expressed genes were evaluated according to their log fold change greater than\\nlog225 and adjusted p values 005\\nFunctional enrichment analysis\\nFunctional enrichment analysis of the significantly differentially expressed genes between\\ndifferent conditions was performed using the R implemented GProfiler version 023125 The\\nenrichment analysis was run as an ordered query ordered by log2FC using an α threshold of 005\\nand using Benjamin Hochberg FDR for multiple testing correction124 Only genes in the Seurat\\ndataset were considered by using a custom domain scope A custom source GMT\\ngp__zSEF_sD9Q_d1M was used It includes all Hallmark gene sets curated gene sets and\\nontology gene sets from the Molecular Signatures Database MsigDB v72126127\\nGene set enrichment analysis\\nTo generate NES scoresassess pathwaylevel changes in gene expression across conditions\\nwe performed GSEA within each cell type cluster and condition comparison126 DE analysis was\\nconducted as previously described and all expressed genes were ranked by average log fold\\nchange between the two conditions This ranked list was used as input to the fgseaMultiLevel\\nfunction from the fgsea R package which implements an adaptive multilevel approach for\\nimproved accuracy in estimating enrichment p values We used the same custom MSigDB gene\\nset collection as previously described filtered to include only gene sets with at least one gene\\nexpressed in the given cluster The analysis output included normalized enrichment scores and\\nadjusted p values for each pathway\\n50\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nCellChat analysis\\nTo infer intercellular signaling networks we used CellChat R package version 220 to analyze\\nligandreceptor mediated communication between cell types57 For each condition we subsetted\\nthe Seurat object to include only cells from the selected condition and 5 major cell types CellChat\\nobjects for each condition were then initialized using the RNA assay and grouped by cell type\\nidentity The secreted signaling subset of the human CellChatDB was used for this analysis The\\ngeneral CellChat pipeline included SubsetDatta to retain only signalingrelated genes\\nidentifyOverExpressedGenes and identifyOverExpressedInteractions to identify potential ligands\\nand receptors computeCommunProb to infer the probability of communication between cell types\\ncomputeCommunProbPathway to summarize interactions at the signaling pathway level\\naggregateNet to construct a global signaling network for each condition We extracted both\\ncounts total number of significant ligandreceptor interactions between each senderreceiver cell\\ntype pair and weights summed communication probabilities representing strength of signaling\\nbetween cell pairs Circle plots were generated for visualization of count and weights\\nCytoscape analysis\\nA STRING network of the significant p value 005 differentially expressed genes DEGs\\nin a given cell cluster was created using the Cytoscape StringApp 220 STRING protein query\\nthrough Cytoscape 3103128129 The network was then clustered by Markov clustering MCL with\\na granularity inflation of 4 to create gene nodes using clusterMaker2130 Functional enrichment\\nwas run on individual nodes using STRING enrichment to determine the enriched pathways and\\nnodes that were associated with similar pathways were grouped together For visualization manual\\nannotations were assigned based on the most abundant or relevant pathways per node The color\\ngradient was applied using Continuous Mapping with the log2FC value of each gene The most\\nenriched 610 clusters were presented in the figure\\nPET analysis\\nTau PET analysis\\nT1weighted T1w MRI and 18Fflortaucipir AV1451 PET images were downloaded from\\nthe ADNI repository For T1w images crosssectional image processing\\nwas performed using FreeSurfer version 7131134 Six fiveminute frames were acquired 75 to 105\\n51\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nminutes postinjection Individual frames were extracted from the image files and coregistered to\\nthe first extracted frame of the raw image file The base frame and coregistered frames were\\nrecombined into a dynamic image set The images were further processed using PETSurfer131132\\nutilizing segmentation results from FreeSurfer We applied partial volume correction PVC with\\na 6mm extent using geometric transfer matrix GTM methods After segmentation and\\nregistration PETSurfer calculates SUVR using the pons as the reference region Average SUVR\\nmeasures were calculated using the DKT135136 and ASAG137 atlases for cortical and subcortical\\nROIs\\nAmyloid PET analysis\\nPreprocessed ¹⁸Fflorbetapir AV45 amyloid PET data were provided by the ADNI database\\nSpecifically we used amyloid positivity status based on the cutoff value of 111 to the global\\ncortical AV45 SUVR normalized by the whole cerebellum These SUVR values were\\npreprocessed using the ADNI UC Berkeley AV45 pipeline138 where PET frames acquired 5070\\nminutes postinjection were motioncorrected averaged coregistered to corresponding T1\\nweighted MRI scans and spatially normalized\\nSubject selection\\nSince ADNI is a longitudinal study that includes individuals who are cognitively unimpaired\\nCU have mild cognitive impairment MCI or have dementiaAlzheimers disease DEM we\\nselected subjects whose APOE genotype was APOE33 APOE34 or APOE44 and used their\\nearliest available PET imaging data for analysis Summarization of the distribution of subjects by\\nAPOE genotype and diagnostic group can be found in the Source Data\\nADNI Data Acquisition\\nPET imaging data used in the preparation of Figure 1 of this article were obtained from the\\nAlzheimers Disease Neuroimaging Initiative ADNI database adniloniuscedu ADNI was\\nlaunched in 2003 as a publicprivate partnership led by Principal Investigator Michael W Weiner\\nMD The primary goal of ADNI has been to test whether serial magnetic resonance imaging MRI\\npositron emission tomography PET other biological markers and clinical and\\nneuropsychological assessment can be combined to measure the progression of mild cognitive\\nimpairment MCI and early Alzheimers disease AD\\n52\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nReference\\n1 Knopman DS Amieva H Petersen RC Chetelat G Holtzman DM Hyman BT\\nNixon RA and Jones DT 2021 Alzheimer disease Nat Rev Dis Primers 7 33\\n101038s4157202100269y\\n2 Cataldi R Sachdev PS Chowdhary N Seeher K Bentvelzen A Moorthy V and\\nDua T 2023 A WHO blueprint for action to reshape dementia research Nat Aging 3\\n469471 101038s43587023003816\\n3 Tahami Monfared AA Byrnes MJ White LA and Zhang Q 2022 Alzheimers\\nDisease Epidemiology and Clinical Progression Neurol Ther 11 553569\\n101007s40120022003388\\n4 Fortea J Pegueroles J Alcolea D Belbin O DolsIcardo O VaqueAlcazar L\\nVidela L Gispert JD SuarezCalvet M Johnson SC et al 2024 APOE4\\nhomozygozity represents a distinct genetic form of Alzheimers disease Nat Med 30\\n12841291 101038s4159102402931w\\n5 Vance JM Farrer LA Huang Y Cruchaga C Hyman BT PericakVance MA\\nGoate AM Greicius MD Griswold AJ Haines JL et al 2024 Report of the\\nAPOE4 National Institute on AgingAlzheimer Disease Sequencing Project Consortium\\nWorking Group Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimers\\nDisease Ann Neurol 95 625634 101002ana26864\\n6 Blanchard JW Akay LA DavilaVelderrain J von Maydell D Mathys H\\nDavidson SM Effenberger A Chen CY ManerSmith K Hajjar I et al 2022\\nAPOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes Nature\\n611 769779 101038s4158602205439w\\n7 van der Lee SJ Wolters FJ Ikram MK Hofman A Ikram MA Amin N and van\\nDuijn CM 2018 The effect of APOE and other common genetic variants on the onset\\nof Alzheimers disease and dementia a communitybased cohort study Lancet Neurol\\n17 434444 101016S147444221830053X\\n8 Kim JP Cho M Kim C Lee H Jang B Jung SH Kim Y Koh IG Kim S\\nShin D et al 2025 Wholegenome sequencing analyses suggest novel genetic\\nfactors associated with Alzheimers disease and a cumulative effects model for risk\\nliability Nat Commun 16 4870 101038s4146702559949y\\n9 Withington CG and Turner RS 2022 AmyloidRelated Imaging Abnormalities With\\nAntiamyloid Antibodies for the Treatment of Dementia Due to Alzheimers Disease\\nFront Neurol 13 862369 103389fneur2022862369\\n10 Honig LS Sabbagh MN van Dyck CH Sperling RA Hersch S Matta A\\nGiorgi L Gee M Kanekiyo M Li D et al 2024 Updated safety results from phase\\n3 lecanemab study in early Alzheimers disease Alzheimers Res Ther 16 105\\n101186s13195024014418\\n11 Honig LS Sabbagh MN van Dyck CH Sperling RA Hersch S Matta A\\nGiorgi L Gee M Kanekiyo M Li D et al 2024 Correction Updated safety results\\nfrom phase 3 lecanemab study in early Alzheimers disease Alzheimers Res Ther 16\\n159 101186s13195024015077\\n12 Riddell DR Zhou H Atchison K Warwick HK Atkinson PJ Jefferson J Xu L\\nAschmies S Kirksey Y Hu Y et al 2008 Impact of apolipoprotein E ApoE\\npolymorphism on brain ApoE levels J Neurosci 28 1144511453\\n101523JNEUROSCI1972082008\\n13 Raulin AC Doss SV Trottier ZA Ikezu TC Bu G and Liu CC 2022 ApoE in\\nAlzheimers disease pathophysiology and therapeutic strategies Mol Neurodegener 17\\n72 101186s13024022005744\\n53\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n14 Lau F Binacchi R Brugnara S CumplidoMayoral A Savino SD Khan I Orso\\nA Sartori S Bellosta P Carl M et al 2025 Using SingleCell RNA sequencing\\nwith Drosophila Zebrafish and mouse models for studying Alzheimers and Parkinsons\\ndisease Neuroscience 573 505517 101016jneuroscience202503042\\n15 Gotz J Bodea LG and Goedert M 2018 Rodent models for Alzheimer disease\\nNat Rev Neurosci 19 583598 101038s4158301800548\\n16 King A 2018 The search for better animal models of Alzheimers disease Nature 559\\nS13S15 101038d41586018057229\\n17 Lin YT Seo J Gao F Feldman HM Wen HL Penney J Cam HP Gjoneska\\nE Raja WK Cheng J et al 2018 APOE4 Causes Widespread Molecular and\\nCellular Alterations Associated with Alzheimers Disease Phenotypes in Human iPSC\\nDerived Brain Cell Types Neuron 98 1294 101016jneuron201806011\\n18 GarciaReitboeck P Phillips A Piers TM VillegasLlerena C Butler M Mallach\\nA Rodrigues C Arber CE Heslegrave A Zetterberg H et al 2018 Human\\nInduced Pluripotent Stem CellDerived MicrogliaLike Cells Harboring TREM2 Missense\\nMutations Show Specific Deficits in Phagocytosis Cell Rep 24 23002311\\n101016jcelrep201807094\\n19 Frederiksen HR Holst B Ramakrishna S Muddashetty R Schmid B and\\nFreude K 2019 Generation of two iPSC lines with either a heterozygous V717I or a\\nheterozygous KM670671NL mutation in the APP gene Stem Cell Res 34 101368\\n101016jscr2018101368\\n20 Gonzalez C Armijo E BravoAlegria J BecerraCalixto A Mays CE and Soto C\\n2018 Modeling amyloid beta and tau pathology in human cerebral organoids Mol\\nPsychiatry 23 23632374 101038s4138001802298\\n21 Tcw J Qian L Pipalia NH Chao MJ Liang SA Shi Y Jain BR Bertelsen\\nSE Kapoor M Marcora E et al 2022 Cholesterol and matrisome pathways\\ndysregulated in astrocytes and microglia Cell 185 22132233 e2225\\n101016jcell202205017\\n22 Popova G Soliman SS Kim CN Keefe MG Hennick KM Jain S Li T\\nTejera D Shin D Chhun BB et al 2021 Human microglia states are conserved\\nacross experimental models and regulate neural stem cell responses in chimeric\\norganoids Cell Stem Cell 28 21532166 e2156 101016jstem202108015\\n23 SabateSoler S Nickels SL Saraiva C Berger E Dubonyte U Barmpa K Lan\\nYJ Kouno T Jarazo J Robertson G et al 2022 Microglia integration into human\\nmidbrain organoids leads to increased neuronal maturation and functionality Glia 70\\n12671288 101002glia24167\\n24 Wenzel TJ Desjarlais JD and Mousseau DD 2024 Human brain organoids\\ncontaining microglia that have arisen innately adapt to a betaamyloid challenge better\\nthan those in which microglia are integrated by coculture Stem Cell Res Ther 15 258\\n101186s13287024038760\\n25 Kim JI Imaizumi K Jurjut O Kelley KW Wang D Thete MV Hudacova Z\\nAmin ND Levy RJ Scherrer G and Pasca SP 2025 Human assembloid model\\nof the ascending neural sensory pathway Nature 642 143153 101038s41586025\\n088083\\n26 Lancaster MA Renner M Martin CA Wenzel D Bicknell LS Hurles ME\\nHomfray T Penninger JM Jackson AP and Knoblich JA 2013 Cerebral\\norganoids model human brain development and microcephaly Nature 501 373379\\n101038nature12517\\n27 Park DS Kozaki T Tiwari SK Moreira M Khalilnezhad A Torta F Olivie N\\nThiam CH Liani O Silvin A et al 2023 iPScellderived microglia promote brain\\n54\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\norganoid maturation via cholesterol transfer Nature 623 397405 101038s41586023\\n067131\\n28 Ji Y Chen X Wang Z Meek CJ McLean JL Yang Y Yuan C Rochet JC\\nLiu F and Xu R 2025 Alzheimers disease patient brain extracts induce multiple\\npathologies in novel vascularized neuroimmune organoids for disease modeling and\\ndrug discovery Mol Psychiatry 30 45584575 101038s4138002503041w\\n29 Chen X Sun G Tian E Zhang M Davtyan H Beach TG Reiman EM Blurton\\nJones M Holtzman DM and Shi Y 2021 Modeling Sporadic Alzheimers Disease\\nin Human Brain Organoids under Serum Exposure Adv Sci Weinh 8 e2101462\\n101002advs202101462\\n30 Miura Y Li MY Revah O Yoon SJ Narazaki G and Pasca SP 2022\\nEngineering brain assembloids to interrogate human neural circuits Nat Protoc 17 15\\n35 101038s4159602100632z\\n31 Li E Benitez C Boggess SC Koontz M Rose IVL Martinez D Drager N\\nTeter OM Samelson AJ Pierce N et al 2025 CRISPRibased screens in\\niAssembloids to elucidate neuronglia interactions Neuron 113 701718 e708\\n101016jneuron202412016\\n32 Xu R Boreland AJ Li X Erickson C Jin M Atkins C Pang ZP Daniels BP\\nand Jiang P 2021 Developing human pluripotent stem cellbased cerebral organoids\\nwith a controllable microglia ratio for modeling brain development and pathology Stem\\nCell Reports 16 19231937 101016jstemcr202106011\\n33 Cerneckis J Bu G and Shi Y 2023 Pushing the boundaries of brain organoids to\\nstudy Alzheimers disease Trends Mol Med 29 659672\\n101016jmolmed202305007\\n34 Bubnys A and Tsai LH 2022 Harnessing cerebral organoids for Alzheimers\\ndisease research Curr Opin Neurobiol 72 120130 101016jconb202110003\\n35 Onesto MM Kim JI and Pasca SP 2024 Assembloid models of cellcell\\ninteraction to study tissue and disease biology Cell Stem Cell 31 15631573\\n101016jstem202409017\\n36 Penney J Ralvenius WT and Tsai LH 2020 Modeling Alzheimers disease with\\niPSCderived brain cells Mol Psychiatry 25 148167 101038s4138001904683\\n37 Rickner HD Jiang L Hong R ONeill NK Mojica CA Snyder BJ Zhang L\\nShaw D Medalla M Wolozin B and Cheng CS 2022 Single cell transcriptomic\\nprofiling of a neuronastrocyte assembloid tauopathy model Nat Commun 13 6275\\n101038s41467022340051\\n38 Vermunt L Sikkes SAM van den Hout A Handels R Bos I van der Flier WM\\nKern S Ousset PJ Maruff P Skoog I et al 2019 Duration of preclinical\\nprodromal and dementia stages of Alzheimers disease in relation to age sex and\\nAPOE genotype Alzheimers Dement 15 888898 101016jjalz201904001\\n39 Huckvale ED Hodgman MW Greenwood BB Stucki DO Ward KM Ebbert\\nMTW Kauwe JSK The Alzheimers Disease Neuroimaging I The Alzheimers\\nDisease Metabolomics C and Miller JB 2021 Pairwise Correlation Analysis of the\\nAlzheimers Disease Neuroimaging Initiative ADNI Dataset Reveals Significant Feature\\nCorrelation Genes Basel 12 103390genes12111661\\n40 Aisen PS Donohue MC Raman R Rafii MS Petersen RC and Alzheimers\\nDisease Neuroimaging I 2024 The Alzheimers Disease Neuroimaging Initiative\\nClinical Core Alzheimers Dement 20 73617368 101002alz14167\\n41 Carrillo MC Sanders CA and Katz RG 2009 Maximizing the Alzheimers\\nDisease Neuroimaging Initiative II Alzheimers Dement 5 271275\\n101016jjalz200902005\\n55\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n42 Mueller SG Weiner MW Thal LJ Petersen RC Jack C Jagust W\\nTrojanowski JQ Toga AW and Beckett L 2005 The Alzheimers disease\\nneuroimaging initiative Neuroimaging Clin N Am 15 869877 xixii\\n101016jnic200509008\\n43 Petersen RC Aisen PS Beckett LA Donohue MC Gamst AC Harvey DJ\\nJack CR Jr Jagust WJ Shaw LM Toga AW et al 2010 Alzheimers Disease\\nNeuroimaging Initiative ADNI clinical characterization Neurology 74 201209\\n101212WNL0b013e3181cb3e25\\n44 Jagust WJ Bandy D Chen K Foster NL Landau SM Mathis CA Price JC\\nReiman EM Skovronsky D Koeppe RA and Alzheimers Disease Neuroimaging I\\n2010 The Alzheimers Disease Neuroimaging Initiative positron emission tomography\\ncore Alzheimers Dement 6 221229 101016jjalz201003003\\n45 Long JM and Holtzman DM 2019 Alzheimer Disease An Update on Pathobiology\\nand Treatment Strategies Cell 179 312339 101016jcell201909001\\n46 Khan UA Liu L Provenzano FA Berman DE Profaci CP Sloan R Mayeux\\nR Duff KE and Small SA 2014 Molecular drivers and cortical spread of lateral\\nentorhinal cortex dysfunction in preclinical Alzheimers disease Nat Neurosci 17 304\\n311 101038nn3606\\n47 Igarashi KM 2023 Entorhinal cortex dysfunction in Alzheimers disease Trends\\nNeurosci 46 124136 101016jtins202211006\\n48 Jiang L Chakraborty P Zhang L Wong M Hill SE Webber CJ Libera J Blair\\nLJ Wolozin B and Zweckstetter M 2023 Chaperoning of specific tau structure by\\nimmunophilin FKBP12 regulates the neuronal resilience to extracellular stress Sci Adv\\n9 eadd9789 101126sciadvadd9789\\n49 Tong M Tu Q Wang L Chen H Wan X and Xu Z 2025 Joint analysis of\\nsinglecell RNA sequencing and bulk transcriptome reveals the heterogeneity of the urea\\ncycle of astrocytes in glioblastoma Neurobiol Dis 208 106835\\n101016jnbd2025106835\\n50 Trapnell C Cacchiarelli D Grimsby J Pokharel P Li S Morse M Lennon NJ\\nLivak KJ Mikkelsen TS and Rinn JL 2014 The dynamics and regulators of cell\\nfate decisions are revealed by pseudotemporal ordering of single cells Nat Biotechnol\\n32 381386 101038nbt2859\\n51 Cheng J Smyth GK and Chen Y 2023 Unraveling the timeline of gene\\nexpression A pseudotemporal trajectory analysis of singlecell RNA sequencing data\\nF1000Res 12 684 1012688f1000research1340782\\n52 Suzuki N Sekimoto K Hayashi C Mabuchi Y Nakamura T and Akazawa C\\n2017 Differentiation of Oligodendrocyte Precursor Cells from Sox10Venus Mice to\\nOligodendrocytes and Astrocytes Sci Rep 7 14133 101038s41598017142070\\n53 Carmen J Magnus T CassianiIngoni R Sherman L Rao MS and Mattson MP\\n2007 Revisiting the astrocyteoligodendrocyte relationship in the adult CNS Prog\\nNeurobiol 82 151162 101016jpneurobio200703001\\n54 Huang H Rubenstein JL and Qiu M 2021 Cracking the Codes of Cortical Glial\\nProgenitors Evidence for the Common Lineage of Astrocytes and Oligodendrocytes\\nNeurosci Bull 37 437439 101007s1226402100675y\\n55 Sadick JS ODea MR Hasel P Dykstra T Faustin A and Liddelow SA 2022\\nAstrocytes and oligodendrocytes undergo subtypespecific transcriptional changes in\\nAlzheimers disease Neuron 110 17881805 e1710 101016jneuron202203008\\n56 Farhangi S Dehghan S Totonchi M and Javan M 2019 In vivo conversion of\\nastrocytes to oligodendrocyte lineage cells in adult mice demyelinated brains by Sox2\\nMult Scler Relat Disord 28 263272 101016jmsard201812041\\n56\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n57 Jin S GuerreroJuarez CF Zhang L Chang I Ramos R Kuan CH Myung P\\nPlikus MV and Nie Q 2021 Inference and analysis of cellcell communication using\\nCellChat Nat Commun 12 1088 101038s41467021212469\\n58 He C Chen F Li B and Hu Z 2014 Neurophysiology of HCN channels from\\ncellular functions to multiple regulations Prog Neurobiol 112 123\\n101016jpneurobio201310001\\n59 Armstrong CM and Hille B 1998 Voltagegated ion channels and electrical\\nexcitability Neuron 20 371380 101016s0896627300809812\\n60 Cooper D and Dimri M 2025 Biochemistry Calcium Channels In StatPearls\\n61 Nahirney PC and Tremblay ME 2021 Brain Ultrastructure Putting the Pieces\\nTogether Front Cell Dev Biol 9 629503 103389fcell2021629503\\n62 Harris KM 2020 Synaptic Odyssey J Neurosci 40 6180\\n101523JNEUROSCI0735192019\\n63 ShapsonCoe A Januszewski M Berger DR Pope A Wu Y Blakely T Schalek\\nRL Li PH Wang S MaitinShepard J et al 2024 A petavoxel fragment of\\nhuman cerebral cortex reconstructed at nanoscale resolution Science 384 eadk4858\\n101126scienceadk4858\\n64 Knott G Marchman H Wall D and Lich B 2008 Serial section scanning electron\\nmicroscopy of adult brain tissue using focused ion beam milling J Neurosci 28 2959\\n2964 101523JNEUROSCI3189072008\\n65 Peters A and Folger C 2013 A website entitled The fine structure of the aging\\nbrain J Comp Neurol 521 12031206 101002cne23280\\n66 Burnsed J Matysik W Yang L Sun H Joshi S and Kapur J 2023 Increased\\nglutamatergic synaptic transmission during development in layer IIIII mouse motor\\ncortex pyramidal neurons Cereb Cortex 33 46454653 101093cercorbhac368\\n67 Apicco DJ Ash PEA Maziuk B LeBlang C Medalla M Al Abdullatif A\\nFerragud A Botelho E Ballance HI Dhawan U et al 2018 Reducing the RNA\\nbinding protein TIA1 protects against taumediated neurodegeneration in vivo Nat\\nNeurosci 21 7280 101038s415930170022z\\n68 Jiang L Ash PEA Maziuk BF Ballance HI Boudeau S Abdullatif AA\\nOrlando M Petrucelli L Ikezu T and Wolozin B 2019 TIA1 regulates the\\ngeneration and response to toxic tau oligomers Acta Neuropathol 137 259277\\n101007s0040101819375\\n69 Jiang L Zhao J Cheng JX and Wolozin B 2020 Tau Oligomers and Fibrils\\nExhibit Differential Patterns of Seeding and Association With RNA Binding Proteins\\nFront Neurol 11 579434 103389fneur2020579434\\n70 Jiang L Lin W Zhang C Ash PEA Verma M Kwan J van Vliet E Yang Z\\nCruz AL Boudeau S et al 2021 Interaction of tau with HNRNPA2B1 and N6\\nmethyladenosine RNA mediates the progression of tauopathy Mol Cell 81 42094227\\ne4212 101016jmolcel202107038\\n71 Koutarapu S Ge J Dulewicz M Srikrishna M Szadziewska A Wood J\\nBlennow K Zetterberg H Michno W Ryan NS et al 2025 Chemical imaging\\ndelineates Abeta plaque polymorphism across the Alzheimers disease spectrum Nat\\nCommun 16 3889 101038s41467025590857\\n72 Busche MA and Hyman BT 2020 Synergy between amyloidbeta and tau in\\nAlzheimers disease Nat Neurosci 23 11831193 101038s4159302006876\\n73 Bloom GS 2014 Amyloidbeta and tau the trigger and bullet in Alzheimer disease\\npathogenesis JAMA Neurol 71 505508 101001jamaneurol20135847\\n74 StPierre MK Carrier M Gonzalez Ibanez F Simoncicova E Wallman MJ\\nVallieres L Parent M and Tremblay ME 2022 Ultrastructural characterization of\\ndark microglia during aging in a mouse model of Alzheimers disease pathology and in\\n57\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\nhuman postmortem brain samples J Neuroinflammation 19 235 101186s12974022\\n025958\\n75 El Hajj H Savage JC Bisht K Parent M Vallieres L Rivest S and Tremblay\\nME 2019 Ultrastructural evidence of microglial heterogeneity in Alzheimers disease\\namyloid pathology J Neuroinflammation 16 87 101186s1297401914739\\n76 DominguezAlvaro M MonteroCrespo M BlazquezLlorca L DeFelipe J and\\nAlonsoNanclares L 2019 3D Electron Microscopy Study of Synaptic Organization of\\nthe Normal Human Transentorhinal Cortex and Its Possible Alterations in Alzheimers\\nDisease eNeuro 6 101523ENEURO0140192019\\n77 Leng K Rose IVL Kim H Xia W RomeroFernandez W Rooney B Koontz M\\nLi E Ao Y Wang S et al 2022 CRISPRi screens in human iPSCderived\\nastrocytes elucidate regulators of distinct inflammatory reactive states Nat Neurosci 25\\n15281542 101038s41593022011809\\n78 Matusova Z Hol EM Pekny M Kubista M and Valihrach L 2023 Reactive\\nastrogliosis in the era of singlecell transcriptomics Front Cell Neurosci 17 1173200\\n103389fncel20231173200\\n79 Miyoshi E Morabito S Henningfield CM Das S Rahimzadeh N Shabestari SK\\nMichael N Emerson N Reese F Shi Z et al 2024 Spatial and singlenucleus\\ntranscriptomic analysis of genetic and sporadic forms of Alzheimers disease Nat Genet\\n56 27042717 101038s4158802401961x\\n80 Neff RA Wang M Vatansever S Guo L Ming C Wang Q Wang E\\nHorgusluogluMoloch E Song WM Li A et al 2021 Molecular subtyping of\\nAlzheimers disease using RNA sequencing data reveals novel mechanisms and targets\\nSci Adv 7 101126sciadvabb5398\\n81 Tsai AP Dong C Lin PB Messenger EJ Casali BT Moutinho M Liu Y\\nOblak AL Lamb BT Landreth GE et al 2022 PLCG2 is associated with the\\ninflammatory response and is induced by amyloid plaques in Alzheimers disease\\nGenome Med 14 17 101186s13073022010220\\n82 Grubman A Chew G Ouyang JF Sun G Choo XY McLean C Simmons RK\\nBuckberry S VargasLandin DB Poppe D et al 2019 A singlecell atlas of\\nentorhinal cortex from individuals with Alzheimers disease reveals celltypespecific\\ngene expression regulation Nat Neurosci 22 20872097 101038s4159301905394\\n83 Habib N McCabe C Medina S Varshavsky M Kitsberg D DvirSzternfeld R\\nGreen G Dionne D Nguyen L Marshall JL et al 2020 Diseaseassociated\\nastrocytes in Alzheimers disease and aging Nat Neurosci 23 701706\\n101038s4159302006248\\n84 Bellenguez C Kucukali F Jansen IE Kleineidam L MorenoGrau S Amin N\\nNaj AC CamposMartin R GrenierBoley B Andrade V et al 2022 New insights\\ninto the genetic etiology of Alzheimers disease and related dementias Nat Genet 54\\n412436 101038s4158802201024z\\n85 Wightman DP Jansen IE Savage JE Shadrin AA Bahrami S Holland D\\nRongve A Borte S Winsvold BS Drange OK et al 2021 A genomewide\\nassociation study with 1126563 individuals identifies new risk loci for Alzheimers\\ndisease Nat Genet 53 12761282 101038s4158802100921z\\n86 Andrews SJ Renton AE FultonHoward B PodlesnyDrabiniok A Marcora E\\nand Goate AM 2023 The complex genetic architecture of Alzheimers disease novel\\ninsights and future directions EBioMedicine 90 104511 101016jebiom2023104511\\n87 Kozlova A Zhang S Sudwarts A Zhang H Smirnou S Byeon SK Thapa C\\nSun X Stephenson K Zhao X et al 2025 PICALM Alzheimers risk allele causes\\naberrant lipid droplets in microglia Nature 101038s4158602509486x\\n58\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n88 Lee SI Yu J Lee H Kim B Jang MJ Jo H Kim NY Pak ME Kim JK\\nCho S et al 2025 Astrocyte priming enhances microglial Abeta clearance and is\\ncompromised by APOE4 Nat Commun 16 7551 101038s41467025629951\\n89 Kim S Chun H Kim Y Kim Y Park U Chu J Bhalla M Choi SH Yousefian\\nJazi A Kim S et al 2024 Astrocytic autophagy plasticity modulates Abeta\\nclearance and cognitive function in Alzheimers disease Mol Neurodegener 19 55\\n101186s1302402400740w\\n90 Avey DR Ng B Vialle RA Kearns NA de Paiva Lopes K Iatrou A De Tissera\\nS Vyas H Saunders DM Flood DJ et al 2025 Uncovering plaqueglia niches in\\nhuman Alzheimers disease brains using spatial transcriptomics Mol Neurodegener Adv\\n1 2 101186s4447702500002z\\n91 Chen Z Simmons MS Perry RT Wiener HW Harrell LE and Go RC 2008\\nGenetic association of neurotrophic tyrosine kinase receptor type 2 NTRK2 With\\nAlzheimers disease Am J Med Genet B Neuropsychiatr Genet 147 363369\\n101002ajmgb30607\\n92 SasakiHamada S Funane T Nakao Y Sasaki R Nagai M Ueta Y Yoshizawa\\nK Horiguchi M Yamashita C and Oka JI 2018 Intranasal administration of\\nneuromedin U derivatives containing cellpenetrating peptides and a penetration\\naccelerating sequence induced memory improvements in mice Peptides 99 241246\\n101016jpeptides201710010\\n93 Roy ER Wang B Wan YW Chiu G Cole A Yin Z Propson NE Xu Y\\nJankowsky JL Liu Z et al 2020 Type I interferon response drives\\nneuroinflammation and synapse loss in Alzheimer disease J Clin Invest 130 1912\\n1930 101172JCI133737\\n94 De Jager PL Srivastava G Lunnon K Burgess J Schalkwyk LC Yu L Eaton\\nML Keenan BT Ernst J McCabe C et al 2014 Alzheimers disease early\\nalterations in brain DNA methylation at ANK1 BIN1 RHBDF2 and other loci Nat\\nNeurosci 17 11561163 101038nn3786\\n95 Lee H Aylward AJ Pearse RV 2nd Lish AM Hsieh YC Augur ZM Benoit\\nCR Chou V Knupp A Pan C et al 2023 Celltypespecific regulation of APOE\\nand CLU levels in human neurons by the Alzheimers disease risk gene SORL1 Cell\\nRep 42 112994 101016jcelrep2023112994\\n96 Lish AM Grogan EFL Benoit CR Pearse RV 2nd Heuer SE Luquez T\\nOrme GA Galle PC Milinkeviciute G Green KN et al 2025 CLU alleviates\\nAlzheimers diseaserelevant processes by modulating astrocyte reactivity and microglia\\ndependent synaptic density Neuron 113 19251946 e1911\\n101016jneuron202503034\\n97 Zamanian JL Xu L Foo LC Nouri N Zhou L Giffard RG and Barres BA\\n2012 Genomic analysis of reactive astrogliosis J Neurosci 32 63916410\\n101523JNEUROSCI6221112012\\n98 Yang Y and Zhang Z 2020 Microglia and Wnt Pathways Prospects for\\nInflammation in Alzheimers Disease Front Aging Neurosci 12 110\\n103389fnagi202000110\\n99 Faust TE Lee YH OConnor CD Boyle MA Gunner G Badimon A Ayata P\\nSchaefer A and Schafer DP 2024 Microgliaastrocyte crosstalk regulates synapse\\nremodeling via Wnt signaling bioRxiv 10110120240208579178\\n100 Cohen E Paulsson JF Blinder P BurstynCohen T Du D Estepa G Adame\\nA Pham HM Holzenberger M Kelly JW et al 2009 Reduced IGF1 signaling\\ndelays ageassociated proteotoxicity in mice Cell 139 11571169\\n101016jcell200911014\\n59\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n101 Kiani L 2024 IGFBP2 levels associated with Alzheimer disease Nat Rev Neurol 20\\n1 101038s41582023009111\\n102 Rauskolb S Andreska T Fries S von Collenberg CR Blum R Monoranu CM\\nVillmann C and Sendtner M 2022 Insulinlike growth factor 5 associates with\\nhuman Ass plaques and promotes cognitive impairment Acta Neuropathol Commun 10\\n68 101186s40478022013525\\n103 Quesnel MJ Labonte A Picard C Zetterberg H Blennow K Brinkmalm A\\nVilleneuve S Poirier J Alzheimers Disease Neuroimaging I and Group PAR\\n2024 Insulinlike growth factor binding protein2 in atrisk adults and autopsy\\nconfirmed Alzheimer brains Brain 147 16801695 101093brainawad398\\n104 Baxter RC 2023 Signaling Pathways of the Insulinlike Growth Factor Binding\\nProteins Endocr Rev 44 753778 101210endrevbnad008\\n105 Miao J Zhang Y Su C Zheng Q and Guo J 2025 InsulinLike Growth Factor\\nSignaling in Alzheimers Disease Pathophysiology and Therapeutic Strategies Mol\\nNeurobiol 62 31953225 101007s12035024044571\\n106 ZegarraValdivia J AranaNombera H PerezFernandez L Del Rocio Casimiro M\\nGallegosManayay V Del Rosario OlivaPiscoya M AlamoMedina R Abanto\\nSaldana E CruzOrdinola MC ParedesManrique C and ChinoVilca B 2025\\nInsulinlike Growth Factor 1 Impact on Alzheimers Disease Role in Inflammation\\nStress and Cognition Curr Issues Mol Biol 47 103390cimb47040233\\n107 Hou X Jin Y Chen J Hong Y Luo D Yin Q and Liu X 2017 IGF1 protects\\nagainst Abeta2535induced neuronal cell death via inhibition of PUMA expression and\\nBax activation Neurosci Lett 637 188194 101016jneulet201611012\\n108 Freude S Hettich MM Schumann C Stohr O Koch L Kohler C Udelhoven M\\nLeeser U Muller M Kubota N et al 2009 Neuronal IGF1 resistance reduces\\nAbeta accumulation and protects against premature death in a model of Alzheimers\\ndisease FASEB J 23 33153324 101096fj09132043\\n109 Zerti D Molina MM Dorgau B Mearns S Bauer R AlAama J and Lako M\\n2021 IGFBPs mediate IGF1s functions in retinal lamination and photoreceptor\\ndevelopment during pluripotent stem cell differentiation to retinal organoids Stem Cells\\n39 458466 101002stem3331\\n110 Migliore L and Coppede F 2022 Geneenvironment interactions in Alzheimer\\ndisease the emerging role of epigenetics Nat Rev Neurol 18 643660\\n101038s4158202200714w\\n111 Liu CC Liu CC Kanekiyo T Xu H and Bu G 2013 Apolipoprotein E and\\nAlzheimer disease risk mechanisms and therapy Nat Rev Neurol 9 106118\\n101038nrneurol2012263\\n112 Fagiani F Pedrini E Taverna S Brambilla E Murtaj V Podini P Ruffini F Butti\\nE Braccia C Andolfo A et al 2024 A gliaenriched stem cell 3D model of the\\nhuman brain mimics the glialimmune neurodegenerative phenotypes of multiple\\nsclerosis Cell Rep Med 5 101680 101016jxcrm2024101680\\n113 Haroutunian V Katsel P and Schmeidler J 2009 Transcriptional vulnerability of\\nbrain regions in Alzheimers disease and dementia Neurobiol Aging 30 561573\\n101016jneurobiolaging200707021\\n114 Ramos EN Jiron GM Danoff JS Anderson Z Carter CS Perkeybile AM\\nConnelly JJ and Erisir A 2024 The central oxytocinergic system of the prairie vole\\nBrain Struct Funct 229 17371756 101007s00429024028321\\n115 Sun J and Kapur J 2012 Mtype potassium channels modulate Schaffer collateral\\nCA1 glutamatergic synaptic transmission J Physiol 590 39533964\\n101113jphysiol2012235820\\n60\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n116 Schneider CA Rasband WS and Eliceiri KW 2012 NIH Image to ImageJ 25\\nyears of image analysis Nat Methods 9 671675 101038nmeth2089\\n117 Berg DA Su Y JimenezCyrus D Patel A Huang N Morizet D Lee S Shah\\nR Ringeling FR Jain R et al 2019 A Common Embryonic Origin of Stem Cells\\nDrives Developmental and Adult Neurogenesis Cell 177 654668 e615\\n101016jcell201902010\\n118 Aten S Kiyoshi CM Arzola EP Patterson JA Taylor AT Du Y Guiher AM\\nPhilip M Camacho EG Mediratta D et al 2022 Ultrastructural view of astrocyte\\narborization astrocyteastrocyte and astrocytesynapse contacts intracellular vesicle\\nlike structures and mitochondrial network Prog Neurobiol 213 102264\\n101016jpneurobio2022102264\\n119 Dobin A Davis CA Schlesinger F Drenkow J Zaleski C Jha S Batut P\\nChaisson M and Gingeras TR 2013 STAR ultrafast universal RNAseq aligner\\nBioinformatics 29 1521 101093bioinformaticsbts635\\n120 Hao Y Hao S AndersenNissen E Mauck WM 3rd Zheng S Butler A Lee\\nMJ Wilk AJ Darby C Zager M et al 2021 Integrated analysis of multimodal\\nsinglecell data Cell 184 35733587 e3529 101016jcell202104048\\n121 Hafemeister C and Satija R 2019 Normalization and variance stabilization of single\\ncell RNAseq data using regularized negative binomial regression Genome Biol 20 296\\n101186s1305901918741\\n122 McInnes LA JohnASaul NathanielAGroßberger LukasBJournal Name Journal\\nof Open Source Software 3 JV and 29 JI 2018 UMAP Uniform Manifold\\nApproximation and Projection Journal Name Journal of Open Source Software Journal\\nVolume 3 Journal Issue 29 Medium X\\n123 Tian W Zhou J Bartlett A Zeng Q Liu H Castanon RG Kenworthy M Altshul\\nJ Valadon C Aldridge A et al 2023 Singlecell DNA methylation and 3D genome\\narchitecture in the human brain Science 382 eadf5357 101126scienceadf5357\\n124 Benjamini Y Drai D Elmer G Kafkafi N and Golani I 2001 Controlling the false\\ndiscovery rate in behavior genetics research Behav Brain Res 125 279284\\n101016s0166432801002972\\n125 Raudvere U Kolberg L Kuzmin I Arak T Adler P Peterson H and Vilo J\\n2019 gProfiler a web server for functional enrichment analysis and conversions of\\ngene lists 2019 update Nucleic Acids Res 47 W191W198 101093nargkz369\\n126 Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA\\nPaulovich A Pomeroy SL Golub TR Lander ES and Mesirov JP 2005 Gene\\nset enrichment analysis a knowledgebased approach for interpreting genomewide\\nexpression profiles Proc Natl Acad Sci U S A 102 1554515550\\n101073pnas0506580102\\n127 Liberzon A Birger C Thorvaldsdottir H Ghandi M Mesirov JP and Tamayo P\\n2015 The Molecular Signatures Database MSigDB hallmark gene set collection Cell\\nSyst 1 417425 101016jcels201512004\\n128 Szklarczyk D Morris JH Cook H Kuhn M Wyder S Simonovic M Santos A\\nDoncheva NT Roth A Bork P et al 2017 The STRING database in 2017 quality\\ncontrolled proteinprotein association networks made broadly accessible Nucleic Acids\\nRes 45 D362D368 101093nargkw937\\n129 Shannon P Markiel A Ozier O Baliga NS Wang JT Ramage D Amin N\\nSchwikowski B and Ideker T 2003 Cytoscape a software environment for\\nintegrated models of biomolecular interaction networks Genome Res 13 24982504\\n101101gr1239303\\n61\\nbioRxiv preprint doi this version posted October 19 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\\n130 Utriainen M and Morris JH 2023 clusterMaker2 a major update to clusterMaker a\\nmultialgorithm clustering app for Cytoscape BMC Bioinformatics 24 134\\n101186s1285902305225z\\n131 Greve DN Svarer C Fisher PM Feng L Hansen AE Baare W Rosen B\\nFischl B and Knudsen GM 2014 Cortical surfacebased analysis reduces bias and\\nvariance in kinetic modeling of brain PET data Neuroimage 92 225236\\n101016jneuroimage201312021\\n132 Greve DN Salat DH Bowen SL IzquierdoGarcia D Schultz AP Catana C\\nBecker JA Svarer C Knudsen GM Sperling RA and Johnson KA 2016\\nDifferent partial volume correction methods lead to different conclusions An 18FFDG\\nPET study of aging Neuroimage 132 334343 101016jneuroimage201602042\\n133 Vahermaa V Aydogan DB Raij T Armio RL Laurikainen H Saramaki J and\\nSuvisaari J 2023 FreeSurfer 7 quality control Key problem areas and importance of\\nmanual corrections Neuroimage 279 120306 101016jneuroimage2023120306\\n134 Fischl B 2012 FreeSurfer Neuroimage 62 774781\\n101016jneuroimage201201021\\n135 Alexander B Loh WY Matthews LG Murray AL Adamson C Beare R Chen\\nJ Kelly CE Anderson PJ Doyle LW et al 2019 DesikanKillianyTourville Atlas\\nCompatible Version of MCRIB Neonatal Parcellated Whole Brain Atlas The MCRIB\\n20 Front Neurosci 13 34 103389fnins201900034\\n136 Desikan RS Segonne F Fischl B Quinn BT Dickerson BC Blacker D\\nBuckner RL Dale AM Maguire RP Hyman BT et al 2006 An automated\\nlabeling system for subdividing the human cerebral cortex on MRI scans into gyral based\\nregions of interest Neuroimage 31 968980 101016jneuroimage200601021\\n137 Fischl B Salat DH Busa E Albert M Dieterich M Haselgrove C van der\\nKouwe A Killiany R Kennedy D Klaveness S et al 2002 Whole brain\\nsegmentation automated labeling of neuroanatomical structures in the human brain\\nNeuron 33 341355 101016s089662730200569x\\n138 Landau SM Breault C Joshi AD Pontecorvo M Mathis CA Jagust WJ\\nMintun MA and Alzheimers Disease Neuroimaging I 2013 Amyloidbeta imaging\\nwith Pittsburgh compound B and florbetapir comparing radiotracers and quantification\\nmethods J Nucl Med 54 7077 102967jnumed112109009\\n62',\n",
              " 'bioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has grant ed bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nTau Protein Modulates an Epigenetic Mechanism of Cellular\\nSenescence\\n1 Claudia Magrin12 Martina Sola12 Ester Piovesana12 Marco Bolis3 Andrea Rinaldi4\\n2 Stéphanie Papin1 Paolo Paganetti1 2\\n3 1Laboratory for Aging Disorders Laboratories for Translational Research Ente Cantonale\\n4 Ospedaliero Bellinzona Switzerland\\n5 2PhD Program in Neurosciences Faculty of Biomedical Sciences Università della Svizzera Italiana\\n6 Lugano Switzerland\\n7 3Functional Cancer Genomics Laboratory Institute of Oncology Research Bellinzona Switzerland\\n8 Bioinformatics Core Unit Swiss Institute of Bioinformatics Bellinzona Switzerland Università\\n9 della Svizzera Italiana Lugano Switzerland Laboratory of Molecular Biology Istituto di Ricerche\\n10 Farmacologiche Mario Negri IRCCS Milano Italy\\n11 4Lymphoma and Genomics Research Program Institute of Oncology Research Bellinzona\\n12 Switzerland\\n13 These authors share last authorship\\n14 Correspondence\\n15 Prof Paolo Paganetti Laboratory for Aging Disorders LRT EOC Via Chiesa 5 6500 Bellinzona\\n16 Switzerland Phone 4158 666 7103\\n17 paolopaganettieocch\\n18 Keywords Tau PRC2 transcription IGFBP3 senescence aging disease\\n19 Abstract\\n20 Progressive Tau deposition in neurofibrillary tangles and neuropil threads is the hallmark of\\n21 tauopathies a disorder group that includes Alzheimers disease Since Tau is a microtubule\\n22 associated protein a prevalent concept to explain the pathogenesis of tauopathies is that abnormal\\n23 Tau modification contributes to dissociation from microtubules assembly into multimeric βsheets\\n24 proteotoxicity neuronal dysfunction and cell loss Tau also localizes in the cell nucleus and evidence\\n25 supports an emerging function of Tau in DNA stability and epigenetic modulation To better\\n26 characterize the possible role of Tau in regulation of chromatin compaction and subsequent gene\\n27 expression we performed a bioinformatics analysis of transcriptome data obtained from Tau\\n28 depleted human neuroblastoma cells Among the transcripts deregulated in a Taudependent manner\\n29 we found an enrichment of target genes for the polycomb repressive complex 2 We further describe\\n30 decreased cellular amounts of the core components of the polycomb repressive complex 2 complex\\n31 and a lower histone 3 trimethylation activity in Tau deficient cells Among the derepressed\\n32 polycomb repressive complex 2 target gene products IGFBP3 protein was found to be linked to\\n33 increased senescence induction in Taudeficient cells Our findings propose a mechanism for Tau\\n34 dependent epigenetic modulation of cell senescence a key event in pathologic aging\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n35 1 Introduction\\n36 Tau pathology is the hallmark of tauopathies a neurodegenerative disorder group that includes\\n37 Alzheimers disease AD where progressive Tau deposition in neurofibrillary tangles and neuropil\\n38 threads correlates with a deteriorating clinical course Long and Holtzman 2019 Autosomal dominant\\n39 mutations in the MAPT gene encoding for Tau lead to a relatively small group of frontotemporal lobar\\n40 degenerations FTLDTau which are classified among frontotemporal dementia Josephs 2018\\n41 diagnosed mostly at 4565 years of age Hutton et al 1998 Spillantini et al 1998 With Tau being a\\n42 microtubulebinding protein a prevalent concept to explain the pathogenesis of tauopathies is that\\n43 abnormal Tau modification eg phosphorylation and folding contributes to Tau dissociation from\\n44 microtubules assembly into multimeric βsheets proteotoxicity neuronal dysfunction and cell loss\\n45 Jeganathan et al 2006 Ludolph et al 2009 In addition to its wellcharacterized role in\\n46 neurodegeneration studies reporting a correlation between MAPT gene products and survival in\\n47 various types of tumors endorse an implication of Tau in cancer Papin and Paganetti 2020 Gargini\\n48 et al 2020 Gargini et al 2019 Cimini et al 2022 Rossi et al 2018 The mechanisms underlying\\n49 these findings may involve microtubuleunrelated Tau functions\\n50 Tau exerts non canonical functions eg it localizes in the cell nucleus and binds DNA Cross et al\\n51 1996 Greenwood and Johnson 1995 Loomis et al 1990 Thurston et al 1996 Heat or oxidative\\n52 stress cause nuclear translocation of Tau which may favor its role in DNA protection Sultan et al\\n53 2011 Neurons knockedout for MAPT display enhanced DNA damage Violet et al 2014 and\\n54 induced DNA damage correlates with nuclear translocation and dephosphorylation of Tau Ulrich et\\n55 al 2018 Chromosomal abnormalities in AD fibroblasts Rossi et al 2008 and frequent DNA\\n56 damage in AD brains Lovell and Markesbery 2007 Mullaart et al 1990 both reinforce the emerging\\n57 function of Tau in DNA stability Tau depletion also modulates the induction of apoptosis and cell\\n58 senescence in response to DNA damage by a mechanism involving P53 the guardian of the genome\\n59 Sola et al 2020 Additional functions of Tau in epigenetic modulation were also reported Rico et\\n60 al 2021 Upon binding to histones Tau stabilizes chromatin compaction Montalbano et al 2021\\n61 Frost et al 2014 Rico et al 2021 Montalbano et al 2020 and affects global gene expression during\\n62 the neurodegenerative process Frost et al 2014 Klein et al 2019 A metaanalysis of dysregulated\\n63 DNA methylation in AD identified over hundreds genomic sites in cortical regions Shireby et al\\n64 2022 growing to thousands when looking at the dentate gyrus of oldest old patients Lang et al\\n65 2022\\n66 DNA and histone modification is an effective mechanism to regulate gene activity Hence with the\\n67 aim to investigate a possible participation of Tau in gene expression we performed a bioinformatics\\n68 analysis of transcriptome data obtained from Taudepleted human neuroblastoma cells Among the\\n69 transcripts deregulated in a Taudependent manner we found an enrichment of target genes for the\\n70 Polycomb Repressive Complex 2 PRC2 a result confirmed by decreased PRC2 protein and histone\\n71 3 H3 methylation in Tau deficient cells Notably among the derepressed gene products Insulin\\n72 Growth Factor Binding Protein 3 IGFBP3 was linked to senescence induction Our findings propose\\n73 a Taudriven mechanism for epigenetic modulation of cell senescence a key event in pathologic aging\\n74 2 Materials and methods\\n75 21 Cell culture\\n76 Human SHSY5Y cells 94030304 SigmaAldrich were cultured in complete Dulbeccos\\n77 Modified Eagle Medium 61965059 Gibco supplemented with 1 nonessential amino acids\\n78 11140035 Gibco 1 penicillinstreptomycin 15140122 Gibco and 10 fetal bovine serum FBS\\n2\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n79 10270106 Gibco Cells were grown at 37C with saturated humidity and 5 CO and maintained in\\n2\\n80 culture for less than one month MAPT knockout cells were as described Sola et al 2020\\n81 22 RNAseq\\n82 Total RNA extraction with the TRIzol Reagent 15596026 Invitrogen was done according to\\n83 the instructions of the manufacturer Extracted RNA was processed with the NEBNext Ultra\\n84 Directional II RNA library preparation kit for Illumina and sequenced on the Illumina NextSeq500\\n85 with singleend 75 base pair long reads The overall quality of sequencing reads was evaluated using\\n86 a variety of tools namely FastQC Wingett and Andrews 2018 RSeQC Wang et al 2012 AfterQC\\n87 Chen et al 2017 and Qualimap GarcíaAlcalde et al 2012 Sequence alignments to the reference\\n88 human genome GRCh38 was performed using STAR v252a Dobin et al 2013 Transcript\\n89 expression was quantified at gene level with the comprehensive annotations v27 release of the Gene\\n90 Transfer File GTF made available by Gencode Harrow et al 2012 Rawcounts were further\\n91 processed in the R Statistical environment and downstream differential expression analysis was\\n92 performed using the DESeq2 pipeline Love et al 2014 Transcripts characterized by low mean\\n93 normalized counts were filtered out by the Independent Filtering feature embedded in DESeq2 alpha\\n94 005 The RNASeq data have the accession no EMTAB8166 and were uploaded on\\n95 \\n96 99c998910b78ed4c The genes differentially expressed between WT and TauKO cells 734 were\\n97 used to interrogate a possible geneset enrichment utilizing the transcription tool of the EnrichR portal\\n98 Chen et al 2013 Kuleshov et al 2016 Xie et al 2021\\n99 23 Pseudoviral particle production and transduction\\n100 Pseudolentiviral particles were produced by transient transfection of HEK293FT cells with 2 μg of\\n101 the pSIFH1puroIGFBP3 shRNA2 or of the control plasmid pSIFH1puroluciferase shRNA and 8\\n102 μg of the feline immunodeficiency virus FIV packaging plasmid mix pFIV34N pVSVG all\\n103 plasmids were kindly provided by Prof Yuzuru Shiio Greehey Childrens Cancer Research Institute\\n104 University of Texas Cell conditioned medium was collected 2 days after transfection and cleared by\\n105 centrifugation at 300 g for 5 min 4C Pseudolentiviruses were 20fold concentrated with centrifugal\\n106 filters MWCO 30 kDa UFC903024 Amicon at 3000 g for 3045 min 4C aliquoted and stored at\\n107 80C\\n108 Human neuroblastoma SHSY5Y cells 1 x105 were seeded into a 24well plate coated with polyD\\n109 lysine p6407 SigmaAldrich one day before pseudolentiviral particle transduction One day after\\n110 transduction cells were supplemented with fresh complete medium and selected in the presence of 25\\n111 gmL puromycin P8833 SigmaAldrich for two weeks\\n112 24 Drugs and cell treatments\\n113 Treatment of SHSY5Y cells with Tazemetostat CAS No 1403254998 S7128 Selleckchem\\n114 was performed at 10 µM for four days staring from a 10 mM stock solution in DMSO vehicle 01\\n115 DMSO was added to the controls\\n116 25 Western blot and immune precipitation\\n117 For direct analysis by western blot total lysates from cells cultured in 6well plates were prepared\\n118 in 50 μL of SDSPAGE sample buffer 15 SDS 83 glycerol 0005 bromophenol blue 16 β\\n119 mercaptoethanol and 625 mM Tris pH 68 and incubated for 10 min at 100C 15 μL per lane of the\\n120 sample was loaded on SDSpolyacrylamide gels SDSPAGE\\n3\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n121 For immune isolation the cells were rinsed with PBS and lysed on ice in 100 μL of AlphaLisa Lysis\\n122 Buffer AL003 PerkinElmer supplemented with protease and phosphatase inhibitor cocktails S8820\\n123 04906845001 SigmaAldrich Cell lysates were treated with benzonase 707463 Novagen for 15\\n124 min at 37C centrifuged at 20000 g for 10 min at 4C and supernatants were collected as cell extracts\\n125 These latter were diluted in HiBlock buffer 10205589 PerkinElmer and incubated overnight at 4C\\n126 with 05 μg of primary antibodies against SUZ12 3737 Cell Signaling Technology or EZH2 5246\\n127 Cell Signaling Technology Protein GSepharose beads 101241 Invitrogen were added for 1 h at\\n128 room temperature RT and the beads were washed three times in PBS with 01 Tween20 Bead\\n129 bound proteins were eluted in SDSPAGE sample buffer by boiling for 10 min at 100C\\n130 After SDSPAGE PVDF membranes with transferred proteins were incubated with primary\\n131 antibodies 0084 μgmL SUZ12 0421 μgmL EZH2 018 μgmL GAPDH ab181602 Abcam 01\\n132 μgmL H3K27me3 C15410069 Diagenode 002 μgmL H3 ab176842 Abcam or 04 μgmL\\n133 IGFBP3 sc365936 Santa Cruz Biotechnology Primary antibodies were revealed with antimouse\\n134 IgG coupled to IRDye RD 680 or antirabbit IgG coupled to IRDye 800CW Licor Biosciences 926\\n135 68070 92632211 on a dual infrared imaging scanner Licor Biosciences Odyssey CLx 9140 and\\n136 quantified with the software provided Licor Biosciences Image Studio V5021 9140500\\n137 26 Immune staining\\n138 For immune staining cells were grown on polyDlysine coated 8well microscope slides 80826\\n139 IBI Ibidi Cells were fixed in 4 paraformaldehyde and stained Ulrich et al 2018 with primary\\n140 antibodies 0168 μgmL SUZ12 0842 μgmL EZH2 16 μgmL H3K27me3 or 15 μgmL p16\\n141 ab108349 Abcam Detection by fluorescent laser confocal microscopy Nikon C2 microscope was\\n142 done with 2 μgmL secondary antibodies antimouse IgG Alexa594 antirabbit IgG Alexa 488 or anti\\n143 rabbit IgGAlexa 647 A11032 A11034 A21245 Thermo Fisher Scientific Nuclei were\\n144 counterstained with 05 μgmL DAPI D9542 SigmaAldrich Images were acquired by sequential\\n145 excitations linebyline scan with the 405 nm laser 46440 emission filter the 488 nm laser\\n146 52550 nm filter the 561 nm laser 561LP nm filter and the 650 nm laser 594633 emission filter\\n147 ImageJ was used for all image quantifications\\n148 27 RNA extraction and RTqPCR\\n149 Total RNA extraction using the TRIzol Reagent 15596026 Invitrogen and cDNA synthesis\\n150 using the GoScript Reverse Transcription Mix Random Primers A2800 Promega were done\\n151 according to the instructions of the manufacturer Amplification was performed with SsoAdvanced\\n152 Universal SYBR Green Supermix 1725271 BioRad with 43 cycles at 95C for 5 sec 60C for 30\\n153 sec and 60C for 1 min using specific primers for EZH2 SUZ12 IGFBP3 GPR37 ITGA3 MRC2 and\\n154 IRF6 gene transcripts Supplementary Table IV Relative RNA expression was calculated using the\\n155 comparative Ct method and normalized to the geometric mean of the GAPDH and HPRT1 mRNAs\\n156 28 SAβGal assay\\n157 Senescenceassociated βgalactosidase SAβGal staining was determined on cells grown in 6well\\n158 plates fixed with 2 paraformaldehyde for 10 min at RT and washed twice with gentle shaking for 5\\n159 min at RT Cells were then incubated with 1 mgmL Xgal 20 mgmL stock in DMF B4252 Sigma\\n160 Aldrich diluted in prewarmed 5 mM K FeCN P8131 SigmaAldrich 5 mM\\n3 6\\n161 K FeCN 3H O P3289 SigmaAldrich and 2 mM MgCl M8266 SigmaAldrich in PBS at\\n4 6 2 2\\n162 pH 60 Acquisition and quantification of the images for SAβGal activity and cell area were done with\\n163 an automated live cell imager Lionheart FX BioTek\\n4\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n164 29 LysoTracker\\n165 For LysoTracker staining cells were seeded in polyDlysine coated 8well microscope slides\\n166 incubated for 10 min at 37C with 025 μM Lysotracker Red L7528 Thermo Fischer Scientific\\n167 Nuclei were counterstained with 25 μgmL Hoechst H3570 Invitrogen for 10 min at 37C\\n168 afterwards cells were washed with complete medium Images of living cells were acquired on a\\n169 fluorescent laser confocal microscope C2 Nikon by sequential excitations linebyline scan with\\n170 the 405 nm laser 46440 nm emission filter and the 561 nm laser 561LP nm filter ImageJ was used\\n171 for all image quantifications Both the lysosomes area and the mean number of lysosomes per cells and\\n172 per images were determined\\n173 3 Results\\n174 31 Transcriptomics analysis of TauKO cells\\n175 We performed a nextgeneration transcription RNAseq analysis of human SHSY5Y\\n176 neuroblastoma cells knockedout for Tau when compared to normal Tauexpressing cells Fig 1A\\n177 The sequences obtained from the six samples analyzed three Tau expressing cell lines three TauKO\\n178 cell lines mapped reliably to 16000 genes Additional 14000 transcripts were expressed at low\\n179 levels and were not included in the differential expression analysis The primary data were stored at\\n180 with open access EMTAB8166 When filtering for differentially\\n181 expressed transcripts in TauKO cells 1388 RNAs displayed a significant change Adj P 05 of\\n182 which 723 RNAs were upregulated in the log2FC range between 031 and 1105 between 124 and\\n183 2000 fold higher than in control Tau expressing cells Supplementary Table I\\n184 We selected these 723 differentially expressed genes to interrogate a possible geneset enrichment\\n185 utilizing the transcription tool of the EnrichR portal Chen et al 2013 Kuleshov et al 2016 Xie et\\n186 al 2021 The CHIPsequencing datasets ChEA 2016 identified an overrepresentation of Polycomb\\n187 Repressive Complexassociated proteins among the 68 datasets showing a significant Adj P 01\\n188 difference Indeed almost half of the enriched CHIPsequencing datasets were obtained from core\\n189 components or known regulators of PRC2 32 or of PRC1 16 Fig 1B Supplementary Table\\n190 II PRC2 actively catalyzes the trimethylation of histone 3 H3 at lysin 27 H3K27me3 Laugesen\\n191 et al 2016 Moritz and Trievel 2018 In agreement with the identification of PRC2 in the CHIP\\n192 sequencing datasets mining of the epigenomics roadmap HM ChIPseq resulted in a 73 enrichment\\n193 of the H3K27me3 signature Adj P 01 in 45 datasets Fig 1C Supplementary Table III\\n194 Altogether analysis of the RNAseq data suggested that upregulation of transcription of a specific set\\n195 of genes in Taudepleted neuroblastoma SHSY5Y cells might ensue from a relief of gene activity\\n196 decline controlled by PRC2\\n197 32 Reduced expression and activity of PRC2 in Taudepleted cell\\n198 We subsequently analyzed the amount of two PRC2 core components in TauKO cells by western\\n199 blot In agreement with what suggested by the transcriptomics data we observed reduced amounts of\\n200 the catalytic subunit EZH2 and the scaffold subunit SUZ12 of PRC2 in TauKO cells when compared\\n201 to Tauexpressing cells Fig 2A Reduced proteins were found also by quantitative immune staining\\n202 of the cells utilizing specific antibodies Fig 2B RTqPCR analysis excluded that the effect on PRC2\\n203 protein resulted from reduced transcription since no difference was found for the EZH2 and SUZ12\\n204 mRNAs Fig 2C data that suggested a Taudependent effect on PRC2 protein stability Nonetheless\\n205 coimmune isolation revealed the presence of the EZH2SUZ2 core complex of PRC2 in TauKO cells\\n206 albeit at reduced levels when compared to controls Fig 2D\\n5\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n207 PRC2 enzymatic activity was determined by western blot and quantitative immune staining of\\n208 H3K27me3 an epigenetic mark produced by the histone methyl transferase activity of PRC2 Guo et\\n209 al 2021 Confirming the lower amounts of the PRC2 complex we found that TauKO cells display\\n210 reduced H3K27me3 Fig 3AB Among the upregulated transcripts found by RNAseq in TauKO\\n211 cells we selected five known PRC2 targets displaying close to average signals Supplementary Table\\n212 I IGFBP3 190x of WT adjP 004 GPR37 93x 015 ITGA3 63x 0173x MRC2 51x 016\\n213 and IRF6 32x 0498 Determination of mRNA expression by RTqPCR validated their upregulation\\n214 Fig 3C indicating again that Taudepletion relieved repression of transcription caused by reduced\\n215 PRC2 activity in Taudepleted cells\\n216\\n217 33 PRC2dependent overproduction of IGFBP3 in TauKO cells\\n218 IGFBP3 protein is a component of the senescenceassociated secreted phenotype SASP Basisty\\n219 et al 2020 Having previously reported that Taudepletion favored cellular senescence Sola et al\\n220 2020 we interrogated the role of IGFBP3 in this process As anticipated from the mRNA data a strong\\n221 overproduction of endogenous IGFBP3 was present in TauKO cells Fig 4A Reinforcing the link\\n222 between PRC2 and IGFBP3 treatment of SHSY5Y cells with Tazemetostat a specific blocker of the\\n223 histone methyl transferase activity of EZH2 Straining and Eighmy 2022 reduced H3K27me3 and\\n224 increased IGFBP3 Fig 4B Lower EZH2 and SUZ12 and higher IGFBP3 was confirmed in an\\n225 independent TauKO cell line Supplementary Fig 1\\n226 34 TauPRC2IGFBP3 triad in senescence\\n227 Increased cellular expression of IGFBP3 is associated with autocrine and paracrine senescence\\n228 induction Elzi et al 2012 and reduced PRC2 is also linked to increased cellular senescence Ito et\\n229 al 2018 Furthermore increased senescence is observed in TauKO cells Sola et al 2020 Thus\\n230 we postulated that PRC2dependent derepression of IGFBP3 in Taudepleted cells may explain the\\n231 induction of cellular senescence We observed first that Tau depletion as well as PRC2 inhibition both\\n232 increased the percentage of SHSY5Y cells entering in senescence as assessed by three independent\\n233 markers P16 senescenceassociated βgalactosidase SAβgal and the number and size of lysosomes\\n234 labelled with the acidotrophic LysoTracker dye Fig 5A Next we reduced IGFBP3 expression in\\n235 TauKO cells by a shRNAbased approach Fig 5B and found that this reduced senescence induction\\n236 in TauKO cells Fig 5C Thus we validated our hypothesis that increased senescence in TauKO SH\\n237 SY5Y cells was likely the consequence of decreased PRC2dependent repression of IGFBP3\\n238 expression\\n239 4 Discussion\\n240 We report data demonstrating a noncanonical role of Tau as a modulator of the epigenetic activity\\n241 of PRC2 inducing cellular senescence in neuroblastoma SHSY5Y cells In our study we identified a\\n242 prevalent PRC2 signature for shared modulation of upregulated transcripts in Taudepleted cells PRC1\\n243 and PRC2 are multisubunit transcriptional repressors that crucially modulate chromatin structure and\\n244 gene expression by distinct enzymatic activities Vijayanathan et al 2022 PRC1 is an E3 ubiquitin\\n245 ligase that catalyzes H2A ubiquitination at lysine119 whereas PRC2 acts as a methyltransferase that\\n246 generates H3K27me3 with some crosstalk between the two complexes GuerardMillet et al 2021\\n247 Confirming the bioinformatics results Tau depletion caused reduced cellular amounts of PRC2 and its\\n248 product H3K27me3 Increased senescence status upon Taudepletion was reproduced through\\n6\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n249 pharmacological inhibition of PRC2 in Tauexpressing cells Finally we report that reversing the up\\n250 regulation of the PRC2target IGFBP3 impaired senescence induction in Taudepleted cells\\n251 Evidence exists for the implication of Tau in chromatin remodeling A pioneering study investigated\\n252 chromatin conformation in mouse and drosophila models of AD as well as in human diseased brain\\n253 whereby a general loss of heterochromatin was associated with aberrant gene expression in all three\\n254 paradigms Frost et al 2014 More recently binding of Tau to histones was linked to the maintenance\\n255 of condensed chromatin Rico et al 2021 Thus Tau may favor chromatin compaction for preventing\\n256 aberrant gene transcription Misfolding hyperphosphorylation or sequestration of Tau in oligomers\\n257 and fibrils typical hallmarks of tauopathies could all result in a negative regulation of this non\\n258 canonical function of Tau In our study we show that in addition to the direct interaction between Tau\\n259 and histones Rico et al 2021 an indirect mechanism involving PRC2 is an additional instrument for\\n260 modulating chromatin compaction\\n261 The role of PRC2 in senescence was shown by findings indicating that impairment of its catalytic\\n262 activity induces a delayed decrease in H3K27me3 at the CDKN2A locus which upregulates p16 the\\n263 SASP phenotype and senescence Ito et al 2018 This function of PRC2 represents a target for\\n264 anticancer therapies eg through EED inhibition associated to derepression of SASPencoding genes\\n265 and entry of proliferative cancer cells in a senescent state Chu et al 2022 Beside the paradoxical\\n266 implication in cancer Yang et al 2021 senescence contributes to neurodegenerative diseases\\n267 Senescent neurons microglia astrocytes and neuronal stem cells were found during the pathogenic\\n268 process Si et al 2021 A recent study in a tauopathy mouse model supported a causal link between\\n269 cell senescence and cognitive decline linked to neuronal loss Indeed p16INK4Apositive senescent\\n270 glial cells were found associated to Tau lesions and strikingly the clearance of these cells prevented\\n271 Tau hyperphosphorylation Tau fibril deposition whilst preserving neuronal survival and cognitive\\n272 functions Bussian et al 2018 We describe now a conceivable mechanism linking depletion of\\n273 functional Tau in tauopathies and senescence induction\\n274 Among the PRC2 targets we identified IGFBP3 as a main driver of senescence resulting from Tau\\n275 depletion Ectopic expression of the SASP component IGFBP3 or its administration to MCF7 or IMR\\n276 90 cells is sufficient to induce senescence whereas IGFBP3 knockdown impairs doxorubicininduced\\n277 senescence Elzi et al 2012 Although the role of PRC2 and IGFBP3 were established independently\\n278 to our knowledge our study is the first one showing IGFBP3 as a main executor of PRC2dependent\\n279 senescence induction and its modulation by Tau protein levels\\n280 PRC2 has numerous functions in the developing central nervous system with many neurogenesis\\n281 linked genes regulated by the PRC2H3K27 axis Liu et al 2017 PRC2 is essential in preserving\\n282 neural progenitor cell identity and neuroepithelial integrity Akizu et al 2016 PRC2 deficiency in\\n283 mice leads to aberrant gastrulation and lack of neural tissue Schumacher et al 1996 Later in\\n284 development a transcription pattern with a PRC2 signature drives neuronal migration and is essential\\n285 for the organization of neural circuits Zhao et al 2015 The rare Weaver syndrome linked to\\n286 developmental cognitive deficits is caused by autosomal dominant mutations in any one of the three\\n287 PRC2 core components EZH2 EED and SUZ12 Deevy and Bracken 2019 However PRC2 is also\\n288 involved in neurodegeneration PRC2 deficiency in striatal neurons of mice reactivates the deleterious\\n289 expression of transcripts that are normally suppressed in these cells ultimately causing premature\\n290 lethality Von Schimmelmann et al 2016 Additional studies implicated PRC2 in ataxia\\n291 telangiectasia Li et al 2013 Parkinsons disease Huntingtons disease and AD Kuehner and Yao\\n292 2019 A metaanalysis of differentially methylated regions in prefrontal neocortex at different disease\\n293 stages has identified in AD several hypermethylated regions which were significantly enriched in\\n294 polycomb repressed regions Zhang et al 2020 These data also link PCR2dependent methylation of\\n7\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n295 H3 with that of CpG islands of the genome another epigenetic mechanism of gene repression Phillips\\n296 2008\\n297 PRC2 lacks sequencespecific DNAbinding ability and therefore relies on accessory proteins for\\n298 targeting specific loci Factors contributing to selective PRC2 recruitment to chromatin are the\\n299 interaction with sequencespecific transcription factors or RNAs and or discerning chromatin features\\n300 Blackledge and Klose 2021 In the fly PRC2 activity is regulated through the interaction with\\n301 transcription factors binding to polycomb response elements often located in proximal promoter\\n302 regions of developmental genes Kassis and Brown 2013 However the orthologue system was not\\n303 found in mammals Bauer et al 2016 Rather it is maybe replaced by the evolution of a mechanism\\n304 based on nonmethylated CpG islands Ku et al 2008 and the action of DNAbinding proteins binding\\n305 to them Proteins with such features are the PRC11 complex member KDM2B or the PRC2members\\n306 PHF1 MTF2 and PHF19 Owen and Davidovich 2022\\n307 PRC histone modifications are heritable over mitotic cell division providing an epigenetic memory\\n308 for stable cell identity and adequate response to stress Reinig et al 2020 Thus PRC2 dysfunction is\\n309 frequently associated with neoplastic progression and is a target for anticancer therapy Comet et al\\n310 2016 Expression of its catalytic subunit EZH2 correlates with cell proliferation and its aberrant\\n311 overexpression is frequent in many types of cancer cells Liu and Liu 2022 However in line with a\\n312 role in tumor suppression lossoffunction of PRC2 is also involved in cancer Liu et al 2017 PRC2\\n313 modulation by Tau implicates this latter in the pathogenesis of cancer supporting the observation that\\n314 the Tau mRNA correlates with survival in several tumors Gargini et al 2019 Papin and Paganetti\\n315 2020 The mechanism explaining this correlation is unknown but may involve the noncanonical role\\n316 of Tau in modulating chromatin compaction and senescence induction This may open new therapeutic\\n317 opportunities for neurodegenerative diseases and cancer\\n318 5 Conflict of Interest\\n319 The authors declare that the research was conducted in the absence of any commercial or financial\\n320 relationships that could be construed as a potential conflict of interest\\n321 6 Author Contributions\\n322 Conceptualization SP PP\\n323 Methods and investigations CM MS EP MB AR\\n324 Supervision SP PP\\n325 Writing original draft SP\\n326 Writing review editing all coauthors\\n327 7 Funding\\n328 The Paganettis lab is founded by the Gelu Foundation the Mecri Foundation and The Charitable\\n329 Gabriele Foundation\\n330 8 Acknowledgments\\n331 We thank the whole laboratory for support and advice during this study\\n332 9 Data Availability Statement\\n8\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n333 The RNASeq data have the accession no EMTAB8166 and were uploaded on\\n334 \\n335 99c998910b78ed4c\\n336\\n337 References\\n338 Akizu N García M A Estarás C Fueyo R Badosa C De La Cruz X MartínezBalbás M\\n339 A 2016 EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing\\n340 p21 Open Biol 6 150227\\n341 Basisty N Kale A Patel S Campisi J Schilling B 2020 The power of proteomics to monitor\\n342 senescenceassociated secretory phenotypes and beyond toward clinical applications Expert\\n343 Rev Proteomics 17 297308\\n344 Bauer M Trupke J Ringrose L 2016 The quest for mammalian Polycomb response elements\\n345 are we there yet Chromosoma 125 47196\\n346 Blackledge N P Klose R J 2021 The molecular principles of gene regulation by Polycomb\\n347 repressive complexes Nat Rev Mol Cell Biol 22 815833\\n348 Bussian T J Aziz A Meyer C F Swenson B L Van Deursen J M Baker D J 2018\\n349 Clearance of senescent glial cells prevents taudependent pathology and cognitive decline\\n350 Nature 562 578582\\n351 Chen E Y Tan C M Kou Y Duan Q Wang Z Meirelles G V Clark N R Maayan A\\n352 2013 Enrichr interactive and collaborative HTML5 gene list enrichment analysis tool BMC\\n353 Bioinformatics 14 128\\n354 Chen S Huang T Zhou Y Han Y Xu M Gu J 2017 AfterQC automatic filtering\\n355 trimming error removing and quality control for fastq data BMC Bioinformatics 18 80\\n356 Chu L Qu Y An Y Hou L Li J Li W Fan G Song BL Li E Zhang L Qi W\\n357 2022 Induction of senescenceassociated secretory phenotype underlies the therapeutic\\n358 efficacy of PRC2 inhibition in cancer Cell Death Disease 13 155\\n359 Cimini S Giaccone G Tagliavini F Costantino M Perego P Rossi G 2022 P301L tau\\n360 mutation leads to alterations of cell cycle DNA damage response and apoptosis Evidence for\\n361 a role of tau in cancer Biochem Pharmacol 200 115043\\n362 Comet I Riising E M Leblanc B Helin K 2016 Maintaining cell identity PRC2mediated\\n363 regulation of transcription and cancer Nature Reviews Cancer 16 803810\\n364 Cross D Tapia L Garrido J Maccioni R B 1996 Taulike proteins associated with\\n365 centrosomes in cultured cells Exp Cell Res 229 37887\\n366 Deevy O Bracken A P 2019 PRC2 functions in development and congenital disorders\\n367 Development 146\\n368 Dobin A Davis C A Schlesinger F Drenkow J Zaleski C Jha S Batut P Chaisson M \\n369 Gingeras T R 2013 STAR ultrafast universal RNAseq aligner Bioinformatics 29 1521\\n370 Elzi D J Lai Y Song M Hakala K Weintraub S T Shiio Y 2012 Plasminogen activator\\n371 inhibitor 1 insulinlike growth factor binding protein 3 cascade regulates stressinduced\\n372 senescence Proceedings of the National Academy of Sciences 109 1205212057\\n373 Frost B Hemberg M Lewis J Feany M B 2014 Tau promotes neurodegeneration through\\n374 global chromatin relaxation Nat Neurosci 17 35766\\n375 GarcíaAlcalde F Okonechnikov K Carbonell J Cruz L M Götz S Tarazona S Dopazo J\\n376 Meyer T F Conesa A 2012 Qualimap evaluating nextgeneration sequencing alignment\\n377 data Bioinformatics 28 26789\\n378 Gargini R SeguraCollar B Herránz B GarcíaEscudero V RomeroBravo A Núñez F J\\n379 GarcíaPérez D GutiérrezGuamán J AyusoSacido A Seoane J PérezNúñez A\\n380 SepúlvedaSánchez J M HernándezLaín A Castro M G GarcíaEscudero R Ávila J\\n9\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n381 SánchezGómez P 2020 The IDHTAUEGFR triad defines the neovascular landscape of\\n382 diffuse gliomas Sci Transl Med 12\\n383 Gargini R SeguraCollar B SánchezGómez P 2019 Novel Functions of the\\n384 NeurodegenerativeRelated Gene Tau in Cancer Front Aging Neurosci 11 231\\n385 Greenwood J A Johnson G V 1995 Localization and in situ phosphorylation state of nuclear\\n386 tau Exp Cell Res 220 3327\\n387 GuerardMillet F Gentile C Paul R Mayran A Kmita M 2021 Polycomb Repressive\\n388 Complexes occupancy reveals PRC2independent PRC1 critical role in the control of limb\\n389 development bioRxiv 20211028466236\\n390 Guo Y Zhao S Wang G G 2021 Polycomb Gene Silencing Mechanisms PRC2 Chromatin\\n391 Targeting H3K27me3 Readout and Phase SeparationBased Compaction Trends in\\n392 Genetics 37 547565\\n393 Harrow J Frankish A Gonzalez J M Tapanari E Diekhans M Kokocinski F Aken B L\\n394 Barrell D Zadissa A Searle S Barnes I Bignell A Boychenko V Hunt T Kay M\\n395 Mukherjee G Rajan J DespacioReyes G Saunders G Steward C Harte R Lin M\\n396 Howald C Tanzer A Derrien T Chrast J Walters N Balasubramanian S Pei B\\n397 Tress M Rodriguez J M Ezkurdia I Van Baren J Brent M Haussler D Kellis M\\n398 Valencia A Reymond A Gerstein M Guigo R Hubbard T J 2012 GENCODE the\\n399 reference human genome annotation for The ENCODE Project Genome Res 22 176074\\n400 Hutton M Lendon C L Rizzu P Baker M Froelich S Houlden H PickeringBrown S\\n401 Chakraverty S Isaacs A Grover A Hackett J Adamson J Lincoln S Dickson D\\n402 Davies P Petersen R C Stevens M De Graaff E Wauters E Van Baren J\\n403 Hillebrand M Joosse M Kwon J M Nowotny P Che L K Norton J Morris J C\\n404 Reed L A Trojanowski J Basun H Lannfelt L Neystat M Fahn S Dark F\\n405 Tannenberg T Dodd P R Hayward N Kwok J B Schofield P R Andreadis A\\n406 Snowden J Craufurd D Neary D Owen F Oostra B A Hardy J Goate A Van\\n407 Swieten J Mann D Lynch T Heutink P 1998 Association of missense and 5splice\\n408 site mutations in tau with the inherited dementia FTDP17 Nature 393 7025\\n409 Ito T Teo Y V Evans S A Neretti N Sedivy J M 2018 Regulation of Cellular Senescence\\n410 by Polycomb Chromatin Modifiers through Distinct DNA Damage and Histone Methylation\\n411 Dependent Pathways Cell Rep 22 34803492\\n412 Jeganathan S Von Bergen M Brutlach H Steinhoff H J Mandelkow E 2006 Global hairpin\\n413 folding of tau in solution Biochemistry 45 228393\\n414 Josephs K A 2018 Rest in peace FTDP17 Brain 141 324331\\n415 Kassis J A Brown J L 2013 Polycomb group response elements in Drosophila and vertebrates\\n416 Adv Genet 81 83118\\n417 Klein HU Mccabe C Gjoneska E Sullivan S E Kaskow B J Tang A Smith R V Xu J\\n418 Pfenning A R Bernstein B E Meissner A Schneider J A Mostafavi S Tsai LH\\n419 YoungPearse T L Bennett D A De Jager P L 2019 Epigenomewide study uncovers\\n420 largescale changes in histone acetylation driven by tau pathology in aging and Alzheimers\\n421 human brains Nature Neuroscience 22 3746\\n422 Ku M Koche R P Rheinbay E Mendenhall E M Endoh M Mikkelsen T S Presser A\\n423 Nusbaum C Xie X Chi A S Adli M Kasif S Ptaszek L M Cowan C A Lander\\n424 E S Koseki H Bernstein B E 2008 Genomewide analysis of PRC1 and PRC2\\n425 occupancy identifies two classes of bivalent domains PLoS Genet 4 e1000242\\n426 Kuehner J N Yao B 2019 The Dynamic Partnership of Polycomb and Trithorax in Brain\\n427 Development and Diseases Epigenomes 3 1724\\n428 Kuleshov M V Jones M R Rouillard A D Fernandez N F Duan Q Wang Z Koplev S\\n429 Jenkins S L Jagodnik K M Lachmann A Mcdermott M G Monteiro C D\\n10\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n430 Gundersen G W Maayan A 2016 Enrichr a comprehensive gene set enrichment\\n431 analysis web server 2016 update Nucleic Acids Res 44 W907\\n432 Lang AL Eulalio T Fox E Yakabi K Bukhari S A Kawas C H Corrada M M\\n433 Montgomery S B Heppner F L Capper D Nachun D Montine T J 2022\\n434 Methylation differences in Alzheimers disease neuropathologic change in the aged human\\n435 brain Acta Neuropathologica Communications 10 174\\n436 Laugesen A Højfeldt J W Helin K 2016 Role of the Polycomb Repressive Complex 2\\n437 PRC2 in Transcriptional Regulation and Cancer Cold Spring Harbor Perspectives in\\n438 Medicine 6\\n439 Li J Hart R P Mallimo E M Swerdel M R Kusnecov A W Herrup K 2013 EZH2\\n440 mediated H3K27 trimethylation mediates neurodegeneration in ataxiatelangiectasia Nat\\n441 Neurosci 16 174553\\n442 Liu PP Xu YJ Teng ZQ Liu CM 2017 Polycomb Repressive Complex 2 Emerging\\n443 Roles in the Central Nervous System The Neuroscientist 24 208220\\n444 Liu X Liu X 2022 PRC2 Chromatin Regulation and Human Disease Insights From Molecular\\n445 Structure and Function Front Oncol 12 894585\\n446 Long J M Holtzman D M 2019 Alzheimer Disease An Update on Pathobiology and\\n447 Treatment Strategies Cell 179 312339\\n448 Loomis P A Howard T H Castleberry R P Binder L I 1990 Identification of nuclear tau\\n449 isoforms in human neuroblastoma cells Proc Natl Acad Sci U S A 87 84226\\n450 Love M I Huber W Anders S 2014 Moderated estimation of fold change and dispersion for\\n451 RNAseq data with DESeq2 Genome Biol 15 550\\n452 Lovell M A Markesbery W R 2007 Oxidative DNA damage in mild cognitive impairment and\\n453 latestage Alzheimers disease Nucleic Acids Res 35 7497504\\n454 Ludolph A C Kassubek J Landwehrmeyer B G Mandelkow E Mandelkow E M Burn D\\n455 J CaparrosLefebvre D Frey K A De Yebenes J G Gasser T Heutink P Hoglinger\\n456 G Jamrozik Z Jellinger K A Kazantsev A Kretzschmar H Lang A E Litvan I\\n457 Lucas J J Mcgeer P L Melquist S Oertel W Otto M Paviour D Reum T Saint\\n458 Raymond A Steele J C Tolnay M Tumani H Van Swieten J C Vanier M T\\n459 Vonsattel J P Wagner S Wszolek Z K 2009 Tauopathies with parkinsonism clinical\\n460 spectrum neuropathologic basis biological markers and treatment options Eur J Neurol 16\\n461 297309\\n462 Montalbano M Jaworski E Garcia S Ellsworth A Mcallen S Routh A Kayed R 2021\\n463 Tau Modulates mRNA Transcription Alternative Polyadenylation Profiles of hnRNPs\\n464 Chromatin Remodeling and Spliceosome Complexes Front Mol Neurosci 14 742790\\n465 Montalbano M Mcallen S Puangmalai N Sengupta U Bhatt N Johnson O D Kharas M\\n466 G Kayed R 2020 RNAbinding proteins Musashi and tau soluble aggregates initiate\\n467 nuclear dysfunction Nat Commun 11 4305\\n468 Moritz L E Trievel R C 2018 Structure mechanism and regulation of polycombrepressive\\n469 complex 2 J Biol Chem 293 1380513814\\n470 Mullaart E Boerrigter M E Ravid R Swaab D F Vijg J 1990 Increased levels of DNA\\n471 breaks in cerebral cortex of Alzheimers disease patients Neurobiol Aging 11 16973\\n472 Owen B M Davidovich C 2022 DNA binding by polycombgroup proteins searching for the\\n473 link to CpG islands Nucleic Acids Res 50 48134839\\n474 Papin S Paganetti P 2020 Emerging Evidences for an Implication of the Neurodegeneration\\n475 Associated Protein TAU in Cancer Brain Sci 10\\n476 Phillips T 2008 The Role of Methylation in Gene Expression Nature Education 1\\n11\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n477 Reinig J Ruge F Howard M Ringrose L 2020 A theoretical model of PolycombTrithorax\\n478 action unites stable epigenetic memory and dynamic regulation Nature Communications 11\\n479 4782\\n480 Rico T Gilles M Chauderlier A Comptdaer T Magnez R Chwastyniak M Drobecq H\\n481 Pinet F Thuru X Buée L Galas M C Lefebvre B 2021 Tau Stabilizes Chromatin\\n482 Compaction Front Cell Dev Biol 9 740550\\n483 Rossi G Dalpra L Crosti F Lissoni S Sciacca F L Catania M Di Fede G Mangieri M\\n484 Giaccone G Croci D Tagliavini F 2008 A new function of microtubuleassociated\\n485 protein tau involvement in chromosome stability Cell Cycle 7 178894\\n486 Rossi G Redaelli V Contiero P Fabiano S Tagliabue G Perego P Benussi L Bruni A C\\n487 Filippini G Farinotti M Giaccone G Buiatiotis S Manzoni C Ferrari R Tagliavini\\n488 F 2018 Tau Mutations Serve as a Novel Risk Factor for Cancer Cancer Res 78 37313739\\n489 Schumacher A Faust C Magnuson T 1996 Positional cloning of a global regulator of anterior\\n490 posterior patterning in mice Nature 383 250253\\n491 Shireby G Dempster E L Policicchio S Smith R G Pishva E Chioza B Davies J P\\n492 Burrage J Lunnon K Seiler Vellame D Love S Thomas A Brookes K Morgan K\\n493 Francis P Hannon E Mill J 2022 DNA methylation signatures of Alzheimers disease\\n494 neuropathology in the cortex are primarily driven by variation in nonneuronal celltypes\\n495 Nature Communications 13 5620\\n496 Si Z Sun L Wang X 2021 Evidence and perspectives of cell senescence in neurodegenerative\\n497 diseases Biomedicine Pharmacotherapy 137 111327\\n498 Sola M Magrin C Pedrioli G Pinton S Salvadè A Papin S Paganetti P 2020 Tau affects\\n499 P53 function and cell fate during the DNA damage response Commun Biol 3 245\\n500 Spillantini M G Murrell J R Goedert M Farlow M R Klug A Ghetti B 1998 Mutation\\n501 in the tau gene in familial multiple system tauopathy with presenile dementia Proc Natl Acad\\n502 Sci U S A 95 773741\\n503 Straining R Eighmy W 2022 Tazemetostat EZH2 Inhibitor J Adv Pract Oncol 13 158163\\n504 Sultan A Nesslany F Violet M Begard S Loyens A Talahari S Mansuroglu Z Marzin D\\n505 Sergeant N Humez S Colin M Bonnefoy E Buee L Galas M C 2011 Nuclear\\n506 tau a key player in neuronal DNA protection J Biol Chem 286 456675\\n507 Thurston V C Zinkowski R P Binder L I 1996 Tau as a nucleolar protein in human\\n508 nonneural cells in vitro and in vivo Chromosoma 105 2030\\n509 Ulrich G Salvade A Boersema P Cali T Foglieni C Sola M Picotti P Papin S \\n510 Paganetti P 2018 Phosphorylation of nuclear Tau is modulated by distinct cellular\\n511 pathways Sci Rep 8 17702\\n512 Vijayanathan M TrejoArellano M G Mozgová I 2022 Polycomb Repressive Complex 2 in\\n513 EukaryotesAn Evolutionary Perspective Epigenomes 6\\n514 Violet M Delattre L Tardivel M Sultan A Chauderlier A Caillierez R Talahari S\\n515 Nesslany F Lefebvre B Bonnefoy E Buee L Galas M C 2014 A major role for Tau\\n516 in neuronal DNA and RNA protection in vivo under physiological and hyperthermic\\n517 conditions Front Cell Neurosci 8 84\\n518 Von Schimmelmann M Feinberg P A Sullivan J M Ku S M Badimon A Duff M K\\n519 Wang Z Lachmann A Dewell S Maayan A Han M H Tarakhovsky A Schaefer\\n520 A 2016 Polycomb repressive complex 2 PRC2 silences genes responsible for\\n521 neurodegeneration Nat Neurosci 19 132130\\n522 Wang L Wang S Li W 2012 RSeQC quality control of RNAseq experiments\\n523 Bioinformatics 28 21845\\n524 Wingett S W Andrews S 2018 FastQ Screen A tool for multigenome mapping and quality\\n525 control F1000Res 7 1338\\n12\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n526 Xie Z Bailey A Kuleshov M V Clarke D J B Evangelista J E Jenkins S L Lachmann\\n527 A Wojciechowicz M L Kropiwnicki E Jagodnik K M Jeon M Maayan A 2021\\n528 Gene Set Knowledge Discovery with Enrichr Current Protocols 1 e90\\n529 Yang J Liu M Hong D Zeng M Zhang X 2021 The Paradoxical Role of Cellular\\n530 Senescence in Cancer Front Cell Dev Biol 9 722205\\n531 Zhang L Silva T C Young J I Gomez L Schmidt M A HamiltonNelson K L Kunkle B\\n532 W Chen X Martin E R Wang L 2020 Epigenomewide metaanalysis of DNA\\n533 methylation differences in prefrontal cortex implicates the immune processes in Alzheimers\\n534 disease Nat Commun 11 6114\\n535 Zhao L Li J Ma Y Wang J Pan W Gao K Zhang Z Lu T Ruan Y Yue W Zhao S\\n536 Wang L Zhang D 2015 Ezh2 is involved in radial neuronal migration through regulating\\n537 Reelin expression in cerebral cortex Sci Rep 5 15484\\n538\\n539\\n540 Figure 1 Deregulation of the PRC2 pathway in human TauKO SHSY5Y neuroblastoma cells\\n541 A Scheme of the procedure for the RNAseq and EnrichR analyses in Tauexpressing WT and\\n542 Tauknockout TauKO cells BC The EnrichR analysis based on 723 upregulated genes in Tau\\n543 KO cells resulted in the enrichment of the PRC2 pathway with the ChIP datasets B and of\\n544 H3K27me3 with the epigenomics datasets C\\n545\\n13\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n546\\n547 Figure 2 Reduced PRC2 complex in TauKO SHSY5Y cells\\n548 A Shown are matched protein amounts of parental WT or TauKO cell lysates analyzed by\\n549 western blot biological triplicates on a single gel with EZH2 SUZ12 or GAPDH primary\\n550 antibodies and antirabbit IgG IRDye 800CW secondary antibody The EZH2 and SUZ12 signals\\n551 were normalized on the respective GAPDH signals and reported as fold of WT mean SD of 9\\n552 biological replicates unpaired MannWhitney test B Determination of nuclear EZH2 or SUZ12\\n553 mean fluorescent intensity analyzed by immune fluorescence staining and laser confocal microscopy\\n554 with EZH2 or SUZ12 antibodies revealed with an antirabbit AlexaFluor 488 antibody Data obtained\\n555 with a DAPI nuclear mask ImageJ are reported as fold of WT mean SEM of 292475 nuclei from\\n556 two EZH2 or three SUZ12 independent experiments unpaired MannWhitney test C Shown\\n557 are RTPCR determination of mRNA with specific primers for EZH2 or SUZ12 Normalization was\\n558 performed on the geometric mean of the GAPDH and HPRT1 mRNA values and reported as fold of\\n559 WT mean SD of 12 biological replicates unpaired MannWhitney test D Shown are matched\\n560 protein amounts of cell lysates subjected to immune isolation IP with EZH2 or SUZ12 antibodies or\\n561 matched amounts of control antibodies ctrl IP Samples were resolved on a single same gel and\\n562 analyzed by western blot with EZH2 or SUZ12 antibodies and secondary antirabbit IgG IRDye\\n563 800CW antibody\\n564\\n14\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n565\\n566 Figure 3 Reduced PRC2 activity in TauKO SHSY5Y cells\\n567 A Shown are matched protein amounts of parental WT or TauKO cell lysates analyzed by\\n568 western blot biological triplicates on a single gel with H3K27me3 H3 or GAPDH primary\\n569 antibodies and antirabbit IgG IRDye 800CW secondary antibody The H3K27me3 and H3 signals\\n570 were normalized for GAPDH and reported as fold of WT for the H3K27me3H3 ratios mean SD\\n571 of 89 biological replicates unpaired MannWhitney test B Nuclear H3K27me3 mean fluorescent\\n572 intensity was determined by immune fluorescence staining and laser confocal microscopy Data\\n573 obtained with a DAPI nuclear mask ImageJ are reported as fold of WT mean SEM of 695716\\n574 nuclei from five independent experiments unpaired MannWhitney test C Shown are RTPCR\\n575 determination of mRNA with specific primers as indicated Normalization was performed on the\\n576 geometric mean of the GAPDH and HPRT1 mRNA values and reported as fold of WT mean SD\\n577 of 312 biological replicates unpaired MannWhitney test\\n578\\n15\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n579\\n580 Figure 4 Increased IGFBP3 in SHSY5Y cells after TauKO or PRC2 inhibition\\n581 A Shown are matched protein amounts of parental WT or TauKO cell lysates analyzed by\\n582 western blot biological triplicates on a single gel with IGFBP3 or GAPDH primary antibodies and\\n583 antimouse IgG IRDye 680RD or antirabbit IgG IRDye 800CW secondary antibodies The IGFBP3\\n584 signals were normalized for GAPDH and reported as fold of WT mean SD of 89 biological\\n585 replicates unpaired MannWhitney test BC Shown is a western blot of matched protein amounts\\n586 of SHSY5Y cells treated for 4 days in the absence WT or presence of 10 μM Tazemetostat\\n587 EZH2i Biological triplicates on a single gel were probed B with H3K27me3 H3 or GAPDH\\n588 primary antibodies and antirabbit IgG IRDye 800CW secondary antibody or C with IGFBP3 or\\n589 GAPDH antibodies Protein signals were normalized for GAPDH and reported as fold of WT mean\\n590 SD of 6 biological replicates unpaired MannWhitney test\\n591\\n16\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n592\\n593 Figure 5 Increased IGFBP3induced senescence in cells\\n594 A Senescence markers were analyzed in parental WT TauKO or 10 μM Tazemetostattreated\\n595 parental EZH2i cells The nuclear P16 fluorescent intensity P16 IF was determined with a DAPI\\n596 nuclear mask ImageJ by immune fluorescence staining and laser confocal microscopy and reported\\n597 as fold of WT mean sem of 19913153 nuclei The percent of senescenceassociated βGal positive\\n598 cells βGal was determined by automated cell imaging mean SD of 714 fields Living cells\\n599 labeled with the acidotrophic dye LysoTracker DOs were imaged on a laser confocal microscope\\n600 and analyzed for the size area of 6433429 DOs and mean number per cell 1318 fields of\\n601 LysoTrackerpositive organelles ImageJ Values are reported as fold of WT mean sem area or\\n602 SD number nonparametric KrustalWallis and Dunns multiple comparison test B Matched\\n603 protein amounts of SHSY5Y cells transduced with mock ctrl or IGFBP3 shRNA IGFBP3KD\\n604 pseudo lentiviral particles were analyzed by western blot biological triplicates on a single gel with\\n605 IGFBP3 or GAPDH primary antibodies and antimouse IgG IRDye 680RD or antirabbit IgG IRDye\\n606 800CW secondary antibodies The IGFBP3 signals were normalized for GAPDH and reported as fold\\n607 of WT mean SD of 9 biological replicates unpaired MannWhitney test C As in A for SH\\n608 SY5Y cells transduced with mock ctrl or IGFBP3 shRNA IGFBP3KD pseudo lentiviral particles\\n609 P16 IF mean sem of 669881 nuclei βGal mean SD of 6 fields DOs area of 456551 DOs\\n610 mean number per cell 5 fields of LysoTrackerpositive organelles ImageJ Values are reported as\\n611 fold of WT mean sem area or SD number unpaired MannWhitney test\\n612\\n17\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n613 Supplementary Figure 1\\n614\\n615 Supplementary Figure 1 Reduced EZH2SUZ12 and increased IGFBP3 in an independent\\n616 TauKO SHSY5Y cell line\\n617 A Nuclear EZH2 or SUZ12 mean fluorescent intensity was analyzed by immune fluorescence\\n618 staining and laser confocal microscopy with EZH2 or SUZ12 antibodies revealed with an antirabbit\\n619 AlexaFluor 488 antibody Data obtained with a DAPI nuclear mask ImageJ are reported as fold of\\n620 WT mean sem of 202208 nuclei EZH2 or 182184 nuclei SUZ12 unpaired MannWhitney\\n621 test B IGFBP3 was determined by western blot for matched protein amounts of parental WT or\\n622 TauKO 2 cell lysates biological triplicates on a single gel Data are reported as fold of WT mean\\n623 SD of 9 biological replicates unpaired MannWhitney test\\n18\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n624 Supplementary Table I Transcripts upregulated in human TauKO SHSY5Y cells Adj P\\n625 05 listed in order of decreasing significance\\nSymbol log2FC Symbol log2FC Symbol log2FC Symbol log2FC\\nCDKN1A 224 TMEM63A 219 WWC3 139 PACSIN2 039\\nC22orf34 885 PDGFA 448 RELB 175 AGA 182\\nSLC12A7 293 ASB9 314 LGR5 209 PRCP 058\\nEVC2 723 ZFP36L2 076 GPX7 086 NTRK2 313\\nDCN 1043 CILP 270 SLC10A3 117 SSPO 279\\nTNFRSF1A 1105 LOC100507156 269 ARHGEF40 099 XYLT1 274\\nHMCN2 205 CAVIN2 465 CXCL16 490 APLP2 077\\nAPOBEC3C 327 HAS2 602 SPATA20 104 CBR3 169\\nCOL3A1 826 TGFB1I1 104 TBX2 091 ABCA7 085\\nMGP 699 CDC42EP1 248 IGFBP2 121 PDLIM7 100\\nRGS11 170 PSMB10 244 IL11RA 140 MEST 465\\nCFLAR 138 OBP2A 569 NFKBIE 127 EDN3 511\\nRHBDF1 425 TRIL 174 LRP1B 568 ZBTB46 151\\nKCNG1 190 DDR1 148 PDE4A 127 BTG2 057\\nSEL1L3 630 SSH3 133 RBPMS2 072 TCTN3 050\\nS100A11 639 CRACR2B 193 AVIL 259 ABLIM3 162\\nCSF1 195 CLU 418 BHLHE40 544 TESK1 076\\nCCDC80 790 VCAN 501 HSD3B7 255 TNFRSF9 324\\nCD9 313 TNS2 197 TPBG 267 PXDC1 220\\nTIMP1 739 S100A10 790 ZNF425 073 LRP10 127\\nPTGS1 625 NT5E 488 MCAM 192 SERTAD1 110\\nRBPMS 608 RDH10 262 KIAA0040 138 SLC26A11 082\\nLTBP2 156 GNG11 104 FOXI3 360 FMN1 287\\nEVA1A 727 MTUS2 511 C1QTNF1AS1 116 FSTL1 217\\nS100A16 704 LAT2 332 PGGHG 112 FAM46C 327\\nGNG3 271 ST6GAL1 261 ORMDL2 085 POP5 064\\nTRIM17 153 HLX 295 KRT17 414 NUAK1 311\\nGLIS2 132 LUM 489 CERCAM 117 ZDHHC1 084\\nMAB21L2 987 PEAR1 078 POLD4 171 IRF2BPL 084\\nMR1 541 S1PR3 165 PLK2 205 SEMA3B 163\\nARHGAP36 304 GPX3 159 ANTXR1 222 RAB3IL1 096\\nTUBB6 131 RBM47 648 VIM 183 BMP1 113\\nA2M 955 NQO1 189 ZC3H12A 150 NOTCH4 141\\nPHLDA3 123 ARSA 129 RBM24 466 LOC101927752 111\\nSYT9 448 SPSB2 129 PANX2 175 STAC 111\\nINSRR 079 PTN 399 SERPINE1 314 COCH 122\\nHGF 1053 TMEM254 086 HECW1 242 CRLF1 375\\nABCC3 627 CCL2 438 CDH2 233 METTL7A 078\\nMOCOS 348 ITPKB 224 AAED1 172 TMEM150C 210\\nC7 290 TP53I13 131 ANXA7 073 TMEM253 184\\nLCAT 119 GPNMB 478 EPS8L2 148 SIRPA 287\\nITGA5 560 ID4 392 SERPINB8 217 CYTH3 049\\nIDUA 164 KIRREL 884 SAMD14 106 ATXN1 237\\nPRR16 184 TRIM5 531 CYSTM1 226 GJC2 161\\nHS3ST3B1 617 KLHL36 120 PPCS 049 TMED1 081\\nOSGIN1 167 SDC4 274 SLC7A4 257 SLC39A11 051\\n19\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nNACC2 142 ABI3BP 564 RAB26 128 RTL5 099\\nCELSR1 530 ITM2A 428 PLEKHG5 076 FOXD1 276\\nGPRC5C 349 KCNH2 084 FAM110B 074 LRRC29 127\\nKCNMB4 125 CORIN 709 CHRNA9 451 WIPI1 122\\nCAVIN1 539 GALNT6 281 RUSC1 072 ADAMTS2 213\\nCHRD 554 THSD4 239 ROM1 078 FBLIM1 158\\nLOXL2 368 IER5L 147 FEZ1 092 SIK2 173\\nERVMER341 340 LDLRAP1 147 KIF26A 100 ZNF467 273\\nTRIOBP 119 PLEKHA4 134 NPC2 171 PTCH2 138\\nMSX2 110 ACADS 112 METRNL 177 NRBP2 059\\nNOTCH1 159 DHRS1 091 AGRN 120 MYO15B 106\\nSPHK1 405 AP1G2 067 HYI 114 CXCL12 316\\nGBP2 629 SP5 648 SMIM3 300 CMTM3 120\\nLAMB3 406 HEG1 346 FN1 299 SLC27A3 107\\nAPLNR 294 CPVL 143 C1orf204 244 ARSB 082\\nFAM129A 395 COL1A2 284 BOK 129 LINC00890 703\\nMMP15 244 GAD1 494 SIX1 668 HES1 139\\nTFEB 232 ARSD 146 SPOCK2 208 PPM1M 073\\nIL13RA1 507 ORAI3 169 FAM124A 132 HBEGF 273\\nSLC12A4 135 ARID3A 063 IGF2BP2 880 COL4A1 116\\nFBXL7 060 ITGA6 465 NRIP2 393 PPL 131\\nTGFBI 617 NRP1 496 CARNS1 378 PCOLCE 101\\nVTN 411 FOXC1 215 EYA4 323 C12orf75 142\\nPGF 243 SHROOM1 140 IL10RB 110 CHGB 134\\nVWA5B2 359 ACPP 617 DNALI1 060 POPDC2 129\\nSP110 459 ARSJ 443 HEXIM1 072 GPRC5A 364\\nFGFRL1 565 COL27A1 211 TGFBR2 289 ANXA4 074\\nACHE 192 CA12 572 BOC 074 NFKB2 113\\nJDP2 188 ACADVL 117 SNTB1 716 MAP3K12 051\\nIGSF11 411 NTNG2 137 SIX2 404 SLC27A1 092\\nLGALS3 136 IFITM2 559 FGFR2 279 HS3ST5 381\\nSPRN 416 SERPINF1 290 C1QTNF1 214 WHRN 147\\nLHFP 296 SIX5 227 FAM114A1 154 ZNF582AS1 137\\nTGM2 251 NTNG1 374 ENDOD1 120 GNAI2 112\\nASL 133 TGFB3 420 CTDSPL 110 NPY 104\\nLAYN 312 CRYM 402 TRADD 102 SLIT2 286\\nHSPB7 351 RRAS 237 PDGFRL 276 DUSP3 086\\nNEDD9 445 MB21D2 310 GALNT2 067 LMF2 088\\nMST1 109 TMBIM1 399 BDKRB2 196 NCK2 045\\nHTRA1 598 HTR4 733 MYO3B 459 MCHR1 323\\nSH2D2A 579 TAPBP 130 CDH11 180 FNDC5 227\\nPTGER2 563 CTSS 436 IFT43 089 CST3 106\\nMAP3K6 126 RAMP1 122 LRPAP1 073 TSPAN9 078\\nTNFRSF12A 422 COL6A2 179 IAH1 069 GNB5 041\\nPTPN14 356 PGAP3 096 S100A2 209 UBA7 228\\nPAQR6 097 PPIC 263 EFEMP2 179 ZFP36 181\\nSLC6A9 224 TPST1 115 HLAC 216 RBM3 044\\nPLA2G4C 306 LRRC4C 591 PLXDC2 596 GBP3 467\\nNOL3 108 GLIPR2 119 SRPX 262 SNX21 057\\nSPON2 388 FECH 045 SLC9A1 138 HPCA 166\\nLTBP1 318 CASP4 453 ACCS 059 LRP1 100\\n20\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nATP8A2 649 SDK2 294 SVIL 237 CHPF2 072\\nSLC16A4 540 PLAU 308 KIAA1217 206 RNH1 093\\nKCNAB1 526 MIR100HG 542 MTCL1 095 CD59 169\\nCORO2B 338 OSBPL5 268 DHRS12 067 SHISA4 116\\nPIEZO1 324 SLC22A18 161 AFAP1L1 170 KCNJ2 381\\nKIF1C 203 CYBA 116 SHISA5 181 TLR2 298\\nINPP1 080 GADD45A 059 ELMO1 106 CD274 308\\nRGS3 254 LMNA 093 RAB7A 031 EVC 105\\nRNASET2 104 SCUBE2 286 COL6A3 251 CEP170B 090\\nPLAT 314 RELN 474 MARCH2 084 CHST14 069\\nCOL7A1 237 PTPN3 375 RABEP2 084 HGSNAT 080\\nC10orf10 627 ARPIN 099 TIRAP 059 FZD7 212\\nPLPP4 573 COL13A1 617 SELENOM 115 MYO1D 141\\nAGT 519 C1QTNF2 227 CYBRD1 296 CNTNAP1 107\\nIGFBP3 425 IL4R 570 IGSF1 113 TPM2 125\\nMELTF 112 SLC31A2 209 RAB38 234 HOMER3 107\\nEHBP1L1 180 TAP1 316 VPS9D1 101 LOC339803 059\\nSYT12 706 PRSS23 316 SFXN5 073 SFRP1 165\\nCYTOR 748 SIPA1 093 TRABD2B 552 GDF15 139\\nTFPI2 236 IL32 361 ADORA2A 214 BOLA3 064\\nTNC 501 ZNF185 203 BAALC 228 GAP43 198\\nNLRC5 323 PAPPA 617 B4GALT1 157 ARHGAP6 271\\nANXA2 203 FAM19A5 334 DKK1 125 DYNC1I1 300\\nADAMTS15 493 SYTL4 299 MARVELD1 081 AHNAK 252\\nSYK 139 EDN1 466 GBX2 609 FAM131B 424\\nSOX9 419 SYNGR3 110 C6orf1 081 IFI6 103\\nCOL5A1 466 DGKQ 115 IL33 588 TGFB1 276\\nGPC3 516 DEPTOR 482 TMEFF2 182 IL11 175\\nFAM89A 533 GLI1 444 PDLIM1 175 RARB 270\\nLOC101927809 362 EPDR1 073 FBXL8 116 CMKLR1 378\\nGJA1 842 TRAF1 360 TMEM8A 089 ZYX 122\\nOLFML3 444 ASTN1 066 OSMR 651 SIAE 113\\nDRAM1 279 EPS8L1 120 FBN1 285 RPN2 053\\nMMP11 197 FSTL3 282 SLC39A13 076 LOC645166 128\\nMETRN 160 FKRP 059 STARD8 171 KLF2 254\\nSCN4B 130 DGKA 122 LOC101927204 344 SPARCL1 688\\nEWSAT1 466 KIAA1211L 237 SPOCD1 423 NTAN1 064\\nSGPP2 340 TBX18 679 DEGS1 058 ANO10 051\\nSH3TC1 170 PID1 347 PNPLA3 400 HHAT 075\\nZFYVE21 080 B3GNT9 106 ISYNA1 096 CREB3L2 128\\nMIR44352HG 583 TNFRSF19 160 IFITM3 494 C19orf66 117\\nANGPTL4 580 GPR37 322 PLTP 086 PLXNB1 048\\nSH3RF3 256 PTHLH 493 KDELR3 227 SCN9A 317\\nCD82 191 DNAJC22 270 CASP8 429 SPATA2L 112\\nDKK2 440 CD151 145 CEL 140 ATG16L2 073\\nNTRK1 127 GAL3ST1 148 NOTCH3 128 NUAK2 239\\nECM1 515 LOXL4 115 SPRY4 116 SPEG 066\\nB3GNT4 291 PMP22 093 COLEC11 080 CEMIP 515\\nSERPINE2 709 SVEP1 468 PHYKPL 050 GFRA1 304\\nTXNDC11 065 LSR 198 MUM1 048 UXS1 107\\nTCF7L1 216 DOCK2 475 RAB20 193 DNASE1L2 175\\n21\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nPPP1R13B 132 PXDN 095 AJUBA 125 B3GAT3 081\\nCLCF1 516 DUSP10 250 CPXM1 104 POLR2L 090\\nTRIM21 273 MRC2 235 NPAS3 429 MAN2B2 066\\nYAP1 561 DUSP6 102 KREMEN1 121 CTTN 031\\nKRT18 521 ABTB1 103 BDKRB1 290 SORBS3 074\\nGABARAPL1 191 ABHD15 119 LGALS1 115 BATF3 242\\nGRIN2C 475 TRPM4 126 LTBP3 093 SEMA3D 422\\nRHOC 179 EPN3 424 LOC100506258 375 B4GALNT3 094\\nLRP4 191 MAN1A1 333 TRIB2 195 ADAM19 185\\nEVA1B 266 TMEM108AS1 336 SGSH 080 EFHD1 177\\nICAM1 482 SCARF2 130 IL17RA 284 AK5 140\\nTAGLN 182 PTPRR 222 FAM120AOS 048 FMNL1 119\\nPLPPR3 126 MIPEP 069 PTGR1 265 ALKAL2 324\\nSSC5D 472 MVP 202 ITGA7 223 MSRB3 238\\nADAMTSL4 343 CORO2A 243 VIPR2 217 SH2B3 086\\nPTPRB 284 OLFML2A 195 TMSB4X 166 GFRA2 231\\nRET 049 ITGA3 265 SUMF1 081 CYB5R2 447\\nPTPRE 426 CPNE2 100 XYLT2 076 TMEM59L 081\\nTHBS2 960 PQLC3 146 TMEM100 347 DSTNP2 094\\nAQP3 309 RPS6KA4 088 COL11A2 194 BRINP1 233\\nFAM20C 685 C1QTNF6 151 ITPR3 145 SPON1 472\\nBCL3 289 SHISA2 542 CDC42BPG 245 LOC101926941 091\\nRENBP 188 MPP4 547 SRD5A3 047 ID1 082\\nALS2CL 185 GPC4 409 HSPB8 313 SH3BGRL3 092\\nECEL1 302 LPAR1 399 LTK 173 CRELD1 078\\nPHLDA1 370 NME3 143 FLI1 530 PSMB8 305\\nFAM111A 450 PBXIP1 207 LHX9 459 ADAMTS7 084\\nACTA2 168 WTIP 304 TSPAN8 252 RBCK1 064\\nTPM1 189 SSBP2 220 SMAGP 237 IRF6 168\\nIL13RA2 448 CHST1 205 FAM196B 505 DRAXIN 128\\nMOV10L1 323 EMILIN1 128 SPRY1 164 NOD2 193\\nTMEM150A 115 CPT1A 076 ASIC3 087 CAPS 073\\nSPARC 282 C1R 274 TTLL3 081\\n626\\n627\\n22\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n628 Supplementary Table II CHiP datasets identified with 723 upregulated transcripts in human\\n629 TauKO cells Adj P01 Analysis performed August 4th 2022\\nChEA_2016 Term Adj P Comment\\nSUZ12 20075857 ChIPSeq MESCs Mouse 122E31 PRC2 core\\nMTF2 20144788 ChIPSeq MESCs Mouse 373E21 PRC21 facultative subunit\\nELK3 25401928 ChIPSeq HUVEC Human 183E17 TX factor\\nRELA 24523406 ChIPSeq FIBROSARCOMA Human 127E12 TX factor NFKB subunit EZH2 interactor\\nSUZ12 18974828 ChIPSeq MESCs Mouse 189E12 PRC2 core\\nTCF21 26020271 ChIPSeq SMOOTH MUSCLE Human 190E12 TX factor basic helixloophelix\\nRACK7 27058665 ChipSeq MCF7 Human 178E11 TX regulator RACK receptor PRC2 regulator\\nSUZ12 27294783 ChipSeq ESCs Mouse 339E11 PRC2 core\\nEGR1 20690147 ChIPSeq ERYTHROLEUKEMIA Human 440E11 TX regulator C2H2 zink finger\\nSUZ12 18692474 ChIPSeq MEFs Mouse 920E11 PRC2 core\\nKDM2B 26808549 ChipSeq K562 Human 220E10 PRC1 core\\nEZH2 27294783 ChipSeq ESCs Mouse 220E10 PRC2 core\\nJARID2 20075857 ChIPSeq MESCs Mouse 620E10 PRC22 facultative subunit\\nRNF2 18974828 ChIPSeq MESCs Mouse 631E10 PRC1 core\\nEZH2 18974828 ChIPSeq MESCs Mouse 631E10 PRC2 core\\nWT1 20215353 ChIPChIP NEPHRON PROGENITOR Mouse 631E10 TX factor\\nRING1B 27294783 ChipSeq ESCs Mouse 675E10 PRC1 core\\nSUZ12 18692474 ChIPSeq MESCs Mouse 105E09 PRC2 core\\nSUZ12 18555785 ChIPSeq MESCs Mouse 407E09 PRC2 core\\nKDM2B 26808549 ChipSeq SUPB15 Human 483E09 PRC1 core\\nSRY 25088423 ChIPChIP EMBRYONIC GONADS Mouse 706E09 TX factor SRYBox\\nKLF4 26769127 ChipSeq PDACCell line Human 339E08 TX Kruppel\\nRNF2 27304074 ChipSeq ESCs Mouse 577E08 PRC1 core\\nWT1 25993318 ChIPSeq PODOCYTE Human 732E08 TX factor\\nJARID2 20064375 ChIPSeq MESCs Mouse 908E08 PRC22 facultative subunit\\nSOX2 20726797 ChIPSeq SW620 Human 131E07 TX factor SRYBox\\nRARG 19884340 ChIPChIP MEFs Mouse 246E07 TX factor ligand activated\\nUBF12 26484160 ChipSeq HMECDERIVED Human 352E07 TX factor RNA transcription\\nRUNX2 24764292 ChIPSeq MC3T3 Mouse 632E07 TX factor\\nTP53 20018659 ChIPChIP R1E Mouse 940E07 TX factor P53 family\\nSMC1 22415368 ChIPSeq MEFs Mouse 109E06 cohesin subunit PRC1 regulator\\nZNF217 24962896 ChIPSeq MCF7 Human 205E06 TX factor repressor PRC2 regulator\\nSA1 22415368 ChIPSeq MEFs Mouse 308E06 cohesin subunit\\nKDM2B 26808549 ChipSeq JURKAT Human 308E06 PRC1 core\\nRING1B 27294783 ChipSeq NPCs Mouse 308E06 PRC1 core\\nKLF5 25053715 ChIPSeq YYC3 Human 308E06 TX Kruppel\\nESR2 21235772 ChIPSeq MCF7 Human 487E06 TX factor hormone activated\\nKDM2B 26808549 ChipSeq DND41 Human 918E06 PRC1 core\\nEOMES 21245162 ChIPSeq HESCs Human 105E05 TX factor Tbox\\nP300 27058665 ChipSeq ZR7530cells Human 149E05 HAT\\nJUN 26020271 ChIPSeq SMOOTH MUSCLE Human 149E05 TX factor protooncogene\\nKLF6 26769127 ChipSeq PDACCell line Human 239E05 TX Kruppel\\nCJUN 26792858 ChipSeq BT549 Human 239E05 TX factor protooncogene\\nCTCF 27219007 ChipSeq ERYTHROID Human 239E05 TX regulator zink finger PRC2 regulator\\nATF3 23680149 ChIPSeq GBM1GSC Human 270E05 TX factor CREB\\n23\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nBACH1 22875853 ChIPPCR HELA AND SCP4 Human 363E05 TX factor CNCbZip PRC2 regulator\\nKDM2B 26808549 ChipSeq SILALL Human 635E05 PRC1 core\\nZFP281 27345836 ChipSeq ESCs Mouse 635E05 TX factor repressor PRC2 regulator\\nCEBPD 21427703 ChIPSeq 3T3L1 Mouse 741E05 TX factor bZIP\\nP63 26484246 ChipSeq KERATINOCYTES Human 000010 TX factor P53 family\\nTP63 17297297 ChIPChIP HaCaT Human 000013 TX factor P53 family\\nEED 16625203 ChIPChIP MESCs Mouse 000014 PRC2 core\\nNFI 21473784 ChIPSeq ESCs Mouse 000016 TX factor CTFNFI family\\nEZH2 27304074 ChipSeq ESCs Mouse 000021 PRC2 core\\nELF3 26769127 ChipSeq PDACCell line Human 000025 TX factor\\nLXR 22292898 ChIPSeq THP1 Human 000025 TX factor ligand activated\\nESR1 21235772 ChIPSeq MCF7 Human 000033 TX factor hormone activated\\nBRD4 25478319 ChIPSeq HGPS Human 000037 TX factor bromodomain\\nSMC3 22415368 ChIPSeq MEFs Mouse 000037 cohesin subunit PRC1 regulator\\nCLOCK 20551151 ChIPSeq 293T Human 000037 TX factor regulation of circadian rhythms\\nCTCF 27219007 ChipSeq Bcells Human 000037 TX regulator zink finger PRC2 regulator\\nSUZ12 16625203 ChIPChIP MESCs Mouse 000057 PRC2 core\\nCREB1 26743006 ChipSeq LNCaPabl Human 000057 TX factor CREB\\nCTCF 21964334 ChipSeq Bcells Human 000057 TX regulator zink finger PRC2 regulator\\nTP53 23651856 ChIPSeq MEFs Mouse 000071 TX factor P53 family\\nKLF4 18358816 ChIPChIP MESCs Mouse 000091 TX Kruppel\\nSOX9 24532713 ChIPSeq HFSC Mouse 000097 TX factor SRYBox\\nNUCKS1 24931609 ChIPSeq HEPATOCYTES Mouse 000097 TX regulator dna repair\\n630\\n24\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n631 Supplementary Table III Epigenomic datasets identified with 723 upregulated transcripts in\\n632 human TauKO cells Adj P01 Analysis performed August 4th 2022\\nEpigenomics Roadmap HM ChIP Term Adj P Comment\\nH3K27me3 H1 64E23 H3K27me3\\nH3K27me3 Colonic Mucosa 12E18 H3K27me3\\nH3K27me3 Mobilized CD34 Primary Cells 29E16 H3K27me3\\nH3K27me3 Fetal Brain 18E15 H3K27me3\\nH3K27me3 iPS20b 12E11 H3K27me3\\nH3K27me3 iPS DF 1911 73E11 H3K27me3\\nH3K27me3 CD34 Primary Cells 31E10 H3K27me3\\nH3K27me3 H9 42E10 H3K27me3\\nH3K27me3 CD8 Memory Primary Cells 31E09 H3K27me3\\nH3K27me3 iPS DF 69 14E08 H3K27me3\\nH3K27me3 CD4 CD25 CD45RA Naive Primary Cells 22E08 H3K27me3\\nH3K27me3 CD8 Naive Primary Cells 32E08 H3K27me3\\nH3K27me3 Rectal Smooth Muscle 40E08 H3K27me3\\nH3K27me3 H1 BMP4 Derived Mesendoderm Cultured Cells 97E08 H3K27me3\\nH2BK20ac IMR90 17E07 H2BK20ac\\nH3K27me3 CD4 CD25int CD127 Tmem Primary Cells 26E07 H3K27me3\\nH3K27me3 Duodenum Mucosa 31E07 H3K27me3\\nH3K27me3 iPS15b 13E06 H3K27me3\\nH3K27me3 H1 BMP4 Derived Trophoblast Cultured Cells 19E06 H3K27me3\\nH3K4me1 CD4 CD25 CD45RA Naive Primary Cells 95E06 H3K4me1\\nH3K27me3 Rectal Mucosa 16E05 H3K27me3\\nH3K4me1 H1 32E05 H3K4me1\\nH3K4me1 Brain Germinal Matrix 34E05 H3K4me1\\nH2BK20ac H1 35E05 H2BK20ac\\nH3K27me3 Brain Germinal Matrix 46E05 H3K27me3\\nH3K4me1 IMR90 58E05 H3K4me1\\nH3K27me3 CD4 CD25 CD45RO Memory Primary Cells 14E04 H3K27me3\\nH3K27me3 Pancreatic Islets 19E04 H3K27me3\\nH3K27me3 CD3 Primary Cells 24E04 H3K27me3\\nH3K27me3 Neurosphere Cultured Cells Cortex Derived 25E04 H3K27me3\\nH2BK12ac IMR90 27E04 H2BK12ac\\nH3K4me1 CD4 CD25 Th Primary Cells 27E04 H3K4me1\\nH3K4me1 Fetal Brain 28E04 H3K4me1\\nH3K27me3 CD4 Naive Primary Cells 32E04 H3K27me3\\nH3K27me3 Stomach Mucosa 43E04 H3K27me3\\nH3K27me3 CD4 CD25 CD127 Treg Primary Cells 52E04 H3K27me3\\nH3K27me3 Fetal Lung 76E04 H3K27me3\\nH3K27me3 CD4 CD25 Th Primary Cells 81E04 H3K27me3\\nH3K27me3 Duodenum Smooth Muscle 00011 H3K27me3\\nH2BK15ac IMR90 00018 H2BK15ac\\nH3K27me3 Brain Hippocampus Middle 00021 H3K27me3\\nH3K27me3 CD4 Memory Primary Cells 00028 H3K27me3\\nH2BK120ac IMR90 00031 H2BK120ac\\nH3K27me3 Brain Substantia Nigra 00031 H3K27me3\\nH3K4me1 iPS DF 69 66E03 H3K4me1\\n25\\nbioRxiv preprint doi this version posted June 5 2023 The copyright holder for this preprint which\\nwas not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n633 Supplementary Table IV qPCR primers\\nmRNA Forward primer 53 Reverse primer 53\\nEZH2 GACCTCTGTCTTACTTGTGGAGC CGTCAGATGGTGCCAGCAATAG\\nSUZ12 CCATGCAGGAAATGGAAGAATGTC CTGTCCAACGAAGAGTGAACTGC\\nIGFBP3 CGCTACAAAGTTGACTACGAGTC GTCTTCCATTTCTCTACGGCAGG\\nGPR37 TTCTGCCTTCCGCTGGTCATCT TGAAGGTGGTGACTCCCAGAGA\\nITGA3 GCCTGACAACAAGTGTGAGAGC GGTGTTCGTCACGTTGATGCTC\\nMRC2 GGCAAGGACAAGAAGTGCGTGT CTTTGGTGACGTTGCTGCGCTT\\nIRF6 AGAGAAGCAGCCACCGTTTGAG GATCATCCGAGCCACTACTGGA\\n634\\n26',\n",
              " 'bioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nCold Atmospheric Plasma for Alzheimers disease\\nXiao Chen1 Zhuonan Yu2 Chunyan Du1 Yueye Huang3 Zhaowei Chen4 Zhen Xu2 \\nZhitong Chen135 \\n1Paul C Lauterbur Research Center for Biomedical Imaging Institute of Biomedical and Health\\nEngineering Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen\\n518055 China\\n2Centre for Translational Medicine Research Development Institute of Biomedical and Health\\nEngineering Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen\\nChina\\n3Advanced Therapeutic Center National Innovation Center for Advanced Medical Devices Shenzhen\\n518100 China\\n4New Cornerstone Science Laboratory MOE Key Laboratory for Analytical Science of Food Safety and\\nBiology College of Chemistry Fuzhou University Fuzhou 350108 P R China\\n5State Key Laboratory of Biomedical Imaging Science and System Shenzhen 518055 China\\nCorresponding author Email ztchen1siataccn ZC zhenxusiataccn ZX\\nchenzwfzueducn ZC\\nXC and ZY contributed equally to this work\\nAbstract\\nLightning has been proposed as a pivotal energy source driving prebiotic chemical\\nevolution and early life processes Similarly external physical stimuli such as sound and\\nlight have been shown to modulate neurophysiological activity and mitigate Alzheimers\\ndisease AD pathology by promoting amyloidβ Aβ clearance Here we demonstrate\\nthat cold atmospheric plasma CAP acts as a joulelevel analog of lightning integrating\\nlight sound and reactive species to modulate AD progression in a mouse model Using\\nmultimodal analyses we show that CAP treatment enhances key neuroimmune signaling\\npathways in an AD murine model including microglial activation without inducing\\npathological alterations at the functional transcriptomic or proteomic levels in healthy\\nmice These findings highlight CAP as a safe and efficacious modality for modulating\\n1\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nneurodegenerative processes establishing a foundation for its therapeutic translation in AD\\nand related disorders\\nKeywords Cold Atmospheric plasma Alzheimers disease Lightning\\nIntroduction\\nAlzheimers disease AD is a progressive neurodegenerative disease characterized by\\nthe accumulation of amyloid beta Aβ plaques and the entanglement of\\nhyperphosphorylated tau protein1 2 These pathological changes collectively lead to\\nsynaptic dysfunction neuropathy and cognitive decline3 Globally AD affects millions of\\npeople and is a major challenge in the field of public health4 Although decades of research\\nhave explored targeted therapeutic strategies for amyloid and tau proteins5 6 these methods\\nhave limited effectiveness in alleviating symptoms or delaying disease progression partly\\ndue to the incomplete understanding of the complex multifactorial pathological\\nmechanisms of AD37 Therapies targeting amyloid proteins have not efficiently improved\\npatient prognosis suggesting that a more comprehensive strategy is needed for AD\\ntreatment\\nCurrently there is no known cure for AD and the efficacy of existing drug treatments\\nis limited highlighting the urgent need for new noninvasive therapies Among emerging\\ntherapies noninvasive physical intervention strategies have attracted growing attention\\nIn recent years studies have shown that there is impaired gamma frequency oscillation 30\\n100 Hz in AD patients and mouse models which is closely related to cognitive\\ndysfunction 8 Gamma frequency sensory stimulation has shown potential as an innovative\\nnonpharmacological intervention inducing brain gamma activity through external stimuli\\nsuch as 40 Hz light flashes or auditory pulses to alleviate AD pathology 9 10 In experimental\\nmodels such as 5xFAD or APPPS1 mice 40 Hz light or sound stimulation not only reduces\\nAβ burden but also improves behavioral test performance including cognitive function\\nand motivation recovery 11\\n2\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nLightning is a common atmospheric phenomenon in nature which is essentially a\\nplasma discharge12 As an active participant in the origin of life lightning produces light\\nsound and reactive nitrogen and oxygencontaining substances13 14 which play a role in\\nnitrogen fixation15 carbon dioxide reduction 16 and the production of life precursor\\nmolecules such as ammonia NH nitrate and formic acid 12 17 Despite its biological\\n4\\nrelevance the potential of lightningsimulating plasma phenomena in therapeutic\\napplications remains less explored\\nHere we propose cold atmospheric plasma CAP as a controllable joulelevel analog\\nof lightning that integrates photonic acoustic and reactive chemical components as a\\nmultimodal physical stimulus1618 Our findings demonstrate that CAP effectively\\nmodulates key signaling pathways implicated in AD progression including microglial\\nactivation while exhibiting no pathological alterations in healthy mice at the functional\\ntranscriptomic or proteomic levels CAP does not induce inflammation or oxidative stress\\nhighlighting its specificity biocompatibility and noninvasive safety profile Collectively\\nthese results establish CAP as a promising and safe physical intervention for\\nneurodegenerative diseases offering a novel paradigm for modulating complex brain\\npathophysiology\\nResults\\n1 The CAPderived reactive species composition is different between different\\nsources\\nOur plasma stimulation system was designed to deliver not only light and sound cues\\nto mice but also gaseous plasma components To achieve this an air pump was integrated\\nto introduce plasma effluents into the chamber while an open outlet at the upper end\\nmaintained air circulation Figure 1A Different carrier gases yield distinct plasma\\nchemistries generating diverse reactive species that influence both plasma behavior and\\npotential biological effects As expected airbased plasma produced abundant reactive\\noxygen and nitrogen species RONS including characteristic emission lines of O I OH\\n3\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nN₂ and N₂ Figure S1A Excited atomic oxygen O I can further react with molecular\\noxygen to form ozone which at high concentrations may be harmful to the respiratory\\nsystem Heliumbased plasma primarily generated reactive nitrogen and oxygen species\\nwith prominent heliumrelated spectral lines Figure S1B Nitrogen plasma yielded a\\nhigher proportion of reactive nitrogen species RNS Figure S1C whereas argon plasma\\nproduced both RNS and ROS together with argonspecific emissions Figure S1D To best\\nreplicate natural atmospheric conditions air plasma was selected for subsequent\\nexperiments\\nA\\nFigure 1 Schematic and characteristics of the CAP device Mice were acclimated to the environment\\nand then randomly assigned to either a control group no CAP exposure or a treatment group receiving\\nCAP for 30 minutes every other day over one month in dedicated devices At the conclusion of the\\ntreatment period behavioral tests were conducted and brains and major organs were collected for\\npathological staining and histological analysis to comprehensively evaluate the treatment effect and safety\\n2 CAP activates diseaseassociated signaling pathways in an AD mouse model\\n4\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nOne of the less explored frontiers for the clinical application of CAP is the\\nneurodegenerative disease We employed the 5xFAD mouse strain a wellestablished\\nmodel of AD to investigate the molecular effects of CAP stimulation Mice were randomly\\nallocated to the control group or CAP treatment group acclimated to the experimental\\nenvironment and underwent CAP intervention for 30 minutes every other day in a\\ndedicated CAP device over a onemonth period RNAsequencing of wholebrain tissues\\nfrom CAPtreated and control 5xFAD mice identified 16006 genes among which 261\\ngenes were differentially expressed distinctly segregating samples into two groups based\\non CAP treatment Figure 2A Several representative upregulated genes were validated in\\nthe brains of CAPtreated AD mice such as components of the complement system C1qa\\nC1qb C1qc C4b the phagocytosis system Fcgr1 and Cd68 and the Tyrobp causal\\nnetwork Trem2 and Tyrobp Figure 2B As these pathways are closely associated with\\nmicroglia activation and phagocytosis we postulated that CAP treatment might enhance\\nthe activity of microglia Further gene ontology analysis revealed an enrichment not only\\nin pathways associated with injurywound healing cytokineschemokines but notably in\\nmicrogliarelated phagocytosis and Tyr pathways within the CAPtreated group Figure\\n2C These results indicate that CAP exerts diverse effects on microglial gene expression\\nparticularly in pathways relevant to phagocytosis which is significantly implicated in\\nAlzheimers disease pathology\\nNext to validate transcriptomic findings qPCR confirmed increased expression of\\ncomplement phagocytic and Tyrobpnetwork genes following CAP exposure Figure 2D\\nConsistently immunofluorescence staining for C1qc Cxcl7a Tyrobp and Trem2\\ndemonstrated elevated protein levels in CAPtreated mice Figure 2E supporting\\nmicroglial activation We performed fluorescence staining for Aβ protein and microglia In\\nthe hippocampal region CA1 green fluorescence increased and pink fluorescence\\ndecreased suggesting microglia activation and Aβ protein reduction Figure 2F These\\nresults indicate that CAP facilitates Aβ clearance via microgliamediated phagocytosis\\n5\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nGiven the transcriptomic and proteomic alterations observed in CAPtreated AD\\nbrains we next examined whether these molecular changes translated into behavioral\\neffects Open field test Ymaze test and gripstrength tests were performed on 5xFAD\\nmice treated with CAP and without CAP exposure to evaluate locomotor activity anxiety\\ncognitive performance and limb muscle strength In the openfield test CAPtreated mice\\nshowed no significant difference in total distance traveled compared with controls\\nindicating that CAP treatment did not impair locomotor function Similarly the time spent\\nand the number of entries in the central zone were comparable between groups suggesting\\nthat CAP treatment would not cause anxietylike behavior Figure 2G Because excessive\\nRONS have been implicated in neurodegenerative pathology we assessed cognitive\\noutcomes using the Ymaze test CAPtreated mice exhibited significantly higher\\nspontaneous alternation counts and rates than those of the sham group P005 indicating\\nimproved spatial working memory Figure 2H Finally the gripstrength test results\\nrevealed no significant difference between groups confirming that CAP treatment did not\\ndamage muscular function Figure 2I Collectively these findings demonstrate that CAP\\ntreatment does not impair motor or anxietyrelated behaviors in AD mice but instead\\npartially enhances memory performance consistent with its neuroprotective molecular\\neffects\\n6\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nFigure2 CAP activates diseaseassociated signaling pathways in a mouse model of AD A Gene\\nHeatmap of differentially expressed genes red and blue represent high and low expression levels\\n7\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nrespectively B Volcano plot showing upregulated red and downregulated green genes C KEGG\\npathway enrichment analysis of differentially expressed genes D Expression levels of C1qa C1qb C1qc\\nC4b Fcgr1 CD68 Trem2 and Tyrobp E Immunofluorescence staining of C1qc Clec7a Tyrobp and\\nTrem2 in CAPtreated and control 5xFAD mouse brains F Double immunofluorescence staining of Aβ\\ngreen and microglia pink in the cortex CA1 and thalamus G Openfield test results including total\\ndistance duration in the center and frequency to the center H Ymaze test results including alternation\\n alternation number total arm entry number and I Gripstrength test results J Behavioral\\nexperiment trajectory diagram Data are presented as mean SE n 3 mice per group Statistical\\nsignificance was calculated via Students ttest P 005\\n3 CAP does not induce a pathological response in healthy mice\\nA major concern regarding CAP application is the potential for reactive species to\\ninduce oxidative stress and inflammation especially along the infusion route in our case\\nthe respiratory system To assess the biosafety of CAP we evaluated hematological\\nbiochemical histological and behavioral parameters in healthy mice exposed to CAP\\nHematological analysis revealed no significant alterations in white blood cell counts or in\\nliver and kidney function compared with untreated controls Figure 3AH indicating the\\nabsence of systemic inflammation or organ toxicity Histological examination using\\nhematoxylin and eosin HE staining showed no morphological abnormalities in major\\norgans following CAP exposure Figure 3I There were no obvious fluctuations in the\\nbody weight through the experiment Figure 3J To further determine whether CAP\\naffected physiological or neurological function we performed openfield Ymaze and\\ngripstrength tests in healthy mice No significant differences were observed between\\nCAPtreated and control groups across locomotor anxietyrelated memory or muscle\\nstrength parameters Figure 3KS Together these findings demonstrate that CAP\\nexposure does not elicit pathological inflammatory or behavioral abnormalities in healthy\\nmice providing preliminary evidence of its safety and biocompatibility for potential\\ntherapeutic applications\\n8\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nFigure 3 CAP does not induce a pathological response in healthy mice AH Behavioral test results\\nfor CAPtreated and sham groups I HE staining images of major organs including the heart liver\\nspleen lung kidney and intestine Scale bar 200 μm J The average body weight of mice during the\\nexperimental period KQ Blood biochemical parameters related to liver and kidney function R\\n9\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nTrajectory diagram of the open field test S Trajectory diagram of the Ymaze test Data are presented as\\nmean SE n 3 mice per group Statistical significance was calculated via Students ttest P 005\\n4 CAP does not induce moleculescale pathological responses in healthy mice\\nThough CAPderived reactive species may not cause pathological alterations at the\\nmacroscopic level they could potentially trigger subtle molecular changes To determine\\nwhether CAPderived reactive species induce transcriptomic abnormalities in healthy mice\\nwe extracted RNA from multiple organs of mice treated with CAP performed RNA\\nsequencing and analyzed the transcriptomic profiles We found that inhalation of CAP\\nderived reactive species caused minimal transcriptomic alterations across all examined\\norgans Figure 4\\nTo further corroborate these findings we performed proteomic analyses of brain\\ntissues from CAPtreated and control mice Similarly inhalation of CAPderived reactive\\nspecies hardly resulted in negligible proteomic changes in all the organs we studied\\nFigure S2 To capture the subtle difference between CAPtreated mice and control mice\\nwe also performed gene set enrichment analysis GSEA based on proteomic data which\\nalso revealed no significant changes Figure S2 Collectively these results demonstrate\\nthat CAPderived reactive species do not induce pathological responses at the proteomic\\nor proteomic level confirming the biosafety of CAP treatment\\n10\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nFigure 4 Transcriptomic analysis of CAPtreated healthy mice A Transcriptomes from different organs\\nwere clustered correctly by principal analysis BH Volcanic diagram of gene expression changes The\\ngenes that were significantly upregulated red and downregulated blue were highlighted The dashed\\nline represents the threshold for significance P005 and fold change log2FC15\\n11\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nDiscussion\\nOur study provides the first evidence that CAP a novel multimodal physical\\nstimulation exerts therapeutic effects in an AD mouse model by modulating key\\nneuroimmune signaling pathways most notably microglial activation without inducing\\nadverse effects in healthy subjects Microglia have been clearly identified as central\\ncoordinators of AD neuroinflammation and regulators of Aβ dynamics18 In AD microglia\\ndisplay substantial heterogeneity Although moderately activated microglia facilitate Aβ\\nclearance excessive activation can trigger chronic and harmful inflammatory reactions\\nexacerbating neuronal damage and synaptic loss19 20 21 The moderate activation of\\nmicroglia observed following CAP exposure may therefore underlie the reduced pro\\ninflammatory cytokine levels and enhanced Aβ phagocytic activity in our model\\neffectively interrupting the inflammatoryAβ feedback loop This phenotype shift likely\\ninvolves altered expression of key microglial receptors such as TREM2 which is closely\\nrelated to Aβ recognition and clearance and microglial function in AD22\\nThe compelling safety profile of CAP represents a critical translational advantage 23\\n24 aligning with the established tolerability of noninvasive neuromodulation techniques\\nincluding transcranial pulse stimulation TPS and gamma stimulation Clinical trials of\\nTPS in AD patients have consistently demonstrated cognitive and neuropsychiatric\\nimprovements with minimal adverse events underscoring the clinical feasibility of non\\ninvasive stimulation paradigms25 Such a favorable safety characteristic is paramount for\\nclinical adoption especially given the vulnerability of the AD population Similarly in our\\nstudies CAP exposure did not induce systemic inflammation oxidative stress or\\nsignificant transcriptomic or proteomic perturbations in healthy animals highlighting its\\nintrinsic biocompatibility This aligns with the lack of serious adverse effects reported in\\nhuman trials employing noninvasive gamma sensory stimulation and transcranial pulse\\nstimulation Consequently CAP leverages the inherent safety benefits of noninvasive\\nphysical energy delivery providing a strong foundation for its clinical advancement as a\\n12\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nwelltolerated and scalable therapeutic strategy for AD suitable for extended or repeated\\napplication regimes required for effective disease modification\\nMechanistically CAP represents a unique multimodal platform that integrates optical\\nacoustic and plasma components into a single bioactive stimulus262728 Based on our\\nobserved stimulus we hypothesize that CAPgenerated RONS act as primary biochemical\\nmediators initiating signaling cascades that modulate microglial activation and\\nneuroinflammatory balance RONS are known to regulate key transcriptional regulators 29\\n30 such as NFκB and Nrf2 which orchestrate inflammatory and antioxidant responses\\nCrucially codelivery of light and acoustic cues at specific frequencies may synergistically\\nenhance the cellular responsiveness to these signaling pathways thereby refining the\\naccuracy of microglial regulation3133 For example previous studies have shown that\\npulsed light stimulation promotes beneficial microglial responses such as increased Aβ\\ncolocalization M1 to M2 transition34 and vascular Aβ clearance while electromagnetic\\nor acoustic pulse therapies can similarly attenuate neuroinflammation and Aβ pathology35\\nCAP thus advances these modalities by integrating multiple synergistic physical and\\nchemical cues within a unified therapeutic framework36 37 We propose that the concurrent\\nexposure to photonic and acoustic energy together with CAPderived biologically active\\nRONS creates a distinctive bioelectrochemical microenvironment Light and sound at\\nspecific frequencies may activate cells enhance membrane permeability or resonate with\\nspecific cell structures or signal molecules thus amplifying the efficacy and specificity of\\nRONSmediated signaling on microglial targets compared with any single mode alone 38\\nSuch coordinated stimulation could facilitate microglial phenotypic reprogramming39\\nenhance TREM2dependent Aβ phagocytosis40 41 22 and lysosomal degradation and\\npromote more effective plaque clearance and attenuation of neurotoxic inflammation than\\nsinglemode physical interventions\\nFuture work should systematically dissect the molecular mechanisms and synergistic\\ninterplay among CAPs constituent components with particular attention to how plasma\\nderived RONS spectra interact with light and soundactivated signaling networks in\\n13\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nmicroglia Longterm safety studies are also warranted to assess the cumulative effects of\\nchronic or repeated CAP exposure Furthermore expanding this approach to human\\ncellular and organoid models will be essential to validate translatability and therapeutic\\nprecision in clinical contexts\\nConclusion\\nThis study provides compelling evidence that CAP a multimodal therapeutic\\nmodality integrating optical acoustic and reactive chemical stimuli exerts profound\\nregulatory effects on AD pathophysiology in murine models By modulating microglial\\nsignaling and inflammatory balance CAP effectively mitigates ADrelated neuropathology\\nNotably comprehensive behavioral transcriptomic and proteomic analyses revealed no\\nadverse alterations in healthy mice underscoring the safety profile of CAP Collectively\\nthese findings establish CAP as a promising noninvasive and mechanistically versatile\\nneuromodulatory strategy for neurodegenerative disease intervention paving the way for\\nits further optimization and clinical development\\nMethod\\nAnimal\\nAnimals were provided food and water by the experimental animal center of Shen\\nzhen Advanced Technology Research Institute Chinese Academy of Sciences SIAT in\\naccordance with rodent feeding standards Methods Animals Procedures were approved\\nby the Research Institutional Animal Care and Use Committee and adhered to standards\\nset forth by the Guide for the Care and Use of Laboratory Animals All of the animal\\nholding rooms were maintained within temperature 1826 C and humidity ranges 30\\n70 described in the ILAR Guide for the Care and Use of Laboratory Animals 1996\\nThe 5xFAD mice and C57BL6 J mice used in the experiment were raised in a standard\\nfeeding environment with a standard lightdark cycle of 12 hours to 12 hours lights on at\\n0700 all experiments were conducted within the light cycle\\n14\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nCAP equipment\\nThe plasma device employed in this study is composed of two metal electrodes 1 mm\\nin diameter facing each other at a distance of 5 mm to generate plasma between the pins\\nthrough an applied electric field Figure 1A Thermal images of the CAP device were\\ntaken using a handheld thermography camera HIKMICRO HMTPH21Pro3AQF The\\ndischarge voltage was measured by an oscilloscope Tektronix TDS2024C with a high\\nvoltage probe Tronovo TR9340A The optical emission spectrometry OES was\\ncharacterized by a highresolution UVvisible spectrometer Brolight BIM6602A series\\nsetting up the optical probe placed 1 cm away from the discharge area\\nCAP stimulation\\nThe experimental flow chart is shown in Figure 1A The mice were removed from the\\nanimal breeding room and kept in a quiet room After getting used to the room for 1 hour\\nplace individual mice in separate chambers This chamber is cylindrical with circular holes\\nwith a diameter of 1cm around the bottom for placing plasma devices The device is\\nconnected to a power source and an air pump While the air pump blows CAP substance\\ninto the chamber the mice also receive the light and sound generated by CAP The top of\\nthe device is not sealed to ensure smooth airflow The mice were divided into two groups\\none control group which did not receive CAP treatment but were placed in the samesized\\ndevice for the same time treatment The other group is the treatment group which received\\nCAP treatment and is treated once every other day for 30 minutes each time for one month\\nTissue collection and processing for immunohistochemistry\\nAfter CAP stimulation mice were given a lethal dose of anesthetic isoflurane\\noverdose followed by cardiac perfusion with PBS pH 74 Then there is PBS containing\\n4 paraformaldehyde PFA After perfusion the skull cap was removed and the brain was\\nstored in 4 PFA for 1824 hours washed in PBS and then dehydrated in 30 sucrose\\nuntil the brain tissue sank embedded in OCT Tissue Tek frozen at 80 C and then cut\\nat 40 μm in a lowtemperature thermostat and mounted on SuperFrost glass slides Then\\nperform immunohistochemistry on the tissue sections mounted on the glass slide\\n15\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nImmunohistochemistry\\nPerform immunohistochemical treatment on coronal brain slices using the following\\nprotocol Firstly wash the tissue with PBS for 10 minutes permeabilize with 01 Triton\\nX100 in PBS for 10 minutes block at room temperature 5 normal donkey serum and\\n01 Triton X100 in PBS for 2 hours and stain overnight with primary antibody\\nimmunostaining in the blocking solution After washing 3 times with blocking buffer for 5\\nminutes add the secondary antibody to the blocking buffer at room temperature for 2 hours\\nand then wash 5 times with PBS for 5 minutes each time Seal with Prolong Gold sealing\\nagent Thermo Fisher Scientific P36930\\nBehavioral Assessments\\nTo evaluate the effects of cold atmospheric plasma treatment on locomotor activity\\nanxietylike behavior spatial working memory and neuromuscular strength a series of\\nbehavioral tests was performed on all mouse groups during the final week of the\\nintervention The tests were conducted in the following order with a 24hour interval\\nbetween each test to minimize carryover effects Open Field Test Ymaze Test and Grip\\nStrength Test All behavioral procedures were conducted in a dedicated soundattenuated\\nbehavioral testing room under consistent dim lighting conditions The mice were allowed\\nto habituate to the testing room for at least 60 minutes before each test session Trials were\\nrecorded and analyzed by the SMART video tracking system SMART v30 Panlab SL\\nBarcelona Spain Grip strength was tested in mouse forelimbs using a grip strength meter\\nStoelting Co\\nOpen Field Test\\nThe open field test was employed to assess general locomotor activity and anxiety\\nlike behavior 42 The apparatus consisted of a squareshaped white Plexiglas arena 40 cm\\n 40 cm 40 cm Each mouse was gently placed in the center of the arena and allowed to\\nexplore freely for 10 minutes The total distance traveled in meters was quantified as an\\nindicator of locomotor activity The time spent and the distance traveled in the central zone\\ndefined as the central 20 cm 20 cm area were measured to evaluate anxietylike\\n16\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nbehavior with decreased activity in the center interpreted as increased anxiety The arena\\nwas thoroughly cleaned with 70 ethanol between trials to eliminate olfactory cues\\nYmaze Test\\nSpatial working memory was evaluated using the spontaneous Ymaze test 43 The Y\\nmaze was made of black Plexiglas with three identical arms each 35 cm long 5 cm wide\\n 10 cm high positioned at 120 angles from each other Each mouse was placed at the\\nend of one designated arm and allowed to explore the maze freely for 10 minutes An arm\\nentry was recorded when all four paws of the mouse were within the arm The sequence of\\narm entries was manually recorded by a blinded experimenter Spontaneous alternation\\nperformance defined as consecutive entries into all three arms without repetition eg\\nsequence ABC was calculated as a measure of working memory The percentage of\\nspontaneous alternation was determined using the following formula Percentage\\nAlternation Number of Alternations Total Arm Entries 2 100\\nGrip Strength Test\\nNeuromuscular function was assessed using a grip strength meter 44eg BioGS3\\nBioseb Vitrolles France The forelimb grip strength of each mouse was measured Briefly\\nthe mouse was held by the tail and allowed to grasp a triangular pull bar connected to the\\nforce sensor with its forepaws The mouse was then pulled backward gently and steadily\\nalong the horizontal plane until it released the bar The peak force in grams or Newtons\\nexerted by the mouse before losing its grip was recorded The test was repeated for five\\nconsecutive trials per mouse with an intertrial interval of approximately 30 seconds and\\nthe average of the three highest readings was used for statistical analysis\\nHistological analysis of hematoxylin and eosin HE staining\\nAfter behavioral testing euthanize the mice and promptly collect the heart liver\\nspleen lung kidney and intestinal tissues Fix the organization in a 4 paraformaldehyde\\nPFA solution at 4 C for 48 hours After fixation the tissue is dehydrated with a series of\\ngraded ethanol removed with xylene and embedded in paraffin Subsequently the\\nembedded tissue coronal sections were sliced into 5 μm thick sections using a rotary slicer\\n17\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nLeica RM2235 Leica Microsystems Germany Install the slices on a glass slide coated\\nwith polyLlysine and dry overnight at 37 C For histological examination the sections\\nwere dewaxed and rehydrated before staining In short the slices were deparaffinized twice\\nin xylene for 10 minutes each time then hydrated for 5 minutes using a decreasing ethanol\\nseries and rinsed in distilled water Stain with hematoxylin and eosin HE according to\\nthe standard protocol and finally fix with neutral resin Inspect stained sections under an\\noptical microscope Olympus BX53 Olympus Corporation Japan and capture digital\\nimages using the accompanying camera system DP27 Olympus\\nQuantitative realtime PCR qPCR analysis\\nAccording to the manufacturers instructions use a commercial RNA isolation kit\\nTRIzol reagent Invitrogen United States to extract total RNA from frozen brain tissue\\nUse NanoDrop2000 instruments ThermoFisher Scientific to determine the concentration\\nand purity of extracted RNA by spectrophotometry RNA samples with an A260A280 ratio\\nbetween 18 and 20 and an A260A230 ratio greater than 20 are considered suitable for\\nsubsequent experiments Synthesize the first strand complementary DNA cDNA from 1\\nµg total RNA using a reverse transcription kit Takara Japan in a reaction volume of 20\\nµL which includes the step of removing genomic DNA contamination Perform\\nquantitative PCR using SYBR Green main mixture on a realtime PCR detection system\\nEach reaction is carried out in a final volume of 20 µL which contains 10 µL of the main\\nmixture 04 µL of each forward and reverse primer 10 µM 2 µL of diluted cDNA\\ntemplate and 72 µL of nucleasefree water The thermal cycling conditions are as follows\\ninitial denaturation at 95 C for 30 seconds followed by denaturation at 95 C for 40 cycles\\nof 5 seconds and annealingextension at 60 C for 30 seconds Perform melting curve\\nanalysis at the end of each run to confirm the specificity of amplification with a single\\npeak representing a single PCR product Table 1 lists the sequences of genespecific\\nprimers used in this study\\n18\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nTable 1 lists the sequences of genespecific primers\\nGene\\nForward primer Reverse primer\\nname\\nC1qb AAGGTGCCTGGCCTCTACTA TTTCTGCATGCTGTCCCGAT\\nC4b TCTGAAGCCTCCAACGTTCC TGGGATGGGGAAGGAAATGC\\nC1qa TGGAGACCTCTCAGGGATGG GATACCAGTCCGGATGCCAG\\nCd68 TAGCCTAGCTGGTCTGAGCA GCAGGAGAGTAACGGCCTTT\\nC1qc CCAACAGCGTCTTCTCTGGT CAGGAACCAGGGTGGACTTC\\nTrem2 GATGTGCTGCCTCTGGTCTT ACCTCCAGTAGCATGTTGGC\\nFcgr1 GCACCACCATCAAGGACTCA GAGACAGAGGCAACCTGACC\\nTyrobp GTCGCTCAGGGTCACAAGAA CCACACGTTGACAGCTAGGT\\nHematological parameters and analysis of liver and kidney function\\nAt the end of the study blood samples were collected from all mice by drawing blood\\nfrom the posterior orbital plexus into two types of collection tubes 1 EDTAK2\\nanticoagulant tubes for hematological analysis and 2 serum separation tubes for\\nbiochemical analysis For complete blood count CBC gently invert the whole blood\\ncollected in the EDTAK2 tube several times to ensure proper mixing and analysis within\\n2 hours after collection Use an automated hematology analyzer such as Sysmex XT\\n2000iV Sysmex Corporation Japan to measure hematological parameters including\\nwhite blood cell WBC count red blood cell RBC count hemoglobin HGB\\nconcentration hematocrit HCT mean corpuscular volume MCV mean hemoglobin\\nMCH mean corpuscular hemoglobin concentration MCHC and platelet PLT count\\nThe analyzer is calibrated daily and quality control is carried out according to the\\nmanufacturers protocol To evaluate liver and kidney function the blood sample in the\\nserum separation tube was coagulated at room temperature for 60 minutes Subsequently\\ncentrifuge the sample at a speed of 3000 g for 15 min at 4 C to separate the serum\\nCarefully divide the supernatant serum into sterile tubes and store at 80 C until analysis\\n19\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nQuantify serum levels of alanine aminotransferase ALT aspartate aminotransferase\\nAST alkaline phosphatase ACAP total protein TP albumin ALB blood urea\\nnitrogen BUN and creatinine CREA using standard colorimetric or enzyme assay kits\\nBioVision USA on an automated biochemical analyzer Hitachi 7020 Japan All\\nanalyses were conducted strictly in accordance with the instructions provided by the\\nreagent kit manufacturer\\nTranscriptome sequencing and bioinformatics analysis\\nTranscriptome sequencing comprises RNA extraction detection library construction\\nand computer sequencing RNA integrity and concentration were rigorously assessed using\\nan Agilent 2100 Bioanalyzer Library preparation commenced with the enrichment of\\npolyadenylated mRNA using oligodT beads The enriched mRNA was fragmented and\\nreversetranscribed into firststrand cDNA using random hexamer primers and MMuLV\\nReverse Transcriptase Secondstrand cDNA was synthesized using DNA Polymerase I\\nand RNase H The resulting doublestranded cDNA was purified endrepaired adenylated\\nand ligated to Illumina adapters Fragments of 370420 bp were sizeselected with\\nAMPure XP beads and PCRamplified Library quality control included quantification\\nQubit 20 Fluorometer size distribution analysis Agilent 2100 Bioanalyzer and\\naccurate assessment of effective concentration by qPCR 2 nM Finally libraries were\\npooled and subjected to 150bp pairedend sequencing on an Illumina NovaSeq 6000\\nplatform employing the SequencingbySynthesis SBS technology\\nFollowing sequencing raw reads were subjected to quality control The clean reads were\\nthen aligned to the reference genome using Hisat2 Gene expression levels were quantified\\nwith featureCounts v150p3 to generate read counts for each gene Based on these\\ncounts and gene lengths FPKM values were calculated to estimate expression abundance\\nDifferential expression analysis between comparative groups was performed using the\\nDESeq2 package v1200 This method employs a negative binomial generalized linear\\nmodel to identify statistically significant differences The resulting pvalues were adjusted\\nfor multiple testing using the BenjaminiHochberg procedure to control the false discovery\\n20\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nrate FDR Functional enrichment analysis was conducted from two complementary\\nperspectives First Gene Ontology GO enrichment analysis for the differentially\\nexpressed genes DEGs was carried out using the clusterProfiler package v381 with\\npvalues corrected for gene length bias Terms with an adjusted pvalue 005 were\\nconsidered significantly enriched Second Gene Set Enrichment Analysis GSEA was\\nimplemented using the GSEA desktop tool to evaluate enrichment in predefined GO and\\nKEGG gene sets without relying on a fixed DEG threshold Genes were ranked by their\\ndifferential expression metric and significance was determined for gene sets enriched at\\nthe top or bottom of the ranked list\\nProteomics and data analysis\\n1 Protein extraction\\nFrozen tissues were pulverized in liquid nitrogen and the powder was lysed in SDT\\nbuffer with 1 DTT The lysate was vortexed sonicated on ice and centrifuged The\\nsupernatant was collected heated at 95C and cooled Proteins were alkylated with IAM\\nin the dark precipitated with cold acetone and the pellet was washed dried and\\nredissolved in DB Buffer\\n2 FFPE samples\\nDeparaffinization of FFPE sections was performed using xylene followed by\\nrehydration through a graded ethanol series and two washes with PBS After PBS removal\\nthe samples were lysed in protein lysis buffer 4 SDS 100 mM Tris pH 76 and\\nincubated at 95C for 10 min with vortexing Subsequently the samples were sonicated on\\nice for 5 min and incubated at 95C for 60 min for decrosslinking Proteins were reduced\\nand alkylated by adding TCEP and CAA at 95C for 5 min The lysate was centrifuged\\n12000 g 15 min 4C and the supernatant was subjected to acetone precipitation as\\ndescribed in section 211 The final protein pellet was dissolved in dissolution buffer 6 M\\nurea 100 mM TEAB pH 85\\n3 Protein digestion\\n21\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nAn aliquot of each protein sample up to 100 µL final volume in DB buffer was\\ndigested with trypsin in 100 mM TEAB pH 85 at 37C for 4 h The reaction was stopped\\nby acidifying with formic acid pH 3 After centrifugation 12000 g 5 min room\\ntemperature the supernatant was desalted using a C18 column The column was washed\\nthree times with a solution of 3 acetonitrile and 01 formic acid and peptides were\\neluted with 70 acetonitrile containing 01 formic acid The eluate was collected and\\nlyophilized\\n4 LCMSMS Analysis using Vanquish Neo UHPLCAstral System\\nLyophilized peptides were reconstituted in 10 µL of mobile phase A 01 formic\\nacid and centrifuged 14000 g 20 min 4 C Subsequently 200 ng of peptide was\\ninjected for analysis Peptide separation was carried out on a Vanquish Neo UHPLC system\\nusing a C18 precolumn 5 mm 300 µm 5 µm and an analytical column PepMap Neo\\n150 µm 15 cm 2 µm both maintained at 50C The detailed gradient is provided in\\nTable 1 Mass spectrometry analysis was performed on an Orbitrap Astral instrument\\nequipped with an Easyspray ion source operating at a spray voltage of 20 kV and an ion\\ntransfer tube temperature of 290C Dataindependent acquisition DIA was employed\\nwith the following parameters full MS scans were acquired over mz 380980 at a\\nresolution of 240000 followed by 300 DIA windows 2 Th width with a normalized\\ncollision energy of 25 MS2 spectra were collected over mz 1502000 at a resolution of\\n80000 with a maximum injection time of 3 ms The acquired data were saved in raw\\nformat for subsequent analysis\\n5 Data analysis\\nRaw data were processed using DIANN software against the protein database\\nSearch parameters included automatic mass tolerance calibration fixed modification of\\ncarbamidomethylation on cysteine variable modification of Nterminal methionine\\nexcision and a maximum of two missed cleavages Results were filtered to retain peptides\\nwith a Global QValue 001 and proteins with a PGQValue 001 Proteins showing a\\n22\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nsignificant difference p 005 log₂FC between experimental and control groups as\\ndetermined by a ttest were defined as differentially expressed proteins DEPs\\n6 Functional analysis of proteins and DEPs\\nAll identified proteins were functionally annotated using InterProScan for Gene\\nOntology GO and InterPro domains including Pfam PRINTS ProDom SMART\\nProSite and PANTHER Protein family and pathway analyses were performed using\\nCOG and KEGG databases For DEPs volcano plots and hierarchical clustering heatmaps\\nwere generated Functional enrichment analyses were conducted for GO InterPro and\\nKEGG pathways Proteinprotein interaction networks were predicted using the STRING\\ndatabase\\nStatistical analysis\\nData are expressed as mean standard error Groups were compared using ttests in\\nPrism ver 80 GraphPad Software Inc San Diego CA USA Correlation and regression\\nanalyses were applied P 005 defined significance\\nAcknowledgement\\nThis work was supported by Shenzhen Key Laboratory of Magnetic Resonance\\nPhysics and Imaging SYSPG20241211173949066 Shenzhen Medical Academy of\\nResearch and Translation C2301011 and Shenzhen Science and Technology Major\\nProject KJZD20230923114406014\\n23\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nReferences\\n1 Chen X et al Microgliamediated T cell infiltration drives neurodegeneration in tauopathy\\nNature 615 668677 doi101038s41586023057880 2023\\n2 GraffRadford J et al New insights into atypical Alzheimers disease in the era of biomarkers\\nLancet Neurol 20 222234 doi101016S1474442220304403 2021\\n3 Yang H et al Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimers\\nDiseases ACS Nano 18 3379233826 doi101021acsnano4c11966 2024\\n4 Scheltens P et al Alzheimers disease Lancet 397 15771590 doi101016S0140\\n673620322054 2021\\n5 Jucker M Walker L C Alzheimers disease From immunotherapy to immunoprevention Cell\\n186 42604270 doi101016jcell202308021 2023\\n6 Self W K Holtzman D M Emerging diagnostics and therapeutics for Alzheimer disease Nat\\nMed 29 21872199 doi101038s41591023025052 2023\\n7 Liu N Liang X Chen Y Xie L Recent trends in treatment strategies for Alzheimers\\ndisease and the challenges A topical advancement Ageing Res Rev 94 102199\\ndoi101016jarr2024102199 2024\\n8 Park M et al Effects of transcranial ultrasound stimulation pulsed at 40 Hz on Abeta plaques and\\nbrain rhythms in 5xFAD mice Transl Neurodegener 10 48 doi101186s4003502100274x\\n2021\\n9 Murdock M H et al Multisensory gamma stimulation promotes glymphatic clearance of amyloid\\nNature 627 149156 doi101038s41586024071326 2024\\n10 Iaccarino H F et al Gamma frequency entrainment attenuates amyloid load and modifies\\nmicroglia Nature 540 230235 doi101038nature20587 2016\\n11 Martorell A J et al Multisensory Gamma Stimulation Ameliorates AlzheimersAssociated\\nPathology and Improves Cognition Cell 177 doi101016jcell201902014 2019\\n12 Hess B L Piazolo S Harvey J Lightning strikes as a major facilitator of prebiotic phosphorus\\nreduction on early Earth Nat Commun 12 1535 doi101038s41467021218492 2021\\n13 Brune W H et al Extreme oxidant amounts produced by lightning in storm clouds Science 372\\n711715 doi101126scienceabg0492 2021\\n14 Liao P Kang J Xiang R Wang S Li G Electrocatalytic Systems for NOx Valorization\\nin Organonitrogen Synthesis Angew Chem Int Ed Engl 63 e202311752\\ndoi101002anie202311752 2024\\n15 Zhang X et al Spaceborne Observations of Lightning NO2 in the Arctic Environ Sci Technol\\n57 23222332 doi101021acsest2c07988 2023\\n16 Jiang H J et al Mimicking lightninginduced electrochemistry on the early Earth Proc Natl Acad\\nSci U S A 121 e2400819121 doi101073pnas2400819121 2024\\n17 Jenewein C MaízSicilia A Rull F GonzálezSouto L GarcíaRuiz J M Concomitant\\nformation of protocells and prebiotic compounds under a plausible early Earth atmosphere Proc\\nNatl Acad Sci U S A 122 e2413816122 doi101073pnas2413816122 2025\\n18 Zhao Y Guo Q Tian J Liu W Wang X TREM2 bridges microglia and extracellular\\nmicroenvironment Mechanistic landscape and therapeutical prospects on Alzheimers disease\\nAgeing Research Reviews 103 102596 doi101016jarr2024102596 2025\\n19 Kodali M et al Residual microglia following shortterm PLX5622 treatment in 5xFAD mice\\nexhibit diminished NLRP3 inflammasome and mTOR signaling and enhanced autophagy Aging\\nCell 24 e14398 doi101111acel14398 2024\\n20 Qiao L et al H2O2responsive multifunctional nanocomposite for the inhibition of amyloidβ\\nand Tau aggregation in Alzheimers disease BMEMat 1 e12011\\ndoi 2023\\n24\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n21 Li Y et al 3Dcultured BMSC exosomes improve cerebral ischemiareperfusion injuryinduced\\nneuronal apoptosis by regulating the microglia polarization BMEMat 3 e70000\\ndoi 2025\\n22 Wang S et al TREM2 drives microglia response to amyloidβ via SYKdependent and \\nindependent pathways Cell 185 doi101016jcell202209033 2022\\n23 Fu D et al Cold atmospheric plasma as a novel drug for cancer therapy J Control Release 386\\n114118 doi101016jjconrel2025114118 2025\\n24 Fang T Chen Z Chen G Advances in cold atmospheric plasma therapy for cancer Bioact\\nMater 53 433458 doi101016jbioactmat202507031 2025\\n25 Shinzato G T et al Noninvasive sound wave brain stimulation with Transcranial Pulse\\nStimulation TPS improves neuropsychiatric symptoms in Alzheimers disease Brain Stimulation\\n17 413415 doi101016jbrs202403007 2024\\n26 Chen G et al Portable airfed cold atmospheric plasma device for postsurgical cancer treatment\\nScience Advances 7 eabg5686 doi101126sciadvabg5686 2021\\n27 Fang T Cao X Shen B Chen Z Chen G Injectable cold atmospheric plasmaactivated\\nimmunotherapeutic hydrogel for enhanced cancer treatment Biomaterials 300 122189\\ndoi101016jbiomaterials2023122189 2023\\n28 Chen Z T Obenchain R Wirz R E Tiny Cold Atmospheric Plasma Jet for Biomedical\\nApplications Processes 9 doi103390pr9020249 2021\\n29 Li Q et al Impaired lipophagy inducedmicroglial lipid droplets accumulation contributes to the\\nbuildup of TREM1 in diabetesassociated cognitive impairment Autophagy 19 26392656\\ndoi1010801554862720232213984 2023\\n30 Li J et al Combination of autophagy and NFE2L2NRF2 activation as a treatment approach for\\nneuropathic pain Autophagy 17 40624082 doi1010801554862720211900498 2021\\n31 Li F et al Lowintensity pulsed ultrasound stimulation LIPUS modulates microglial activation\\nfollowing intracortical microelectrode implantation Nat Commun 15 5512 doi101038s41467\\n024497099 2024\\n32 Prichard A et al Brain rhythms control microglial response and cytokine expression via NF\\nkappaB signaling Sci Adv 9 eadf5672 doi101126sciadvadf5672 2023\\n33 Tao L et al Microglia modulation with 1070nm light attenuates Abeta burden and cognitive\\nimpairment in Alzheimers disease mouse model Light Sci Appl 10 179 doi101038s41377021\\n006173 2021\\n34 Li Y et al Ultrasound Controlled AntiInflammatory Polarization of Platelet Decorated Microglia\\nfor Targeted Ischemic Stroke Therapy Angew Chem Int Ed Engl 60 50835090\\ndoi101002anie202010391 2021\\n35 Lin Y et al Electromagnetic pulse exposure induces neuroinflammation and bloodbrain barrier\\ndisruption by activating the NLRP3 inflammasomeNFkappaB signaling pathway in mice\\nEcotoxicol Environ Saf 292 117972 doi101016jecoenv2025117972 2025\\n36 Chen G et al Transdermal cold atmospheric plasmamediated immune checkpoint blockade\\ntherapy Proceedings of the National Academy of Sciences of the United States of America 117\\n36873692 doi101073pnas1917891117 2020\\n37 Cao X et al RSL3loaded nanoparticles amplify the therapeutic potential of cold atmospheric\\nplasma J Nanobiotechnology 23 136 doi101186s12951025032116 2025\\n38 Liu Y et al Matrix stiffnessdependent microglia activation in response to inflammatory cues in\\nsitu investigation by scanning electrochemical microscopy Chem Sci 15 171184\\ndoi101039d3sc03504b 2023\\n39 Chen C et al Exosomes Derived from M2 Microglial Cells Modulated by 1070nm Light\\nImprove Cognition in an Alzheimers Disease Mouse Model Adv Sci Weinh 10 e2304025\\ndoi101002advs202304025 2023\\n25\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n40 Lv Z et al Clearance of betaamyloid and synapses by the optogenetic depolarization of microglia\\nis complement selective Neuron 112 740754e747 doi101016jneuron202312003 2024\\n41 Zhao Y et al TREM2 Is a Receptor for βAmyloid that Mediates Microglial Function Neuron 97\\ndoi101016jneuron201801031 2018\\n42 Qiu S et al Adultonset CNS myelin sulfatide deficiency is sufficient to cause Alzheimers\\ndiseaselike neuroinflammation and cognitive impairment Molecular Neurodegeneration 16 64\\ndoi101186s13024021004887 2021\\n43 Lv S et al Integrated dopamine sensing and 40 Hz hippocampal stimulation improves cognitive\\nperformance in Alzheimers mouse models Nature Communications 16 5948\\ndoi101038s41467025609031 2025\\n44 Bellantuono I et al A toolbox for the longitudinal assessment of healthspan in aging mice Nat\\nProtoc 15 540574 doi101038s4159601902561 2020\\n26\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nSupplementary data\\nFigure S1 Plasma device diagram and characteristics A Optical emission spectrumOES of air source\\nplasma B OES of helium source plasma C OES of nitrogen source plasma D OES of argon source\\nplasma\\n27\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n28\\nbioRxiv preprint doi this version posted November 10 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nFigure S2 Proteomic analysis of brain proteins in healthy mice treated with CAPA Hierarchical\\nclustering of important proteins The color scale represents the relative protein level B Volcanic maps\\nof different protein abundances The proteins that were significantly upregulated red and downregulated\\nblue were highlighted log2FC 15 adjusted pvalue005 The dashed line represents the threshold\\nC GO enrichment analysis Significant enrichment of differentially expressed proteins ranked by log10\\nadjusted pvalue DE Gene Set Enrichment Analysis GSEA\\n29',\n",
              " 'bioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nTitle The Cell Subtypes Selection by Genes CSSG algorithm for discovering cell\\npopulations in high resolution\\nJakub Kubiś1 Maciej Figiel1\\n1 Institute of Bioorganic Chemistry Polish Academy of Sciences Poznań Poland\\nCorresponding author\\nMaciej Figiel PhD\\nInstitute of Bioorganic Chemistry Polish Academy of Sciences\\nNoskowskiego 1214\\n61704 Poznań Poland\\nPhone 48618528503 ext 1150\\nORCID 0000000339614635\\nEmail mfigielibchpoznanpl\\nKeywords singlecell scRNAseq machine learning algorithm pipeline high\\nresolution cellular heterogeneity brain disease\\n1\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nAbstract\\nThe recent massive improvements in transcriptomics and singlecell\\ntechnologies have led to a rising volume of data and demand for advances in\\nbioinformatics processing Existing methods are not fully capable of discovering\\ngenetic markers responsible for highresolution cellular tissue heterogeneity cell\\nlineages during organism development and cell differentiation with rare intermediate\\npopulations In response to demand we have generated a new Cell Subtypes\\nSelection by Genes CSSG algorithm which is supported by a dedicated and fully\\nautomatic JSEQ pipeline The new CSSG algorithm is iterative parallel and able to\\nmake decisions for discovering cell populations in tissues based on transcript\\noccurrence in cells The CSSGJSEQ is complemented by a new strategy and\\nspecialized algorithm for the naming of cell populations Our approach allows for high\\nresolution tracing of cell populations finding relations and hierarchy between them\\nparticularly important for complex tissues such as the brain The pipeline allows the\\nestablishment of developmental differentiation and pathogenic trajectory and takes a\\nsnapshot of a current physiological or pathological cellular stage of the investigated\\norgan at the transcriptional level\\n2\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nIntroduction\\nSinglecell RNA sequencing scRNAseq generates highvolume of\\ntranscriptomic data sets containing information about each cells gene expression\\nseparately demanding complicated multistep bioinformatics analysis The required\\napproach is a reduction of dimensionality expression of genes and their relations by\\nspecialized methods PCA UMAP or tSNE to be able to percept and interpret the\\ndata 1 Reduced dimensions permit further clustering analysis which allows the\\nexploration of the primary sources of heterogeneity of cell composition in the tissue\\nSuch an approach is prone to the loss of biologically significant information In the case\\nof scRNAseq it can cause a loss of information about rare cell populations that are\\nnormally neglected but exhibit important biological functions such as in the brain In\\naddition disease development may start from a small change in a small population of\\ncells of which recognition is crucial for developing therapy Therefore we decided to\\ncreate the singlecell algorithm called Cell Subtypes Selection by Gene CSSG\\nmethods supported by a fully algorithmicbased and automatic JSEQ pipeline with a\\ncustomdeveloped cell population naming algorithm The CSSG algorithm conducts\\nthe iterative summing of matrices containing information on gene occurrence in cells\\nbelonging to one cluster which is subsetted into detailed cell subtypes Based on\\nalgorithmic decisionmaking the CSSG algorithm delivers information about cell\\nintermediate stages maturation status rare population functions trajectories and\\ninteractions between them\\nThe brain is a very complex structure where a variety of cell types express a\\nunique set of genes at different steps of development and maturation 2 These\\ncellular populations and universal gene sets are essential for maintaining brain regions\\ngeneral anatomical positioning and connectivity between regions to preserve the\\nessential state of brain functionality required Therefore a slight difference in cellular\\npopulations may greatly impact brain structure functionality and neurodegenerative\\ndisease development eg Alzheimers or Parkinsons\\nTherefore the cell heterogeneity of the brain is an excellent model to test our\\nCSSG algorithm and to unravel the highresolution cell complexity of the organ Using\\nour CSSGJSEQ we performed deep bioinformatics analysis of the brain singlecell \\nsinglenuclei data including 812945 cells We revealed 620 subtypes of various brain\\ncell populations from different brain regions\\nThreestep pipeline validation was conducted by comparing the cell subtype\\ncomposition of clusters with and without the CSSG determining the trajectories of\\noligodendrocyte development and finally by tracking the relation of the cell populations\\npossibly related to Alzheimers disease with specific expression of AD genes such as\\nApoe App Mapt Psen1 Psen2 and Trem2 We concluded that the CSSGJSEQ\\napproach is suitable for complex analysis of scRNAseq data to reveal the very high\\nresolution of rare cell populations which are highly significant in brain development\\nand disease\\n3\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nMaterials and methods\\nData\\nThe singlecell raw count sequencing data were acquired from public\\nrepositories The data were used for pipeline functional tests highresolution cell type\\ndiscovery and analysis of cell types causative to Alzheimers disease The data for the\\nmouse hypothalamus mouse thalamus and human organoids were acquired from\\nNCBI GEO Mouse hypothalamus HYP 7 329 cells data contain lateral hypothalamic\\nareas from male and female mice GSM3562050 and GSM3562051 respectively 3\\nMouse thalamus TH 7 365 cells from the embryo E125 GSE122012 4 Three\\nand six months human brain organoids HBO 38 987 cells were acquired from\\nGSE129519 5 Data from the adult mouse for motor cortex MCTX 13 539 cells\\nMD704 MD705 auditory cortex ACTX 35 594 cells MD717 MD720 MD21\\norbitofrontal cortex OCTX 19 531 cells MD716 MD717 entorhinal cortex ECTX\\n80 653 cells MD720 MD721 MD698699 hippocampus HIP 6 555 cells MD718\\nMD719 and cerebellum CER 611 034 cells 6 were acquired from Broad Institute\\ndata portal The data used for the analysis were\\nderived from different sequencing methods including singlecell and singlenucleus\\nTherefore for unification purposes all mitochondrial genes and metabolismrelated\\ngenes were removed based on genes from MitoCarta20 7 The data processed by\\nthe pipeline are available on NCBI GEO\\nAll computation stages were performed on a workstation configured with AMD\\nRyzen Threadripper 3960X 24Core 380 GHz processor 256GB of RAM Windows\\n10 Pro running Ubuntu 2004 LTS virtual machine Automatical analysis\\nJSEQ_scRNAseq included software and their versions on GitHub in documentation\\nManual analysis RStudio Version 131093 with R version 403\\nJSEQ singlecell analysis pipeline\\nAll analyses of raw singlecell data were performed using our JSEQ singlecell\\nanalysis pipeline Fig 1A The pipeline scripts and the source code is available on\\nGitHub The pipeline and its source\\ncode are available for academic use The JSEQ pipeline contains modules for all\\napplications arranged and controlled by the queue and control points that prove that\\nall conditions required for the next step are met This way interoperability between\\nconsecutive stepspoints is established based on storing temporary data in the project\\nworking directory Moreover the data for the pipeline can be delivered in multiple\\nformats The pipeline allows for analyzing both singlecell or singlenuclei data in\\ndifferent input formats\\nPipeline phase data preparation and generation of the count matrix\\nIn case the entire pipeline is initiated from raw sequencing reads the genome\\ndownload module must be run first In the JSEQ options the user can select human\\nor mouse or custom genome JSEQ offers automatic download of the genomes\\nfrom GENECODE versions GRCh38p13 for human or GRCm38p6 for mouse \\n 8 The option custom offers additional\\npossibilities such as setting the download of other genomes versions or species from\\nGENECODE NCBI and ENSEMBLE The custom option requires editing a simple\\ntext configuration file The file also contains other options such as switching on and\\n4\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\noff quality control of bases in sequencing results in case of lack of quality information\\nin fasta files and the annotation enrichment by a specialized tool\\nThe analysis starts with quality control of the reads fastp v0220 9 which\\nprovides trimming of the adapters bases quality control minimal length control\\nimportant for UMI and barcode information included in Read1 and poly base tails\\ntrimming Subsequently genome indexing and mapping are performed by STAR\\nv250a followed by double quality control The control is an important step that\\ninvolves repairing UMI and barcode sequences by UMItools 10 and DropSeq\\nv240 11 Finally the matrix of counts is generated in sparse format DropSeq\\nv240 All the external applications are controlled by JSEQ functions\\nPipeline phase processing count matrix\\nThe analysis at this stage starts after creating the count matrix in the previous\\nphase or can be started with previously prepared data in the format of the count matrix\\nas a separate project in JSEQ The advanced analysis uses features from Seurat\\nv315 package 12 as a framework where we incorporated a range of JSEQ\\napproaches data exchange and algorithms to discover rare cell populations in high\\nresolution together with their lineage and parent population\\nIn brief the stages of the count matrix analysis in CSSGJSEQ are 1\\nmultistage quality control 2 data normalization and standardization 3 data\\ndimensionality reduction with principal components PC analysis 4 automatic\\nadjustment of PCs number 5 multistage clustering 6 selecting clusterspecific\\nsubclasses genes 7 selection of gene combinations explaining cluster heterogeneity\\nCSSG algorithm 8 cluster subsetting and coclustering 9 selecting subcluster\\nspecific genes defining subtypes 9 naming of cells optional helps to understand the\\nheterogeneity of generated populations intuitively 10 data visualization 11\\ngenerating a complexity report with data explanation graphs tables and description\\nIn detail and for the current analysis the quality control steps consisted of 1\\nremoving cells with less than 500 genes per cell 2 removing contaminations with\\ndouble or multiple cells for one barcode 3 removing cells with unknown origin\\ntypically less than 10 per 1000 cells in a cluster Data normalization was performed\\nby logCPM1 formula individual for each cell Variable genes across datasets were\\nestimated using the equal frequency method by variance stabilizing transformation\\nPrincipal components PC were calculated on scaled data and the number of PCs for\\nfurther analysis was automatically adjusted to the correct number The adjustment\\nuses the variability check of the explained variance in consecutive PCs Next the\\nestimated PCs were used for clustering with an algorithm such as the KNN knearest\\nneighbor with Jaccard distance and SNN shared nearest neighbor graph with\\nLouvain modularity optimization algorithms incorporated in Seurat Marker genes\\nspecific to obtained cell clusters were calculated based on the MAST algorithm 13\\nThe UMAPs plots heatmaps bar plots and other scatterplots were used for data\\nvisualization More information about the pipeline and available functions are provided\\nin JSEQ singlecell pipeline manual deposited on the GitHub platform\\nCSSG validation methods\\nIn the study we also conducted validation of our CSSG algorithm i an\\ninvestigation of gene expression between subtypes and additional clustering for\\nrefining the estimation of population trajectories and ii an examination of specific\\ndiversity of expression between Alzheimers disease genes to establish disease\\n5\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nrelations between cell subtypes and the degree of their involvement in the disease For\\ncomparing deregulated expression DE of genes between subtypes we used the\\ndirect difference in expression subtype 1st normalized expression subtracted from\\nsubtype 2nd normalized expression and WilcoxonTest We used hierarchical\\nclustering with the wardD algorithm to draw relations between particular subtypes for\\nboth analyses of the trajectories and the Alzheimers related genes Analysis and\\ndiagrams were prepared in RStudio Version 131093 with R version 403\\nResults\\nThe preconditions for the CSSG algorithm\\nWe developed a unique new scRNAseq CSSG algorithm Cell Subtypes\\nSelection by Genes which is nested on our JSEQ platform and was prepared and\\ncustomized for running this algorithm combined name CSSGJSEQ The algorithm\\nand the pipeline provide a unique algorithmic decisive approach for preparing very\\nhighresolution tissue cell composition in terms of populations and cell intermediate\\nstates The pipeline is designed to maximize the amount of input scRNAseq data and\\napplies various control steps to reach the maximum possible data quality Moreover\\nthe obtained data can be modified andor used for further analysis with little effort\\nFinally it meets the requirements of everyday researchers with little IT background for\\na scRNAseq tool that provides a high degree of automatic processing In addition our\\nnaming approach creates names for cell classes subclasses and subtypes showing\\nin the name of the population the cascade of names for the most important marker\\ngenes The such naming principle can also demonstrate trajectories between\\nintermediate cell states\\nOur CSSG helps to obtain more efficient results from singlecell sequencing\\ncontaining lower numbers of cells andor lesser depth of data sequencing To achieve\\nthis we performed a series of tests with different datasets different sequencing\\ndepths different numbers of cells different degrees of tissue development etc and\\nestablished a course of action to maximize the obtained results using additional\\nanalysis features To confirm the superiority of our algorithm we also conducted many\\nvalidating analyses described in the methodology\\n6\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nFigure 1 CSSGJSEQ general workflow CSSG algorithm details and cell population naming\\nstrategy A Graphical scheme of CSSGJSEQ pipeline workflow Two major data entry points in the\\nJSEQ pipeline raw read data entry point in fastq format or preanalyzed count data table entry point in\\nthe workflow brief CSSG algorithm working scheme and implementation steps B scheme of the\\nCSSG matrixbased iterative and algorithmic decisive approach and visualized means of statistics\\ncalculation to obtain the final results C Original method of cell population naming generated for high\\nresolution CSSG results All names consist of descending detail degrees and the final name is\\nsubdivided into class subclass and subtype parts The mean of cell population naming is based on a\\ncascade where consecutive name parts are selected based on metadata files\\n7\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nDecisive and automated CSSG algorithm for highresolution scRNAseq\\nanalysis\\nThe classical singlecell analysis is sufficient for many applications however in\\nsuch a method the obtained clusters still contain unexplained heterogeneity cell\\nsubpopulations The information is consequently hidden and can not be reliably\\ndiscovered without specialized approaches Moreover we know the influence of many\\ngenes on specific cellular processes the precise range and scale of gene expression\\nlevels and the combinations that govern cellular processes are primarily unknown\\nHence we do not fully understand the influence of subtle gene expression levels on\\nrare population formation we often discard information on subtle changes and discard\\ncell populations that may be significant Therefore we created CSSG algorithm Fig\\n1B a very powerful algorithmic tool that discovers the diversity of individual gene\\noccurrence inside initial cell clusters and allows for the generation of smaller less\\nheterogeneous subsets which we call subpopulation In the CSSG approach we\\ndecided to shift our focus from information about the single gene expression levels to\\nthe presence of the collective sets of gene expressions in single cells We transformed\\nexpression levels in each cell inside a particular cluster into binary data where the\\nvalue 1 denotes the presence of the gene expression and 0 represents the lack of\\ngene expression in a single cell belonging to one cluster\\nEach iteration of the CSSG algorithm focuses on a single cluster inside which\\nstarts the next sequence of iterations that explains the heterogeneity of the cluster\\nStarting the sequence of iterations inside the cluster requires a pair of data matrices\\nThe first matrix simply consists of repetitions of one vector which contains binary data\\nfor one gene for each cell in the cluster of cells is the of columns The second\\nmatrix contains binary data for each gene row and for each cell in the cluster\\ncolumns excluding the data for the gene repeated in matrix 1 Then the summing of\\ntwo matrices equation 1 is performed and repeated until all combinations of two\\ngenes in the cluster are obtained Subsequently the action of CSSG obtains all\\npossible combinations for 2 3 or more genes using binary matrices and calculates\\nrelevant statistics When appropriate combinations of genes are established for all\\nclusters the algorithm returns a table of the best combinations explaining\\nheterogeneity for each cluster which are then used in cell subtyping and naming\\nThe intuitive principle of adding a par of matrices results in the matrix where the\\ncooccurrence of two or more genes in a single cell in the examined cluster is denoted\\nas a multiplicity of 1 value eg 234 n For example the presence of only one\\ngene out of all genes in the current iteration in one cell is denoted as 1 and the\\nexpression lack of any is denoted as 0 The value 2 or greater present in the matrix\\ncooccurrence of two or more genes in one cell does not explain the heterogeneity\\nand is obviously not favorable for discovering rare populations it may however\\nconstitute an intermediate form between cell subtypes The possible number of two\\ngene combinations C n in one cell is between 1 and the factorial n 𝑙𝑖𝑚𝐶 𝑛 1𝑛\\n𝐶𝑛\\nwhere n is the maximum number of marker genes inside the analyzed cluster To\\nimprove the performance of the CSSG it uses only preselected by MAST algorithm\\nmarker genes to each cluster at a significant level p 005 of the WilcoxonTest It is\\none of the elements that greatly reduces computation time CPU and RAM usage\\nThe CSSG algorithm network in each iteration calculates the specific statistics\\nthat serve as a weight limiting the amount of data in iterations because the number of\\ncombinations in the successive iterations tends to infinity The following statistics\\nparameters loss_pval equation 2 assumpted value describing the number of cells\\n8\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\ndiscarded during cluster analysis According to the loss_pval parameter cells are\\ndiscarded when no marker gene occurs in these cells within the analyzed cluster The\\nuser can also change the loss_pval parameter reflecting the principal weight for the\\nCSSG algorithm network that the expected combination of genes heterogeneity for\\nan analyzed cluster was reached and that algorithm can stop processing the analyzed\\ncluster stop point If the algorithm can not reach an equal or lower value than the user\\ndefined loss_pval default 0001 it will search a combination with the lowest loss_pval\\nthat can be obtained For example if in a cluster containing 100 cells and one cell can\\nnot be described by any marker genes the minimal loss_pvale which can reach is\\n001 so the algorithm would iterate infinitely and never finish Another important\\nparameter governing the CSSG algorithm is the ht equation 3 heterogeneity factor\\nwhich is a value informing the algorithm about the level of heterogeneity of the cluster\\nexplained by the genes combinations The ht is also one of the wights for algorithm\\nnetwork influencing further decisions of the algorithm during analysis which is\\nexplained in the subsequent paragraph The adj_ht equation 4 adjusted\\nheterogeneity factor is the heterogeneity factor value adjusted by the value of\\ndiscarded cells from the cluster The aim of the adj_ht is to introduce the compromise\\nbetween maximal possible heterogeneity and the number of discarded cells within the\\ncluster\\nIn the process of finding the optimal heterogeneity subsequent combinations of\\ngenes are forwarded to the next iteration of the analyses based on algorithm decision\\nevoked by the loss_pval and ht parameters Such parameters obtained for all gene\\ncombinations are used to select weights using quartile statistics Q25 first quartile\\nand Q75 third quartile The first weight for the algorithm network is determined when\\nall combinations of the two genes are achieved At this point only combinations of\\ngenes with ht value greater than the third quartile of all estimated ht values ht Q75\\nof all ht are subjected to further analysis steps When including three and more gene\\ncombinations are required to explain optimal heterogeneity the loss_pval determines\\nthe weight for the transfer of data to further analysis The weight is calculated based\\non the first quartile of all loss_pval statistics loss_pval Q25 of all loss_pval\\nUsed weights are necessary to reduce the number of results to only highly\\nrelevant combinations Although the algorithm is optimized for multiprocessing the\\nexcessive number of gene combinations can extend the algorithms working time and\\nmay lead to CPU and RAM overload If all conditions are reached and all sensitive\\ngene combinations are determined in the analysis the results are saved to the final\\nresult table of clusters heterogeneity with their statistics\\nBased on the table of cluster heterogeneity the cluster subsetting is conducted\\ninside each cluster using the dominant expression maxlogCPM1 of genes from\\nthe best genes combination based on the ht or adj_ht statistic for a given cluster The\\nuser can decide which parameter is best suitable for the current singlecell experiment\\ndepending on the required resolution level The cell subtyping can be conducted\\naccording to both parameters including all consequences they cause and are\\ndescribed above The default setting is adj_ht to minimize cells discarded from the\\ncluster The minimum number of cells in the subtypes is checked using the binomial\\ntest at a significance level 01 in the case of very rare subpopulations Cell subtypes\\nwith lower pvalue are excluded from the analysis All parameters for CSSG and for\\nsubtyping workflow can be set in the configuration file\\n9\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\n10\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nCell population naming algorithm\\nWe developed a cell population naming algorithm to support our CSSG\\nmethods The algorithm is responsible for establishing the naming of the received cell\\nclasses class name subclasses two marker genes of the subclass and subtypes\\nsingle marker gene of the subtype The advanced algorithm has been designed to\\ncreate systematics of the cell population complexity in analyzed tissue The algorithm\\nalways requires two tables the table containing marker genes metadata differing for\\neach step of naming class subclass etc and the other table containing expression\\nlevels meanlogCPM 1 of all genes found in metadata in all clusters for naming\\nclass and subclass or all subtypes for naming subtypes In the process of cell\\nnaming the algorithm selects the gene with the maximal expression for each cluster\\nor each subtype and subsequently the algorithm screens metadata to name the cell\\npopulation defined by this gene In the case of naming class and the first part of\\nsubclass name a gene name the metadata table contains arbitrary predefined and\\nmost current stateoftheart literature and databases of cell marker genes For the\\nsecond part of the subclass name the cell naming algorithm uses the table of cluster\\nspecific markers selected by the MAST algorithm Finally for naming subtypes the\\nalgorithm uses genes from the table of heterogeneity obtained from the CSSG\\nalgorithm Figure 1C summarizes the naming approach which is based on the cascade\\nprinciple of gene tables and information in the metadata table where the final cell\\npopulation name is composed of the cell class name two genes names for the\\nsubclass and the gene name for the subtype\\nIn addition the brain as a model tissue for our pipeline and algorithm is a\\nparticular challenge since it is very complex and contains a multitude of regions and\\ncell types Therefore especially for the brain tissue we constructed an enhanced\\nmetadata table with markers for different brain subclasses belonging to neuronal non\\nneuronal and progenitor cell types The neuronal part of cell names is based on genes\\ninvolved in particular categories The categories are signaling related to\\nneurotransmitters Tab 1 signaling by neuropeptides ligand or receptor or calcium\\nbinding proteins Tab 2 and by neurotransmitter released such as excitatory\\nglutamate inhibitory GABA glycine and modulatory choline noradrenaline\\nserotonin dopamine and nitric oxide In addition for the cerebellum we can\\ndistinguish Purkinje inhibitory Golgi inhibitory and granule excitatory cell classes\\nIn the case of nonneuronal and progenitor cell names the first subclass marker used\\nis the one that defines the cell type from table 3 eg Oligodendrocytes Olig2 NPCs\\nSox2 etc\\n11\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nTable 1 Table of genes that are markers for brain cell populations neuronal and nonneuronal selected\\nby extensive stateoftheart literaturemining The marker genes of the cell populations were selected\\naccording to literature reports assuming that the marker gene is unique through the brain Brain region\\nspecific markers were avoided The table was used as the metadata for generation cell class or cell\\nclasssubclass name parts\\nType Specyfic cell Marker Source\\nGad1\\nGABAergic\\nGad2 1416\\nGlutamatergic Slc17a7\\nSlc18a3\\nSlc5a7\\nCholinergic 3 14\\nSlc5a8\\nChat\\nSlc6a3\\nDopaminergic\\nNr4a2\\nNeuronal\\nNoradrenergic Slc6a2\\nDbh\\n14 17\\nSlc6a4\\nSerotonergic\\nTph2\\nGlycinergic Slc32a1\\nNitrinergic Nos1\\nPurkinje Pcp2 6 17\\nGranule Gabra6\\n6\\nGolgi Lgi2\\nAqp4 16 18 19\\nAgt 14 20\\nAstrocytes\\nSlc1a3\\n14\\nMyoc\\nOlig2 21\\nOpalin 15\\nOligodendrocytes\\nMag 22\\nMog 16 18\\nPdgfra 16 18 19\\nGlial OPCs\\nCspg4 21 23 24\\nBergmann Gdf10 2527\\nFoxJ1 6 14\\nEpendymal Ccdc153 20 22\\nLmx1a 18\\nPpp1r1b\\n28\\nTanacytes Dio2\\nGpr50 14\\nChoroid plexus Ttr 6 14 29\\nMrc1 18 20 30\\nMacrophages\\nCx3cr1 16 20 30\\nImmune Tyrobp 15 23\\nMicroglial C1qc 30\\nTmem119 23 27\\nNostrin 15\\nEndothelial\\nCldn5 14 30\\nVtn 14 23 30\\nVascular Pericytes\\nRgs5 31\\nMural Mustn1 22\\nFibroblast Dcn 14\\nNSCs Sox2 16 32\\nGbx2\\nHoxa1\\nProgenitor NPCs Pax7 31\\nNkx12\\nFoxG1\\nGPCs Snx5 24\\n12\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nTable 2 Table of genes that are exclusively markers for neuronal brain cell populations selected by\\nextensive stateoftheart literaturemining As in Table 1 the marker genes of the cell populations were\\nselected to be unique through the brain The table was used as the additional metadata mainly for\\ngeneration cell subclass name parts of neuronal cells\\nType Marker Source\\nSst Cort Npy Pyy Grp Cck Nts Nmb Rln1 Rln2 Rln3 Trh Adcyap1\\nNeuropeptides Crh Tac1 Tac2 Tac3 Pomc Penk Pdyn Pth Vip Gal Nmu Avp Oxt 3 22 3335 wwwgenecardsorg\\nAgrp Nps Npvf Npw Pnoc Cartpt Hcrt1 Hcrt2 Gnrh1 Gnrh2\\nOprk1 Oprd1 Pth1r Vipr1 Vipr2 Galr1 Galr2 Galr3 Nmur1 Nmur2\\nNeuropeptide receptors Avpr1a Avpr1b Avpr2 Oxtr Gnrhr1 Gnrhr2 Hcrtr1 Hcrtr2 Mc3r Mc4r 20 36 wwwgenecardsorg\\nNpsr Npffr1 Npffr2 Npbwr1 Npbwr2 Oprl1\\nCalciumbinding\\nCalb1 Calb2 Pvalb 14 33 34\\nproteins\\n13\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nCSSG validation by examination of the global complexity of the brain and\\nhuman brain organoids\\nWe validated our CSSG algorithm results by conducting an extensive analysis\\nof the mouse brain and human brain organoids In the case of brain structures the\\nalgorithm discovered many todate unrevealed cell population subtypes To examine\\nthe validity of brain complexity we plotted the relations of the number of cells the\\nnumber of subclasses and the number of subtypes Fig 2 We always found linear\\nrelations in the case of fairly mature populations The relations of the cells vs\\nsubclasses are also linear for organoids similar to mature cells Interestingly there is\\nno more linearity for organoid cells when cell vs subtypes or subtypes vs subclasses\\nare plotted Such behavior confirms that in the case of human brain organoids most\\ncells are in the stage of intensive development which results in increased\\nheterogeneity of data and a greater number of subtypes obtained On average we\\nhave detected 24 subclasses which created on average of 62 subtypes with the\\nexception of the human brain organoids where we detected 22 subclasses and 157\\nsubtypes Together this demonstrates our algorithms advancement in explaining\\ncellular tissue heterogeneity\\nFigure 2 The diagrams demonstrate the relationship between the numbers of cells subclasses\\nand subtypes before and after using the CSSG algorithm The number of cells vs subclasses\\ndiagram before using the CSSG algorithm reveals the linear relation for all datasets The CSSG\\nanalysis causes a dramatic enrichment of results by introducing new populations called subtypes This\\nprocess increases cellular resolution and knowledge about the cellular structure of the tissue The\\nsubtypes are characterized by lower heterogeneity of cells belonging to a single subtype therefore we\\nobtain high consistency of cellular composition In addition the analysis after the CSSG approach cell\\nnumber vs a number of subtypes and subtypes vs cell classes reveals an extreme example of an\\norganoid where there is no linearity with brain regions and where CSSG discovered very many subtypes\\nThis indicates that particularly immature tissues such as organoids exhibit particular diversity\\n14\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nOverall we obtained 239 cell subclasses and 620 subtypes Tab 3 in the\\nanalysis In neuronal cell types were 326 subtypes including 200 excitatory 102\\ninhibitory and 24 modulatory subtypes The nonneuronal cells contained 124\\nsubtypes consisting of gliallike astrocytes and oligodendrocytes etc vascularlike\\nand immune cells We also identified many progenitor cell subtypes 170 prominent\\nin the thalamus and human brain organoids\\nInterestingly the striatum hypothalamus and thalamus contain a variety of cell\\nsubpopulations characterized by markers that define neurons with double excitatory\\nand inhibitory roles such as dopaminergic cholinergic etc\\nIn all neuronal types we identified many subpopulations characterized by\\nimportant neuropeptides their receptors and calciumbinding protein such as Sst 24\\nsubtypes Pvalb 13 Npy 11 and Adcyap1r1 10 Oprm1 116 Cck 56 and Calb1\\n9 Cck 4 Adcyap1 2 Adcyap1r1 2 Calb1 2 Oprk1 2 Oprl1 2 Oprm1 2\\nand Rxfp1 2\\nTogether we demonstrated differences between obtained cell subtypes greatly\\nincreasing the resolution of populations and improving brain complexity knowledge\\nExamples of clearly improved cluster separations are shown in Figure 3 The entire\\nsubclass pattern and the resulting subtypes can be checked in supplement 11\\nDetailed tables describing the composition of the subtypes with markers and extended\\nenrichment conducted for genes presented in the subtypes in supplement 12\\n15\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nFigure 3 The CSSGJSEQ algorithm has the ability to perform the onestepseparation of an\\ninitial cluster comprising only subclasses used in traditional lowresolution analysis to multiple\\ncell subtypes and their genetic markers from the brain OCTX ECTX scRNAseq and human\\nbrain organoids Note that a single cluster can produce unbiased diversity by CSSG only by decisive\\naction The data are visualized using parts of the UMAP plots\\n16\\nTable 3 The summary of highresolution cellular brain complexity obtained by CSSGJSEQ The table\\ncontains neuronal nonneuronal and progenitor cell populations of all analyzed brain regions and their\\ndominant markers for subclass The numbers in brackets indicate numbers of cell subtypes lowest level\\nof cell population in cell cluster attributed to brain region class and arbitrary groups\\nBrain region Organoid n Type Group n Class n Dominant subclass marker n\\nCerebellum CER\\n117\\n17\\nlanorueN\\nExcitatory 102 Granule 102 Oprm1 91 Crhr1 7 Calb2 4\\nPurkinje 6 Calb1 6\\nInhibitory 15 GABAergic 8 Pvalb 8\\nGolgi 1 Penk 1\\nExcitatory 24 Glutamatergic 24 Cck 14 Oprm1 8 Calb1 1 Trhr 1\\nAuditory cortex GABAergic 6 Sst 3 Pvalb 1 Npy 1 Vip 1\\nInhibitory 7\\n36 Glycinergic 1 Sst 1\\nModulatory 5 Dopaminergic 5 Cck 3 Oprk1 2\\nExcitatory 28 Glutamatergic 28 Cck 16 Oprm1 9 Rxfp1 1 Grp 1 Sst 1\\nEntorhinal cortex GABAergic 7 Vip 2 Cck 2 Hcrtr2 2 Tac1 1\\nInhibitory 10\\n40 Glycinergic 3 Sst 3\\nModulatory 2 Dopaminergic 2 Oprm1 2\\nCck 10 Oprm1 3 Calb1 2\\nExcitatory 16 Glutamatergic 16\\nMotor cortex Cckbr 1\\n22 Sst 2 Npy 2 Vip 1\\nInhibitory 6 GABAergic 6\\nPvalb 1\\nExcitatory 15 Glutamatergic 15 Cck 8 Oprm1 5 Trhr 2\\nGABAergic 8 Calb2 2 Npy 2 Vip 2 Pvalb 1 Sst 1\\nOrbitofrontal cortex Inhibitory 9\\nGlycinergic 1 Sst 1\\n26\\nDopaminergic 1 Rxfp1 1\\nModulatory 2\\nNitrinergic 1 Npy 1\\nSst 11 Trhr 3 Adcyap1r1 2 Cck 2 Npy 2 Pvalb 2 Gal 1 Calb1\\nStriatum Inhibitory 25 GABAergic 25\\n1 Crh 1\\n27\\nModulatory 2 Cholinergic 2 Tacr1 1 Calb1 1\\nExcitatory 14 Glutamatergic 14 Cck 8 Calb1 6\\nHippocampus\\nInhibitory 3 GABAergic 2 Npy 2\\n19\\nModulatory 2 Dopaminergic 2 Cck 1 Rxfp1 1\\nHypothalamus Inhibitory 17 GABAergic 17 Adcyap1r1 8 Oprl1 3 Sst 2 Cartpt 2 Calb1 1 Calb2 1\\n35 Modulatory 8 Nitrinergic 8 Adcyap1r1 2 Oprl1 2 Avp 1 Calb1 1 Calb2 1 Pdyn 1\\nThalamus Inhibitory 10 GABAergic 10 Pnoc 7 Npy 2 Pomc 1\\n13 Modulatory 3 Dopaminergic 3 Adcyap1 2 Pomc 1\\nOrganoids 1 Inhibitory 1 GABAergic 1 TAC3 1\\nCerebellum\\n23\\nlanoruennoN\\nAstrocytes 4 Aqp4 2 Slc1a3 2\\nOligodendrocytes 5 Mog 4 Mag 1\\nChPCs 3 Ttr 3\\nGliallike 17\\nEpendymal 2 Lmx1a 1 Ccdc153 1\\nBergmann 1 Gdf10 1\\nOPCs 2 Pdgfra 2\\nPericytes 2 Vtn 2\\nVascularlike 4\\nEndothelial 2 Cldn5 2\\nImmune 2 Macrophages 2 Cx3xr1 2\\nAstrocytes 6 Slc1a3 6\\nOligodendrocytes 4 Mog 2 Cck 2\\nGliallike 12\\nAuditory cortex OPCs 2 Pdgfra 2\\n14 Tanacytes 2 Ppp1r1b 2 Penk 1\\nEndothelial 1 Cldn5 1\\nVascularlike 2\\nPericytes 1 Vtn 1\\nAstrocytes 10 Slc1a3 9 Aqp4 1\\nGliallike 15 Oligodendrocytes 2 Mag 2\\nOPCs 3 Pdgfra 3\\nEntorhinal cortex Endothelial 4 Cldn5 4\\n29 Vascularlike 7 Pericyte 1 Vtn 1\\nFibroblast 2 Dcn 2\\nMacrophages 6 Cx3cr1 6\\nImmune 7\\nMicroglial 1 C1qc 1\\nAstrocytes 3 Slc1a3 3\\nGliallike 6 Oligodendrocytes 1 Mag 1\\nMotor cortex\\nOPCs 2 Pdgfra 2\\n8\\nVascularlike 1 Endothelial 1 Cldn5 1\\nImmune 1 Macrophage 1 Cx3cr1 1\\nAstrocytes 4 Slc1a3 4\\nOligodendrocytes 3 Mag 2 Mog 1\\nGliallike 9\\nOPCs 1 Pdgfra 1\\nOrbitofrontal cortex\\nTanacytes 1 Ppp1r1b 1\\n12\\nVascularlike 2 Endothelial 2 Cldn5 2\\nMicroglial 1 C1qc 1\\nImmune 1\\nMacrophages 1 Cx3cr1 1\\nAstrocyte 2 Slc1a3 2\\nHippocampus\\nGliallike 5 Oligodendrocyte 1 Mog 1\\n5\\nOPCs 2 Pdgfra 2\\nAstrocytes 3 Slc1a3 3\\nGliallike 12 Oligodendrocytes 7 Oligo2 3 Mog 2 Mag 2\\nHypothalamus OPCs 2 Pdgfra 2\\n18 Endothelial 2 Cldn5 2\\nVascularlike 4\\nPericytes 2 Rgs5 2\\nImmune 2 Microglial 2 C1qc 1 Tyrobp 1\\nOrganoids 2 Gliallike 2 Astrocytes 2 Aqp4 1 Agt 1\\nThalamus\\n17\\nrotinegorP\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nSteam 5 NSCs 5 Sox2 5\\nNPCs 6 Gbx2 6\\nPrecursor 12\\nGPCs 6 Snx5 6\\nOrganoids Steam 74 NSCs 74 SOX2 74\\n153 Precursor 79 NPCs 79 FOXG1 65 SSTR2 14\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nCSSGJSEQ in cell fate and trajectory discovery\\nMost importantly the CSSGJSEQ performs exact mining of genetic markers in\\nthe initial cell clusters which initially seem to have a uniform differentiation status The\\nresulting subtypes isolated from the initial cluster have a combination of markers that\\nallows separating into specific populations with substantially distinct differentiation and\\nmaturation stages For instance the subtypes showing the same second marker of\\nsubclass in cell name Fig 4 and belonging to one initial cluster are now assigned to\\ndifferent classes namely oligodendrocytes and OPCs This demonstrates the high\\nresolution capabilities of the pipeline to generate the trajectories of cells such as\\noligodendrocytes showing detailed cell fate In addition we used all identified\\noligodendrocyte populations from the cerebellum hypothalamus orbitofrontal cortex\\nand hippocampus and conducted hierarchical clustering of their subtypes Moreover\\nbased on literature collection including singlecell experiments solely based on the\\nanalysis of oligodendrocytic fates we established precise developmental and\\ndifferentiation status of individual oligodendrocyte subtypes named OPC\\noligodendrocyte precursor cells COP differentiationcommitted oligodendrocyte\\nprecursors preMO premyelinating oligodendrocytes NFO newly formed\\noligodendrocytes MFO myelinforming oligodendrocytes and MOL mature\\noligodendrocytes in previous works We confronted our subclass and subtypes and\\ntheir precise markers obtained by CSSGJSEQ with the collection of previous works\\nWe noticed that our subclass and subtype markers information arranged as a cascade\\nof gene names Fig 1C reflecting the intermediate oligodendrocyte cell maturation\\nstages visually demonstrated as the hierarchical tree Fig 4\\n18\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nFigure 4 The CSSGJSEQ algorithms are suitable for demonstrating unbiased trajectories of cell\\ndevelopment The figure demonstrates that CSSG analysis data suggested oligodendrocyte subtypes\\nas their intermediate stages revealing the trajectory of oligodendrocyte development The identified cell\\ntypes and their markers were confronted with stateoftheart literature data The CSSGgenerated data\\nconfirmed that identified populations were not described to date or were described before but were not\\nlinked by trajectory previously or their relations were already reported\\n19\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nCSSGJSEQ algorithm in ADrelated genes analysis\\nWe also used the CSSGJSEQ outputs to examine the suitability of our\\napproach to biological problems focused on important genes involved in Alzheimers\\ndisease We analyzed the distribution of Apoe App Mapt Psen1 Psen2 and Trem2\\ngenes in the cell population globally within brain regions hypothalamus HYP\\nthalamus TH motor cortex MCTX auditory cortex ACTX orbitofrontal cortex\\nOCTX entorhinal cortex ECTX hippocampus HIP cerebellum CER and human\\nbrain organoids HBO supplement 131 and then focused on differences in AD gene\\nexpression among the subtypes belonging to one initial cluster supplement 132\\nFigure 5 The CSSGJSEQ in one step determines highresolution brain cell subtypes from\\nhippocampus and cortex areas selectively containing gene transcripts with an inevitable role in\\nAD development The selection of the canonical AD gene allows to mine of the global diversity of cell\\npopulations that can be affected by AD in the hippocampus HIP motor cortex MCTX orbitofrontal\\ncortex OCTX entorhinal cortex ECTX and auditory cortex ACTX Note that CSSG determined many\\nneuronal populations where the occurrence of transcripts for App Mapt Psen1 and Psen2 is highly\\ncorrelated Increased expression of the Apoe gene is characteristic of populations of astrocytes\\nmicroglial endothelial and pericyte cells Trem2 is present in mouse brains in microglial populations and\\nsometimes correlates with the Apoe gene The CSSG also identifies populations with the composition\\nof AD genes that was not described before\\n20\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nAnalysis of the gene distribution across the different mouse brain regions and\\nHBO shows that Apoe is most expressed and strongly related to Astrocytes and OPCs\\nin the OCTX MCTX ACTX ECTX TH HYP STR CER HBO Fig 5 6 7\\noligodendrocytes in the MCTX OCTX ECTX ACTX HIP HYP Fig 5 6 and\\nependymal cells in the CER Fig 7 Interestingly most data sets coherently\\ndemonstrate that high expression of Apoe is present in nonglial cells and neurons\\nsuch as in vascular cells in the MCTX OCTX ECTX ACTX HIP STR HYP CER\\nFig 5 6 7 immune cells in the OCTX ECTX HYP CER Fig 5 6 7 and\\nglutamatergic neurons in the OCTX ECTX ACTX HIP Fig 5 Finally Apoe\\nexpression is also present in precursors namely in GPCs TH HBO Fig 6 7 and\\nNPCs in the HBO Fig 7\\nFigure 6 The CSSGJSEQ in one step determines highresolution brain cell subtypes from the\\nstriatum STR thalamus TH and hypothalamus HYP areas which selectively contain gene\\ntranscripts with an inevitable role in AD development The brain regions contain many GABAergic\\ncells which express AD genes Again high correlation of App Mapt Psen1 and Psen2 occurs\\nApoe is mostly not associated with Mapt Psen1 Psen2 and Trem2 genes in\\ncell populations The partner of Apoe occurring the most is the App gene which is\\nvisible in some subtypes of astrocytes OPCs oligodendrocytes pericytes choroid\\nplexus and glutamatergic cells in the whole brain Fig 5 6 7 The strong relation\\nbetween Apoe and App expression is seen in one subtype of astrocytes widely present\\nin NPCs derived from HBO Fig 7 and also the strong partner of some endothelial\\ncells The connection of Apoe expression with other genes such as Mapt Psen1\\nPsen2 and Trem2 is sparsely present but it largely depends on the cells subclass\\nand subtype\\nThe App gene is expressed with high frequency in neurons across the mouse\\nbrain Fig 5 6 7 and HBO Fig 7 and is highly accompanied by the expression of\\nMapt Psen1 and Psen2 The combined correlation among Mapt Psen1 and Psen2\\nexpression highly depend on the cell subclass and subtype\\n21\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nFigure 7 The CSSGJSEQ in one step determines highresolution brain cell subtypes from\\ncerebellum CER and human brain organoids HBO containing gene transcripts with a role in\\nAD development Both scRNAseq datasets contain many cell subtypes The cerebellum contains a\\nlarge variety of subtypes however App Mapt Psen1 and Psen2 gene transcripts highly occur in\\ninhibitory neurons such as Purkinje cells while the occurrence in granule cells is lower In the case of\\nhuman brain organoids cell populations mainly demonstrate an early developmental stage and divide\\nbetween progenitors subtypes and subtypes with neuronal stem cell characteristics Compared to\\nsubtypes of NSC progenitors are already committed populations with APP MAPT PSEN1 and PSEN2\\nrelated to AD genes but do not coexpress APOE The NSC subtypes in organoids often coexpress\\nAPOE together with APP MAPT PSEN1 and PSEN2\\nThe increased Trem2 gene expression is very strongly related to immune cells\\nand some astrocyte subtypes In a few cases we note an increased expression of\\nTrem2 in glutamatergic subtypes in the ECTX ACTX HIP Fig 5 and GPCs in the\\nTH Fig 6 NPCs in the HBO Fig 7 tanycytes in the STR HYP endothelial in the\\nSTR Fig 6 and oligodendrocytes in the ACTX Fig 5\\n22\\nTable 4 Tabular representation of cell populations which show the most statistically significant\\ndifferences in expression of AD genes Apoe App Mapt Psen1 Psen2 Trem2 while the expression\\ndifferences in the single cell population must occur combined at the global level region and at the local\\nlevel cluster The table contains subtypes belonging to different regions OCTX ECTX STR CER\\nHYP and HBO Such comparison of highresolution subtypes allowed for identifying clusters containing\\nsubtypes that are the most heterogenous in relation to expression and a number of AD genes These\\nsubtypes are compared to other subtypes within one initial cluster local using the WilcoxonTest\\nstatistics and real deregulated expression numbers relate to subtypes normalized expression which is\\na difference of subtype 1st expression minus subtype 2nd expression The level of significance p\\nvalue 005 005 001 0001 All results for other subtypes and regions are collected\\nin the supplement 132 table\\nRegion Subtypes interaction Subclass Apoe App Mapt Psen1 Psen2 Trem2\\n23\\nmulleb\\nerecC\\nPurkinje Calb1 Ebf1 Col18a1 \\nGranule Oprm1 Ebf1 A330008l17rik\\n1f\\nbE\\n021 004 005 106 097 0 \\nPurkinje Calb1 Ebf1 Col18a1 \\n036 001 011 078 098 0 \\nGranule Oprm1 Ebf1 Ranbp17\\nPurkinje Calb1 Ebf1 Col18a1 \\n014 103 066 114 118 0003 \\nGranule Oprm1 Ebf1 Ebf1\\nPurkinje Calb1 Ebf1 Col18a1 \\n028 091 047 111 126 0 \\nGranule Oprm1 Ebf1 Tmem132c\\nPurkinje Calb1 Ebf1 Col18a1 \\n002 147 091 126 131 0 \\nGranule Oprm1 Ebf1 Synpr\\nPurkinje Calb1 Ebf1 Col18a1 \\n006 104 102 123 127 0 \\nGranule Oprm1 Ebf1 Asic2\\nPurkinje Calb1 Ebf1 Col18a1 \\n0003 115 081 118 125 0 \\nGranule Oprm1 Ebf1 Ntrk3\\nPurkinje Calb1 Ebf1 Col18a1 003 12 081 117 13 0 \\nGranule Oprm1 Ebf1 Kcnd3\\nPurkinje Calb1 Ebf1 Col18a1 \\n002 136 106 118 127 002 \\nGranule Oprm1 Ebf1 D630045j12rik\\nPurkinje Calb1 Ebf1 Col18a1 \\n021 144 08 116 128 0 \\nGranule Oprm1 Ebf1 Tspan18\\nPurkinje Calb1 Ebf1 Col18a1 \\n009 124 089 134 115 0 \\nGranule Oprm1 Ebf1 Angpt1\\nPurkinje Calb1 Ebf1 Col18a1 \\n039 138 11 132 133 0 \\nGranule Oprm1 Ebf1 Ptgds\\nPurkinje Calb1 Ebf1 Col18a1 \\n01 142 093 122 103 002 \\nGranule Oprm1 Ebf1 Sorbs1\\nPurkinje Calb1 Ebf1 Col18a1 \\n005 068 078 115 126 0 \\nGranule Oprm1 Ebf1 Cadm2\\nGranule Oprm1 Xist Xist \\nGranule Oprm1 Xist Lsamp ts\\niX\\n017 112 086 063 022 0 \\nGranule Oprm1 Xist Xist \\n053 116 131 068 026 0 \\nGranule Oprm1 Xist Pcdh9\\nlanihrotnE xet\\nroc\\nAstrocytes Slc1a3 Plpp3 Gpc5 \\nAstrocytes Slc1a3 Plpp3 Lingo2 3pplP\\n04 303 288 052 052 003 \\nAstrocytes Slc1a3 Plpp3 Apoe \\n192 295 281 052 047 004 Astrocytes Slc1a3 Plpp3 Lingo2\\nMacrophages Cx3cr1 Hmha1 Inpp5d \\nMicroglial C1qc Hmha1 C1qa 1ahmH 092 129 029 001 021 12 \\nMacrophages Cx3cr1 Hmha1 Hexb \\n087 129 125 053 052 104 \\nGlutamatergic Oprm1 Hmha1 Cdh2\\nsumalahtopyH\\nOligodendrocytes Mog Plp1 Mal \\nOligodendrocytes Mag Plp1 Opalin 1plP\\n106 047 129 179 01 005 \\nOligodendrocytes Mog Plp1 Plp1 \\n149 242 416 018 001 013 \\nOPC Pdgfra Plp1 Lhfpl3\\nOPC Pdgfra Gpr17 S100a1 \\nOligodendrocytes Mag Gpr17 Frmd4a\\n71rpG\\n289 467 168 0 062 024 \\nOligodendrocytes Olig2 Gpr17 Tnr \\n212 284 153 014 048 019 Oligodendrocytes Mag Gpr17 Frmd4a\\nOligodendrocytes Mag Gpr17 Frmd4a \\n289 467 168 0 062 024 \\nOPC Pdgfra Gpr17 S100a1\\nOligodendrocytes Mag Gpr17 Frmd4a \\n212 284 153 014 048 019 \\nOligodendrocytes Olig2 Gpr17 Tnr\\nlatnorfotibroO\\nxet\\nroc\\nAstrocytes Slc1a3 Car2 Glul \\nGlutamatergic Cck Car2 Aplp1\\n2raC\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\n277 086 022 008 019 007 \\nAstrocytes Slc1a3 Car2 Glul \\n243 149 04 035 011 01 Oligodendrocytes Mog Car2 Plp1\\nAstrocytes Slc1a3 Car2 Cd81 \\n236 116 072 016 012 001 \\nOligodendrocytes Mog Car2 Plp1\\n24\\nsdion\\nagroO\\nNSCs SOX2 CDC20 CCNB2 \\nNSCs SOX2 CDC20 CA2\\n02CDC\\n394 259 204 042 027 0 \\nNSCs SOX2 CDC20 CCNB1 \\n372 229 212 027 024 0 \\nNSCs SOX2 CDC20 CA2\\nNSCs SOX2 CDC20 MKI67 \\n371 275 207 03 02 0 NSCs SOX2 CDC20 CA2\\nNSCs SOX2 CDC20 CA2 \\n367 233 257 059 027 0 \\nNSCs SOX2 CDC20 NUF2\\nNSCs SOX2 CDC20 CA2 \\n396 301 178 024 027 0 \\nNSCs SOX2 CDC20 CDC20\\nmutairtS\\nGABAergic Sst Npy Npy \\nGABAergic Sst Npy Sst ypN\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\n036 747 157 089 129 0 \\nCholinergic Tacr1 Npy Tacr1 \\n006 74 17 069 316 0 \\nGABAergic Sst Npy Sst\\nThanks to the resolution offered by CSSGJSEQ we were able to conduct\\nstatistical and differential expression analysis of ADrelated genes between cell\\nsubtypes within an initial cluster subclass supplement 132 and we identified\\nclusters containing subtypes that are the most heterogenous in relations to expression\\nand a number of AD genes Tab 4 Strikingly inside the most heterogenous clusters\\nthere are subtypes with a different class affiliation for instance subtypes occurring in\\nOCTX ECTX STR and CER Fig 8 and Tab 4 The change of affiliation may result\\nfrom a few reasons These may be related to i processes that change cell lineages\\nduring development such as various populations of oligodendrocytes and OPCs Fig\\n4 8 ii cellular responses resulting from endocrine or paracrine stimuli resulting from\\nthe interplay between several subtypes within a cluster eg such as inflammatory\\nresponses potentially taking place in astrocytes and macrophages Fig 8 and Tab 4\\niii incorrect assignment of subpopulations to the cluster as a consequence of\\nclustering algorithms itself eg Purkinje occurring among granule subtypes Fig 8\\nand Tab 4 In all these cases CSSG subtyping is the superior method to better\\nunderstand cell interactions as well as improve data quality by picking up misallocated\\ncells We also carried out subtypes hierarchical clustering which revealed\\ndependences and their relations Exact AD subtypes relations are presented in the\\ndiscussion The possibility of selective analysis of genes in exactly defined\\nsubpopulations in high resolution can contribute to marker discovery and a better\\nunderstanding of AD disease pathogenesis and the interaction between cells\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nFigure 8 Relationships of populations of cell subtypes expressing characteristic genes related\\nto AD obtained by CSSGJSEQ Importantly the selected globally highresolution subtypes eg from\\nOCTX ECTX STR CER HYP and HBO allow for tracking the subpopulation relations to other\\nsubtypes belonging to one initial cluster using hierarchical clustering Inside the most heterogenous\\nclusters there are subtypes with different class affiliations for instance subtypes occurring in OCTX\\nECTX STR and CER The change of affiliation may be related to i processes that change cell lineages\\nduring development also presented in Figure 4 ii cellular responses resulting from endocrine or\\nparacrine stimuli resulting from the interplay between several subtypes within a cluster eg such as\\ninflammatory responses potentially taking place in astrocytes and macrophages also in Tab 4 iii\\nincorrect assignment of subpopulations to the cluster as a consequence of clustering algorithms itself\\neg Purkinje occurring among granule subtypes also listed in Tab 4\\nDiscussion\\nData generated in massive life science experiments are analytically challenging\\nsince they contain many variables resulting in high volumes of data A particular\\nexample of large variability is scRNAseq data containing a high number of individual\\ntranscripts within a high number of singlecell transcriptomes Such data complexity\\ndemands a multistage analysis mainly including dimensionality reduction clustering\\nand selection of significantly deregulated features between clusters and requires\\ndefining multiple parameters such as PC neighbors distance etc Countless\\nparameter settings result in the generation of a large number of potential false positive\\nand false negative results leading to the overinterpretation of experiments\\nThere are a variety of scRNAseq analytical tools containing straightforward\\nanalytical methods for instance dimensional reduction by principal components\\nfollowed by the secondary dimensional reduction based on UMAP or tSNE used for\\ncluster visualization The correct principal components are selected based on the\\nvisual presentation of the percent of explained variance and JackStraw analysis of the\\nPC significance Adding even more principal components to explain more data\\nvariance can result in a more positive influence on results however such an approach\\nis also associated with an increase in dimensionality which can negatively impact the\\nresults Therefore manipulating the number of PCs can not explain the whole\\nheterogeneity of cell populations but may only improve it However the experimenter\\nis still unsure if added or subtracted even statistically relevant PCs reveal authentic or\\nartificial biological final results\\nSuch caveats about the danger of omitting some specific components with\\nrelevant information are often debated within the singlecellspecialized research\\ncommunity or\\nmentseurat_communitybmp Therefore the decision to select relevant PCs is\\n25\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\ncrucial unfortunately too much depends on user decision which may lead to\\nmisinterpretation Such initial reduction of dimensionality is essential and influences\\nfurther steps of cell clustering In addition subsequent steps mentioned above namely\\nKNN and SNN require even more adjustable and obligatory parameters Using such\\nmethods we can quickly obtain the general cell diversity of the tissues and visualize\\ndominant cell populations The heterogeneity offered by such an approach is suitable\\nfor many applications however does not allow for efficient and reliable detection of\\nintermediate and instant cell stages trajectories and cell fates which is critical for\\ndynamic processes such as development and disease progression\\nAddressing all the aspects needs a new approach for the bioinformatic\\nprocessing of singlecell data and for establishing highresolution tissue profiles such\\nas the brain However several conditions need to be fulfilled for a successful approach\\nFirst the data flow between applications that starts with reads mapping repairing and\\ndetermination of basic clusters etc needs to be always uniform Second the\\napplications need interoperability between each other to pass the data according to\\nthe handtohand principle with equal parameters which means automatic and\\ndecisive data handling between all applications The third requirement is the selection\\nand preservation of highquality data and if the data are of nonsufficient quality they\\nshould first undergo the improvement of quality by our repairing algorithms The aim is\\nto retrieve as much information from the dataset as possible and represent uniform\\npreprocessed quality for feeding the CSSG algorithm to later explain cell population\\nheterogeneity with high resolution\\nSuch data processing can decrease the possibility that the discovered rare\\npopulations are artificial and exist without the support of their lineage and should\\nprovide the experimenter with needed confidence The approach eliminates manual\\nparameter change and runs repeated calculations in search of convincing dimensional\\nreduction for a particular rare population Moreover the cell number of a particular\\nsubtype is additionally subjected to quality control by binominal test therefore the\\nprobability of inclusion of artificial subtypes is minimized\\nThe most powerful feature of the CSSG algorithm is its focus on the real\\nbiological values of the differentiated occurrence of genes selected as marker genes\\nfor a given cluster In subsequent iterations of operations on the matrices the algorithm\\nselects the best combination of marker genes the presence of which is best described\\nby the heterogeneity of the cluster filling the gaps between maker genes Thanks to\\nthis we are able to identify the best combination of genes that explain the internal\\ndiversity of the cluster The obtained combinations of genes constitute a minimal\\nelement explaining the real biological heterogeneity resulting from the constantly\\nchanging functions of cells derived from the same lineage during their life which often\\nresults from the variability in the expression of individual single genes Importantly\\nevery dataset has its individual profile of heterogeneity which is determined by\\nsequencing depth library preparation cell lineage in a sample and sample\\nprocessing Therefore it is critical to analyze the datasets from other sources\\nindependently in order to obtain only biologically relevant differences and avoid\\nexperimentrelated bias\\nThanks to this approach we established 620 cell subtypes derived from 239\\nbase cell subclasses across the different parts of the mouse brain and in the human\\nbrain organoids Moreover based on the CSSGselected markers presented in\\nobtained subtypes we could notice that they differed in the development stages\\nmaturation status and signaling Therefore the results were used to demonstrate the\\n26\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\npipeline advantage to establish exact trajectories of cell population inside and between\\ncell clusters\\nFor instance the oligodendrocytes are a powerful model of brain cell\\ndifferentiation presenting many intermediate cell stages We defined the model of\\noligodendrocyte lineage by the collective screening of many works describing\\nprecursors and mature cells The works show oligodendrocyte lineages of OPC COP\\npreMO NFO MFO and MOL 3741 In brief the markers for OPCs are Vcan 37\\nC1ql1 38 and Cspg5 and S100a1 37 39 and Xylt1 important in the pathway 42\\nleading to the synthesis of chondroitin sulfate proteoglycans CSPG involved in OPC\\ndifferentiation towards myelinproducing cells 40 Moreover in the literature the COP\\nvs OPC cells show higher expression of Tns3 and Vcan which are marker parts of\\nmodel 37 The preMO as intermediate cells was also proposed as the cell stage\\nbefore NFO oligodendrocytes and in addition the preMO stage starts to express Mag\\n41 Our literature model points on Gpr17 gene as related to preMO 41 and to the\\nearly development of oligodendrocytes 23 37 41 In addition we have selected Tnr\\ngene as another preMO marker candidate The Tnr is involved in oligodendrocytes\\ndifferentiation but inhibits myelin membrane formation 43 The next form is the NFO\\npresenting Frmd4a and Fyn genes 37 the St18 which is needed for\\noligodendrocytes formation 44 The MOL phase express Anl 37 Mbp 45 Prr5l\\n45 and coexpression of Car2 with Plp1 is related to this cell stage 46 Finally the\\nexpression of Mog 23 Opalin Mal and Plp1 37 genes responsible for myelin\\nformation are widely expressed in MFOL and MOL\\nTrajectories of cell differentiation can be determined based on analyzing the\\nsubtypes expressing the dominant genes selected by CSSG which are the molecular\\nswitches of trajectories The relations between the subtypes can now be determined\\nby hierarchical clustering which builds the cell population trajectories The above\\nparadigm of CSSG and hierarchical clustering was used for the oligodendrocyte\\nmolecular switches and subpopulation relations We noticed that the paradigm results\\nshowed the oligodendrocytes decreasing maturity along the hierarchy in the lineage\\ntree To assign the names of the lineage stages we used the literaturebased model\\nof oligodendrocyte differentiation described above and confronted with markers\\nforming names of our cell population of subclass and subtypes see the cell population\\nnaming rules Such a complex model of trajectories was never shown previously with\\nsuch resolution in one experiment using complex brain tissue\\nIn a similar approach as trajectories and as another pipeline validation step we\\ntraced the relations between cell populations types subclasses and subtypes\\nspecifically expressing Alzheimers disease genes such as Apoe App Mapt Psen1\\nPsen2 and Trem2 in mouse brain and human brain organoids Fig 5 6 7 and\\nsupplement 131\\nIncreased expression of the Apoe gene is characteristic for astrocyte microglial\\nendothelial and pericyte cells 4750 The expression of Apoe is also present in OPCs\\nand oligodendrocytes where it is involved in the migration and maturation of OPCs\\nand oligodendrocytes and general brain remyelination 51 In neurons the Apoe\\nsilencing results in the downregulation of proliferation in favor of differentiation\\nfollowed by increased excitatory current and release of neurotransmitters 52 Using\\nthe CSSGJSEQ we demonstrated high expression of Apoe in subtypes of non\\nneuronal cells and in several glutamatergic subtypes\\nAppApoe protein product interaction regulates Aβ aggregation and clearance\\nand may influence the development of plaques and tau pathology 53 In our results\\nthe coexpression of the genes is characteristic for some vascular endothelial\\n27\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\npericytes fibroblast immune astrocyte glutamatergic and NSC subtypes Our\\nanalysis can pinpoint the exact subtypes where such an interaction may potentially\\noccur and become an accurate AD therapy target\\nIn general the expression pattern of ADinvolved genes is already complicated\\nin cell types therefore it is impossible to explain cellular disease complexity without\\nsplitting the proposed cell populations into subtypes For instance Apoe Trem2 and\\nothers are traditionally regarded as glial markers but both markers expression is also\\nfound in several subtypes of neuronal cells For the orbitofrontal subclass initial\\ncluster we obtained four subtypes Fig 8 that belong to up to three different cell\\ntypes including astrocytes oligodendrocytes and glutamatergic cells At the highest\\nlevel two hierarchical clusters in our graph contain two astrocytic populations with\\ndifferent markers We observed astrocytes expressing Cd81 a critical regulator of\\nneuronalinduced astrocytic differentiation 54 next to the classical astrocyte subtype\\nexpressing Glul 55 Next our hierarchy revealed the glutamatergic cell subtype\\nfollowed by the oligodendrocyte subtype Such hierarchical assignment of subtypes\\ngenerated by the CSSGJSEQ approach is very interesting since some populations of\\nastrocytes may acquire new functions Some astrocytes namely their intermediate\\npopulations may release glutamate 56 or may convert to oligodendrocytes 57 58\\nin response to injury or disease stimuli Another candidate for intermediate cellular\\nsubtypes can be identified in the subclass of macrophages in the entorhinal cortex\\nwhere the particular subtype of macrophages expresses Cdh2 gene We hypothesized\\nthat the population might be in the intermediate subtype stage characteristic of\\nglutamatergic cells Also in response to inflammation the microglial can start the\\nproduction of glutamate 59 The CSSGJSEQ isolated cellular intermediate stages\\nshow marked patterns of genes expression causative to AD The analysis can point at\\nnew cellular targets and the relation of AD gene expression to search for new\\ntherapies\\nConclusion\\nSinglecell RNA sequencing generates high volumes of data demanding\\ncomplicated multistep bioinformatics analysis and specialized applications Existing\\nsolutions are not reliably applicable to discover the high level of tissue heterogeneity\\ncellular lineages during development and differentiation with many intermediate rare\\npopulations Therefore we have generated a new algorithmic strategy and pipeline for\\nrare cell population discovery which we called CSSGJSEQ The CSSG algorithm\\nprocesses scRNAseq data expressed as binary matrix data about genes occurrence\\nin each cell inside the cluster in an iterative and parallel way The action of the CSSG\\nis complemented with a new naming algorithm that uses a cascade of CSSG results\\nand the metadata of marker genes to generate names of cell classes subclasses and\\nsubtypes We conclude that the CSSG and naming approach allows for tracing cell\\npopulations with high resolution finding relations between them to data mine the\\nhierarchy between cell populations and establishing developmental differentiation\\nand pathogenic trajectory The important advantage of our pipeline is that it is able to\\ntake a snapshot of a current physiological or pathological stage of the investigated\\norgan or a cell population which is particularly important for complicated tissues such\\nas the brain\\n28\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nSupplementary Data\\nSupplementary data supplement 11 supplement 12 and supplement 13\\n131 132 have been combined into one HTML file containing extended results\\nfor all brain regions and human brain organoids The supplement is available at the\\nfollowing link for convenience\\n \\nThe QR code aids the access to supplementary data for the\\nmanuscript from the level of a web browser for all brain\\nregions linked to UMAPs in PDF static format or HTML\\ninteractive format\\nCompeting interest\\nThis work was supported by the grant from the National\\nScience Centre Poland grant number\\n201831BNZ303621 and NCBR The National Centre for Research and\\nDevelopment Horizon 2020 ADMIRE grant number 959748\\nAcknowledgment\\nWe sincerely thank the Broad Institute for generating their openaccess single\\ncell data portal Sustaining and\\nupdating the comprehensive singlecell dataset freely available to researchers from\\nthe community greatly accelerates the development of singlecell research and\\ndedicated bioinformatics solutions like creating and testing our CSSGJSEQ algorithms\\nand pipeline\\nConflict of interest\\nThe authors declare that the research was conducted in the absence of any\\ncommercial or financial relationships that could be construed as a potential conflict of\\ninterest\\n29\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nReferences\\n1 NarayanA BergerB and ChoH 2021 Assessing singlecell transcriptomic\\nvariability through densitypreserving data visualization Nat Biotechnol 39\\n765774\\n2 HawrylyczM MillerJA MenonV FengD DolbeareT Guillozet\\nBongaartsAL JeggaAG AronowBJ LeeCK BernardA et al 2015\\nCanonical Genetic Signatures of the Adult Human Brain Nature Neuroscience\\n18 18321844\\n3 MickelsenLE BolisettyM ChimileskiBR FujitaA BeltramiEJ CostanzoJT\\nNaparstekJR RobsonP and JacksonAC 2019 Singlecell transcriptomic\\nanalysis of the lateral hypothalamic area reveals molecularly distinct\\npopulations of inhibitory and excitatory neurons Nature Neuroscience 22 642\\n656\\n4 GuoQ and LiJYH 2019 Defining developmental diversification of diencephalon\\nneurons through single cell gene expression profiling Development 146\\n5 VelascoS KedaigleAJ SimmonsSK NashA RochaM QuadratoG\\nPaulsenB NguyenL AdiconisX RegevA et al 2019 Individual brain\\norganoids reproducibly form cell diversity of the human cerebral cortex Nature\\n570 523527\\n6 KozarevaV MartinC OsornoT RudolphS GuoC VanderburgC NadafN\\nRegevA RegehrWG and MacoskoE 2021 A transcriptomic atlas of mouse\\ncerebellar cortex comprehensively defines cell types Nature 598 214219\\n7 CalvoSE ClauserKR and MoothaVK 2016 MitoCarta20 An updated\\ninventory of mammalian mitochondrial proteins Nucleic Acids Research 44\\n8 HarrowJ FrankishA GonzalezJM TapanariE DiekhansM KokocinskiF\\nAkenBL BarrellD ZadissaA SearleS et al 2012 GENCODE The\\nreference human genome annotation for the ENCODE project Genome\\nResearch 22 17601774\\n9 ChenS ZhouY ChenY and GuJ 2018 Fastp An ultrafast allinone FASTQ\\npreprocessor Bioinformatics 34\\n10 SmithT HegerA and SudberyI 2017 UMItools Modeling sequencing errors\\nin Unique Molecular Identifiers to improve quantification accuracy Genome\\nResearch 27 491499\\n11 Dropseq toolkit 2018 Broad Institute 101093bioinformaticsbts635\\n12 ButlerA HoffmanP SmibertP PapalexiE and SatijaR 2018 Integrating\\nsinglecell transcriptomic data across different conditions technologies and\\nspecies Nature Biotechnology 36 411420\\n13 FinakG McDavidA YajimaM DengJ GersukV ShalekAK SlichterCK\\nMillerHW McElrathMJ PrlicM et al 2015 MAST A flexible statistical\\n30\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nframework for assessing transcriptional changes and characterizing\\nheterogeneity in singlecell RNA sequencing data Genome Biology 16 113\\n14 ZeiselA HochgernerH LönnerbergP JohnssonA MemicF van der ZwanJ\\nHäringM BraunE BormLE La MannoG et al 2018 Molecular\\nArchitecture of the Mouse Nervous System Cell 174 9991014\\n15 HodgeRD BakkenTE MillerJA SmithKA BarkanER GraybuckLT\\nCloseJL LongB JohansenN PennO et al 2019 Conserved cell types\\nwith divergent features in human versus mouse cortex Nature 573 6168\\n16 FanX FuY ZhouX SunL YangM WangM ChenR WuQ YongJ\\nDongJ et al 2020 Singlecell transcriptome analysis reveals cell lineage\\nspecification in temporalspatial patterns in human cortical development\\nScience Advances 6\\n17 PengJ ShengAL XiaoQ ShenL JuXC ZhangM HeST WuC and\\nLuoZG 2019 Singlecell transcriptomes reveal molecular specializations of\\nneuronal cell types in the developing cerebellum Journal of Molecular Cell\\nBiology 11 636648\\n18 GokceO StanleyGM TreutleinB NeffNF CampJG MalenkaRC\\nRothwellPE FuccilloM V SüdhofTC and QuakeSR 2016 Cellular\\nTaxonomy of the Mouse Striatum as Revealed by SingleCell RNASeq Cell\\nReports 16 11261137\\n19 McKenzieAT WangM HaubergME FullardJF KozlenkovA KeenanA\\nHurdYL DrachevaS CasacciaP RoussosP et al 2018 Brain Cell Type\\nSpecific Gene Expression and Coexpression Network Architectures Scientific\\nReports 8\\n20 ChenR WuX JiangL and ZhangY 2017 SingleCell RNASeq Reveals\\nHypothalamic Cell Diversity Cell Reports 18 32273241\\n21 KishimotoTE UchidaK ThongtharbA ShibatoT ChambersJK NibeK\\nKagawaY and NakayamaH 2018 Expression of Oligodendrocyte Precursor\\nCell Markers in Canine Oligodendrogliomas Veterinary Pathology 55 634\\n644\\n22 CampbellJN MacoskoEZ FenselauH PersTH LyubetskayaA TenenD\\nGoldmanM VerstegenAMJ ReschJM McCarrollSA et al 2017 A\\nMolecular Census of Arcuate Hypothalamus and Median Eminence Cell Types\\nNature neuroscience 20 484496\\n23 ArtegianiB LyubimovaA MuraroM van EsJH van OudenaardenA and\\nCleversH 2017 A SingleCell RNA Sequencing Study Reveals Cellular and\\nMolecular Dynamics of the Hippocampal Neurogenic Niche Cell Reports 21\\n32713284\\n24 TakeuchiA TakahashiY IidaK HosokawaM IrieK ItoM BrownJB\\nOhnoK NakashimaK and HagiwaraM 2020 Identification of Qk as a Glial\\n31\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nPrecursor Cell Marker that Governs the Fate Specification of Neural Stem Cells\\nto a Glial Cell Lineage Stem Cell Reports 15 883897\\n25 BorggreweM GritC VainchteinID BrouwerN WesselingEM LamanJD\\nEggenBJL KooistraSM and BoddekeEWGM 2021 Regionally diverse\\nastrocyte subtypes and their heterogeneous response to EAE Glia 69 1140\\n1154\\n26 KoiralaS and CorfasG 2010 Identification of novel glial genes by singlecell\\ntranscriptional profiling of Bergmann glial cells from mouse cerebellum PLoS\\nONE 5\\n27 CarterRA BihannicL RosencranceC HadleyJL TongY PhoenixTN\\nNatarajanS EastonJ NorthcottPA and GawadC 2018 A SingleCell\\nTranscriptional Atlas of the Developing Murine Cerebellum Current Biology 28\\n29102920e2\\n28 LangletF 2019 Tanycyte gene expression dynamics in the regulation of energy\\nhomeostasis Frontiers in Endocrinology 10\\n29 GuoQ and LiJYH 2019 Defining developmental diversification of\\ndiencephalon neurons through single cell gene expression profiling\\nDevelopment Cambridge 146\\n30 KalishBT CheadleL HrvatinS NagyMA RiveraS CrowM GillisJ\\nKirchnerR and GreenbergME 2018 Singlecell transcriptomics of the\\ndeveloping lateral geniculate nucleus reveals insights into circuit assembly and\\nrefinement Proceedings of the National Academy of Sciences of the United\\nStates of America 115 E1051E1060\\n31 EzeUC BhaduriA HaeusslerM NowakowskiTJ and KriegsteinAR 2021\\nSinglecell atlas of early human brain development highlights heterogeneity of\\nhuman neuroepithelial cells and early radial glia Nature Neuroscience 24 584\\n594\\n32 NelsonBR HodgeRD DazaRAM TripathiPP ArnoldSJ MillenKJ and\\nHevnerRF 2020 Intermediate progenitors support migration of neural stem\\ncells into dentate gyrus outer neurogenic niches eLife 9\\n33 HarrisKD HochgernerH SkeneNG MagnoL KatonaL GonzalesCB\\nSomogyiP KessarisN LinnarssonS and HjerlingLefflerJ 2018 Classes\\nand continua of hippocampal CA1 inhibitory neurons revealed by singlecell\\ntranscriptomics PLOS Biology 16\\n34 HabibN AvrahamDavidiI BasuA BurksT ShekharK HofreeM\\nChoudhurySR AguetF GelfandE ArdlieK et al 2017 Massively parallel\\nsinglenucleus RNAseq with DroNcseq Nature Methods 14 955958\\n35 MuñozManchadoAB Bengtsson GonzalesC ZeiselA MungubaH\\nBekkoucheB SkeneNG LönnerbergP RygeJ HarrisKD LinnarssonS\\net al 2018 Diversity of Interneurons in the Dorsal Striatum Revealed by Single\\nCell RNA Sequencing and PatchSeq Cell Reports 24 21792190\\n32\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\n36 SmithSJ SmbülU GraybuckLT CollmanF SeshamaniS GalaR\\nGlikoO ElabbadyL MillerJA BakkenTE et al 2019 Singlecell\\ntranscriptomic evidence for dense intracortical neuropeptide networks eLife 8\\n37 MarquesS ZeiselA CodeluppiS Van BruggenD FalcãoAM XiaoL LiH\\nHäringM HochgernerH RomanovRA et al 2016 Oligodendrocyte\\nheterogeneity in the mouse juvenile and adult central nervous system Science\\n352 13261329\\n38 BandlerRC VitaliI DelgadoRN HoMC DvoretskovaE Ibarra MolinasJS\\nFrazelPW MohammadkhaniM MacholdR MaedlerS et al 2022 Single\\ncell delineation of lineage and genetic identity in the mouse brain Nature 601\\n404409\\n39 DeloulmeJC RaponiE GentilBJ BertacchiN MarksA LabourdetteG and\\nBaudierJ 2004 Nuclear expression of S100B in oligodendrocyte progenitor\\ncells correlates with differentiation toward the oligodendroglial lineage and\\nmodulates oligodendrocytes maturation Molecular and Cellular Neuroscience\\n27 453465\\n40 ClementeD OrtegaMC MeleroJerezC and de CastroF 2013 The effect of\\ngliaglia interactions on oligodendrocyte precursor cell biology during\\ndevelopment and in demyelinating diseases Frontiers in Cellular Neuroscience\\n7\\n41 HughesEG and StocktonME 2021 Premyelinating Oligodendrocytes\\nMechanisms Underlying Cell Survival and Integration Frontiers in Cell and\\nDevelopmental Biology 9 117\\n42 GokhmanD NissimRafiniaM AgranatTamirL HousmanG GarcíaPérezR\\nLizanoE CheronetO MallickS NievesColónMA LiH et al 2020\\nDifferential DNA methylation of vocal and facial anatomy genes in modern\\nhumans Nat Commun 11 1189\\n43 CzopkaT Von HolstA SchmidtG FfrenchConstantC and FaissnerA 2009\\nTenascin C and tenascin R similarly prevent the formation of myelin membranes\\nin a RhoAdependent manner but antagonistically regulate the expression of\\nmyelin basic protein via a separate pathway Glia 57 17901801\\n44 NajmFJ LagerAM ZarembaA WyattK CaprarielloA V FactorDC\\nKarlRT MaedaT MillerRH and TesarPJ 2013 Transcription factor\\nmediated reprogramming of fibroblasts to expandable myelinogenic\\noligodendrocyte progenitor cells Nature Biotechnology 31 426433\\n45 FalcãoAM BruggenD MarquesS MeijerM JäkelS AgirreE Samudyta\\nFloriddiaEM VanichkinamDP FFrenchConstantC et al 2019 Disease\\nspecific oligodendrocyte lineage cells arise in multiple sclerosis Nature\\nMedicine 24 18371844\\n46 FloriddiaEM LourençoT ZhangS van BruggenD HilscherMM KukanjaP\\nGonçalves dos SantosJP AltınkökM YokotaC LlorensBobadillaE et al\\n33\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\n2020 Distinct oligodendrocyte populations have spatial preference and\\ndifferent responses to spinal cord injury Nature Communications 11 115\\n47 LanfrancoMF SepulvedaJ KopetskyG and RebeckGW 2021 Expression\\nand secretion of apoE isoforms in astrocytes and microglia during inflammation\\nGlia 69 14781493\\n48 YamazakiY ShinoharaM YamazakiA RenY AsmannYW KanekiyoT and\\nBuG 2020 ApoE Apolipoprotein E in Brain Pericytes Regulates Endothelial\\nFunction in an IsoformDependent Manner by Modulating Basement Membrane\\nComponents Arteriosclerosis thrombosis and vascular biology 40 128144\\n49 FernandezCG HambyME McReynoldsML and RayWJ 2019 The role of\\napoE4 in disrupting the homeostatic functions of astrocytes and microglia in\\naging and Alzheimers disease Frontiers in Aging Neuroscience 11\\n50 Berenji ArdestaniS EftedalI PedersenM JeppesenPB NørregaardR and\\nMatchkovV V 2020 Endothelial dysfunction in small arteries and early signs\\nof atherosclerosis in ApoE knockout rats Scientific Reports 10 111\\n51 LiL LiR ZacharekA WangF LandschootWardJ ChoopM ChenJ and\\nCuiX 2020 ABCA1 ApoE HDL Signaling Pathway Facilitates Myelination\\nand Oligodendrogenesis after Stroke Interantional Journal of Molecular\\nScience 21\\n52 LinYT SeoJ GaoF FeldmanHM WenHL PenneyJ CamHP\\nGjoneskaE RajaWK ChengJ et al 2018 APOE4 Causes Widespread\\nMolecular and Cellular Alterations Associated with Alzheimers Disease\\nPhenotypes in Human iPSCDerived Brain Cell Types Neuron 98 1141\\n1154e7\\n53 WisniewskiT and DrummondE 2020 APOEamyloid interaction Therapeutic\\ntargets Neurobiology of Disease 138\\n54 KelićS LevyS SuarezC and WeinsteinDE 2001 CD81 regulates neuron\\ninduced astrocyte cellcycle exit Molecular and Cellular Neuroscience 17 551\\n560\\n55 BoisvertMM EriksonGA ShokhirevMN and AllenNJ 2018 The Aging\\nAstrocyte Transcriptome from Multiple Regions of the Mouse Brain Cell\\nReports 22 269285\\n56 SatarkerS BojjaSL GurramPC MudgalJ AroraD and NampoothiriM\\n2022 Astrocytic Glutamatergic Transmission and Its Implications in\\nNeurodegenerative Disorders Cells 11 126\\n57 LiuX LiC LiJ XieL HongZ ZhengK ZhaoX YangA XuX TaoH et\\nal 2022 EGF signaling promotes the lineage conversion of astrocytes into\\noligodendrocytes Molecular Medicine 28\\n58 KhanghahiAM SatarianL DengW BaharvandH and JavanM 2018 In vivo\\nconversion of astrocytes into oligodendrocyte lineage cells with transcription\\n34\\nbioRxiv preprint doi this version posted April 21 2023 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is\\nmade available under aCCBYNCND 40 International license\\nfactor Sox10 Promise for myelin repair in multiple sclerosis PLoS ONE 13 1\\n18\\n59 DingL XuX LiC WangY XiaX and ZhengJC 2021 Glutaminase in\\nmicroglia A novel regulator of neuroinflammation Brain Behavior and\\nImmunity 92 139156\\n35',\n",
              " 'bioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nIntegrated phenotypic and proteomic\\n1\\nscreening identifies toptier Alzheimers\\n2\\ndisease therapeutic targets\\n3\\n4\\n5 Authors\\n6 Gregory A Carya1 Qianjin Lib1 Jesse C Wileyc Carolyn A Paisied Yuhong Dub Elizabeth L Zoellerb\\n7 Duc Duongb Haian Fub Nicholas T Seyfriedb Allan I Leveyb Ranjita Betarbetb Gregory W Carterad\\n8 for The EmorySageSGCJAX TREATAD Centere\\n9\\n10 Author information\\n11 aThe Jackson Laboratory for Mammalian Genetics Bar Harbor ME\\n12 bEmory University School of Medicine Atlanta GA USA\\n13 cUniversity of Kansas Lawrence KS USA\\n14 dThe Jackson Laboratory for Genomic Medicine Farmington CT\\n15\\neadknowledgeportalorgTREATADESSCenter\\n16 1These authors contributed equally\\n17\\n18 Corresponding author\\n19 Gregory W Carter The Jackson Laboratory Bar Harbor ME gregorycarterjaxorg\\n1\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n20 ABSTRACT\\n21 Introduction Alzheimers disease AD is a complex neurodegenerative disorder Hundreds of\\n22 therapeutic targets have been nominated through genetic and multiomic studies but effective\\n23 prioritization remains a major bottleneck\\n24\\n25 Methods We applied an integrative screening framework to assess 29 candidate targets from risk\\n26 enriched biological domains Using diseaserelevant murine BV2 microglial cell lines with stable\\n27 Psen2 knockdown we performed siRNAmediated perturbations followed by cellular phenotypic\\n28 assays and quantitative proteomics\\n29\\n30 Results Twentyfive candidate targets significantly altered at least one phenotype with stronger\\n31 effects in Psen2 knockdown cells Integrated proteomic analyses identified several perturbations that\\n32 reversed ADassociated molecular patterns Five targetsAp2a2 Pdhb Pdha1 Dlat and Psmc3\\n33 impacted both phenotypes and related proteomic responses\\n34\\n35 Discussion We established a scalable platform for target functional validation that bridges unbiased\\n36 systemslevel assessments of AD risk with experimental evidence The ESSJ TREATAD center will\\n37 prioritize further resource development for these validated targets\\n38\\n2\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n39 Abbreviations\\n40 Alzheimers Disease AD Target Enablement to Accelerate Therapy Development in AD TREAT\\n41 AD Accelerating Medical Partnership for AD AMPAD Gene Set Enrichment Analysis GSEA\\n42 Gene Ontology GO\\n43 1 BACKGROUND\\n44 Alzheimers disease AD is a lateonset progressive neurodegenerative disorder that\\n45 presents an immense and escalating burden on global healthcare systems patients and caregivers\\n46 1 There is an urgent need for the development of novel therapeutic interventions that can\\n47 ameliorate these burdens However therapeutic development efforts are challenging given the\\n48 complex multifactorial nature of the disease The interplay among genetic lifestyle and\\n49 environmental risk factors over decades of life obscures which diseasealtered processes are optimal\\n50 targets for effective interventions 2 Systemslevel analyses such as genomewide association\\n51 studies GWAS and multiomic analyses have been used to address and catalog this complexity\\n52 These studies have yielded extensive lists of potential therapeutic targets The largest genome wide\\n53 association studies implicate over 75 genomic loci in disease risk 3 while the AD Knowledge Portal\\n54 agoraadknowledgeportalorg currently lists over 900 targets nominated for therapeutic development\\n55 based on the Accelerating Medicines Partnership for Alzheimers Disease AMPAD nominations 4\\n56 Effectively prioritizing these candidate targets remains a significant bottleneck\\n57 We have previously described an approach to integrate signatures of risk from AD case data\\n58 5 This framework uses evidence from genetic association studies eg GWAS QTL and from\\n59 transcriptomic and proteomic assessment of differential expression in postmortem brain to score AD\\n60 risk genomewide This risk score is paired with the AD biological domains biodomains which\\n61 enumerate the molecular features commonly implicated in the disease The biodomains are\\n62 functionalized via annotation of each with a set of largely unique Gene Ontology GO terms Using\\n3\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n63 these resources highlighted especially strong enrichment for disease risk among the Synapse\\n64 Immune Response Lipid Metabolism and Mitochondrial Metabolism domains 5 We interrogated\\n65 these riskenriched processes with orthogonal approaches to articulate interpretable hypotheses\\n66 based on the systemslevel signatures of risk We generated two exemplar hypotheses with this\\n67 approach 1 mitochondrial hypometabolism leads to an increased susceptibility to\\n68 neurodegeneration and 2 chronic neuroinflammation via overactivation of the innate immune\\n69 response leads to neurodegenerative pathology in AD These hypotheses are not novel and reflect\\n70 consensus opinions from recent years regarding disease pathogenesis 68 However these\\n71 hypotheses have been developed through systematic integration of disease risk signatures and\\n72 bioinformatic pipelines are used to identify candidate riskenriched targets related to each overarching\\n73 hypothesis area Each hypothesis emanates from a specific GO term ie mitochondrion\\n74 GO0005739 and innate immune response GO0045087 each having several hundred annotated\\n75 risk genes It is not clear from the available data which of the predicted driver genes are capable of\\n76 affecting the targeted biology in appropriate cellular contexts\\n77 To resolve this question we have developed a robust experimental system to screen\\n78 candidate driver genes for those that are capable of affecting the biology under investigation Figure\\n79 1 Given the nature of the exemplar hypotheses we first used a microglial surrogate cell system to\\n80 assess the impact of targeting the nominated genes The genes were knocked down in the microglial\\n81 surrogate lines and phenotypes relevant to mitochondrial function and immune response were\\n82 assayed Proteomic responses were also assessed following target knockdown We integrated the\\n83 results from cellular phenotype assays with proteomic responses to identify targets that both affect\\n84 the phenotypes under investigation and impact associated biodomain terms in the proteomic results\\n85 Of the 29 candidate targets screened we identify strong support for five targets Ap2a2 Pdhb\\n86 Pdha1 Dlat and Psmc3 that both significantly impact the cellular phenotypes screened and\\n87 corresponding biodomain terms Importantly perturbation of each of these targets demonstrated the\\n4\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n88 capacity to reverse the proteomic signatures associated with disease in these experiments This work\\n89 establishes a platform to filter and validate prioritized candidate therapeutic targets to those that have\\n90 the greatest potential to impact diseaserelevant biology This platform will be used by the Emory\\n91 SageSGCJAX TREATAD center to prioritize candidate targets for the development of additional\\n92 target enabling packages by the center\\n93 2 METHODS\\n94 21 Cell Culture and siRNAMediated Target Knockdown\\n95 Murine microglial BV2 cell lines stably expressing Presenilin 2 Psen2 shiRNA or scrambled\\n96 siRNA as previously described 9 were kindly provided by Dr Suman Jayadev University of\\n97 Washington School of Medicine in Seattle Washington Cells were cultured in DMEMF12 11 10\\n98 FBS and 5 mgml puromycin selection antibiotic\\n99 Candidate targets were selected from two broad hypothesis areas each derived from related\\n100 GO terms from the AD biological domains biodomains 5 1 immune response from the innate\\n101 immune response term GO0045087 and 2 mitochondrial metabolism from the mitochondrion\\n102 term GO0005739 These terms were both riskenriched based on the results of GSEA using the AD\\n103 target risk score 5 and were also implicated in early disease pseudotemporal states 10 Through\\n104 examination of proteinprotein interaction networks centered on the proteins in each hypothesis area\\n105 integration with AMPAD nominated targets from Agora agoraadknowledgeportalorg and a target\\n106 novelty analysis we identified 29 candidate targets 17 targets within the Immune Response\\n107 hypothesis area and 14 targets within the Mitochondrial Metabolism hypothesis area with 2 common\\n108 targets Figure 1 Six of the 29 candidates have been previously nominated by AMPAD\\n109 investigators and there is a mix of genes with transcripts and proteins that are both up and down in\\n110 AD brains postmortem Figure S1A We confirmed the expression of the candidate target genes in\\n5\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n111 publicly available gene expression datasets from BV2 cells GEO accessions GSE162526\\n112 GSE132739 and GSE137741 by averaging the log2 transformed expression values from each\\n113 dataset and plotting a heatmap Figure S1B\\n114 A custom library of siRNAs against BioHyV targets ONTARGETplus siRNA was\\n115 purchased from Horizon Discovery which consisted of a pool of four siRNA per target\\n116 Supplementary Table S1 Approximately 1824 hours before transfection cells were seeded in 384\\nμ\\n117 well plates 1200 cells in 25 l media were dispensed into each well of a 384well plate using\\n118 multidrop combi ThermoFisher Scientific siRNAs were transfected with TransITX2 Mirus MIR\\n119 6000 at 25 nM final concentration After 72 hours of transfection a panel of assays were performed\\n120 as described in the following including cell viability mitochondrial membrane potential phagocytosis\\nκ\\n121 and NF B reporter assays\\n122 Knockdown efficiency of the siRNAs was confirmed with realtime PCR Figure S1C Cells\\n123 were washed with PBS twice Total RNA was isolated using the RNeasy Kit Qiagen following the\\nμ\\n124 protocol of the manufacturer Complementary DNA was reversetranscribed from 1 g of total RNA in\\nμ\\n125 a 20 l reaction with a reverse transcription kit QIAGEN 205313 The reverse transcription\\nμ\\n126 products were diluted 30 times with distilled H O and 15 l was used as template for each real time\\n2\\n127 PCR reaction The reactions were performed using SsoAdvanced Universal SYBR Green Supermix\\n128 BioRad 1725274 The thermal cycling conditions were composed of an initial denaturation step at\\n129 95 C for 1 min 40 cycles at 95 C for 10 s and 60 C for 50 s The experiments were carried out in\\nΔΔ\\n130 triplicate Relative quantification of fold changes in gene expression was obtained by the 2 Ct\\n131 method with GAPDH as the internal reference gene The sequences of primers used for RTPCR are\\n132 listed in Supplementary Table S2\\n133 22 Cellular Phenotypic Assays\\n6\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nμ\\n134 Cell viability assay 5 l CellTiterBlue reagent Promega G8088 was added to each well of\\n135 a 384well plate after 72 hours after siRNA transfection After incubating for 4 hours at 37C\\n136 Fluorescence Intensity FI which is corresponding to the number of living cells was measured with\\n137 PHERAstar FSX BMG Labtech plate reader Ex 560nm and Em 590nm Wells containing medium\\n138 only were used as background signals The assay was run in three separate batches with three\\n139 biological replicates per batch for a total 9 measurements per siRNA and BV2 cell line\\n140 Mitochondrial membrane potential assay MitoTracker TMRM ThermoFisher I34361 was\\nμ\\n141 diluted in culture medium containing the nuclear stain Hoechst 33342 2 l staining solution was\\nμ\\n142 added to each well to final concentration of 100 nM TMRM and 10 gml Hoechst 33342 After 30\\n143 minutes incubation at 37C cells were imaged with ImageXpress Micro Molecular Devices and the\\n144 average fluorescence intensity of the cells were quantified based on cell number indicated by\\n145 Hoechst staining with MetaXpress 6 The assay was run in seven separate batches with three\\n146 biological replicates per batch for a total of 21 measurements per siRNA and BV2 cell line\\n147 Phagocytosis assay pHrodo Green Zymosan BioParticles Conjugate ThermoFisher \\nμ\\n148 P35365 was dissolved in PBS and mixed with Hoechst 33342 4 g Zymosan Bioparticles\\nμ\\n149 Conjugates were added to each well with Hoechst 33342 at final concentration of 10 gml After 2 hr\\n150 incubation at 37C cells were imaged with ImageXpress Micro Molecular Devices and data were\\n151 analyzed with MetaXpress 6 The assay was run in three separate batches with three to six biological\\n152 replicates per batch for a total of 12 measurements per siRNA and BV2 cell line\\nκ\\n153 NFkappaB reporter assay Stable cell lines expressing luciferase driven by an NF B response\\n154 element were generated by transfecting BV2Scramble and BV2Psen2KD cells with plasmid\\nκ\\n155 pGL432luc2PNF BREHygro Promega E8491 3 days after transfection hygromycin was\\nμ κ\\n156 applied to cells at concentration of 400 gml to select stable cell lines For the NF B reporter assay\\n157 cells harboring the luciferase reporter gene were transfected with siRNA for target gene knockdown\\n7\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nμ\\n158 3 days after transfection cells were treated with either LPS 01 gml or vehicle for 6 hours\\n159 Luciferase signal was measured with EnVision 2103 Multilabel plate Reader PekinElmer The assay\\n160 was run in three separate batches with four to five biological replicates per batch for a total of 14\\n161 measurements per siRNA BV2 cell line and LPS dose\\n162 Statistical analyses Each assay was analyzed by first computing an average across all\\n163 biological replicates per batch then a log2fold change was computed by comparing the average\\n164 target siRNA values to the average control siRNA values within the same BV2 cell line and LPS dose\\n165 where applicable A linear mixed model with random effects was fit using the lmer function from the\\n166 lme4 R package 11 to assess the statistical significance for each assay The log2 fold change\\n167 values were modeled as a combination of fixed effects siRNA and BV2 cell line and random effects\\n168 experimental batch Calculation of estimated marginal means and posthoc statistical testing was\\n169 performed with the emmeans R package 12 Assay hits were defined as any knockdown that\\ncorrected pvalue 005 All results are reported\\n170 achieved an effect with a BenjaminiHochberg 13\\n171 Supplemental Table S3\\n172 23 Proteomic Analyses\\n173 Cell Homogenization and Protein Digestion Cell pellets were lysed in lysis buffer 8 M urea 10\\ncid3\\n174 mM Tris 100 mM NaH2PO4 pH 85 and protein concentration was determined by bicinchoninic\\ncid3μ\\n175 acid BCA assay Pierce For protein digestion 25 g of each sample was aliquoted and volumes\\ncid3\\n176 normalized with additional lysis buffer Samples were reduced with 5 mM dithiothreitol DTT at room\\ncid3 cid3\\n177 temperature for 30 min followed by 10 mM iodoacetamide IAA alkylation in the dark for another\\ncid3\\n178 30 min Lysyl endopeptidase Wako at 125 ww was added and digestion allowed to proceed\\ncid3\\n179 overnight Samples were then 7fold diluted with 50 mM ammonium bicarbonate Trypsin Promega\\n180 was then added at 125 ww and digestion proceeded overnight The peptide solutions were\\n8\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n181 acidified to a final concentration of 1 volvol formic acid FA and 01 volvol trifluoroacetic acid\\ncid3\\n182 TFA and desalted with a 10 mg HLB column Oasis Each HLB column was first rinsed with 1 mL\\ncid3\\n183 of methanol washed with 1 mL 50 volvol acetonitrile ACN and equilibrated with 21 mL 01\\ncid3\\n184 volvol TFA The samples were then loaded onto the column and washed with 21 mL 01\\n185 volvol TFA Elution was performed with 2 volumes of 05 mL 50 volvol ACN From each\\n186 sample 10 of the eluent was split out for single shot DIA 10 was used to make a combined\\n187 global internal standard and 80 was saved for TMT labeling All aliquots were dried by speedvac\\n188 and stored\\n189 Single Shot DIA Liquid Chromatography Mass Spectrometry All samples were resuspended in\\nμ μ\\n190 10 l of loading buffer 01 FA 003 TFA 1 ACN and 1 l analyzed by liquid chromatography\\n191 coupled to tandem mass spectrometry Peptide eluents were separated on a custom inhouse packed\\nμ μ\\n192 CSH 17 m 15 cm 150 M internal diameter ID by a Ultimate U3000 RSLCnano ThermoFisher\\n193 Scientific Buffer A was water with 01 volvol formic acid and buffer B was 80 volvol\\n194 acetonitrile in water with 01 volvol formic acid Elution was performed over a 30 min gradient with\\n195 flow rate at 1500 nLmin The gradient was from 1 to 99 solvent B Peptides were monitored on a\\n196 timsTOF HT Bruker Scientific using the machine standard diaPASEF method for short gradients\\n197 mass range from 475 to 1000 mobility range of 085 to 127 1K0 25 Da nonoverlapping windows\\n198 and a cycle time of 095 s\\n199 Database Searches and Protein Quantification All data were analyzed using DIANN v181\\n200 14 searched against the UniProtKB mouse protein database August 2020 with 91413 target\\n201 sequences The parameters were specified as follows CP1 canonical tryptic specificity minimum\\n202 fragment mz of 200 and maximum fragment mz of 5000 fixed modification for carbamidomethylation\\ncid3\\n203 of cysteine 5702146 Da variable modifications for methionine excision oxidation of methionine\\n204 15994915 Da and acetylation 42010565 Da maximum of 2 missed cleavages minimum\\n9\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n205 peptide length of 7 and maximum peptide length of 50 minimum precursor mz of 200 and maximum\\n206 precursor mz of 5000 minimum precursor charge of 1 and maximum precursor charge of 4 MS1\\n207 and MS2 mass accuracy of 10 ppm smart profiling and MBR matchbetweenruns enabled and\\n208 precursor level qvalue was set to 1\\n209 Differential Expression Testing and Functional Annotation Approximately five replicate\\n210 samples were generated for each siRNA and BV2 cell line for a total of 310 samples that were\\n211 analyzed by mass spectrometry An average of 6576 proteins were identified per sample Figure\\n212 S2BC and some samples had fewer proteins identified with one sample having only 565 proteins\\n213 identified Figure S2BC The samples with fewer protein IDs tend to also have higher median log2\\n214 protein intensity Figure S2B which may reflect protein degradation To limit the potential for these\\n215 samples to influence downstream analyses we excluded 11 samples with fewer than 6100 proteins\\n216 identified per sample which resulted in 3 to 6 replicates per siRNA and BV2 cell line Figure S2A A\\n217 large proportion of proteins 4850 were identified in over 300 samples Figure S2D Principal\\n218 components analysis on the 310 samples Figure S2EG revealed BV2 cell line ie psen2_kd vs\\n219 scramble was the biggest contributor to intrasample variance and explained 41 of that variance\\n220 Figure S2F Specific target knockdowns contributed less to sample variance but can be appreciated\\n221 Figure S2G Protein differential abundance was assessed using oneway ANOVA followed by post\\n222 hoc correction using Tukeys HSD as previously described 15 Supplementary Table S4 Gene set\\n223 enrichment analysis GSEA was run with the gseGO function from the clusterProfiler R package\\n224 v4126 16 against the orgMmegdb annotation database v3191 17 The log2 fold change for\\n225 each protein was used as a ranking statistic for GSEA and significantly enriched Gene Ontology GO\\n226 terms were mapped onto the TREATAD biodomains syn25428992v10 5 Supplementary Table\\n227 S5\\n228 24 Postmortem Brain Proteomics Data\\n10\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n229 An integrated metaanalysis of postmortem brain proteomics samples from the AMPAD\\n230 consortium was previously performed 5 encompassing 1188 brain proteomics samples Gene set\\n231 enrichment analysis GSEA was run with the gseGO function from the clusterProfiler R package\\n232 v4126 16 against the orgHsegdb annotation database v3191 18 The metaanalysis\\n233 treatment effect for each protein was used as a ranking statistic for GSEA and significantly enriched\\n234 Gene Ontology GO terms were mapped onto the TREATAD biodomains syn25428992v10 5\\n235 25 GSEA Term Correlation\\n236 Significantly enriched GO terms from the siRNA knockdown proteomics experiments in BV2\\n237 cells were compared with the significantly enriched GO terms from AD postmortem brain proteomics\\n238 The normalized enrichment score NES for GO terms that were either nonsignificant or not identified\\n239 in one analysis were set to 0 GO terms were then grouped into biodomains 5 and Kendalls rank\\n240 correlation was computed for terms within each biological domain using the NES values from each\\n241 analysis The correlation pvalues were corrected for multiple testing using BenjaminiHochberg\\n242 correction 13\\n243 26 Biological Domain Protein Correlation\\n244 Proteins were grouped into biodomains based on annotation to a term within each domain For\\n245 each biological domain the Pearson correlation was computed between the log fold change values\\n246 for proteins following target knockdown in BV2 cells and the metaanalysis treatment effect for each\\n247 orthologous protein from the human dataset The correlation pvalues were corrected for multiple\\n248 testing using BenjaminiHochberg correction 13\\n249 27 Integrating Phenotypic and Proteomic Signatures\\n250 The GSEA results for each GO term were compared with the results from the cellular\\n251 phenotypic assays For each siRNA and BV2 cell line we used Spearmans rho to correlate GO term\\n11\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n252 normalized enrichment scores NES with the calculated effect sizes from the linear mixed models for\\n253 each assay We did not include the LPS treated NFkB assay results given that LPS induction was\\n254 not performed prior to proteomic analysis The correlation test pvalue was corrected for multiple\\n255 hypothesis testing with BenjaminiHochberg correction 13 Significantly correlated terms and\\n256 phenotype effects are listed Supplemental Table S6\\n257 28 Microglia Subtype Datasets\\n258 To aid in the characterization of the Psen2 knockdown BV2 cell line we collected protein lists\\n259 defining different microglial states and subtypes Proteomic coexpression modules defined from\\n260 mouse and human microglial sets were accessed from the publication 19 Transcripts associated\\n261 with distinct microglial subtypes were identified from published single cell analyses Subtype specific\\n262 gene lists were generated based on supplemental materials from mouse microglial datasets 20\\n263 filtered FDR 005 homeostatic N 549 DAM N 627 and 21 filter kME 0975 homeostatic N\\n264 396 proinflammatory DAM N 302 antiinflammatory DAM N 399 Subtype specific gene lists\\n265 were also generated from human microglial subtype analyses 22 homeostatic N 178 genes DAM\\n266 N 146 genes and the gene lists were converted to mouse ortholog identifiers using the gorth\\n267 function from the gprofiler2 R package v023 23 GSEA was run against these custom gene lists\\n268 using the fgseaMultilevel function from the fgsea R package v1300 24 The log fold change\\n269 values from proteomic assessment of control siRNA treated psen2 knockdown versus control siRNA\\n270 treated scramble BV2 cells was used as a ranking statistic\\n271 3 RESULTS\\n272 31 Psen2 knockdown microglia are proinflammatory\\n273 The nature of the exemplar hypotheses ie Immune Response and Mitochondrial Metabolism\\n274 and subordinate candidate targets selected for exploration suggests that microglial cells would be a\\n12\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n275 relevant cell type to test target function Microglia are the resident innate immune cells of the brain\\n276 and influence neuroinflammatory processes that are commonly observed across neurodegenerative\\n277 conditions including AD Moreover genetic association studies have implicated genes expressed by\\n278 microglia in AD risk 2526 Specific microglial cell states are more strongly implicated in AD\\n279 pathogenesis 2022 To screen for potential AD therapeutic targets it is important to consider cell\\n280 states that are diseaserelevant and so we chose to use mouse BV2 microglia cell lines in which the\\n281 Psen2 gene is stably knocked down by shRNA ie psen2_kd along with a control line ie\\n282 scramble Mutations in both PSEN1 and PSEN2 are causal for autosomal dominant forms of AD 27\\n283 and in bulk transcriptomic metaanalyses of AMPAD data the PSEN2 transcript is significantly\\n284 decreased in AD brains relative to control brains Figure S3A It has been shown that Psen2\\nγ\\n285 functions are distinct from Psen1 functions in microglia and that either secretase inhibition or\\n286 specifically Psen2 knockdown in these BV2 cells results in an exaggerated cytokine response 9\\n287 When we compared the function of the Psen2 knockdown psen2_kd BV2 cell line with the\\n288 scramble BV2 cell line we noted an array of phenotype differences that indicate the Psen2\\n289 knockdown cells are a relevant model for AD microglial states The Psen2 knockdown condition\\n290 affects the expression of nominated target genes Figure S1C and in particular Ifih1 which is 37fold\\n291 upregulated in the Psen2 knockdown cells When we compare the proteomes between Psen2\\n292 knockdown and scramble cell lines there is increased expression of proteins from a number of GO\\n293 terms within the Immune Response Apoptosis Lipid Metabolism and Oxidative Stress biodomains\\n294 among others Figure 2A The upregulation of Immune Response Lipid Metabolism and Oxidative\\n295 Stress domain terms are significantly positively correlated with terms that are impacted in AD Figure\\n296 2B Specifically of the 197 Immune Response domain terms that are up in AD postmortem brain 60\\n297 are also up in the Psen2 knockdown BV2 cells when compared with the scramble BV2 cells Figure\\n298 2C Along with upregulated expression of Immune Response biodomain proteins we also noted a\\n299 higher baseline of positivity from the phagocytosis assays in the Psen2 knockdown cell line compared\\n13\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n300 with the scramble cells eg see Figure 3A We tested microglial proteomic coexpression modules\\n301 19 and found that the proteins upregulated in the Psen2 knockdown cells are significantly enriched\\n302 for a module related to Macrophage cytokine production while proteins that are downregulated in\\n303 Psen2 knockdown cells are significantly enriched for an RNA processing module Figure S3B\\n304 Finally when we tested for proteins associated with different transcriptomically defined microglial\\n305 subtypes 2022 we found that an enrichment for disease associated and homeostatic microglial\\n306 subtypes indicating that proteins associated with these relevant microglial cell states are expressed\\n307 higher in Psen2 knockdown BV2 cells than the scramble cells In summary the Psen2 knockdown\\n308 BV2 cell line is relatively more proinflammatory and may represent a cell state that is more disease\\n309 relevant than the control BV2 cells\\n310 32 Target perturbations impact relevant cellular phenotypes\\n311 We validated the knockdown of targets by siRNA in BV2 cells using realtime PCR assays\\n312 prior to further testing of cellular phenotypes and proteomic responses We confirmed over 50\\n313 knockdown for most targets with many as high as 7080 knockdown Figure S1C Two targets had\\n314 knockdown levels below 50 TICAM1 knockdown averaged a 46 reduction in expression while\\n315 DHX58 knockdown averaged a 19 reduction Figure S1C\\n316 Cellular phenotype screening was performed following 72 hours of siRNA knockdown of\\n317 targets in each BV2 cell line Example images are shown for the phagocytosis assay Figure 3A and\\n318 MitoTracker assay Figure 3B Because of the baseline differences between the Psen2 knockdown\\n319 and scramble cell lines especially for the immune assays the cell lines were analyzed separately\\n320 and results are shown separately for each background A summary of all results from cell phenotype\\n321 assays is shown Figure 3C and more detailed results are contained in the supplemental figures\\n322 alamarBlue Figure S4 MitoTracker Figure S5 NFkB Figure S6 phagocytosis Figure S7 Overall\\n323 25 of the 29 targets 86 hit rate were identified as a significant hit in at least one assay across our\\n14\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n324 panel The assays showed differential sensitivities to perturbation with the NFkB reporter assay\\n325 following LPS induction having the highest hit rate 19 hits 65 followed by NFkB reporter without\\n326 LPS induction 11 hits 38 MitoTracker 5 hits 17 and phagocytosis and alamarBlue 3 hits\\n327 each 10 Importantly the Psen2 knockdown cells were more sensitive to target knockdown For\\n328 the mitochondrial phenotypes ie alamarBlue and Mitotracker assays all hits were exclusive to the\\n329 Psen2 knockdown cells For the immune phenotypes there were more hits in the Psen2 knockdown\\n330 than scramble cells for the phagocytosis assay there were 2 hits in Psen2 knockdown and 1 in\\n331 scramble and for the NFkB reporter following LPS induction there were 16 hits for Psen2 knockdown\\n332 cells and 11 hits for scramble For the NFkB reporter assay in the absence of LPS induction there\\n333 were an equivalent number of hits in each cell line 7 hits though 5 hits were unique for one cell line\\n334 or the other and only 2 hits were common between cell lines There were also 5 hits from the NFkB\\n335 reporter assay following LPS induction that had different directionality in the different cell lines The\\n336 hits for the MitoTracker assay were specific to targets nominated from the mitochondrial hypothesis\\n337 area while hits for the phagocytosis and alamarBlue assays were specific to targets nominated from\\n338 the immune hypothesis area and NFkB hits were from both hypothesis areas The most impactful\\n339 target perturbations include Ap2a2 Psmc3 Itgav Pkm Pdha1 Pdhb and Pdhx which were each hits\\n340 in multiple different assays These results highlight the impact of perturbing the nominated targets on\\n341 relevant cellular phenotypes and emphasize the importance of the diseaserelevant Psen2\\n342 knockdown cell line for sensitization to those perturbations\\n343 33 Identification of targets that reverse disease associated proteomic signatures\\n344 As with the cellular phenotypes the proteomic analyses of target knockdowns revealed a\\n345 range in the degree of impact Most targets had very few significantly differentially expressed proteins\\n346 identified while a few had hundreds to over a thousand significant protein differences Figure 4A\\n347 We examined the proteomic effect on the target of each knockdown and found that for all but five\\n15\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n348 proteins Ifih1 Traf3 Tlr4 Ticam1 and Kat5 there was a negative log fold change for the targeted\\n349 protein Figure S2H The perturbation with the largest impact was Ap2a2 with 913 significantly\\n350 affected proteins in scramble cells and 1292 significantly affected proteins in Psen2 knockdown cells\\n351 Yy1 Ap2a2 and Arhgef2 each had several hundred more differentially expressed proteins in Psen2\\n352 knockdown cells than scramble cells while Pdha1 had more differentially expressed proteins in\\n353 scramble cells GSEA tests were run to identify GO terms that were significantly altered within each\\n354 perturbation experiment Figure 4B The targets with the largest number of differentially expressed\\n355 proteins ie Ap2a2 Pdhb Yy1 etc also had the largest number of significantly enriched GO terms\\n356 Most targets had a similar number of enriched terms from each cell line but as with the differential\\n357 expression analysis Yy1 knockdown had a larger impact on Psen2 knockdown cells with 361\\n358 significantly enriched terms from Psen2 knockdown cells and none from scramble cells Conversely\\n359 Itgav and Ano6 had over 140 significantly enriched terms in scramble cells and either 0 or 1 from\\n360 Psen2 knockdown cells\\n361 Biological domain enriched terms were correlated between target knockdowns in BV2 cells\\n362 and postmortem brain proteomics from AD cases versus controls Figure 4C 16 of the 29 targets\\n363 tested had biological domain term enrichments that were significantly correlated with AD Of these\\n364 Pdhb Dlat Ap2a2 Pdha1 Yy1 and Psmc3 had significant correlations over four or more\\n365 biodomains Several knockdowns induce term enrichments that are anticorrelated with AD\\n366 Knockdown of Ap2a2 Arhgef2 Dlat Dld and Pdhb each resulted in increased expression of proteins\\n367 annotated to Mitochondrial Metabolism GO terms reversing the broad downregulation of these\\n368 functions that are associated with AD in postmortem brain proteomics For example knockdown of\\n369 Ap2a2 resulted in the upregulation of proteins from 46 and 56 GO terms from the Mitochondrial\\n370 Metabolism domain of the 88 that are down in AD Figure 4D Protein level correlation by biological\\n371 domain supports the reversal of Mitochondrial Metabolism disease associated signatures by\\n372 knockdown of Ap2a2 Arhgef2 Dlat Dld and Pdhb Figure S8 Similarly knockdown of Dlat Pdha1\\n16\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n373 Pdhb and Psmc3 each resulted in decreased expression of proteins annotated to Immune Response\\n374 GO terms reversing the upregulation of these processes that is seen in AD brain proteomics For\\n375 example knockdown of Pdhb resulted in the downregulation of 28 and 41 GO terms from the\\n376 Immune Response domain of the 182 that are up in AD Figure 4E All of the effects of Yy1 which\\n377 are restricted to Psen2 knockdown cells result in changes that are positively correlated with AD\\n378 There are also positive correlations with disease for many of these knockdowns in the DNA Repair\\n379 Epigenetic and RNA Spliceosome domains Overall there is strong support for perturbation of Ap2a2\\n380 Dlat and Pdhb inducing a reversal of diseaseassociated proteomic signatures in BV2 cells\\n381 34 Integrated cell phenotypes and proteomics identifies toptier targets\\n382 Alignment between the cell phenotype and proteomics highlighted relevant GO term\\n383 enrichment patterns that were correlated with phenotypic effect sizes Figure 5A Of the GO terms\\n384 that are significantly correlated with the MitoTracker effect sizes the most directly relevant is\\n385 mitochondrial inner membrane the NES values for which are negatively correlated with assay effect\\nρ\\n386 size Spearmans 04 adjusted p 0016 This suggests a compensatory response where\\n387 knockdowns that lead to decreases in MitoTracker signal tend to also drive an upregulation in the\\n388 expression of mitochondrial inner membrane proteins Likewise the alamarBlue assay effect sizes\\n389 were negatively correlated with NES values for the regulation of mitotic cell cycle phase transition\\nρ\\n390 GO term Spearmans 0679 adjusted p 84x106 This suggested that perturbations leading to\\n391 a decrease in metabolically active cells are also increasing the expression of proteins that regulate\\n392 cell cycle checkpoints and arresting cell division Conversely the immune assays tend to have\\n393 positive correlations with relevant terms For example the effect sizes from the phagocytosis assay\\nρ\\n394 are positively correlated with the NES values for the phagocytosis GO term Spearmans 0468\\n395 adjusted p 00097 which reveals a direct mechanistic link where the increase in cellular\\n396 phagocytosis is associated with the increased expression of the proteins involved in the process The\\n17\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n397 effect sizes for the NFkB assay are also positively correlated with the NES values for the GO term\\nρ\\n398 proteasome accessory complex Spearmans 0519 adjusted p 00299 which is consistent\\n399 with the role of the proteasome in the activation of NFkB signaling through destruction of IkB 28 By\\n400 linking phenotypic outcomes with their corresponding molecular correlates this approach enables the\\n401 identification of targets that exert coordinated effects on both cellular phenotypes and the biological\\n402 processes captured by GO terms\\n403 Specific examples of these associations are shown Figure 5BI Psmc3 inhibition leads to a\\n404 decrease in alamarBlue signal in both scramble and Psen2 knockdown cell lines with a slightly\\n405 stronger effect in the Psen2 knockdown line Figure 5B This is mirrored in the GSEA enrichment\\n406 patterns for regulation of mitotic cell cycle phase transition which has a larger NES value and a\\n407 smaller pvalue for the inhibition of Psmc3 in the Psen2 knockdown cell line Figure 5C The\\n408 knockdown of Pdhb has a much stronger effect on the MitoTracker assay readout in Psen2\\n409 knockdown cells Figure 5D In this case the proteomic response for the mitochondrial inner\\n410 membrane is strong and significant for both cell lines though the NES is larger and the enrichment\\n411 has a smaller pvalue in the Psen2 knockdown cell line Figure 5E The inhibition of Pdha1 has a\\n412 stronger effect on NFkB reporter output in the scramble cell line Figure 5F and the relative strength\\n413 is reflected in the enrichment statistics for the proteasome accessory complex GO term which has a\\n414 more negative NES value and a smaller pvalue in the scramble cell line Figure 5G The knockdown\\n415 of Ap2a2 has a larger impact on the phagocytic activity of Psen2 knockdown cell line than the\\n416 scramble cell line Figure 5H which is reflected in the GSEA statistics for the phagocytosis term\\n417 following Ap2a2 knockdown which has a negative NES value but is not significant in the scramble\\n418 cell line and has a more negative NES value and is significant in the Psen2 knockdown cell line\\n419 Taken together the identification of specific targets that significantly alter both cellular phenotypes\\n420 and the related molecular signatures provides compelling evidence that these perturbations directly\\n421 impact the underlying biology\\n18\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n422 4 DISCUSSION\\n423 Effective prioritization of candidate targets is challenging but essential for advancing novel AD\\n424 therapeutics We have developed an experimental framework to assess prioritized targets in a cell\\n425 specific context The screening platform established here involves perturbation of nominated targets\\n426 in an appropriate cell line and subsequent assays of cellular functions relevant to the hypotheses\\n427 under investigations along with measurement of molecular changes The molecular readouts also\\n428 enable direct comparison with disease omic measures to highlight which target perturbations drive\\n429 molecular changes that are correlated or anticorrelated with disease associated molecular changes\\n430 Through integration of the results from assays of cellular phenotypes with the specific and related\\n431 proteomic changes we identify the most robust targets that have direct impacts on the hypothesized\\n432 biological functions and represent the strongest candidates for further development efforts\\n433 We screened 29 candidates linked to immune or mitochondrial hypotheses in BV2 microglia\\n434 and measured phenotypes and proteomic responses We used this hypothesis validation workflow to\\n435 filter the list of 29 candidate targets to five toptier targets that both impact relevant phenotypes and\\n436 induce proteomic changes that reverse ADassociated signatures AP2A2 PDHB PDHA1 DLAT\\n437 and PSMC3 Three of these targets PDHA1 PDHB and DLAT encode protein components of the\\n438 E1 and E2 subunits of the pyruvate dehydrogenase PDH complex PSMC3 is a component of the\\n439 19S regulatory subunit of the proteasome and AP2A2 is the alpha subunit of the adaptor protein\\n440 complex AP2\\n441 Decreased expression and function of genes and proteins involved in mitochondrial\\n442 bioenergetics including PDH subunits is an early and consistent hallmark of AD associated\\n443 neurodegeneration Figure S1A 29 Animal model studies supports the role of PDH complex\\n444 members in AD pathophysiology including that PDH kinase inhibition prevented neuron loss and\\n445 improved memory performance 30 that conditional knockout of Pdha1 impairs memory function\\n19\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n446 31 and Dlat knockdown reduced neuronal damage and cognitive deficits 32 There are likely cell\\n447 type specific implications of modulation of PDH given that phosphorylation levels of PDH are\\n448 correlated with neuronal activity 33 while shifts between oxidative phosphorylation and glycolysis\\n449 are associated with changes in microglial states 34 The results from our experiments support\\n450 inhibition of PDH subunits impacting both mitochondrial membrane polarity and NFkB signaling\\n451 Figure 3C Figure 5A as well as reversing disease associated proteomic signatures in both the\\n452 Mitochondrial Metabolism and Immune Response biodomains Figure 4C Both PDHA1 and PDHB\\n453 are targets that have been nominated by several AMPAD teams for therapeutic development 35\\n454 and here we find further evidence supporting their therapeutic potential\\n455 Like the PDH complex there is extensive evidence that proteasome function is impaired early\\n456 in AD pathogenesis 3637 and impaired proteasome functions are associated with memory deficits\\nβ\\n457 in mice 38 While various neurodegenerationassociated oligomeric proteins including A directly\\n458 inhibit proteasome function 3940 increased proteasome activity has been observed in reactive glia\\nβ\\n459 around A plaques 41 While the proteasome is involved in activating NFkB signalling 28 it also\\n460 influences microglial cytokine signaling and memory performance in mouse models 42 The specific\\n461 implication of the PSMC3 subunit is supported by genetic fine mapping that identified PSMC3 among\\n462 others at the CELF1SPI1 locus 43 and methylation QTL studies that implicate differential\\n463 methylation at the locus in AD risk 44 Inhibition of Psmc3 induced a reversal of disease related\\n464 Immune Response biological domain signatures and directly impacted immune and cell viability\\n465 phenotypes especially in the disease relevant Psen2 knockdown BV2 microglia line Figure 35\\n466 Given the proteasomal involvement in activation of NFkB signaling it is notable that inhibition of\\n467 Psmc3 resulted in increased NFkB reporter activity However Psmc3 inhibition also resulted in\\n468 generally increased expression of proteasome accessory subunit proteins particularly in Psen2\\n469 knockdown BV2 cells Figure 5A Overall these results support the therapeutic potential for\\n470 modulation of the proteasome including PSMC3 in AD\\n20\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n471 The AP2 complex participates in the assembly of clathrincoated vesicles CCV at the plasma\\n472 membrane and induces clathrin mediated endocytosis along with CCV accessory proteins and AD\\n473 risk genes PICALM and BIN1 45 AP2 interacts with PICALM and LC3 to mediate the endocytosis\\n474 and autophagy of the APP Cterminal fragment 46 and regulates the endosomal trafficking and\\n475 lysosomal delivery of BACE1 influencing amyloid generation 47 AP2 subunits have been found in\\n476 detergent insoluble fractions in AD brains 48 further supporting the association of the AP2 complex\\n477 with neuropathological accumulation Rare variation in a variable number tandem repeat VNTR\\n478 region near AP2A2 is associated with neocortical phosphotau burden 49 Importantly the AP2\\n479 alpha subunits differentially associate with intraneuronal paired helical filaments AP2A1 and IBA1\\n480 microglia AP2A2 in human brain tissue 48 suggesting an approach to drive interventions toward\\n481 either microglial or neuronal AP2 complexes This is an important consideration given that neuronal\\nβ\\n482 specific knockouts of AP2 complex members lead to increased A production 47 whereas our\\n483 results endorse inhibition of Ap2a2 in microglia as therapeutically beneficial Ap2a2 knockdown in the\\n484 Psen2 knockdown BV2 cell line reduced both microglial phagocytosis and NFkB signaling Figure\\n485 3C as well as decreased cell viability perhaps in conjunction with alterations of cell cycle\\n486 checkpoints Figure 5A Inhibition of Ap2a2 in BV2 microglia also reversed diseaseassociated\\n487 proteomic signatures in the Mitochondrial Metabolism and Metal Binding and Homeostasis domains\\n488 and reversed Oxidative Stress Proteostasis and Vasculature biological domain signatures\\n489 specifically in the Psen2 knockdown cells Figure 4C AP2 subunits including AP2A1 AP2B1 and\\n490 AP2M1 have each been nominated by AMPAD investigators for therapeutic development 35 and\\n491 here we provide evidence supporting the therapeutic potential of an additional AP2 subunit AP2A2\\n492 An important throughline in our data is the importance of including a sensitized cell condition\\n493 Using Psen2 knockdown BV2 cells revealed heightened baseline phagocytosis and ADrelevant\\n494 proteomic signatures Figure 2 Figure 3 Figure S2 Inclusion of the Psen2 knockdown line gets us\\n495 closer to understanding the effects of target perturbation in a diseaserelevant context Indeed our\\n21\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n496 results highlight many phenotypic and proteomic responses that are significant only in the sensitized\\n497 cell line While the inclusion of Psen2 knockdown cells here is revelatory future efforts will explore\\nβ\\n498 additional disease relevant stressors such as exposure to oligomeric A or oligomeric tau that may be\\n499 more directly relevant to more common lateonset forms of AD\\n500 We found limited support for hypothesis specificity of target perturbations potentially indicated\\n501 coordinated disease relevance of metabolic and immune dysfunction For example only targets\\n502 nominated from the Mitochondrial Metabolism hypothesis area impacted MitoTracker assay\\n503 phenotypes and only targets nominated from the Immune Response hypothesis area had significant\\n504 effects in the phagocytosis assay Figure 3C However only Immune Response targets affected the\\n505 metabolically sensitive alamarBlue assay phenotype and both target sets affected NFkB reporter\\n506 phenotypes Figure 3C Moreover the proteomic responses of the targets showed no hypothesis\\n507 specificity as the Mitochondrial hypothesis targets Pdhb Pdha1 and Dlat all reversed Immune\\n508 Response domain proteomic responses whereas the Immune hypothesis targets Ap2a2 and Arhgef2\\n509 both reversed Mitochondrial Metabolism domain proteomic responses Figure 4C In the context of\\n510 immune response and mitochondrial functions this is perhaps unsurprising given what is known\\n511 about the interplay of bioenergetics and immune functions 5052 We would not have appreciated\\n512 this lack of target specificity were it not for our unbiased multidimensional screening strategy We\\n513 intend to refine the target and hypothesis nomination process based on the lessons learned here and\\n514 for example would focus future hypotheses on points of functional convergence between\\n515 biodomains\\n516 Several other limitations of this work restrict the nature of the conclusions we are able to draw\\n517 Because our screening system relies on immortalized murine BV2 cells which diverge from human\\n518 microglia in vivo the results of this work should be viewed as primarily a filter for the nominated\\n519 targets Were able to rapidly prioritize candidates for further study using these results and definitive\\n22\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n520 target validation will require testing in human iPSC derived microglia or in vivo models Another\\n521 limitation is the reliance on siRNAmediated target knockdown which introduces variability in the\\n522 levels of target suppression eg Figure S1C and may include offtarget effects that confound\\n523 interpretation Followup with approaches such as CRISPRaCRISPRi systems which enable the\\n524 activation or inhibition respectively of target genes would provide orthogonal data to support our\\n525 conclusions Indeed the results from some targets imply that increasing expression of the target may\\n526 be preferable eg knockdown of Yy1 produced disease correlated effects across domains\\n527 suggesting that perhaps activation would lead to anticorrelated therapeutic effects\\n528 41 Conclusion\\n529 We have developed a robust platform for screening TREATAD nominated targets for\\n530 functional engagement of biological hypotheses Employing this strategy filtered the list of 29\\n531 candidate targets to five toptier targets that are promising leads for further investigation and resource\\n532 development by the EmorySageSGCJax TREATAD center The results from this work as well as\\n533 all enabling reagents developed through work by the center will be made openly available as a\\n534 resource to the AD research community Ultimately the approach developed here demonstrates\\n535 potential to accelerate AD therapeutic target discovery\\n536 REFERENCES\\n537 1 Alzheimers Association 2025 Alzheimers Disease Facts and Figures nd\\ncid3\\n538 2 Cummings JL Zhou Y Lee G Zhong K Fonseca J Leisgang Osse AM et al\\n539 Alzheimers disease drug development pipeline 2025 Alzheimers Dement Transl Res Clin Interv\\n540 202511e70098 \\n23\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n541 3 Bellenguez C Küçükali F Jansen IE Kleineidam L MorenoGrau S Amin N et al New\\n542 insights into the genetic etiology of Alzheimers disease and related dementias Nat Genet\\n543 20225441236 \\n544 4 Hodes RJ Buckholtz N Accelerating Medicines Partnership Alzheimers Disease\\n545 AMPAD Knowledge Portal Aids Alzheimers Drug Discovery through Open Data Sharing\\n546 Expert Opin Ther Targets 20162038991 \\n547 5 Cary GA Wiley JC Gockley J Keegan S Amirtha Ganesh SS Heath L et al Genetic\\n548 and multiomic risk assessment of Alzheimers disease implicates core associated biological\\n549 domains Alzheimers Dement Transl Res Clin Interv 202410e12461\\n550 \\n551 6 Swerdlow RH Mitochondria and Mitochondrial Cascades in Alzheimers Disease J\\n552 Alzheimers Dis JAD 201862140316 \\n553 7 Heneka MT Carson MJ El Khoury J Landreth GE Brosseron F Feinstein DL et al\\n554 Neuroinflammation in Alzheimers disease Lancet Neurol 201514388405\\n555 \\n556 8 De Strooper B Karran E The cellular phase of alzheimers disease Cell 2016164603\\n557 15 \\n558 9 Jayadev S Case A Eastman AJ Nguyen H Pollak J Wiley JC et al Presenilin 2 Is the\\nγ\\n559 Predominant Secretase in Microglia and Modulates Cytokine Release PLOS ONE\\n560 20105e15743 \\n24\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n561 10 Mukherjee S Heath L Preuss C Jayadev S Garden GA Greenwood AK et al\\n562 Molecular estimation of neurodegeneration pseudotime in older brains Nat Commun\\n563 2020115781 \\n564 11 Bates D Mächler M Bolker B Walker S Fitting Linear MixedEffects Models Using\\n565 lme4 J Stat Softw 201567148 \\n566 12 Lenth RV emmeans Estimated Marginal Means aka LeastSquares Means 2025\\n567 13 Benjamini Y Hochberg Y Controlling the False Discovery Rate A Practical and\\n568 Powerful Approach to Multiple Testing J R Stat Soc 199557289300\\n569 \\n570 14 Demichev V Messner CB Vernardis SI Lilley KS Ralser M DIANN neural networks\\n571 and interference correction enable deep proteome coverage in high throughput Nat Methods\\n572 202017414 \\n573 15 Johnson ECB Carter EK Dammer EB Duong DM Gerasimov ES Liu Y et al Large\\n574 scale deep multilayer analysis of Alzheimers disease brain reveals strong proteomic disease\\n575 related changes not observed at the RNA level Nat Neurosci 20222521325\\n576 \\n577 16 Xu S Hu E Cai Y Xie Z Luo X Zhan L et al Using clusterProfiler to characterize\\n578 multiomics data Nat Protoc 2024193292320 \\n579 17 Carlson M orgMmegdb 2017 \\n580 18 Carlson M orgHsegdb 2017 \\n25\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n581 19 Lloyd AF MartinezMuriana A Davis E Daniels MJD Hou P Mancuso R et al Deep\\n582 proteomic analysis of microglia reveals fundamental biological differences between model\\n583 systems Cell Rep 202443114908 \\n584 20 KerenShaul H Spinrad A Weiner A MatcovitchNatan O DvirSzternfeld R Ulland TK\\n585 et al A Unique Microglia Type Associated with Restricting Development of Alzheimers Disease\\n586 Cell 201716912761290e17 \\n587 21 Rangaraju S Dammer EB Raza SA Rathakrishnan P Xiao H Gao T et al\\n588 Identification and therapeutic modulation of a proinflammatory subset of diseaseassociated\\n589 microglia in Alzheimers disease Mol Neurodegener 20181324 \\n590 01802548\\n591 22 Zhou Y Song WM Andhey PS Swain A Levy T Miller KR et al Human and mouse\\n592 singlenucleus transcriptomics reveal TREM2dependent and TREM2independent cellular\\n593 responses in Alzheimers disease Nat Med 20202613142 \\n594 01906959\\n595 23 Kolberg L Raudvere U Kuzmin I Vilo J Peterson H gprofiler2 an R package for\\n596 gene list functional enrichment analysis and namespace conversion toolset gProfiler\\n597 F1000Research 20209ELIXIR709 \\n598 24 Korotkevich G Sukhov V Budin N Shpak B Artyomov MN Sergushichev A Fast gene\\n599 set enrichment analysis BioRxiv 2016 \\n600 25 Nott A Holtman IR Coufal NG Schlachetzki JCM Yu M Hu R et al Brain cell type\\n601 specific enhancerpromoter interactome maps and diseaserisk association Science\\n602 201936611349 \\n26\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n603 26 Novikova G Kapoor M Tcw J Abud EM Efthymiou AG Chen SX et al Integration of\\n604 Alzheimers disease genetics and myeloid genomics identifies disease risk regulatory elements\\n605 and genes Nat Commun 2021121610 \\n606 27 Cacace R Sleegers K Van Broeckhoven C Molecular genetics of earlyonset\\n607 Alzheimers disease revisited Alzheimers Dement J Alzheimers Assoc 20161273348\\n608 \\n609 28 Hayden MS Ghosh S Shared principles in NFkappaB signaling Cell 2008132344\\n610 62 \\n611 29 Wang W Zhao F Ma X Perry G Zhu X Mitochondria dysfunction in the pathogenesis\\n612 of Alzheimers disease recent advances Mol Neurodegener 20201530\\n613 \\n614 30 Sakimura K Kawai T Nashida R Ishida Y Harada K Suzuki T et al A novel PDHK\\n615 inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid\\n616 pathology in 5xFAD mouse a model of Alzheimers disease Alzheimers Res Ther 202416197\\n617 \\n618 31 Chen W Sun X Zhan L Zhou W Bi T Conditional Knockout of Pdha1 in Mouse\\n619 Hippocampus Impairs Cognitive Function The Possible Involvement of Lactate Front Neurosci\\n620 202115 \\n621 32 Ma X Sun Y Li C Wang M Zang Q Zhang X et al Novel Insights Into DLATs Role in\\n622 Alzheimers DiseaseRelated Copper Toxicity Through Microglial Exosome Dynamics CNS\\n623 Neurosci Ther 202430e70064 \\n27\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n624 33 Yang D Wang Y Qi T Zhang X Shen L Ma J et al Phosphorylation of pyruvate\\n625 dehydrogenase inversely associates with neuronal activity Neuron 2024112959971e8\\n626 \\n627 34 Baik SH Kang S Lee W Choi H Chung S Kim JI et al A Breakdown in Metabolic\\n628 Reprogramming Causes Microglia Dysfunction in Alzheimers Disease Cell Metab 201930493\\n629 507e6 \\n630 35 Greenwood AK Montgomery KS Kauer N Woo KH Leanza ZJ Poehlman WL et al\\n631 The AD Knowledge Portal A Repository for MultiOmic Data on Alzheimers Disease and Aging\\n632 Curr Protoc Hum Genet 2020108e105 \\n633 36 Keller JN Hanni KB Markesbery WR Impaired Proteasome Function in Alzheimers\\n634 Disease J Neurochem 2000754369 \\n635 37 Jiang S Srikanth M Serpe R Yavari S Gaur P Collins GA et al Early proteasome\\n636 downregulation and dysfunction drive proteostasis failure in Alzheimers disease Brain J Neurol\\n637 2025awaf222 \\n638 38 Ribeiro FC Cozachenco D Heimfarth L Fortuna JTS De Freitas GB De Sousa JM et\\n639 al Synaptic proteasome is inhibited in Alzheimers disease models and associates with memory\\n640 impairment in mice Commun Biol 202361127 \\n641 39 Thibaudeau TA Anderson RT Smith DM A common mechanism of proteasome\\n642 impairment by neurodegenerative diseaseassociated oligomers Nat Commun 201891097\\n643 \\n28\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nβ\\n644 40 Tseng BP Green KN Chan JL BlurtonJones M LaFerla FM A inhibits the\\n645 proteasome and enhances amyloid and tau accumulation Neurobiol Aging 200829160718\\n646 \\n647 41 Orre M Kamphuis W Dooves S Kooijman L Chan ET Kirk CJ et al Reactive glia\\n648 show increased immunoproteasome activity in Alzheimers disease Brain 2013136141531\\n649 \\n650 42 Wagner LK Gilling KE Schormann E Kloetzel PM Heppner FL Krüger E et al\\n651 Immunoproteasome deficiency alters microglial cytokine response and improves cognitive\\n652 deficits in Alzheimers diseaselike APPPS1 mice Acta Neuropathol Commun 2017552\\n653 \\n654 43 Xu M Liu Q Bi R Li Y Li H Kang WB et al Coexistence of Multiple Functional\\n655 Variants and Genes Underlies Genetic Risk Locus 11p112 of Alzheimers Disease Biol\\n656 Psychiatry 20239474359 \\n657 44 Ohlei O Sommerer Y Dobricic V Homann J Deecke L Schilling M et al Genome\\n658 wide QTL mapping across three tissues highlights several Alzheimers and Parkinsons disease\\n659 loci potentially acting via DNA methylation MedRxiv Prepr Serv Health Sci\\n660 20232023122223300365 \\n661 45 Nelson PT Fardo DW Katsumata Y The MUC6AP2A2 Locus and Its Relevance\\n662 to Alzheimers Disease A Review J Neuropathol Exp Neurol 20207956884\\n663 \\n664 46 Tian Y Chang JC Fan EY Flajolet M Greengard P Adaptor complex AP2PICALM\\n665 through interaction with LC3 targets Alzheimers APPCTF for terminal degradation via\\n666 autophagy Proc Natl Acad Sci 2013110170716 \\n29\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n667 47 Bera S CamblorPerujo S Calleja Barca E NegreteHurtado A Racho J De Bruyckere\\n668 E et al AP2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in\\n669 neurons EMBO Rep 202021e47954 \\n670 48 Srinivasan S Gal J Bachstetter A Nelson PT Alpha adaptins show isoformspecific\\n671 association with neurofibrillary tangles in Alzheimers disease Neuropathol Appl Neurobiol\\n672 202248e12776 \\n673 49 Katsumata Y Fardo DW Bachstetter AD Artiushin SC Wang WX Wei A et al\\n674 Alzheimer Disease PathologyAssociated Polymorphism in a Complex Variable Number of\\n675 Tandem Repeat Region Within the MUC6 Gene Near the AP2A2 Gene J Neuropathol Exp\\n676 Neurol 202079321 \\n677 50 Fairley LH Lai KO Wong JH Chong WJ Vincent AS DAgostino G et al Mitochondrial\\n678 control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimers\\n679 disease Proc Natl Acad Sci U S A 2023120e2209177120\\n680 \\n681 51 Minhas PS LatifHernandez A McReynolds MR Durairaj AS Wang Q Rubin A et al\\n682 Restoring metabolism of myeloid cells reverses cognitive decline in ageing Nature\\n683 20215901228 \\n684 52 Devanney NA Stewart AN Gensel JC Microglia and macrophage metabolism in CNS\\n685 injury and disease The role of immunometabolism in neurodegeneration and neurotrauma Exp\\n686 Neurol 2020329113310 \\n30\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n687 ACKNOWLEDGEMENTS\\n688 The authors would like to thank Dr Suman Jayadev for providing the BV2 cell lines used in this work\\n689 Data used in this study were obtained from the Accelerating Medicines Partnership Program for\\ncid3\\n690 Alzheimers Disease AMP AD Consortium members below Mayo RNAseq Study Study data were\\n691 provided by the following sources The Mayo Clinic Alzheimers Disease Genetic Studies led by Dr\\ncid3\\n692 Nilufer Ertekin Taner and Dr Steven G Younkin Mayo Clinic Jacksonville FL using samples from\\n693 the Mayo Clinic Study of Aging the Mayo Clinic Alzheimers Disease Research Center and the Mayo\\n694 Clinic Brain Bank Data collection was supported through funding by NIA grants P50 AG016574 R01\\n695 AG032990 U01 AG046139 R01 AG018023 U01 AG006576 U01 AG006786 R01 AG025711 R01\\n696 AG017216 R01 AG003949 NINDS grant R01 NS080820 CurePSP Foundation and support from\\n697 Mayo Foundation Study data include samples collected through the Sun Health Research Institute\\n698 Brain and Body Donation Program of Sun City Arizona The Brain and Body Donation Program is\\n699 supported by the National Institute of Neurological Disorders and Stroke U24 NS072026 National\\n700 Brain and Tissue Resource for Parkinsons Disease and Related Disorders the NIA P30 AG19610\\n701 Arizona Alzheimers Disease Core Center the Arizona Department of Health Services contract\\n702 211002 Arizona Alzheimers Research Center the Arizona Biomedical Research Commission\\ncid3\\n703 contracts 4001 0011 05 901 and 1001 to the Arizona Parkinsons Disease Consortium and the\\n704 Michael J Fox Foundation for Parkinsons Research Religious Orders StudyMemory and Aging\\n705 Project ROSMAP We are grateful to the participants in the Religious Order Study and the Memory\\n706 and Aging Project This work was supported by the US National Institutes of Health U01 AG046152\\n707 R01 AG043617 R01 AG042210 R01 AG036042 R01 AG036836 R01 AG032990 R01 AG18023\\ncid3\\n708 RC2 AG036547 P50 AG016574 U01 ES017155 KL2 RR024151 K25 AG041906 01 R01\\n709 AG30146 P30 AG10161 R01 AG17917 R01 AG15819 K08 AG034290 P30 AG10161 and R01\\n710 AG11101 Mount Sinai Brain Bank MSBB This work was supported by grants R01AG046170\\n711 RF1AG054014 RF1AG057440 and R01AG057907 from the NIHNIA R01AG046170 is a\\n31\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\ncid3\\n712 component of the AMP AD Target Discovery and Preclinical Validation Project Brain tissue\\n713 collection and characterization was supported by NIH HHSN271201300031C\\n714 CONFLICTS\\n715 GAC QL JCW CAP YD ELZ DD HF NTS RB No conflicts of interest AIL is a\\n716 paid consultant for EmTheraPro Cognito Therapeutics Cognition Therapeutics and Alamar GWC\\n717 is a paid consultant for Astrex Pharmaceuticals\\n718 FUNDING SOURCES\\n719 The research reported in this manuscript was carried out by the EmorySageSGCJAX TREATAD\\n720 Center and supported by NIA grant U54AG065187\\n721 CONSENT STATEMENT\\n722 No human participants were recruited for this work The details of the Institutional Review Board\\n723 IRBoversight body that provided approval or exemption for the research described are given as\\n724 follows Western Institutional Review BoardCopernicus Group WCG IRB of Sage Bionetworks\\n725 gave ethical approval for this work\\n726 KEY WORDS\\n727 Alzheimers Disease Immune Mitochondria Proteomics\\n728 LEGENDS\\n729 Figure 1 Overview of the design of the current study siRNA knockdown was performed against 29\\n730 targets from two hypothesis areas top right in two different murine BV2 microglial cell lines one\\n731 wildtype ie scramble and one where Psen2 has been stably knocked down top left Following 72\\n32\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n732 hours of target knockdown a series of cellular and molecular phenotypes were assayed including\\n733 MitoTracker TMRM and alamarBlue to assess mitochondrial function and pHrodo Green and NFkB\\n734 luciferase reporter activity Quantitative proteomic measurements were also made following target\\n735 knockdown Created in BioRender Cary G 2025 \\n736\\n737 Figure 2 Proteomic assessment of Psen2 knockdown BV2 microglia compared with wildtype ie\\n738 scramble BV2 microglia A GSEA results showing significantly differentially expressed GO terms\\n739 points from each biological domain facets and how the proteins from those terms are differentially\\n740 expressed in Psen2 knockdown BV2 cells xaxis The size of each point corresponds to the log\\n10\\n741 adjusted pvalue for the term enrichment B Correlation plot across AD biodomains showing\\n742 domains where GO term enrichments are correlated with enrichments from lateonset AD brain\\n743 proteomics from AMPAD The size of each point reflects the size of the overlap between analyses\\n744 and the fill color indicates the correlation direction Correlations that are significant following multiple\\n745 hypothesis testing correction are outlined with a box C Example of Immune Response biological\\n746 domain terms enriched in each case showing the distribution of term NES values from each analysis\\n747 top and the numbers of terms in each class bottom\\n748\\n749 Figure 3 BV2 cell phenotypes following target knockdown A Example images from the pHrodo\\n750 Green phagocytosis assay top and nuclear counterstain bottom from control siRNA and Ap2a2\\n751 siRNA treated cultures The results from both wildtype and Psen2 knockdown cell lines are shown\\nB Example images from the MitoTracker TMRM assay top and nuclear counterstain bottom in\\n752\\nPsen2 knockdown cells from control siRNA and three different target knockdowns Pdhb Pdha1 and\\n753\\nDlat C Summary of all assay results for each target Targets that modify the indicated phenotype\\n754\\n33\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nwith an adjusted pvalue 005 are plotted with a triangle the size of each point is scaled to the\\n755\\nsignificance of the observed effect and the fill for each point shows the computed effect size of target\\n756\\nknockdown in the indicated assay\\n757\\n758\\nProteomic responses to target knockdown A The number of significantly adjusted p\\n759 Figure 4\\nvalue 005 differentially expressed proteins in each target knockdown and each BV2 cell line B\\n760\\nThe number of significantly enriched GO terms from GSEA analyses for each target in each BV2 cell\\n761\\nline C Correlation plots across AD biodomains targets and cell lines showing domains where GO\\n762\\nterm enrichments are correlated with enrichments from lateonset AD brain proteomics from AMPAD\\n763\\nThe size of each point reflects the size of the overlap between analyses and the fill color indicates the\\n764\\ncorrelation direction Correlations that are significant following correction for multiple hypothesis\\n765\\ntesting are outlined with a box D Example of Mitochondrial Metabolism domain term enrichments\\n766\\nfrom AMPAD and Ap2a2 knockdown in each cell line showing the distribution of term NES values\\n767\\nfrom each analysis top and the numbers of terms in each class bottom E Example of Immune\\n768\\nResponse domain term enrichments from AMPAD and Pdhb knockdown in each cell line showing\\n769\\nthe distribution of term NES values from each analysis top and the numbers of terms in each class\\n770\\nbottom\\n771\\n34\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\n772\\n773 Figure 5 Integration of cell phenotype effects and GO term enrichments for target knockdowns A\\n774 Correlation of cellular assay effect size xaxis with GO term NES value yaxis for the assay and\\n775 GO term indicated in the header of each plot The header also shows the correlation statistics\\n776 between the assay effect size and term enrichment values The shape of each point denotes the\\n777 corresponding cell line and knockdowns that resulted in a significant term enrichment have a fill value\\n778 corresponding to the significance of the term enrichment Detailed examples of specific assay results\\n779 are shown for Psmc3 B Pdhb D Pdha1 F and Ap2a2 H Detailed examples of GSEA term\\n780 enrichment statistics for specific GO terms are shown for Psmc3 C Pdhb E Pdha1 G and\\n781 Ap2a2 I\\n35\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license\\nbioRxiv preprint doi this version posted October 16 2025 The copyright holder for this preprint\\nwhich was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made\\navailable under aCCBY 40 International license']"
            ]
          },
          "execution_count": 35,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "list(cleaned_text.values())[:5]\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "rijphfmei6ea"
      },
      "source": [
        "#### Создаем датафрейм, для более удобного анализа"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "q0Z2n_KMAc8R"
      },
      "outputs": [],
      "source": [
        "df = pd.DataFrame.from_dict(\n",
        "    sections_by_pdf,\n",
        "    orient=\"index\"\n",
        ").reset_index()\n",
        "\n",
        "df = df.rename(columns={\"index\": \"pdf\"})"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 293
        },
        "id": "Un7fV0z8AjD4",
        "outputId": "b4522f2c-01cb-43c0-b37e-96e6d51e37fd"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 27,\n  \"fields\": [\n    {\n      \"column\": \"pdf\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 27,\n        \"samples\": [\n          \"2025.12.09.692941v1.full.pdf\",\n          \"2025.07.11.659973v2.full.pdf\",\n          \"2025.12.04.692105v1.full.pdf\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 27,\n        \"samples\": [\n          \"Recent advances in antiamyloid therapies for Alzheimers disease have been promising but they have also highlighted critical challenges including increased vascular complications such as amyloidrelated imaging abnormalities Emerging evidence suggests that the soluble epoxide hydrolase may be a promising therapeutic target due to the involvement of sEHderived diols in inflammation oxidative stress and vascular destabilization APPPS1 mice were crossed with an inducible soluble epoxide hydrolase knockout mouse line The knockout was induced before onset of amyloid deposition and then the mice were analyzed using histological molecular and RNA sequencing techniques Here we identify astrocytic soluble epoxide hydrolase as a key mediator of vascular instability in Alzheimers disease Targeted astrocytespecific deletion of soluble epoxide hydrolase in APPPS1 mice dramatically mitigated vascular changes reducing the vascular amyloid burden by 6795 and preserving VEcadherin architecture Importantly vasomotion was markedly impaired in the Alzheimers disease model and was preserved in soluble epoxide hydrolasedeficient animals Transcriptomic profiling of vasculature in APPPS1xsEH\\u0394AC mice revealed upregulated expression of genes critical for neurovascular protection These findings identify soluble epoxide hydrolase as a central regulator of neurovascular dysfunction and underscore its therapeutic potential in increasing vascular stability in Alzheimers disease Author affiliations which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license 1 Neurovascular Disorders Institute of Cell Biology and Neuroscience Biologicum Goethe University Frankfurt MaxvonLaue Str 13 Frankfurt am Main Germany 2 Max Planck Institute for Heart and Lung Research Bad Nauheim Germany 3 Buchmann Institute for Molecular Life Sciences BMLS Institute of Cell Biology and Neuroscience Goethe University Frankfurt MaxvonLaueStr 15 D60438 Frankfurt am Main Germany 4 Department of Physics Chemistry and Biology Link\\u00f6ping University SE581 83 Link\\u00f6ping Sweden 5 Institute for Vascular Signaling Centre for Molecular Medicine Goethe University Frankfurt Frankfurt am Main Germany 6 Clinic for Internal Medicine V with a focus on angiology Campus Kiel Universit\\u00e4tsklinikums SchleswigHolstein 7 Department of Entomology and Nematology UC Davis Comprehensive Cancer Center University of California Davis California 95616 United States 8 University of British Columbia Dept of Cellular and Physiological Sciences and School of Biomedical Engineering Vancouver British Colombia Canada V6T 1Z3 9 Max Planck Institute for Brain Research MaxvonLaueStr 4 60438 Frankfurt am Main Germany Corresponding author Prof Dr Jasmin Hefendehl MaxvonLaue Str 13 Frankfurt am Main Germany hefendehlbiounifrankfurtde Running Title Lipid mediators in Alzheimers disease\",\n          \"Noncoding genetic variants underlie many complex diseases yet identifying and interpreting their functional impacts remains challenging Lateonset Alzheimers disease LOAD a polygenic neurodegenerative disorder exemplifies this challenge The disease is strongly associated with noncoding variation including common variants enriched in microglial enhancers and rare variants that are hypothesized to influence neurodevelopment and synaptic plasticity These variants often perturb regulatory sequences by disrupting transcription factor TF motifs or altering local TF interactions thereby reshaping gene expression and chromatin accessibility However assessing their impact is complicated by the contextdependent functions of regulatory sequences was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license underscoring the need to systematically examine variant effects across diverse tissues cell types and cellular states Here we combined in vitro and in vivo massively parallel reporter assays MPRAs with interpretable machinelearning models to systematically characterize common and rare variants across myeloid and neural contexts Parallel profiling of variants in four immune states in vitro and three mouse brain regions in vivo revealed that individual variants can differentially and even oppositely modulate regulatory function depending on cell type and cellstate contexts Common variants associated with LOAD tended to exert stronger effects in immune contexts whereas rare variants showed more pronounced impacts in brain contexts Interpretable sequencetofunction deeplearning models elucidated how genetic variation leads to celltypespecific differences in regulatory activity pinpointing both direct transcriptionfactor motif disruptions and subtler tuning of motif context To probe the broader functional consequences of a locus prioritized by our reporter assays and models we used CRISPR interference to silence an enhancer within the SEC63OSTM1 locus that harbors four functional rare variants revealing its gatekeeper role in inflammation and amyloidogenesis These findings underscore the contextdependent nature of noncoding variant effects in LOAD and provide a generalizable framework for the mechanistic interpretation of risk alleles in complex diseases Main Lateonset Alzheimers disease LOAD the most prevalent neurodegenerative disorder worldwide exhibits strong heritability1 Its genetic architecture comprises multiple components including the strong influence of the APOE \\u03b54 allele2 common variants with weaker effects and rare variants Genomewide association studies GWAS36 have identified numerous common variants minor allele frequency MAF 001 that are enriched for functions in immune cells particularly microglia and macrophages This genetic landscape implicates neuroinflammation and mirrors the broad observed failure of microglial functions in LOAD brains78 impaired surveillance910 reduced amyloid \\u03b21112 and tau clearance1314 dysregulated injury response1516 and altered inflammatory regulation1718 Notably top risk genes such as BIN1 and TREM2 encode proteins crucial for maintaining myeloid homeostasis dysfunction in these genes perturbs processes like endocytosis1920 lipid metabolism1921 and cytokine signaling1922 thereby accelerating neurodegeneration2324 Human singlenucleus transcriptomic studies further delineate distinct microglial activation states and several of these states display more prominent LOADassociated gene expression signatures suggesting state specific genetic effects2526 Although finemapping efforts are increasingly narrowing down GWAS signals2731 in the immune context pinpointing the exact causal variants and their functional mechanisms remains a major challenge In contrast to GWAS wholegenome sequencing WGS of 2247 individuals from 605 multiplex LOAD families uncovered 13 loci with consistent association of rare variant MAF 001 clusters such as CTNNA2 KIF2A SYTL3 CLSTN2 NALCN and FNBP1L whose products are pivotal for synaptic function and neurodevelopment32 was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license This suggests that neuronintrinsic genetic risk constitutes a previously underappreciated dimension of LOAD Nevertheless limited statistical power for individual rare variants within these clusters obscures the identity of the causal alleles and their precise functional consequences therefore remain unknown Thus directly measuring the effects of individual rare alleles and benchmarking them against common variants is essential to establish their relative impact and underlying mechanisms Furthermore immuneversusneural celltype divergence underscores the importance of analyzing genetic variants in diseaserelevant cell types and states Consequently there is a critical need for systematic largescale functional measurements that directly compare common and rare variants coupled with detailed mechanistic interpretations in diseaserelevant cellular contexts Both the GWAS and WGS studies suggest that LOAD is predominantly driven by noncoding variants3632 Noncoding genetic variants contribute to the risk of many complex diseases by disrupting gene regulation often through interference with transcription factor TF binding at cisregulatory elements CREs such as enhancers and promoters3335 The activity of these CREs can be highly celltypespecific and even statespecific shaped by the availability and dynamics of distinct TFs3639 This specificity implies that the effects of genetic variants on CRE function and consequently on disease risk are likewise contextdependent4041 LOAD GWAS variants show significant enrichment in microglia and macrophage enhancers potentially disrupting immune enhancer activities4243 A wellcharacterized CRE is the microgliaspecific enhancer 25 kb upstream of BIN1 that harbors the lead LOAD risk variant rs6733839 CRISPRmediated deletion of this enhancer in human iPSCderived microglia selectively lowers BIN1 mRNA and protein levels suggesting rs6733839 may modulates LOAD risk by altering microglial BIN1 expression43 Although epigenomic modeling that integrates open chromatin histone marks and threedimensional contacts now permits prediction of variant impacts on these CREs current models still struggle to resolve the resulting transcriptional and cellular consequences because of the versatile combinatorial nature of TF function Quantifying the functional consequences of noncoding genetic variation is intrinsically difficult regulatory elements act in highly contextspecific manner and typically elicit subtler phenotypic changes than coding mutations44 Massively parallel reporter assays MPRAs overcome many technical barriers by coupling thousands of synthesized cis regulatory elements CREs to barcoded reporter constructs positioned either upstream or downstream of a minimal promoter to measure transcription factordriven enhancer activity 45 Allelic MPRAs directly contrasting CREs that differ by a single nucleotide now provide a robust highthroughput readout of allelespecific regulatory effects30314648 Traditional in vitro MPRAs achieve excellent transfection efficiency and statistical power yet they only approximaterather than fully replicatethe in vivo cellular identity of their target cell type Recent in vivo tissue MPRAs including our AAV based systemic platform sysMPRA49 extended this paradigm to native contexts such as adult brain tissue enabling measurement of regulatory dynamics within complex cellular environments4950 Thoughtful selection of the experimental system therefore remains critical for accurately inferring variant function Additionally while MPRA was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license effectively quantifies variant impacts on transcription elucidating downstream effects on endogenous gene expression remains limited To bridge this gap methods such as CRISPR interference CRISPRi51 and CRISPRbased excision43 have been employed to perturb enhancers enabling profiling of affected gene expression implicated in LOAD though still at a relatively limited scale283043 Collectively these experimental advances establish a versatile toolkit for disentangling the consequences of regulatory variants across diverse cellular contexts Complementing these experimental approaches computational methodologies continue to evolve to interpret how genetic variants influence context and celltypedependent gene expression Early computational frameworks relied on position weight matrices representing individual TF motifs52 Over the past decade sequencetofunction models such as DeepSEA53 Enformer54 ChromBPNet55 DeepAllele56 and GET57 have advanced the field by using deep neural networks to learn combinatorial regulatory codes directly from DNA Although predicting gene expression from sequence alone remains difficult these architectures now deliver stateoftheart accuracy on chromatin feature prediction Within this deeplearning landscape convolutional neural networks CNNsneural networks that apply learnable filters to scan sequence features such as TF motifscontinue to excel at regulatory genomics tasks including celltypespecific enhancer classification58 and genetic variant effect inference27 Although transformer based selfsupervised genomic large language models aspire to achieve zeroshot prediction by learning the DNA languagethat is by modeling genomewide sequence context and longrange dependenciesab initiosupervised CNNs and their derivatives54 currently deliver superior predictive performance greater computational efficiency andcruciallyenhanced interpretability for uncovering underlying biology5960 Recently multimodal foundation models such as AlphaGenome61 have emerged aiming to unify multiple biological data modalities for predicting variant effects however these larger models remain limited in their ability to capture celltypespecific and statespecific nuances a task at which simpler CNN architectures still outperform6263 Together these advances in deep learning provide a powerful yet still evolving framework for mechanistically informed prediction of variant effects on gene regulation To clarify how noncoding risk alleles shape LOAD in immune and neural contexts we curated 599 LOADassociated variants 186 rare variants MAF 001 106 low frequency variants 001 MAF 005 and 307 common variants MAF 005 from GWAS and WGS selecting those that overlap open chromatin in microglia macrophages or neurons Fig 1a Variants were grouped by chromatin accessibility in resting and activated immune cells into immunespecific enhancers ubiquitously active elements and regions with limited accessibility Fig 1b most reside in intronic intergenic or promoterproximal positions consistent with distalenhancer activity In this study we established an integrated experimental and computational framework that combines contextdependent in vitro and in vivo MPRA interpretable CNN models and CRISPRi perturbation Fig 1c Leveraging a validated THP1 macrophage model that recapitulates canonical immune states together with mouse brain tissue from the was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license cortex hippocampus and striatum that captures native neural context this approach i quantifies the regulatory impact of hundreds of LOADassociated variants ii prioritizes functionally impactful alleles iii dissects their celltype and statespecific mechanisms and iv enables indepth functional analysis of a diseaseriskassociated enhancer harboring functional rare variants Together this framework connects noncoding genetic variation to contextdependent regulatory mechanisms and ultimately to the key genes and molecular pathways involved in LOAD Results Characterization of THP1 macrophages as an innateimmunecell model for LOAD Mononuclear phagocytes including microglia macrophages and monocytes are implicated in the genetic predisposition to LOAD56274264 Microglia the resident macrophages of the central nervous system continuously survey the brain parenchyma910 clear amyloid\\u03b2 A\\u03b21112 and tau aggregates1314 respond to neural injury1516 and modulate neuroinflammation1718 all of which are processes dysregulated in LOAD78 Although microglia are the primary brainresident immune cells perivascular macrophages and recruited monocytederived macrophages also participate in plaque clearance and secrete proinflammatory cytokines6568 In microgliadepleted mouse models of LOAD it was found that monocytederived macrophages repopulated the entire brain and could functionally substitute microglia marked by amyloid plaque association as well as Trem2expression69 Moreover peripheral inflammation could induce microglia immune memory through epigenetic reprogramming modifying LOAD pathology70 Together with microglia peripheral immune cells are also increasingly recognized as LOAD modulators2771 To model mononuclear phagocytes and LOADassociated microglial states2526 we adopted THP1 cells as a macrophage model leveraging their transcriptomic similarity to primary microglia and macrophages72 and their ease of genetic and pharmacological manipulation In contrast HMC3 microglia showed limited transcriptomic resemblance to primary microglia and were therefore used only as a secondary model in this study Using chromatin accessibility ATACseq and transcriptome profiling RNAseq we characterized THP1 macrophages throughout differentiation and upon stimulation with interferon\\u03b2 IFN\\u03b2 interferon\\u03b3 IFN\\u03b3 or lipopolysaccharide plus IFN\\u03b3 LPSIFN\\u03b3 modeling antiviral M1polarized and hyperinflammatory states respectively Supplementary Tables 1 and 2 Upon differentiation from monocytes THP1 macrophages demonstrated upregulated immune responses and reduced cellcycle activity confirming successful differentiation Extended Data Fig 1a IFN\\u03b2 and IFN\\u03b3 treatments predominantly increased chromatin accessibility at promoters and enhancers activating gene expression whereas LPSIFN\\u03b3 triggered broader chromatin remodeling that both opened and closed regulatory regions leading to concurrent gene activation and repression Extended Data Fig 1bc 2ac IFN\\u03b2 activated viral defense and leukocyte chemotaxis pathways IFN\\u03b3 induced genes involved in bacteriallipid sensing and protein trafficking was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license LPSIFN\\u03b3 not only elicited robust interferon responses but also pronounced inflammatory responses Extended Data Fig 1d 2b Marker genes for microglia and macrophages eg TREM2 IBA1 remained robustly expressed and exhibited state specific modulation in each state Extended Data Fig 2d Previous studies have shown that THP1 macrophages exhibit transcriptomic similarity to both primary and stemcell derived microglia72 we further demonstrate that they also share epigenomic profiles with stemcellderived microglia Extended Data Fig 1e These results demonstrate that we are able to capture gene expression and open chromatin profiles associated with different inflammatory states of mononuclear phagocytes Human singlenucleus transcriptomic studies of postmortem brain tissue and cortical biopsies from living individuals have identified 12 distinct microglial states in LOAD2526 We next examined how THP1 macrophages under different treatments might recapitulate these states LPSIFN\\u03b3 treatment induced marker genes of inflammatory microglial states identified in human postmortem brains MG10 MG2 and MG8 ordered by descending inflammatory strength Marker genes of the MG10 state indicative of strong inflammation exhibited the highest upregulation Extended Data Fig 2e Inflammatory microglia are closely associated with amyloid plaques2526 Sun et al demonstrated that amyloid\\u03b2 fibrils induce inflammatory responses in iPSCderived microglia25 Notably LPSIFN\\u03b3 stimulation of THP1 macrophages recapitulated the late 24 h inflammatory response induced by amyloid\\u03b2 fibrils Extended Data Fig 2f demonstrating the pathological relevance of LPSIFN\\u03b3driven inflammation Disease associated microglia DAM signatures distributed across MG3 MG4 and MG10 were all upregulated by LPSIFN\\u03b3 stimulation further underscoring its disease relevance Extended Data Fig 2e Additionally antiviral state marker genes MG11 were robustly upregulated by both IFN\\u03b2 and LPSIFN\\u03b3 consistent with LPSmediated endogenous IFN\\u03b2 production Extended Data Fig 2e These findings reflect that the THP1 macrophages can recapitulate several key microglial states observed in the brains of LOAD human subjects Inflammatory and antiviral microglial states in human brains are enriched for LOAD GWAS variants2526 We performed stratified linkage disequilibrium score regression S LDSC and observed significant enrichment of LOAD GWAS variants in open chromatin from THP1 macrophage states comparable to that in primary microglia macrophages and iPSChESCderived microglia whereas no significant enrichment was detected in neurons Extended Data Fig 1f Collectively these data illustrate that THP1 macrophages can recapitulate key microglial marker gene expression activation states and epigenomic features linked to LOAD providing a practical model for dissecting LOADassociated immune mechanisms Contextdependent MPRA identified LOADrisk enhancers across neural and immune contexts To systematically evaluate common and rare LOAD variant effects on cisregulatory activities we designed MPRA constructs with barcoded 227bp synthetic CREs carrying reference or alternate alleles downstream of a minimal promoter which captures enhancerlike activities Fig 2a CREs were open chromatin peakcentered variants was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license close to open chromatin peak summit variantcentered distal variants or motif shuffled disrupting local TF motifs providing multiple readouts of variant effects Fig 2a Supplementary Table 3 We assayed the library of 1600 CREs in four immune states resting IFN\\u03b2 IFN\\u03b3 LPSIFN\\u03b3 by transfecting both THP1 macrophages and the alternative microglia model HMC3 with HEK293T cells included as a nonimmune control To capture neural activity in vivo the same library was delivered noninvasively to the brains of four mice via retroorbital injection of AAVPHPeB virus We dissected out and measured the regulatory activity of CREs in three brain regions cortex hippocampus and striatum Fig 2b Using median absolute deviation MAD scores as a measure of enhancer activity we found high reproducibility between replicates Pearsons r 0809 in vitro r 0607 in vivo Extended Data Fig 3a Activity profiles clustered by cell type strongly correlated within immune or neural contexts but moderately across them highlighting distinct regulatory landscapes and additional interspecies differences Fig 2c Supplementary Table 4 Approximately 13 of tested CREs PMAD 005 showed significant enhancer activity in macrophages or brain tissue Extended Data Fig 3b Supplementary Table 4 Immune and ubiquitous CREs were more frequently active in THP1 macrophages consistent with ATACseq annotations whereas in brain tissue immune but not ubiquitous CREs retained activity Fig 2d Many of those ubiquitous CREs were at promoters which may not operate as efficiently in assays in which the candidate CRE is cloned in downstream of the TSS7374 This assay limitation likely explains why immune rather than ubiquitous CREs appeared more active in brain tissue Elastic net regression on TF motifs explained a substantial proportion of variance in enhancer activities R\\u00b2 090 P 0001 in vitro R\\u00b2 048 P 0001 in vivo permutation test despite higher noise in in vivo measurements underscoring the central role of motif composition in shaping enhancer activity notably TFs linked to neural development and differentiation including MEF2B CRX CLOCK NR2E1 and POU3F4 emerged as key contributors to brain enhancer specificity Fig 2e We further identified both cell typespecific as well as broadly active enhancer Fig 2f for example a distal enhancer at the BIN1 locus rs13025765rs13025717 was selectively active in macrophages while a segment of the NRN1 promoter rs192104059 showed brainspecific activity Among interferon stimulations LPSIFN\\u03b3 hyperinflammatory produced the most distinct enhancer responses In THP1 macrophages 146 CREs 10 showed significant activity changes in response to LPSIFN\\u03b3 treatment nearly half of which overlapped differentially accessible chromatin regions while IFN\\u03b2 and IFN\\u03b3 alone affected only three and one CREs respectively Fig 2c Supplementary Table 5 Similarly in HMC3 microglia 97 CREs responded to LPSIFN\\u03b3 Supplementary Table 5 Notably LPSIFN\\u03b3 induced widespread enhancer repression while activating only a small subset of enhancers highlighting the role of repressive TFs in inflammatory responses Fig 2g The nearest genes to these LPSIFN\\u03b3responsive CREs were enriched in immune activation pathways underscoring their functional relevance Fig 2h Motif analysis revealed that the AP1 family motif FOSL2 and ELK1 gained positive regulatory influence under LPSIFN\\u03b3 whereas NRF2 NFE2L2 acted as a negative regulator pointing to dynamic TF remodeling during inflammation Extended Data Fig was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license 3c These results reveal that LOAD risk variants converge on cell typespecific and inflammationsensitive enhancers providing reliable measurement of their regulatory effects Our MPRA assay provides a comprehensive annotation of which LOAD associated variants containing CREs are active across different brain regions and monocyte cell states Contextdependent MPRA identified regulatory LOAD variants across immune and neural contexts Having mapped a highconfidence atlas of enhancer activity across immune and neural contexts we next asked how LOAD variants modulate those activities Screening 599 candidate variants with 855 pairs of constructs we identified expressionmodulating variants emVars FDR 005 in THP1 macrophages and HMC3 microglia under four immune states and in vivo in the cortex hippocampus and striatum Extended Data Fig 4a Supplementary Table 6 Of these 104 emVars were shared between THP1 macrophages and brain tissue 188 were exclusive to THP1 not detected in brain tissue though possibly present in HMC3 and 72 were unique to brain tissue not detected in THP1 though possibly present in HMC3 Extended Data Fig 4b Among emVars with significant effects in both contexts approximately 48 exhibited opposite allelic directions reflecting distinct modes of regulatory activity across tissues The variants effects displayed celltypespecific patterns Extended Data Fig 4c When aggregated across immune states or brain regions emVars within active enhancers segregated into brainspecific immunespecific and nonspecific clusters Fig 3a underscoring a sharp celltype divergence in regulatory impact Consistent with previous open chromatin partitioning Fig 1b immunespecific emVars were enriched in immune CREs brainspecific emVars preferentially resided in regions of low chromatin accessibility and nonspecific emVars were overrepresented in ubiquitous CREs although these trends were not statistically significant \\u03c7\\u00b2 test p 03 Extended Data Fig 4d This divergence prompted us to investigate whether the genetic origins of LOAD variants are associated with their observed regulatory effects Common LOAD variants identified by GWAS are enriched in microglial enhancers3629424375 whereas rare variants from patientfamily sequencing studies often map to neuraldevelopment and synapticplasticity genes32 We therefore tested the hypothesis that common variants are more likely to exert effects in immune cells whereas rare variants have greater functional consequences in neural contexts Consistent with this prediction in THP1 macrophages common variants produced larger expression changes than rare variants whereas in brain tissue this pattern was reversed Fig 3b with the strongest effects observed among the most common variants MAF 029 Extended Data Fig 4e Although modest our findings support a model where common LOAD variants primarily influence immune regulation while rare variants more frequently modulate neural functions was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license To investigate the mechanisms driving this celltype divergence we next examined TF motif enrichment near emVars comparing it directly to motif enrichment within open chromatin regions in THP1 macrophages and brain tissue Motifs enriched in open chromatin were also preferentially enriched near emVars within the same cellular context with consistent representation across TF families Brainactive emVars were predominantly associated with motifs from TF families involved in neural development and function including TALEtype homeodomain HOXrelated NKrelated and Fos related families Fig 3c In contrast emVars active in THP1 macrophages were enriched for immunerelated TF families such as ETSrelated IRF STAT and NF\\u03baB Together these analyses highlight distinct celltypespecific regulatory codes through which LOADassociated variants exert their effects We next directly tested whether the TFmotif contexts surrounding these variants functionally modulate enhancer activities Given that LOAD variants are often predicted to disrupt immunerelated TF motifs we analyzed a set of motifshuffled enhancers in which a 25bp window surrounding each variant was fully shuffled to disrupt the predicted immunerelated TFmotif context a design we refer to as motifcontext shuffling Because singlenucleotide variants typically weaken rather than abolish TF binding sites we hypothesized that complete motif ablation would elicit larger transcriptional shifts In both THP1 macrophages and HMC3 microglia most motif context shuffling events caused significant disruption of enhancer activity FDR 005 Supplementary Table 7 and produced markedly larger changes in reporter expression than singlenucleotide substitutions with the strongest effects observed at motif contexts containing STAT MEF2 IRF AP1 and SPI1 motifs FDR 005 Fig 3d Motifcontext shuffling either increased or decreased transcription though certain TF motif contexts showed consistent directional biases For example IRF STAT and AP 1related motif contexts preferentially decreased transcription upon disruption in THP1 macrophages highlighting their roles as transcriptionalactivating contexts Fig 3e These findings provide strong evidence that variants are associated with functionally active TFmotif contexts TFs involved in immunesignaling pathways such as the interferon response are often transiently activated thus variants disrupting these TFbinding sites may exert regulatory effects only under specific immune conditions To explore this possibility we analyzed variant effects separately in antiviral IFN\\u03b2 M1polarized IFN\\u03b3 and hyperinflammatory LPSIFN\\u03b3 states in both THP1 macrophages and HMC3 microglia We detected significant statespecific emVars FDR 005 in all conditions except IFN\\u03b2stimulated HMC3 cells Under hyperinflammatory stimulation we identified seven statespecific emVars in THP1 macrophages and four in HMC3 cells Fig 3f Supplementary Table 8 Notably rs10838702T SPI1 and rs17515931T CLU reduced transcription exclusively under hyperinflammatory conditions whereas rs62427420G SEC63 reduced transcription only in resting cells Several variants exhibited more complex patterns rs73972710T CTDP1 rs73000577C UBA5 and rs636317C MS4A4E increased transcription in both resting and stimulated states but showed stronger activation upon stimulation whereas rs549746751A GET3 exerted opposing effects depending on the immune state These examples reflect regulatory was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license scenarios in which variants disrupt TF binding that is active only in a specific state alter the strength of binding in a statedependent manner or engage distinct TFs acting on the same sequence under different immune conditions In summary our MPRA identifies both celltypespecific and immunestatespecific effects of LOADassociated variants on enhancer activity Contextdependent disruption of regulatory activity is associated with key TFbinding motifs and with the variants allele frequency common versus rare Deeplearning models interpret celltype and immunestatespecific variant effects To interpret how LOAD genetic variants influence regulatory codes in MPRA we trained CNN regression models on ATACseq data from multiple cell types including stimulated and unstimulated THP1 macrophages hESCiPSCderived microglia THP1 monocytes mouse cortex and striatum and HEK293T cells These models accurately predicted chromatin accessibility in holdout data from matched or related cell types Spearmans \\u03c1 08 while predictions across divergent cell types yielded moderate performance Spearmans \\u03c1 05 highlighting the cell type specificity of the regulatory codes they captured Fig 4a Using SHAP76based importance scores and TFMoDISco77 we show that the models learned key cell typespecific TF motifs Immunerelated motifs SPI CEBP RUNX were enriched in macrophage and microglia models while neural motifs EGR MEF2 RFX were enriched in brain models FDR 005 Fig 4b Only models trained on stimulated cells learned immune statespecific motifs with IRF NF\\u03baB CREBATF and BATF promoting chromatin accessibility and ZEB reducing accessibility in interferon treated cells To dissect TF roles in hyperinflammatory responses we trained a model specifically on differentially accessible chromatin regions from LPSIFN\\u03b3treated THP 1 macrophages Extended Data Fig 5a This model revealed NF\\u03baB IRFSTAT and CTCF motifs as drivers of chromatin opening while surprisingly SPI and CEBP motifs were linked to chromatin closure Fig 4b SPI1 PU1 was previously found to be a microglial transcriptional repressor in latestage LOAD78 that is marked by neuroinflammation79 suggesting a potential repressive role in hyperinflammatory responses Together these results demonstrate that the models successfully learned distinct transcription factor codes that underlie cell type and statespecific patterns of chromatin accessibility We evaluated the models on LOAD variantcontaining sequences in the MPRA library and found that immunetrained models discriminated against immune CREs from low ATAC sequences while braintrained models favored ubiquitous over immune CREs reflecting distinct regulatory codes Fig 4c The models recapitulated the TF motif enrichments seen in the matched ATACseq datasets capturing both celltype and statespecific activity as well as elements inducible by LPSplusIFN\\u03b3 stimulation FDR 005 Extended Data Fig 3de Overall these findings highlight that these models capture the generalizable regulatory codes making them valuable tools for interpreting cell type and statespecific enhancer function was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license We then applied in silico mutagenesis to assess allelic effects of LOAD variants Supplementary Table 9 facilitated by generating a null distribution from negative sequences and estimating prediction uncertainty via Monte Carlo dropout in our CNN The models effectively distinguished variants with strong versus weak regulatory effects in MPRA assays performed in THP1 macrophages with a similar trend observed for brain tissue demonstrating concordance between predictions and experimental data Fig 4d By integrating predicted accessibility changes and SHAP importance scores which were significantly correlated Spearmans \\u03c1 08 Extended Data Fig 5b the models identified variants that exhibit effects across cell types as well as variants with effects biased toward the immune or neural contexts P 01 Fig 4e Among the strongest outliers were rs636317 MS4A4E and rs755951 PTK2B both of which alter CTCF motifs Immunebiased variants were identified near EPHA1 MS4A4A BIN1 PICALM and PTK2B all key microglial regulators while brainbiased hits included variants near SORL1 SNAP25 and NAPG central to synaptic vesicle trafficking and amyloid precursor protein processing Interestingly some variants showed consistent directional effects across cell types while others displayed opposing effects Extended Data Fig 5c These results suggest that the models can identify significant regulatory variants that align with MPRA data and capture their contextdependent effects To determine celltypespecific effects of each allele we performed linear regression on predicted allelic differences including cell type immune versus neural as a covariate to isolate contextdependent effects This analysis highlighted two major classes of variants i those with a consistent direction but stronger effects in one cell type and ii those with opposite effects between immune and neural contexts Fig 4f Extended Data Fig 5d 5e Surprisingly common variants in HLADRB1 and HLADQA1 typically associated with microglial function showed stronger predicted effects in brain tissue For example exclusively in the neural context the minor G allele of rs9271162 HLADRB1 disrupts a TALEtype homeodomain binding site the minor T allele of HLADRB1 generates a repressive motif that reduces MEF2 binding and the minor C allele of rs3104416 HLADQA1 creates an EGR motif Extended Data Fig 5f Notably a substantial subset of these variants overlap with MPRAvalidated emVars For example rs13025765 BIN1 identified as an emVar in both THP1 macrophages and brain tissue increases accessibility in immune cells but decreases accessibility in the brain when the minor T allele is present Together these findings highlight the power of our models to resolve allelespecific regulatory effects with celltype precision We next explored immune statespecific effects with models trained on LPSIFN\\u03b3 IFN\\u03b3 IFN\\u03b2treated or resting THP1 macrophages Fig 4g Extended Data Fig 5g Variants with robust contextspecificity were identified such as rs13025765 BIN1 which showed stronger effects under LPSIFN\\u03b3 stimulation compared to the resting state and rs189835276 SEC63 which displayed stronger effects under all three interferonactivated conditions Models trained on LPSIFN\\u03b3responsive sequences provided mechanistic insight Extended Data Fig 3d For example the restingstate model predicted that for rs73972710 CTDP1 the major C allele forms a repressive ZBT motif at rest while the minor T allele disrupts this motif and increases transcription was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license upon stimulation the model revealed a chromatinopening advantage for the major allele masking the restingstate repression and reducing allelic differences matching MPRA findings Fig 4h Fig 3f These examples demonstrate how the models uncover the regulatory mechanisms underlying the statespecific effects observed in experimental data Collectively these findings demonstrate that LOAD risk variants exhibit dynamic cell type and immune statespecific regulatory effects and highlight the utility of deep learning models for predicting and interpreting variantmediated disruptions in gene regulation Functional regulatory LOAD variants By examining the overlap between MPRA data and machinelearning predictions we found that both rare and common emVars predicted by models are distributed across THP1 macrophages and brain tissue forming hotspots where multiple variants converge within the same locus to modulate gene expression Fig 5a Within a given locus certain minor alleles enhance transcription whereas others attenuate it highlighting the complexity of gene regulation in these systems Two previously uncharacterized hotspots SEC63OSTM1 and NELL2DBX2 were particularly enriched for rare variants with pronounced allelic effects in both macrophages and brain tissues variants in a NELL2 intron were active exclusively in brain tissue Extended Data Fig 6 The immuneassociated BIN1 locus the secondstrongest genetic signal for LOAD risk36 also emerged among the top hits Although the disease risk is most often attributed to the coding \\u03b54 allele of APOE we observed potent noncoding variant effects at the APOEAPOC1 and APOC2 loci in both neural and immune contexts Together these findings illustrate how multiple distinct variants within the same locus can reshape the regulatory landscapes in a contextdependent manner providing new insights into LOADassociated genetic mechanisms Integrating multidimensional measurements of genetic variant effects sequencelevel regulatory activity and motif context function we synthesized a mechanistic model of regulatory variant actions Fig 5b Variants can i destroy or create a core TF site ii finetune the strength of adjacent TF motifs or iii rebalance competition among neighboring activators and repressors motif shuffling represents the extreme case of class i Guided by this framework we prioritized candidate functional regulatory variants that met stringent criteria including significant enhancer activity allelespecific transcriptional differences and where applicable disruption of a motif context Fig 5c Supplementary Table 10 Notably the majority of these prioritized variants also exhibited consistent predicted effects across our machine learning models After establishing a highconfidence set of functional regulatory variants we examined their genomic context to identify the genes they regulate Because the majority of candidate functional regulatory variants are located in nonpromoter regions we posited that they act through distal enhancers that physically contact target promoters To nominate enhancergene pairs we applied the ActivityByContact ABC model80 to Hi C H3K27ac ChIPseq and ATACseq profiles from resting and LPSIFN\\u03b3stimulated was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license THP1 macrophages81 thereby integrating chromatin interaction frequency with enhancer activity Supplementary Table 11 Interestingly our analysis revealed three target genes TAS2R60 AZGP1 PIP associated with bitter taste sensory pathways which were enriched among functional regulatory variants in THP1 macrophages Extended Data Fig 4f The integrated MPRAmachinelearning framework uncovered a rich set of context dependent functional regulatory variants and through ABC modelling associated each variant cluster with candidate target genes Equipped with these genomic links we next interrogated the mechanisms by incorporating model interpretation with CRISPR perturbations to pinpoint how specific alleles rewire transcriptional programs in immune and neural states Mechanistic interpretation of functional regulatory variants at BIN1 MS4A and SEC63OSTM1 loci Within the functional regulatory variants that show impacts on enhancer activities several loci stand out as multiple variants showing divergent effects Fig 6a These include i an wellcharacterized BIN1 enhancer ii an enhancer within the critical MS4A locus whose gene products modulate TREM2 expression and microglial state8283 and iii a newly identified enhancer overlapping a rare variant cluster at SEC63OSTM1 locus Here we show how these variants influence transcription via modulating TF activities differently in immune and neural contexts Finemapping at BIN1 has prioritized rs6733839 an SNP within a microgliaspecific enhancer near a SPI1 motif where the minor T allele creates an MEF2 site and increases chromatin accessibility in iPSCderived microglia potentially elevating transcription3684 Previous MPRA assays in HEK293T and THP1 cells showed no significant allelespecific effects though subtle upregulation was noted3031 Here we comprehensively evaluated rs6733839 using contextdependent multilayered approaches Fig 6b SNPcentered MPRA constructs again showed no significant allelespecific effects in THP1 macrophages brain tissue or HEK293T cells However peakcentered constructs with rs6733839 at the 5 or 3 ends unexpectedly revealed T alleledriven transcriptional repression in THP1 macrophages and HMC3 microglialike cells Machine learning models predicted increased chromatin accessibility for the T allele in both macrophages and brain tissue Interestingly immune models suggested the T allele strengthened the nearby SPI1 motif leading to the observed repression in immune cells while brain models predicted gainoffunction with MEF2 motif consistent with upregulation detected in brain MPRA constructs Synthetic enhancer tiling and motif shuffling analyses further revealed that the motif context surrounding rs6733839 operates as a contextdependent repressor exhibiting potential combinatorial interactions with adjacent motifs Extended Data Fig 7 Its repression can be masked by a potent upstream activator resulting in an overall activating outcome however it can also push downstream activators toward inactivity Combined interactions with both upstream and downstream motifs result in net repression Collectively these data illustrate the complexity of enhancer logic where a single motif may exert activating or was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license repressive functions contingent on local sequence context and the composition of bound TFs We also characterized rs13025717 a variant in the adjacent BIN1 enhancer previously predicted to have its T allele disrupt a KLF4 motif meanwhile indirectly affecting the nearby PU1 SPI1 binding8485 Fig 6b In THP1 MPRA the T allele reduced transcription and models predicted decreased chromatin accessibility due to KLF4 motif loss This variant has also been reported as a BIN1 eQTL in monocytes and a SPI1 binding QTL in the Blymphoblastoid cell line GM1287885 Another variant rs13025765 showed opposing effects between THP1 and brain reflecting differential engagement of SPIB in immune cells versus RFX in neural contexts Fig 6b Together these findings reveal how multiple BIN1 enhancer variants modulate LOAD risk through distinct TF mechanisms In MS4A a major open chromatin region within MS4A6E intron 1 is accessible in both microglia and neurons but becomes less accessible under LPSIFN\\u03b3 stimulation in THP1 macrophages Fig 6c We identified variants with contextspecific motif effects the T allele of rs10897049 strengthened an ETS motif increasing transcription in macrophages but not in brain the minor A allele of rs4477457 disrupted an E2F motif reducing transcription in brain but not in macrophages and rs10792265 created an RFX motif that may compete with E2F reducing transcription in brain but not in THP1 macrophages These results highlight how individual motif disruptions can drive divergent immune and neuronspecific transcriptional outcomes In the SEC63OSTM1 intergenic region four rare variants within an enhancer showed distinct MPRA profiles three reduced transcription alleles and one increased transcription Fig 6d Notably these variants are not in linkagedisequilibrium LD indicating independent effects ML analyses suggest that the minor allele T of rs147038704 upregulates SPI1 motifs yet represses transcription while rs115607757 G allele weakens a bZIP site reducing macrophage transcription but increasing brain expression The rs189835276 T allele disrupts an ETS motif increasing macrophage transcription Chromatin analysis HiC ATACseq H3K27ac ChIPseq of publicly available data81 in THP1 macrophages reveals that this active enhancer is positioned within a chromatin loop connecting the OSTM1 promoter and a distal CTCF site at AFG1L HiC data also show that the enhancer lies within a highcontact region with the SEC63 promoter Extended Data Fig 8 ab These results suggest that the enhancer has the potential to regulate both OSTM1 and SEC63 expression Consistently RNAseq confirms strong expression of OSTM1 and SEC63 Supplementary Table 12 Functionally SEC63 and OSTM1 are involved in ER import and lysosomal acidification linking them to LOADrelated ER stress lysosomal dysfunction and APP trafficking To clarify the enhancers regulatory role we performed CRISPRi knockdowns of the enhancer as well as SEC63 and OSTM1 in THP1 macrophages under both resting and hyperinflammatory conditions Surprisingly enhancer repression left SEC63 and OSTM1 unchanged but elevated the LOAD effector genes GSAP and SSH1 by 30 Fig 6e In the resting state the perturbation upregulated complement genes and was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license downregulated proliferation pathways G2M checkpoint E2F and MYC targets steering macrophages toward an M1like state Fig 6f Under LPSIFN\\u03b3 stimulation the same knockdown amplified TNF\\u03b1NF\\u03baB Notch and KRASup signatures and further suppressed E2F targets reinforcing inflammatory metabolic and prosurvival pathways Collectively these data indicate that the enhancer functions as a gatekeeper for innateimmune signaling GSAP and SSH1 were also upregulated in amyloidtreated iPSCmicroglia and LPSIFN\\u03b3stimulated THP1 macrophages Supplementary Table 12 implicating their roles in inflammation Notably knockdown of SEC63 or OSTM1 also affected immune response pathways and cellular metabolism with SEC63 knockdown producing broader effects especially under inflammatory conditions underscoring their critical roles in macrophage function Fig 6e Extended Data Fig 8c 8d 8e Together these findings reveal how functional regulatory variants at BIN1 MS4A and SEC63OSTM1 modulate transcription through distinct cell type and contextspecific mechanisms highlighting the critical roles of enhancer architecture and TF networks in orchestrating immune and neural programs relevant to LOAD Discussion GWAS and rare variant studies continue to expand the catalogue of LOAD risk variants yet finemapping these loci remains challenging In GWAS tightly linked variants often share indistinguishable association statistics making it hard to nominate the true causal allele within each LD block Conversely WGS highlights ultrarare variants but their effect estimates are underpowered without complementary functional evidence Compounding these issues LOAD pathogenesis spans multiple cell types and tissues so variants must be interpreted in the specific cellular contexts where they exert their effects Our study combined contextdependent in vitro and in vivo MPRA deep learning models and CRISPRi perturbations to systematically map the cell type and state specific regulatory effects of 599 LOADassociated noncoding variants By examining both common and rare variants across human myeloid cell lines brain tissue and diverse immune states we uncovered striking heterogeneity in functional outcomes We found several variants exhibiting opposing effects across cell types underscoring the importance of testing variants in diseaserelevant tissue cellular and immune conditions This integrated framework highlights how noncoding variation shapes distinct immune and neural regulatory programs offering mechanistic insights into the genetic architecture of LOAD Although previous GWAS and epigenomic studies highlighted the enrichment of LOAD risk variants in microglial and macrophage enhancers most functional work has focused narrowly on common variants or immune contexts leaving rare variants and neural settings largely unexplored Here we systematically compare common and rare LOAD variants across immune and neural contexts using reporter assays and deep learning We show that common variants tend to exert stronger regulatory effects in immune was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license cells whereas rare variants tend to affect transcription more significantly in the brain context These findings support our hypothesis that common LOAD variants identified by GWAS and enriched in microglial enhancers3629424375 are more likely to affect immune regulatory programs whereas rare variants identified through patientfamily sequencing studiesoften mapped to genes involved in neural development and synaptic plasticity32are more likely to exert their effects in a neural context Although the rare variants we tested are frequently located in regions with low ATAC signal their potential gainoffunction roles or activities during developmental stageswhen chromatin is generally more accessibleshould be considered Additionally during aging cells can undergo epigenomic erosion2986 a process in which closed chromatin becomes more accessible and active regulatory elements lose activities leading to loss of cell identity potentially enabling these variants buried in closed chromatin to exert effects later in life The role of rare variants remains underappreciated in LOAD research and identifying and understanding their functional impact is only the beginning By integrating MPRA and machine learning interpretations we identified regulatory hotspots where multiple variants converge to modulate gene expression Mechanistically variants disrupt or strengthen TF binding sites finetune motif strength or rebalance competition among adjacent activators and repressors Leveraging multidimensional measurements we nominated functional regulatory variants and link enhancers to their target genes including an unexpected enrichment of sensory genes implicated in early LOAD deficits in THP1 macrophages Detailed analyses of representative loci revealed mechanisms underlying cell type specific variant effects Fig 6 Extended Data Fig 7 At BIN1 prior MPRA studies using SNPcentered constructs failed to detect allelespecific effects however by employing longer peakcentered constructs we uncovered a reproducible repressive effect of the rs6733839 T allele in macrophages mediated by SPI1 rather than the previously predicted MEF2 motif Motif tiling further revealed complex interactions between the variants local context and neighboring motifs Similarly the rs13025717T allele in another BIN1 enhancer was previously shown to reduce transcription in HEK293T MPRAs In our THP1 macrophage MPRAs we observed T alleledriven repression only in SNPcentered constructs while peakcentered constructs showed no effect Model predictions pointed to SPKLF motif disruption in immune but not neural contexts These findings along with the results of Ernst et al45 and Klein et al73 highlight how variant positioning and CRE length critically influence the detection and interpretation of regulatory effects underscoring the need for diverse MPRA designs to capture motif interactions In parallel with the recent work of Bond et al31 we examined variant effects under immune stimulation We showed that LPSIFN\\u03b3 which mimics the hyperinflammatory state relevant to LOAD elicited the most pronounced chromatin remodeling ATACseq and enhanceractivity shifts MPRA in THP1 macrophages Notably at the resting THP1 macrophages rs73972710 CTDP1 the major C allele forms a repressive ZBT motif at rest whereas the minor T allele disrupts this motif and elevates transcription was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license upon LPSIFN\\u03b3 stimulation the major allele gains higher motif scores that mask the restingstate repression and reduces allelic differences a pattern captured by both our models and MPRA readouts Fig 3f 4h Beyond CTDP1 several variants at other LOAD risk lociincluding the immuneregulatory MS4A cluster which multiple fine mapping studies have implicated in disease susceptibility2728308587showed comparable allelebystimulation interactions further underscoring the importance of assaying variants in diseaserelevant cellular states These cases along with our immunestate profiling of macrophages demonstrate that the magnitude of LOAD associated variant effects is dynamically tuned by cellular states such as the inflammatory states implicated in the disease Context dependence therefore extends beyond celltype specificity to a temporal dimension in which immune activation scales variant impact Evaluating candidate variants within diseaserelevant immune milieus is thus essential for revealing their full pathogenic potential At the SEC63OSTM1 intergenic enhancer we identified four functional regulatory rare variants with independent allelespecific transcriptional effects in THP1 macrophages mediated through immune motifs Although HiC analysis implicated enhancer interactions with the nearby genes SEC63 and OSTM1 CRISPRimediated enhancer perturbation unexpectedly increased expression of distant LOAD effector genes notably GSAP and SSH1 while enhancing proinflammatory signaling pathways without altering SEC63 or OSTM1 transcript levels \\u03b3Secretase activating protein GSAP promotes amyloid\\u03b2 production via interactions with the \\u03b3secretase complex and amyloid precursor protein APP88 whereas Slingshot1 SSH1 an actin phosphatase attenuates Nrf2mediated antioxidant responses with its loss ameliorating A\\u03b2 and tau pathology89 Thus increased expression of GSAP and SSH1 likely exacerbates complementary pathogenic mechanisms in LOADamyloid deposition and oxidative stressindicating the enhancer typically serves as a suppressor of these detrimental pathways Remarkably although GSAP and SSH1 reside on chromosomes distinct from the enhancer both genes exhibited altered expression following enhancer perturbation and were upregulated in the inflammatory macrophages likely reflecting secondary consequences of enhanced innate immune activation These findings highlight a notable instance wherein distal noncoding regulatory elements modulate LOADassociated networks through noncanonical or higherorder interactions linking noncoding genetic variation to amyloidogenesis oxidative stress and neuroinflammation These mechanistic insights were enabled by several technical advances that improved both the sensitivity and resolution of our measurements Transcriptomic and epigenomic profiling of cytokinestimulated THP1 macrophages ensured that variant effects were assayed in immune states relevant to LOAD pathophysiology We optimized electroporationbased delivery of MPRA libraries into THP1 cells which are typically challenging to transfect enabling reproducible detection of stimulusresponsive enhancer activities Building on previous work by Brown et al49 which demonstrated systemic AAVmediated MPRA delivery across the bloodbrain barrier sysMPRA we achieved increased reproducibility and larger library sizes using pseudobarcoding strategies that aggregate barcodes with similar representation to establish robust was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYND 40 International license expression estimates across individual animals In parallel we adapted convolutional neural networks from Ramamurthy et al27 to predict chromatin accessibility using 500 bp sequences achieving consistent performance across cell types and datasets including those generated in different laboratories To quantify machine learning predicted variant effects with confidence we applied both celltypematched null distributions and dropoutbased uncertainty estimation Together these innovations enabled highconfidence contextspecific dissection of noncoding variant function at scale laying the foundation for systematic interpretation of regulatory architecture in LOAD Several limitations warrant mention THP1 and HMC3 cells while experimentally tractable are surrogates for primary human microglia and macrophages and do not fully capture the complexity of the brain immune milieu Although we have previously demonstrated an overall conservation of the regulatory code between rodent and primate9091 our in vivo MPRAs in mice may introduce crossspecies regulatory differences Moreover synthetic CREs though powerful may overlook contributions from longrange chromatin contacts topological features or promoterlike elements We also note that some variants such as rs563571689 at the last nucleotide of APOE exon 1 are predicted to alter splicing without affecting MPRA output highlighting the importance of complementary assays to capture the full regulatory landscape While we identified variants with effects specific to brain tissue rather than immune cells we lacked the statistical power to resolve regionspecific effects within the brain Furthermore variants with cell typerestricted regulatory functions may be masked in bulktissue MPRAs due to their limited representation in the sampled population Continued method development is needed to achieve singlecell resolution within the native tissue context Emerging dropletbased singlecell9293 and spatially resolved62 MPRA platforms offer a promising path to pinpoint subtle contextspecific effects such as those acting in neural subtypes or immune activation states not represented in our current in vitro systems Our findings open key avenues for future research including systematic enhancergene mapping investigation of variant effects in motifmotif interactions functional studies of hotspot genes and defining the cellular states where variants become active to guide therapeutic strategies Together these efforts will deepen our understanding of noncoding genetic risks and advance the development of precision therapies for LOAD\",\n          \"Alzheimers disease AD is the leading cause of dementia in the elderly yet effective therapies remain lacking Here we identify monoacylglycerol lipase MAGL the principal enzyme that degrades the endocannabinoid 2 arachidonoylglycerol 2AG in the brain specifically in astrocytes as a promising therapeutic target for AD APP transgenic TG mice with astrocytespecific MAGL deletion TGaKO but not neuronspecific deletion TG \\u03b2 nKO exhibit markedly reduced A pathology neurodegeneration and neuroinflammation along with preserved synaptic structure and function and improved cognition These benefits are recapitulated in TG mice by AAV mediated silencing of astrocytic MAGL whereas MAGL overexpression exacerbates neuropathology and accelerates synaptic and cognitive decline Transcriptomic analyses reveal that dysregulated synapse inflammation and ADrelated gene expression profiles are reversed in TGaKO mice MAGL expression is elevated in astrocytes from both AD patients and TG mice Remarkably a single intracerebroventricular ICV injection of AAVMAGLshRNA administered at either presymptomatic or postsymptomatic stages prevents or reverses neuropathology and synaptic and cognitive impairments in TG mice providing preclinical evidence that astrocytic MAGL silencing represents an effective therapeutic strategy for AD Key words Cannabinoid neurodegenerative disease dementia hippocampus gene therapy which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNC 40 International license\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"introduction\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 25,\n        \"samples\": [\n          \"Alzheimers disease AD is the most common cause of dementia in the elderly Currently more than 69 million people in the United States and 55 million people worldwide are living with AD related dementia ARAD these numbers are projected to rise to 127 million in the United States and 153 million globally by 2050 Despite decades of intense effort no therapies effectively prevent treat or halt AD progression While continued elucidation of disease mechanisms is essential there is an urgent public health need to develop novel effective interventions The etiology and progression of AD are now recognized as multifactorial involving diverse mechanisms and signaling pathways In this context the endocannabinoid system has emerged as a promising therapeutic avenue for AD 12 given its broad roles in physiological pharmacological and pathological processes 34 Endocannabinoids are endogenous lipid signaling mediators distinct from \\u0394 \\u0394 exogenous cannabinoids such as 9tetrahydrocannabinol 9THC the principal psychoactive constituent of cannabis Among these 2arachidonoylglycerol 2AG is the most abundant endocannabinoid Accumulating evidence indicates that 2AG plays a critical role in maintaining brain homeostasis by modulating synaptic transmission and plasticity resolving neuroinflammation and protecting neurons from harmful insults 1513 Thus enhancing 2AG signaling is broadly beneficial in the brain Following synthesis however 2AG is rapidly degraded by several enzymes with monoacylglycerol lipase MAGL serving as the principal hydrolase in the brain 11417 While 2AG exerts antiinflammatory and neuroprotective effects its hydrolysis product arachidonic acid serves as a precursor for proinflammatory and neurotoxic prostaglandins eg PGE2 and leukotrienes eg LTB4 1820 Therefore MAGL inhibition confers a dual effect it augments beneficial 2AG signaling while concurrently reducing proinflammatory neurotoxic eicosanoids 1513162124 Consistent with this which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNC 40 International license mechanism early studies demonstrated that systemic MAGL inactivation alleviates neuropathology and improves synaptic function and cognitive performance in AD animal models 2328 supporting MAGL as a potential therapeutic target for AD 123252932 However accumulating evidence suggests that systemic MAGL inactivation whether pharmacological inhibition or genetic deletion can elicit adverse effects in both the brain and peripheral tissues 3339 Importantly selective inactivation of MAGL in neurons alone was recently shown to impair synaptic and cognitive functions 40 suggesting that intact neuronal 2AG metabolism is critical for maintaining normal cognition Because MAGL also catalyzes the final step of triglyceride lipolysis its systemic inactivation may potentially alter lipid and energy homeostasis 41 Together these findings indicate that global MAGL inactivation may not achieve the optimal therapeutic outcome for AD In line with this view we recently found that astrocytespecific MAGL deletion but not neuron specific inactivation alleviates neuropathology reduces neuroinflammation and improves synaptic and cognitive functions in a traumatic brain injury TBI model 42 These results suggest that the neuroprotection observed with systemic MAGL inactivation arises primarily from limiting 2AG degradation in astrocytes rather than in neurons thereby revealing a cell typespecific role for 2AG signaling in both physiology and disease 14243 Accordingly we pursued a cell typespecific strategy to target MAGL in AD\",\n          \"Lateonset sporadic Alzheimers disease AD is the most common dementia with a predicted prevalence in 2050 of 138 million in the United States and 152 million worldwide 12 The brain changes in AD begin 20 or more years before symptoms appear 3 11 of people aged 65 and older have AD and this prevalence grows to 32 for people aged 85 and more 4 At the genetic level carriers of the Apolipoprotein E ApoE epsilon 4 allele have a greater risk to develop AD 5 AD is characterized by progressive memory and behavioral impairment owing to degeneration of limbic and cortical areas of the brain Pathological hallmarks of the disease are extracellular amyloid plaques and intraneuronal phosphoTau tangles formation synaptic atrophy and neuronal cell death 6 Amongst patients with amyloid plaques and Tautangles a small fraction of those can maintain normal cognition a phenomenon referred to as cognitive resilience 78 Recently the Myocyte Enhancer Factor 2A and C MEF2AC genes were identified as key players at promoting cognitive resilience in AD through activation of synaptic transmission and cognitionrelated genes 9 Chromatin profiling studies of AD brains also revealed an Alzheimers resilient epigenetic signature with a Gene Ontology GO for cellcell adhesion via plasma membrane adhesion molecules synaptic transmission and neural development in neurons and inflammatory response in microglia 10 While the respective contribution of genetic lifestyle and environment in ADs etiology remains complex advanced age represents the greatest risk factor to develop AD 4 Aging is characterized by the accumulation of genetic mutations and loss of epigenetic information 1112 In mice faithful repair of genetically induced DNA breaks is sufficient to trigger accelerated aging including erosion of the epigenetic landscape and loss of cell identity 13 Notably singlecell analyses revealed epigenetic erosion and loss of cell identity in latestage AD brains a phenomena not seen in old control brains 14 AD brains neurons also show features reminiscent of accelerated aging including loss of heterochromatin alterations of the nuclear envelope and persistent DNA damage response 1518 Proteins of the Polycomb Group PcG family form large molecular complexes that regulate epigenomic cell memory and play multiple functions during development cancer and aging 19 EZH2 is the catalytic unit of the Polycomb repressive complex 2 PRC2 and mediates gene silencing through bi and trimethylation of histone H3 at lysine 27 H3K27me3 2021 RING1 is the catalytic unit of the Polycomb repressive complex 1 PRC1 and mediates gene silencing through monoubiquitylation of histone H2A at lysine 119 H2Aub 22 During development one of the 3 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission general functions of PcG is to prevent the expression of lineagerestricted genes in pluripotent stem cells and later to prevent expression of pluripotency genes in somatic cells 2324 The Bcell Moloney leukemia insertion site 1 BMI1 protein prevents RING1ab autoubiquitylation and degradation and works as the core unit for canonical PRC1 activities in somatic cells 25 The repressive histone mark H3K9me3 accumulates at genepoor and repeatcontaining heterochromatin 26 Notably BMI1 is enriched at H3K9me3associated heterochromatin and its deficiency impairs histone H3K9me3 deposition and maintenance 2728 BMI1 is required to prevent senescence or apoptosis of somatic cells and cancer cells 293119 Bmi1null mice present growth retardation and cerebellar degeneration together with premature ocular and brain aging 3233 BMI1 expression is reduced in AD brains and BMI1 inactivation in neurons results in the accumulation of betaamyloid and Tau tangles 34 Bmi1 mice develop with old age behavioral and brain anomalies resembling AD 15 BMI1 protein levels are reduced in the serum of minimal cognitive impairment and AD patients 35 and a minor allele of BMI1 was associated with slower cognitive decline in AD 36 altogether suggesting that BMI1 is an AD modifying gene The induced pluripotent stem cell iPSC technology allows reprogramming of somatic cells into pluripotent stem cells capable of selfrenewal and differentiation into cell progenies of the 3 primordial germ layers 3738 By analogy with sexual reproduction reprograming rejuvenates adult somatic cells erasing agingassociated epigenomic marks 39 Primed human iPSCs are developmentally equivalent to the postimplantation epiblast 4041 While iPSCs and embryonic stem cells are apparently very similar their epigenome differs substantially Notably iPSCs can acquire aberrant DNA methylation DNAme states and retain part of the epigenetic memory of the cell of origin especially those at H3K9me3enriched and laminaassociated chromatin regions 4243 Similarly mouse embryos produced by nuclear transfer retain from donor cells reprograming resistant chromatin regions enriched for H3K9me3 and which imped normal development 44 Multiple iPSC lines have been generated from AD patients somatic cells Notably differentiation of AD iPSCs into cortical neurons can recapitulate ADrelated pathologies such as elevated Ab42 secretion pTau accumulation dendritic atrophy and neuronal cell death 344546 Interestingly induced neurons produced by transcription factor overexpression in AD human dermal fibroblasts HDFs show reduced neuronal maturation activation of stress response genes and increased expression of stem cell and cancerrelated genes This phenotype was not observed in induced neurons produced from HDFs of old control donors 47 Since most AD patients do not carry defined diseasecausing genetic mutations 48 it remains unclear however why AD neurons generated from 4 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission either HDFs or iPSCs present these anomalies Herein we describe the molecular characterization of control and AD iPSC lines We found subtle but significant gene expression differences between undifferentiated control and AD iPSCs together with heterochromatin and DNAme alterations Unexpectedly differentially methylated DNA regions DMRs in iPSCs were highly enriched for MEF2s binding sites Differentiation of AD iPSCs into neuroepithelial NE cells resulted in less efficient neural induction and elevated ZIC2 ZIC5 and WNTrelated gene expression Advanced AD neuronal cultures presented a dedifferentiation phenotype expressed nonneuronal lineage genes and developed several pathologies observed in AD brains Many of these neuronal pathologies were improved following BMI1 overexpression 5 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission\",\n          \"Alzheimers disease AD a leading cause of dementia worldwide is a progressive neurodegenerative disorder that gradually impairs memory cognition behavior and executive functions13 AD is defined by two primary pathological hallmarks the accumulation of extracellular amyloid\\u03b2 A\\u03b2 plaques and intracellular neurofibrillary tau tangles accompanied by gliosis and neuronal loss Despite substantial advances in understanding AD pathology the complex interplay of genetic cellular and environmental factors makes the mechanisms of the disease progression an enigma Among genetic risk factors carrying the \\u03b54 allele of apolipoprotein E APOE4 represents the strongest contributor to lateonset AD45 Accumulating evidence from epidemiological and genomewide association studies GWAS has shown that APOE4 heterozygotes are two to three times more likely and homozygotes up to 12 to 15 times more likely to develop AD compared with APOE3 populations468 In this study we analyzed positron emission tomography PET imaging data from nondemented preclinical individuals in the Alzheimers Disease Neuroimaging Initiative ADNI cohort and found that even among cognitively normal control participants both APOE4 heterozygotes and homozygotes show significantly increased amyloid\\u03b2 and tau burden compared with noncarriers demonstrating that APOE4 drives early pathological changes well before clinical symptoms emerge Figure 1 Furthermore APOE4 increases the risk of amyloidrelated imaging abnormalities during treatment with secondgeneration antiamyloid monoclonal antibodies and diminishes therapeutic efficacy 911 Despite its central role in AD pathogenesis the mechanisms by which APOE4 potentiates pathological amyloid and tau burden exacerbates disease severity and confers treatment resistance remain elusive Progress in understanding AD and APOE4 has been limited by the lack of models that accurately capture human pathophysiology While animal models have provided critical insights into amyloid processing tau aggregation and neuroinflammation speciesspecific differences prevent full recapitulation of the human brain and the complex interplay of AD pathologies This limitation is particularly pronounced for APOE4 as APOE exhibits speciesspecific differences in its evolution structure and posttranslational modifications between rodents and humans1213 Rodent models even those expressing humanized APOE encounter difficulty in reproducing the phenotypes observed in human populations1416 Human induced pluripotent stem cell hiPSC based models have emerged as powerful tools to overcome these limitations1720 By 4 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission reprogramming patientderived cells into neurons astrocytes and other brain cell types hiPSC models allow the study of AD mechanisms in a human genetic context21 Advances in stem cell engineering have further enabled the generation of threedimensional 3D brain organoids or assembloids selforganizing multicellular structures that recapitulate aspects of human brain development cellular diversity and architecture2226 Organoids and assembloids provide unique opportunities to investigate cellular interactions and disease processes in a physiologically relevant environment that is difficult to achieve in conventional 2D cultures2732 However most current organoid systems remain limited in cellular composition often lacking or exhibiting delayed development of key nonneuronal cell types and rarely incorporate diseaserelevant stressors in a controlled and systematic manner3336 To overcome the challenges in understanding the pathophysiology of AD and recapitulate human heterogeneity we built on our previously published Asteroid model37 to develop Masteroids 3D cultures composed of hiPSCderived neurons astrocytes microglia and endogenously generated oligodendrocytes In this study we established Masteroid models using hiPSCs carrying APOE4 and their isogenic APOE3 controls combining tau and amyloid pathologies to more comprehensively model AD progression Our Masteroid system was specifically designed to capture both the proteopathic and genetic contributors to AD Neurons were initially seeded with tau oligomers to prime the system for pathological tau aggregation and then combined with astrocytes and microglia to form mature multicellular 3D Masteroids The cultures were subsequently exposed to extracellular amyloid\\u03b2 oligomers creating a comprehensive environment that models intermediate and advanced stages of neurodegeneration After four weeks ADMasteroids faithfully recapitulated multiple hallmark features of AD pathology including A\\u03b2 deposition tau aggregation widespread neurodegeneration astrogliosis and robust microglial activation Notably the presence of APOE4 markedly exacerbated all of these pathological phenotypes highlighting its critical role in disease progression Electron microscopy revealed that Masteroids recapitulated ultrastructural features of the human brain including neuronal synaptic structures neuronglial interactions glial phagocytic activity and early myelination development Electrophysiological recordings confirmed Masteroid neurons had excitation ability action potentials in response to current injection and synaptic events Leveraging singlecell RNA sequencing we identified IGFBPs as distinct mediators and highlighted signaling pathways involved in amyloid\\u03b2 and tauassociated cellular dysfunction 5 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission providing new mechanistic insights Strikingly treatment of ADMasteroids with IGFBP inhibitor NBI 31772 significantly reduced neurodegeneration astrogliosis and microglial activation demonstrating a direct role for IGFBP signaling in driving AD pathogenesis Together these\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"conclusion\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 26,\n        \"samples\": [\n          \"Introduction As the population ages the incidence of Alzheimers disease AD is increasing yet because of a lack of knowledge about disease pathogenesis there are no earlyintervention therapies available There is however agreement that vascular defects and dysfunction of the bloodbrain barrier BBB are early events in the onset of AD15 Despite extensive research into amyloid\\u03b2 A\\u03b2 pathology and cerebral amyloid angiopathy CAA the molecular mechanisms underlying the breakdown of the BBB in AD remain elusive In the cerebral circulation there is a close association between endothelial cells pericytes and astrocytes which make up the neurovascular unit NVU and there is evidence to implicate pericyte loss with compromised BBB integrity in AD patients67 One pathway that has been linked to pericyte loss and the breakdown of the bloodretinal barrier in diabetic mice and humans is linked to the soluble epoxide hydrolase sEH This enzyme can generate fatty acid diols such as 1920 DHDP that can essentially dissolve endothelial cells as well as endothelial cellpericyte junctions8 Importantly sEH expression is elevated in models of vascular cognitive impairement910 small vessel disease11 type 2 diabetes12 and AD1314 Studies have shown that inhibiting sEH can reduce neuroinflammation lower parenchymal amyloid burden enhance functional hyperemia and improve cognitive function in AD models1315 All of these reports suggest that targeting sEH may be a promising approach to delay key pathological features of AD111316 Given the strong association between sEH and vascular dysfunction this study set out to determine 1 whether sEH disrupts astrocytepericyte communication in AD in a manner similar to that observed in diabetic retinopathy 2 how astrocytespecific sEH inhibition reduces parenchymal amyloid as well as vascular amyloid deposition which could pave the way for transformative advancements in AD treatment and 3 how genetic ablation of astrocytic sEH impacts vasomotion in AD with a particular focus on CAA Currently many patients are excluded from current antiamyloid therapeutic interventions due to cerebrovascular risk factors such as CAA which increase the risk of amyloidrelated imaging abnormalities ARIA17 In light of the current ongoing amyloid trials these findings underscore astrocytic sEH as a central regulator of vascular degradation in AD and reveal its inhibition as a promising therapeutic avenue for preserving neurovascular unit integrity and mitigating A\\u03b2driven neuropathology which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Materials and methods Mouse Lines All experimental procedures and husbandry were carried out in accordance with regulations of the state of Hessen Germany and by the animal welfare committee of Johann Wolfgang Goethe Universit\\u00e4t Frankfurt am Main Mice had unrestricted access to food and water All Cre systems were induced by 002g mL5 \\u00b5l g of tamoxifen via intraperitoneal injection for five consecutive days Genotyping Genotypes were determined from ear or tail biopsies by alkaline lysis 50 mM NaOH 95 C 45 min followed by neutralization 15 M TrisHCl pH 88 Stereotaxic intracranial Injections of adenoassociated viral vectors Stereotaxic injections were performed under fentanylmidazolammedetomidine anesthesia Coordinates were defined relative to bregma AP 015 mm ML 002 mm DV 015 mm Virus was infused at 01 \\u03bclmin and the needle was left in place for 10 min before withdrawal as described previously18 Mice received postoperative analgesia buprenorphine 0015 mgml for 3 days and were monitored until sacrifice Tissue preparation and immunohistochemistry Mice were perfused with PBS followed by 4 paraformaldehyde PFA Brains were postfixed for 2 hours cryoprotected in 30 sucrose and sectioned coronally Freefloating sections were permeabilized blocked and incubated with primary antibodies overnight at 4 C followed by fluorophoreconjugated secondary antibodies For VEcadherin detection tyramide signal amplification SuperBoost Invitrogen was used according to manufacturer instructions Sections were mounted in FluoromountG Cranial window surgery To be able to visualize the brain vasculature in a living mouse cranial windows were implanted on the hindlimb somatosensory cortex as described19 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Briefly the mice were anesthetized with a combination of fentanylmidazolammedetomidine 10 \\u00b5lg their heads were shaved and the mice were positioned in a stereotaxic apparatus Once the head was fixed in position the area was cleaned with povidone iodine solution followed by Softasept N After the surgery the animals were removed from the stereotaxic apparatus injected with buprenorphine 666 \\u03bclg and antidote 10 \\u03bclg Mice were then allowed to recover in the cage on a warm surface Generation of adenoassociated viruses An adenoassociated virus serotype 9 AAV9based delivery system was employed to overexpress sEH in vivo The open reading frame ORF of human EPHX2 sEH transcript variant 1 was PCRamplified from a HepG2 cDNA pool and cloned into a singlestranded AAV ssAAV genome plasmid under the control of the astrocytespecific minimal human glial fibrillary acidic protein promoter gfaABC1D Lee et al 2008 To enable identification and tracking of transduced cells an eGFP reporter was coexpressed from the same transcript in a bicistronic design linking sEH and eGFP via a selfcleaving porcine teschovirus1 2A P2A peptide A construct expressing eGFP under the gfaABC1D promoter served as control For AAV vector production HEK293T cells at low passage were transfected with the respective AAV genome plasmid and the adenoviral helper construct pDP9rs encoding the capsid and helper factors After 72 h cells and culture media were collected and recombinant AAV particles were isolated using iodixanol gradient ultracentrifugation Purified vectors were filtered concentrated and their genomic titer determined by quantitative PCR as described previously20 Western blotting of whole brain homogenates Brains were perfused with PBS and then homogenized in RIPA buffer Proteins were separated by SDSPAGE Novex 1020 Tricine Mini Protein Gels Invitrogen cat no EC66252BOX Novex Tricine SDS Running Buffer Invitrogen cat no LC1675 and transferred onto nitrocellulose membranes with 02 \\u00b5m pores Whatman Dassel Germany using the Mini TransBlot Cell BioRad Membranes were probed over night with specific primary antibodies as indicated and then with peroxidaseconjugated antirabbit or antimouse secondary antibodies for 1 hour at room temperature Bound antibodies were visualized by enhanced chemiluminescence reagent which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Millipore and a ChemiDoc MP Imaging System BioRad Quantification of band intensities were analyzed by the Image Lab software BioRad version 601 Equal loading was assessed using antibodies to GAPDH Image acquisition and data analysis Immunohistochemistry samples were analyzed with FIJI software and Imaris software Imaris software v 97 Oxford Instruments In vivo data were analyzed with FIJI and posteriorly with Jupyter Notebook run Phyton script or Matlab version R2022a 2Photon microscope A custom made 2Photon microscope built according to the steps described elsewhere 21 was used for the in vivo experiments A Chameleon Ultra II laser Coherent was used as well as an MP285A Sutter Instrument Company for motor control and ScanImage software Vidrio Technologies for image acquisition Laser emission was detected by two photomultiplier tubes Hamamatsu Photonics a 695dcxxr primary and a T560LPXR secondary dichroic mirror an ET52550m2P and an ET60570m2P bandpass filter Chroma Technology Corporation A head fixation system that allowed imaging of the same regions of interest based on consistent coordinates was used as described22 Images were acquired at a laser power 50mW RNA spatial sequencing Brains were embedded in OCT and frozen in isopentane Sections 10 \\u03bcm were processed using the 10x Genomics Visium Spatial Gene Expression platform according to the manufacturers protocols RNA integrity was verified RIN 7 prior to library preparation Libraries were sequenced and analyzed following standard workflows sEHGFAP Colocalization analysis Cortical regions of 9monthold APPPS1 mice were imaged using a confocal laser scanning microscope The images were analyzed in Fiji The images were despeckled and had the background subtracted by using the rolling ball method with 50 pixels The plugin colocalization colormap version 12_11_2019 was used to get the index of correlation sEH proximity to plaques Laser scanning confocal microscopy images were used for analysis of sEH immunoreactivity in proximity to plaques The images were analyzed using Imaris A consistent threshold was set and which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license the distance of the sEH surface from the MethoxyX04 surface was recorded and then binned according to instances in which the distances were observed sEH proximity to CAA Laser scanning confocal microscopy images were used for analysis of sEH immunoreactivity in proximity to CAA by using hFTAA to visualize the CAA on vessels In Fiji the polygon tool was used to draw a ROI around CAA deposits The selection area was enlarged by 25microns Selection of both ROIs the XOR feature was used to isolate the 25micron region around the CAA The intensity of sEH immunoreactivity was measured in this ROI For nonCAA burdened controls similar sized vessels were used to measure the amount of sEH immunoreactivity in 25 micron regions Intravenous Alexa Fluor 555 Cadaverine injection Mice were put into surgical plane of anesthesia by injection of ketamine and xylazine at 180 mgkg and 10 mgkg of body weight respectively 70 \\u03bcL of Alexa Fluor 555 cadaverine 1 mgml was injected into the retroorbital venous sinus and circulated for 30 minutes before mouse was sacrificed by overdose of ketaminexylazine Mice were then perfused with 4 PFA Please see Tissue Preparation Plaque analysis Densecore and diffuse amyloid were segmented using MethoxyX04 and hFTAA respectively with Fiji particle analysis APP and Cadaverine analysis Epifluorescence images of cortical regions were processed using Fiji imaging software The polygon tool was used to select the tissue The intensity of the channel was measured and the mean intensity was recorded The mean of each mouse was recorded for analysis Process length analyses Epifluorescence or max projection of laser scanning confocal images were analyzed using Fiji software A skeleton of the respective signal and the normalization signal were created using a skeletonizing script provided by Dr Michael Candlish and Dr Eloah De Biasi An algorithm from Robust Quantification of In Vitro Angiogenesis Through Image Analysis23 was used in which the lengths are calculated from the middle of one pixel to the middle of another Cortex covered area by vascularassociated components in aging and disease which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Images of the cortex area were taken at the epifluorescence microscope The thresholded area was then skeletonized23 The results provided the length of the vasculature and Hic1 tdTomato cell coverage post skeletonization and was further normalized by tissue area to determine vessel coverage in the tissue as well as overall Hic1 tdTomato coverage A total of two images per mouse was analyzed when possible and the acquired values were averaged and used for statistics Hic1 tdTomato somata counting and process length analyses The images used for the previous analyses were also processed for Hic1 tdTomato somata counting and process length quantification For somata counting the images were processed using FIJI where Gaussian blur filter sigma 2 followed by background subtraction using the rolling ball method 50 pixels was applied Afterwards somatas were manually counted with the cell counter tool Vasomotion analysis To analyze variations in vasomotion in CAA burdened vessels and WT healthy vessels acquired images were opened in FIJI As described elsewhere24 a line was drawn across the arteriole of interest in FIJI and saved as a ROI for further application A collection of scripts kindly shared to our group by Dr Leon P Munting were then used to acquire the power spectral density of each of the analyzed vessels as well as the maximum amplitude of vasomotion which was showed directly at Matlab and posteriorly copied into Prism for statistics Vasomotion measurements To assess the presence of vasomotion in CAA and healthy vessels heterozygous and wildtype APPPS1 mice aged 916 months were used Cranial windows were implanted as previously described For region of interest ROI determination animals were anesthetized with fentanylmidazolammedetomidine 10 \\u00b5lg and tail vein injected with Alexa 633 Hydrazide and 1 fluorescein in sterile saline to visualize the brain vasculature A PlanApochromat W 40x10 DIC VISIR Zeiss objective was used for ROI imaging Alexa hydrazide positive vessels were considered arterioles For vasomotion detection animals were anesthetized with a combination of Ketamine 1 \\u03bclg and Xylazine 05 \\u03bclg to avoid Isoflurane interferences on cerebrovasculature tone24 Animals were subsequently ip injected with 1 fluorescein in sterile saline ScanImage software was used for vasomotion detection where 256x256 images were acquired A total of 1266 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license frames were acquired at a 422 Hz rate for a total period of 5 minutes 24 Vessels were imaged at 800 nm with a zoom of 2 and the red channel was excluded from the data attainment Microbleedings For this experiment Hic1CreERT2Rosa26LSLtdTomato APPPS1 mice ranging from 12 to 23 months of age were used The vasculature was visualized with 1 fluorescein and A\\u03b2 with MethoxyX04 injected 24h prior to imaging Capillaries chosen to be ablated were approximately 100 \\u00b5m below the brain surface Zstack images 512x512 1 \\u00b5m step size 2x zoom of pre and post ablation capillaries were acquired with a PlanApochromat W 40x10 DIC VISIR Zeiss at 800 nm optimal excitation of the fluorescein signal 900 nm and 1047 nm optimal excitation of the tdTomato signal Statistical analysis All statistical analysis was done using GraphPad Prism 10 software All specific tests used are state in the figure legends or in the main text Outliers were excluded using the ROUT method using standard settings in GraphPad Prism 10 software All data in the graphs are shown as mean of each animal SEM unless otherwise stated Results Vascular stability is impaired in APPPS1 mice BBB dysfunction is an early pathological event observed in individuals with AD12 therefore we assessed BBB integrity in APPPS1 mice following intravenous injection of Cadaverine This revealed detectable and generalized vascular leakage in APPPS1 mice Extended Fig 1AB To further characterize the underlying mechanisms of BBB disruption we analyzed the organization of endothelial junctional proteins within the capillary bed This revealed a pathologydependent disorganization of adherens junctions marked by fragmented and discontinuous VEcadherin staining along the vascular endothelium Such alterations in junctional architecture are consistent with compromised barrier integrity and thus contribute to the observed Cadaverine extravasation Extended Fig 1CD To better visualize how the cells of the NVU are affected in AD we crossed APPPS1 mice with a stromal progenitor cell SPC reporter line Hic1tdTomato as SPCs play an essential role in the repair of injured vessels25 To investigate vascular repair dynamics targeted in vivo capillary ablation was performed by laser lesioning and recovery was followed over 28 days which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license This revealed that the recovery of vessel flow was markedly impaired in Hic1tdTomato APPPS1 mice Fig 1AB This indicates that AD pathology hampers efficient vessel repair and recovery consistent with our initial hypothesis that the BBB dysfunction negatively affects vessel recovery after acute injury Given the central role of Hic1tdTomato SPCs as key regulators of BBB integrity we hypothesized that alterations in this cell population might contribute to the vascular defects observed in AD To address this we observed Hic1tdTomato cells in the APPPS1 mouse model In the absence of AD cortical areas of 8 and 20monthold animals displayed stable Hic1 tdTomato cell coverage and somata numbers Fig 2AB In contrast both parameters were significantly reduced in agematched 8 and 20monthold APPPS1 animals Fig 2C indicating that AD pathology directly affects Hic1tdTomato SPCs To assess whether the decrease in Hic1tdTomato SPC somata and coverage was linked to vascular rarefaction vascular density was calculated by analysing the length of vessels per area of brain The results showed that vessel coverage of Podocalyxin expressing endothelial cells was unchanged in all animal groups Extended Fig 2AB Amyloid pathology drives robust sEH expression in cortical astrocytes To further investigate the mechanisms underlying SPC loss we examined the intercellular communication of astrocytes and SPCs as both cell types play essential roles in maintaining vascular stability Upregulation of astrocytic enzyme sEH has previously been implicated in vascular dysfunction and neurovascular unit instability813 Consistent with that we observed elevated sEH expression in cortical areas from APPPS1 mice compared to wildtype controls particularly in reactive astrocytes Extended Fig 3AC There was also a clear spatial association between cells with high sEH expression and A\\u03b2 deposits detected using MethoxyX04 Extended Fig 3DE Given our focus on the vasculature we examined the relationship between sEH expression and A\\u03b2 deposition along cerebral vessels This revealed consistently stronger astrocyte sEH immunoreactivity close to vessels in APPPS1 mice in comparison to agematched controls Fig 3A The most striking finding was that sEH expression was particularly high around CAA which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license burdened hFTAA vessels Podocalyxin versus nonburdened vessels in the same animal Fig 3BC suggesting a direct link between CAA and sEH upregulation Vascular amyloidosis is associated with loss of arteriolar Hic1 tdTomato cells Next we sought to determine whether the observed Hic1tdTomato SPC loss was spatially linked to CAA When comparing Hic1tdTomato SPC coverage on CAA burdened CAA and unburdened arterioles CAA we found that Hic1tdTomato SPC numbers were significantly reduced on CAA arterioles while Hic1tdTomato SPC coverage was similar on CAA arterioles from APPPS1 mice compared to wildtype controls Fig 4AB To determine the physiological impact of arteriolar CAA accumulation we assessed vasomotion in CAA and wildtype mice arterioles and detected a significant reduction in the maximum amplitude of vasomotion frequency in CAA arterioles compared to controls Fig 4CE Thus vascular amyloidosis has a direct negative effect on spontaneous vascular contractions Together our findings identified coincident A\\u03b2associated upregulation of sEH loss of Hic1tdTomato SPCs and impaired vascular integrity Impact of astrocytic deletion of sEH in APPPS1 mice To demonstrate cause and effect and make a functional link between sEH and the vascular pathology characterized by SPCs APPPS1 mice were crossed with inducible astrocytespecific sEH knockout mice generating APPPS1 x Ephx2 flox x Aldh1l1CreERT2 herein referred to as APPPS1xsEH\\u0394AC To determine whether astrocytic sEH contributes to the pathogenesis of AD tamoxifen was administered to 45weekold mice ie before the onset of A\\u03b2 deposition and amyloidosis was studied at 9 months of age Given the distinct roles of dense core plaques and diffuse amyloid depositions in AD pathology26 we quantified both forms through histological analysis to assess potential differences in A\\u03b2 burden Our analysis showed that astrocytic specific sEH deletion led to a dramatic over 60 reduction in dense core plaques as well as a more subtle but still significant decrease in diffuse amyloid Fig 5AB Overall A\\u03b2 burden in the APPPS1xsEH\\u0394AC mice was significantly reduced Fig 5C indicating that the deletion of astrocytic sEH had a robust influence on A\\u03b2 deposition in this model Most importantly beyond parenchymal plaques CAA which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license burden on vessels was dramatically reduced by over 65 in APPPS1xsEH\\u0394AC when compared to APPPS1 mice Fig 5D A\\u03b2 plaques are closely associated with dystrophic neurites which are indicators of neuronal dysfunction and degeneration27 Given the observed reduction in A\\u03b2 burden we next investigated whether sEH deletion could mitigate neuronal injury Indeed we detected a 3011 reduction in amyloid precursor protein APP a marker for neuronal injury around amyloid plaques in APPPS1xsEH\\u0394AC indicating that astrocytespecific deletion of sEH has profound therapeutic effects on both amyloid burden and amyloiddriven neurotoxicity Extended Fig 4AC To further dissect the pathway by which astrocytespecific sEH deletion can lead to a decrease in A\\u03b2 load we analyzed APP processing however we found it to be unaffected Extended Fig 5AB We then looked at LRP1 because it is a main transporter responsible for the efflux of A\\u03b2 across the BBB and its upregulation has been associated with enhanced A\\u03b2 clearance from the brain28 Given its involvement in A\\u03b2 metabolism and vascular health2931 we hypothesized that the reduction in A\\u03b2 could be caused by increased levels of LRP1 expression Using wholebrain lysates we were able to detect a significant increase in LRP1 expression in APPPS1xsEH\\u0394AC mice Extended Fig 5C indicating that the observed reduction in A\\u03b2 burden is at least partially caused by increased clearance via LRP1 Deletion of astrocytespecific sEH increases vascular integrity in APPPS1 mice Our findings suggested that the A\\u03b2induced upregulation of the sEH in astrocytes and CAA leads to Hic1tdTomato SPC loss and vascular dysfunctionBBB breakdown To test this we assessed relative VEcadherin concentration32 a key protein in maintaining vascular integrity While APPPS1 mice showed a significant 3295 reduction in relative VEcadherin concentration compared to wildtype controls APPPS1xsEH\\u0394AC mice exhibited only a 227 reduction Fig 6AB These results reveal a substantial preservation of vessel stability in APPPS1xsEH\\u0394AC mice suggesting that astrocytic sEH deletion provides a protective effect despite the presence of A\\u03b2 pathology which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Viral overexpression of sEH induces BBB disruption and vascular cell loss To provide a stronger mechanistic link between sEH and BBB dysfunction and to exclude additional effects of AD pathology a viral vector was used to locally overexpress the sEH in astrocytes of wildtype mice The AAV9ssgfaABC1DsEH2PAEGFP viral vector used contained a gfaABC1D promotor region to facilitate the selective targeting of astrocytes Controls animals underwent identical procedure and were treated with a control AAV9ssgfaABC1DEGFP virus This control virus shared the same promoter and reporter gene so that the target regions could be identified and the assessment of mechanical disruption of the injection could be accounted for in the analysis The bicistronic expression of sEH and eGFP facilitated the visualization of sEH overexpression In the viral target region a 7732 local reduction of relative VEcadherin concentration was observed when compared to the contralateral region Fig 7AB This magnitude of reduction was not detected in sham mice injected with control virus where there was only a 544 reduction in relative VEcadherin concentration between the target region and the contralateral side Extended Fig 6AC Collectively the preservation of VEcadherin in the APPPS1xsEH\\u0394AC mice and the localized reduction of VEcadherin in wildtype mice transduced to overexpress sEH in localized areas provide compelling evidence that sEH significantly contributes to compromised BBB integrity in AD In line with our observations of SPC loss in APPPS1 mice we also detected a significant loss in Hic1tdTomato cells within the viral target region in wildtype mice compared to the contralateral side Fig 7CD In regions close to sEH expressing cells there was a 2963 reduction of Hic1 tdTomato compared to the contralateral side but only a 459 reduction of Hic1tdTomato in the viral target region in mice injected with control virus Extended Fig 6BD This result underscores a striking correlation between sEH upregulation and vascular dysfunction To determine a causal relationship between sEH modulation and the resultant loss of Hic1 tdTomato cells in both the APPPS1 model and the viral overexpression experiments we conducted a migration assay using 1920DHDP a diol produced generated by the sEH3334 that can stimulate pericyte migration8 Previously published data indicate that 1920DHDP influences pericytes and perivascular fibroblasts which make up 608 and 178 of our Hic1tdTomato which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license SPC population respectively by inducing a morphological shift towards a migratory phenotype 825 Indeed treating Hic1tdTomato SPCs with 1920DHDP for 16 hours Fig 7EF had a significant impact on the migration of SPCs in vitro These results allowed us to conclude that sEH activity can precipitate Hic1tdTomato SPC loss in the absence of any underlying disease state or existing pathologyprepathology Transcriptomic profile of APPPS1xsEH\\u0394AC vessels reveal vascular resilience Next spatial RNA sequencing was performed to gain deeper insight into the transcriptomic differences in APPPS1xsEH\\u0394AC close to the vasculature Our findings reveal a coordinated upregulation of genes associated with vascular stability and neuronal protection Of the differentially expressed genes we found four that were particularly important for vascular stability neuroprotection and immune responseGlial cell linederived neurotrophic factor Gdnf35 Sushi Von Willebrand Factor Type A EGF And Pentraxin Domain Containing 1 Svep13637 Protocadherin 12 or VEcadherin2 Pcdh1238 and chemokine ligand 1 Cxcl139 All of these genes were upregulated in the vessels from APPPS1xsEH\\u0394AC versus APPPS1 mice Fig 8AB Specifically Gdnf which encodes GNDF one of the most potent neuroprotectants for dopaminergic neurons40 was upregulated in APPPS1xsEH\\u0394AC vessels Fig 8B This finding was particularly relevant as GDNF also contributes to the maintenance of endothelial barrier function4142 suggesting a dual role in both neuronal and vascular protection The upregulation of Pcdh12 which encodes for VEcadherin2 further contributes to vascular integrity through its superior aggregation properties compared to conventional VEcadherin43 Svep1 is involved in immune response regulation by modulating vascular permeability through endothelial remodeling processes44 Additionally Cxcl1 promotes endothelial cell survival and supports barrier function by stimulating endothelial repair mechanisms through enhanced endothelial cellcell interactions and cytoskeletal reorganization45 Beyond its vascular effects Cxcl1 coordinates inflammatory response via recruitment of neutrophils and other immune cells46 The upregulation of these genes suggests that the deletion of sEH in astrocytes may trigger an adaptive or protective response in the vasculature restoring vascular integrity through immune modulation Rescue of vasomotion in APPPS1xsEH\\u0394AC mice which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Remarkably assessment of cerebrovascular dynamics in APPPS1xsEH\\u0394AC mice revealed a striking preservation of vasomotion Fig 8C While control APPPS1 mice exhibited profound impairment in vasomotion the genetic ablation of astrocytic sEH appeared to fundamentally improve this process Even though we observed CAA occurrence on some vessels at later ages APPPS1xsEH\\u0394AC mice maintain superior functional integrity and resilience compared to APPPS1 mice These findings highlight the potential of sEH inhibition as a therapeutic strategy capable of persevering neurovascular coupling even in the context of established amyloid pathology Discussion Our findings reveal that BBB dysfunction in AD is closely linked to sEHdriven Hic1cell loss and impaired vasomotion particularly in vascular regions harboring A\\u03b2 deposits Accordingly we observed that CAAcharacterized by the accumulation of A\\u03b2 in vessel walls strongly correlates with these pathological changes underscoring that localized vascular A\\u03b2 burden directly contributes to BBB impairment in AD Furthermore we reveal a spatially regulated mechanism through which A\\u03b2 associated sEH upregulation around CAA drives BBB breakdown through loss of Hic1cells and VEcadherin reduction causing pathological structural alterations to the vasculature In APPPS1 mice we observe chronic vascular issues such as vascular leakage unstable BBB and diseaserelated reduced Hic1cell coverage similar to those seen in patients with AD47 Moreover we observed robust sEH expression in the cortical area that is not observed in the wildtype condition Notably sEH upregulation is most pronounced around CAAburdened vessels where it coincides with a marked reduction of Hic1cells Given that Hic1 cells serve a primary role in maintaining BBB integrity this spatial relationship suggested a potential casual mechanism between sEH activity and vascular dysfunction We speculate that lipid metabolism mediated by sEH may impact vascular stability as shown previously in models of diabetic retinopathy8 Specifically the metabolic byproduct 1920 dihydroxydocosapentaenoic acid 1920DHDP has been shown to displace VEcadherin from endothelial cell junctions via incorporation into lipid rafts ultimately leading to pericyte loss Consistent with this hypothesis our in vitro experiments revealed that 1920DHDP induces migration of Hic1 offering mechanistic insight into our reported findings AD affects multiple which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license cell types making it challenging to isolate a single mechanism of action To circumvent the potential confounding effects of AD pathology on our target cells in vivo we employed viral overexpression of astrocytic sEH in wildtype mice to investigate its specific role in the absence of diseaserelated influences With this experiment we demonstrate that local sEH overexpression alone was enough to lead to a localized loss of Hic1 cells and disruption of the junctional protein VEcadherin contributing to BBB dysfunction Hence these findings directly implicated sEH activity in vascular destabilization independent of AD pathology As our data demonstrate increased sEH expression during AD progression is spatially associated with amyloid deposition whether in the parenchyma or along vessel walls thereby initiating the described mechanistic pathway We thus hypothesized that suppressing sEH activity has the potential to rescue the observed vascular dysfunction in APPPS1 mice To test this we generated an astrocyte specific sEH knock out model crossed with APPPS1 mice APPPS1xsEH\\u0394AC This data indeed showed that genetic ablation of astrocytic sEH alone is sufficient to preserve vascular stability even in the presence of ongoing AD pathology This stabilization allows for the sustained integrity of the BBB evident by the preservation of VEcadherin Our findings confirm that the observed pathological alterations are driven by sEH activity and not by other potential ADrelated mechanisms or downstream effects and that targeted removal of sEH can effectively rescue vascular function despite AD pathology These findings provide compelling evidence that astrocytic sEH is a key regulator of vascular integrity underscoring the promise of it being a therapeutic target for mitigating vascular dysfunction Even more compelling is the association of reduced A\\u03b2 burden in APPPS1xsEH\\u0394AC mice that we show is due to enhanced clearance via transport across the BBB by LRP1 which has increased protein levels in APPPS1xsEH\\u0394AC mice48 However in addition to the increase in potential transport of A\\u03b2 across the BBB via LRP1 we cannot rule out the contribution of additional mechanisms influencing A\\u03b2 dynamics such as altered glial activity or changes to other perivascular clearance pathways In addition to the vascular alterations we show that sEH is involved in inflammationrelated pathological processes given its colocalization with reactive astrocytes sEH metabolizes EETs key lipid mediators which stunt proinflammatory pathways and cytokineinduced endothelial activation33 Beyond depleting these protective molecules sEH upregulation has been associated with increased expression of adhesion molecules such as VCAM1 and ICAM1 which enhances which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license leukocyte adhesion and infiltration of immune cells3349 While this response is beneficial in a healthy condition facilitating immune surveillance and tissue repair in diseases like AD where we show that injury response is blunted this can impede normal cellular functions and contribute to the disease progression Reduced relative VEcadherin concentration and Hic1 cell loss compromises BBB integrity and could contribute to chronic neuroinflammation and in turn A\\u03b2 accumulation by further impairing its clearance from the brain and allowing peripheral inflammatory factors to enter actively driving deposition Our results show that sEH inhibition is a viable therapeutic strategy not only due to the reduction of A\\u03b2 burden shown in this study but also because it promotes the stability of the neurovascular unit Most interestingly vasomotion analyses revealed that genetic ablation of astrocytespecific sEH maintained proper vascular function when compared to APPPS1 mice demonstrating that sEH deletion allows for functional protection to the cerebral vasculature despite the AD pathology Notably although some CAA coverage is observed in older APPPS1xsEH\\u0394AC mice this does not appear functionally relevant as vasomotion is restored This preservation of vascular function likely stems from increased LRP1 expression which enhances amyloid beta clearance These findings may reflect a temporal shift of CAA onset in APPPS1xsEH\\u0394AC mice or possibly protective alterations in A\\u03b2 maturation state that preserve vascular activity We and others have found that CAA predominantly compromises arterioles50 the vessels responsible for vasomotion Extended Fig7AB Notably we observe a clear correlation between vasomotion dysfunction and CAA occurrence Given that vasomotion modulates cortical blood flow at resting state by about 20 these findings carry exceptional importance for the impact on brain health51 The therapeutic implications of these findings extend beyond basic neurovascular mechanisms and offer potential solutions to critical limitations in current AD treatment paradigms Currently anti amyloid antibody therapies present a promising future in AD management however their application is substantially restricted by safety concerns especially among patients with cerebrovascular risk factors such as the presence of CAA or APOE \\u01904 alleles due to their increase risk of AmyloidRelated Imaging Abnormalities ARIA which can cause headaches confusion seizures and even hemorrhages5256 Our results show that sEH inhibition preserves vascular integrity and function even in vessels affected by CAA By pharmacologically targeting sEH it may be possible to fortify the NVU against the destabilizing effects of antiamyloid antibodies Such an approach could potentially expand the therapeutic window for treatment interventions to which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license include previously excluded populations Our study provides strong evidence that administering an sEH inhibitor in conjunction with current A\\u03b2 amyloid interventions could aid in the efficiency of the drugs while also reducing the risk of ARIA through increasing the integrity of NVU In summary we have identified a pivotal role of sEH in the AD pathology We show that genetic ablation of astrocytespecific sEH in our AD model preserves vascular stability mitigates A\\u03b2 burden and alleviates associated neuronal injury Conversely we have found that in otherwise healthy mice sEH overexpression causes a localized reduction of VEcadherin as well as Hic1 cell loss These findings underscore the importance of sEH in NVU dynamics and therefore the importance of regulating sEH activity in maintaining vascular homeostasis This strongly highlights sEH inhibition as a potential earlyintervention therapy for AD and that it could also enhance the effectiveness of current therapies by improving BBB integrity and NVU resilience potentially lowering the risk of ARIA Figure 1 Cerebral amyloidosis impairs capillary repair upon microbleeds A Representative pictures of a lost upper image and recovered lower image capillary portraying the ROIs before after and 28 days after the microbleed indicated by arrowhead Scale bar 20 \\u03bcm B Pie charts displaying the percentages of lost and recovered vessels in Hic1tdTomato APPPS1 and Hic1 tdTomato mice Hic1tdTomato APPPS1 animals have significantly less capillary recovery following microbleed compared to Hic1tdTomato mice Figure 2 SPC loss in the capillary bed in a model of cerebral amyloidosis A Representative images showing the Hic1tdTomato cell signal in the mouse cortex in different ages in control and diseased mice Zoomed in images highlight the reduction in cell coverage and Hic1tdTomato somata Scale bar 100 \\u03bcm zoomed in scale bar 50 \\u03bcm B Number of Hic1tdTomato somata was unchanged in normal aging showing a significant reduction in number in the disease model in both age groups C Aging did not affect Hic1tdTomato cell coverage however cerebral amyloidosis resulted in a significant reduction in SPCs in the cortical area 8 months Hic1 tdTomato n5 mice 8 months Hic1tdTomato APPPS1 n5 mice 20 months Hic1tdTomato n4 mice 20 months Hic1tdTomato APPPS1 n4 mice Ordinary oneway ANOVA \\u0160\\u00edd\\u00e1ks multiple comparisons p 001 p 0001 p 00001 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Figure 3 sEH expression increases around CAAburdened vessels A APPPS1 mice have higher sEH immunoreactivity around vessels compared to agematched controls n 3 Ordinary oneway ANOVA p 005 p 0001 BC CAAburdened vessels are associated with sEH immunoreactivity when compared to CAAnegative vessels n 3 twotailed unpaired ttest p 005 Figure 4 CAA associated with tdTomato cell loss at 8 months A Representative images showing arterioles green Hic1tdTomato cells red and CAA white in 8month Hic1 tdTomato and Hic1tdTomato APPPS1 CAA and CAA Scale bar 5 \\u03bcm B CAA vessels have reduced Hic1tdTomato somata coverage in comparison to CAA vessels and control Hic1 tdTomato control n 12 vessels 5 mice Hic1tdTomato APPPS1 CAA n16 vessels 5 mice Hic1tdTomato APPPS1 CAA n18 vessels 5 mice Ordinary oneway ANOVA \\u0160\\u00edd\\u00e1ks multiple comparisons p 001 p 00001 C Representative figure of one of the ROIs analyzed for vasomotion Scale bar 20 \\u03bcm D Significantly different maximum amplitude of vasomotion 01Hz between wildtype and CAA vessels from APPPS1 animals Wildtype n 14 vessels 4 mice APPPS1 CAA n 13 vessels 3 mice Twotailed unpaired ttest p 001 E Representative power spectral density graphs from a wildtype and an APPPS1 mouse Notice the smaller amplitude of the peaks around 01Hz in the APPPS1 mouse yellow rectangle Figure 5 Knocking sEH out in APPPS1 mice has a neuroprotective effect by significantly reducing amyloid plaque burden and CAA A Representative images of amyloid burden reduction between APPPS1xsEH\\u0394AC and APPPS1 mice B When crossbreeding an astrocyte specific sEH knock out mouse with the APPPS1 mouse a significant reduction in diffused amyloid hFTAA green and dense amyloid MethoxyX04 blue can be observed n 4 Ordinary one way ANOVA p 005 p 00001 CD Not only is there a significant reduction in plaque covered area but there is also a significant reduction in overall plaque numbers n 4 two tailed unpaired ttest 005 E Most significantly there is a decrease in CAA occupied area n 4 twotailed unpaired ttest p 005 Figure 6 Knocking out sEH increases vascular integrity in AD mice AB Relative VE cadherin concentration has a significant reduction in APPPS1 mice however there is a pronounced protective effect on vascular integrity when sEH is knocked out as evidenced by the absence of which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license discernible differences between the knockout model and the wildtype mouse n 4 Ordinary one way ANOVA p 005 Figure 7 Overexpression of sEH is associated with BBB disruption AB Relative VE cadherin cyan concentration was reduced within the viral region VR green n 3 onetailed paired ttest p 005 CD There is Hic1tdTomato cell loss red on vessels blue in VR n 4 onetailed paired ttest p 005 E Schematic of migration assay used with Hic1 tdTomato cells F Isolated Hic1tdTomato cells were treated with 3 \\u03bcM of 1920DHDP for 16 hours causing a significant amount of migration in vitro compared to vehicle control n 4 two tailed ratio paired test p 0005 Figure 8 Transcriptomic profile of vessels altered in APPPS1xsEH\\u0394AC mice compared to APPPS1 mice A Representative image of vessel selection using RNA spatial sequencing B Heat map of spatial sequencing data shows that DEGs between vessels of APPPS1 mice and vessels of APPPS1xsEH\\u0394AC mice C Vasomotion is preserved in APPPS1xsEH\\u0394AC mice when compared to APPPS1 and wildtype mice Wildtype n 14 vessels 4 mice APPPS1 n 18 vessels 5 mice APPPS1xsEH\\u0394AC n 18 vessels 6 mice Twoway ANOVA Tuckeys multiple comparisons p 001 Data availability Any additional requests for data should be addressed to Prof Jasmin Hefendehl hefendehlbiounifrankfurtde Funding MD received funding from Josef Buchmann PhD Starter Scholarship JKH received funding from the Deutsche Forschungsgemeinschaft DFG German Research Foundation 4b03813475 419157387 Emmy Noether Award HE 686731 SFB 1531 Projektnummer 456687919 the Alzheimers Association AARF17529810 and the Alzheimer Forschung Initiative eV 20041 BMBF FK01EW2308A NeuronERANET CardioPulmonary Institute CPI EXC 2026 Project ID 390649896 and CRC1080 to Prof Dr Amparo AckerPalmer 221828878 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license Competing interests The authors declare no competing interests References 1 Cai Z Qiao P Wan C Cai M Zhou NK Li Q Role of BloodBrain Barrier in Alzheimers Disease Journal of Alzheimers disease JAD 201863 412231234 doi103233JAD180098 2 Chen Y He Y Han J Wei W Chen F Bloodbrain barrier dysfunction and Alzheimers disease associations pathogenic mechanisms and therapeutic potential Front Aging Neurosci 2023151258640 doi103389fnagi20231258640 3 Alzheimers disease A matter of bloodbrain barrier dysfunction Journal of Experimental Medicine 20172141131513169 doi101084JEM20171406 4 Greene C Hanley N Campbell M Bloodbrain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders Transl Psychiatry 2020101373 doi101038s41398020010543 5 van de Haar HJ Burgmans S Jansen JFA et al BloodBrain Barrier Leakage in Patients with Early Alzheimer Disease Radiology 20162812527535 doi101148radiol2016152244 6 Armulik A Genov\\u00e9 G M\\u00e4e M et al Pericytes regulate the bloodbrain barrier Nature 20104687323557561 doi101038nature09522 7 Uemura MT Maki T Ihara M Lee VMY Trojanowski JQ Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia Front Aging Neurosci 20201280 doi103389fnagi202000080 8 Hu J Dziumbla S Lin J et al Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy Nature Published online December 1 2017 doi101038nature25013 9 Yu D Hennebelle M Sahlas DJ et al Soluble Epoxide HydrolaseDerived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment Transl Stroke Res 2019105522533 doi101007s1297501806725 10 Davis CM Zhang WH Bah TM et al Agedependent cognitive impairment hydrocephalus and leukocyte infiltration in transgenic mice with endothelial expression of human EPHX2 NPJ Aging 2022819 doi101038s41514022000901 11 Yu D Liang N Zebarth J et al Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins Small Vessel Disease Markers and Neurodegeneration in Stroke J Am Heart Assoc 2023121e026901 doi101161JAHA122026901 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license 12 Anita NZ Herrmann N Ryoo SW et al Cytochrome P450soluble epoxide hydrolase oxylipins depression and cognition in type 2 diabetes J Diabetes Complications 2024389108826 doi101016jjdiacomp2024108826 13 Tang C Border JJ Zhang H et al Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimers disease and diabetesrelated dementia rat models Geroscience Published online February 4 2025 doi101007s11357025015508 14 Wang S Qi C Rajpurohit C et al Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model Mol Neurodegener 20252044 doi101186s1302402500844x 15 Fang X Border JJ Zhang H et al A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction Neuroinflammation Amyloid Burden and Cognitive Impairments in the hAPPPS1 TgF344AD Rat Model of Alzheimers Disease Int J Mol Sci 20252662433 doi103390ijms26062433 16 Ghosh A Comerota MM Wan D et al An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimers disease Sci Transl Med 202012573eabb1206 doi101126scitranslmedabb1206 17 S\\u00f6derberg L Johannesson M Gkanatsiou E et al Amyloidbeta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloidrelated imaging abnormalities Sci Rep 202414110868 doi101038s41598024616912 18 Lowery RL Majewska AK Intracranial Injection of Adenoassociated Viral Vectors J Vis Exp 2010452140 doi1037912140 19 Hefendehl JK WegenastBraun BM Liebig C et al Longterm in vivo imaging of \\u03b2amyloid plaque appearance and growth in a mouse model of cerebral \\u03b2amyloidosis J Neurosci 2011312624629 doi101523JNEUROSCI5147102011 20 Schnitzbauer J Strauss MT Schlichthaerle T Schueder F Jungmann R Superresolution microscopy with DNAPAINT Nat Protoc 201712611981228 doi101038nprot2017024 21 Rosenegger DG Tran CHT LeDue J Zhou N Gordon GR A high performance costeffective open source microscope for scanning twophoton microscopy that is modular and readily adaptable PLoS One 2014910e110475 doi101371journalpone0110475 22 Hefendehl JK Milford D Eicke D et al Repeatable target localization for longterm in vivo imaging of mice with 2photon microscopy Journal of Neuroscience Methods 20122052357363 doi101016jjneumeth201110029 23 Niemisto A Dunmire V YliHarja O Wei Zhang Shmulevich I Robust quantification of in vitro angiogenesis through image analysis IEEE Trans Med Imaging 2005244549553 doi101109TMI2004837339 24 van Veluw SJ Hou SS CalvoRodriguez M et al Vasomotion as a driving force for paravascular clearance in the awake mouse brain Neuron 20201053549561e5 doi101016jneuron201910033 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license 25 Bernier LP Hefendehl JK Scott RW et al Brain pericytes and perivascular fibroblasts are stromal progenitors with dual functions in cerebrovascular regeneration after stroke Nat Neurosci 2025283517535 doi101038s4159302501872y 26 Li JJ Dolios G Wang R Liao FF Soluble BetaAmyloid Peptides but Not Insoluble Fibrils Have Specific Effect on Neuronal MicroRNA Expression PLoS ONE 201493e90770 doi101371journalpone0090770 27 Grace EA Rabiner CA Busciglio J Characterization of neuronal dystrophy induced by fibrillar amyloid \\u03b2 implications for Alzheimers disease Neuroscience 20021141265273 doi101016S0306 452202002415 28 Storck SE Meister S Nahrath J et al Endothelial LRP1 transports amyloid\\u03b2142 across the blood brain barrier J Clin Invest 20161261123136 doi101172JCI81108 29 Laudati E Gilder AS Lam MS et al The activities of LDL Receptorrelated Protein1 LRP1 compartmentalize into distinct plasma membrane microdomains Molecular and Cellular Neuroscience 2016764251 doi101016jmcn201608006 30 Van Gool B Storck SE Reekmans SM et al LRP1 Has a Predominant Role in Production over Clearance of A\\u03b2 in a Mouse Model of Alzheimers Disease Mol Neurobiol 2019561072347245 doi101007s1203501915942 31 Xu G Green CC Fromholt SE Borchelt DR Reduction of lowdensity lipoprotein receptorrelated protein LRP1 in hippocampal neurons does not proportionately reduce or otherwise alter amyloid deposition in APPswePS1dE9 transgenic mice Alzheimers Research Therapy 20124212 doi101186alzrt110 32 Cao J Schnittler H Putting VEcadherin into JAIL for junction remodeling Journal of Cell Science 20191321jcs222893 doi101242jcs222893 33 Morisseau C Hammock BD Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health Annual review of pharmacology and toxicology 20125337 doi101146annurevpharmtox 011112140244 34 Imig JD Hammock BD Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Nat Rev Drug Discov 2009810794805 doi101038nrd2875 35 Barker RA Bj\\u00f6rklund A Gash DM et al GDNF and Parkinsons Disease Where Next A Summary from a Recent Workshop J Parkinsons Dis 103875891 doi103233JPD202004 36 Chen L Liu D Yi X et al The novel miR1269bregulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3KAkt pathway Cell Death Dis 2020115320 doi101038s4141902025358 37 Elenbaas JS Pudupakkam U Ashworth KJ et al SVEP1 is an endogenous ligand for the orphan receptor PEAR1 Nat Commun 2023141850 doi101038s41467023364860 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license 38 Bei J MirandaMorales EG Gan Q et al Circulating exosomes from Alzheimers disease suppress VE cadherin expression and induce barrier dysfunction in recipient brain microvascular endothelial cell bioRxiv Preprint posted online April 6 202320230403535441 doi10110120230403535441 39 Silva RL Lopes AH Guimar\\u00e3es RM Cunha TM CXCL1CXCR2 signaling in pathological pain Role in peripheral and central sensitization Neurobiology of Disease 2017105109116 doi101016jnbd201706001 40 Yasuhara T Shingo T Date I Glial cell linederived neurotrophic factor GDNF therapy for Parkinsons disease Acta Medica Okayama 20076125156 41 Igarashi Y Utsumi H Chiba H et al Glial Cell LineDerived Neurotrophic Factor Induces Barrier Function of Endothelial Cells Forming the BloodBrain Barrier Biochemical and Biophysical Research Communications 19992611108112 doi101006bbrc19990992 42 Kanjanasirirat P Saengsawang W Ketsawatsomkron P et al GDNF and cAMP significantly enhance in vitro bloodbrain barrier integrity in a humanized tricellular transwell model Heliyon 20241020e39343 doi101016jheliyon2024e39343 43 Telo P Breviario F Huber P Panzeri C Dejana E Identification of a Novel Cadherin Vascular Endothelial Cadherin2 Located at Intercellular Junctions in Endothelial Cells Journal of Biological Chemistry 1998273281756517572 doi101074jbc2732817565 44 Ferreira CS Da Silva AT Brustolini OJB et al Immune and vascular modulation by HERVs the role of CXCR1 and IL18RAP in dengue severity progression Front Immunol 2025161557588 doi103389fimmu20251557588 45 Han Y Dong Y Li X et al CXCL1 induces the contraction of endothelial cytoskeleton and increases permeability in mouse cerebral endothelium bEND3 cells by promoting protein kinase B phosphorylation Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2023392117123 46 Girbl T Lenn T Perez L et al Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis Immunity 201849610621076e6 doi101016jimmuni201809018 47 Shi H Koronyo Y Rentsendorj A et al Identification of early pericyte loss and vascular amyloidosis in Alzheimers disease retina Acta Neuropathol 20201395813836 doi101007s0040102002134 w 48 Liu CC Hu J Zhao N et al Astrocytic LRP1 Mediates Brain A\\u03b2 Clearance and Impacts Amyloid Deposition J Neurosci 2017371540234031 doi101523JNEUROSCI3442162017 49 Zhang D Xie X Chen Y Hammock BD Kong W Zhu Y Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo Circulation research 20121106808 doi101161CIRCRESAHA111259325 50 Vinters HV Cerebral amyloid angiopathy A critical review Stroke 1987182311324 doi10116101STR182311 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license 51 Broggini T Duckworth J Ji X et al Longwavelength traveling waves of vasomotion modulate the perfusion of cortex Neuron 20241121423492367e8 doi101016jneuron202404034 52 Premkumar DR Cohen DL Hedera P Friedland RP Kalaria RN Apolipoprotein Eepsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimers disease Am J Pathol 1996148620832095 53 Jucker M Walker LC Alzheimers disease From immunotherapy to immunoprevention Cell 20231862042604270 doi101016jcell202308021 54 Iacobucci G Lecanemab Experts criticise European Commission approval of Alzheimers drug BMJ 2025389r796 doi101136bmjr796 55 Oeffentlichkeitsarbeit DA fuer P und The decision is incomprehensible Statements of DZNE experts on the refusal of Lecanemab by European Medicines Agency DZNE Accessed February 18 2025 statementsofdzneexpertsontherefusaloflecanemabbyeuropeanmedicinesagency 56 Foley KE Wilcock DM Three major effects of APOE\\u03b54 on A\\u03b2 immunotherapy induced ARIA Front Aging Neurosci 2024161412006 doi103389fnagi20241412006 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBY 40 International license\",\n          \"Introduction Alzheimers disease AD is the most prevalent form of neurodegeneration with ominous societal impacts The AD brain accumulates neurofibrillary tangles NFTs comprised of aggregated tau protein encoded by MAPT gene a core pathology centrally associated with the clinical manifestation Chang et al 2021 Wang and Mandelkow 2016 Among tauopathies neurodegenerative disorders that share excessive tau aggregation primary tauopathies are caused by the genetic predisposition of various MAPT mutations Goedert and Jakes 2005 A secondary tauopathy AD brains harbor abundant amyloid plaques and build up 38 times more tau protein than nondiseased controls leading to the development of NFTs containing non mutated tau Hu et al 2002 Khatoon et al 1992 Knopman et al 2021 Scheltens et al 2021 Yamamori et al 2007 Abundantly expressed in neurons tau primarily associates with and stabilizes microtubules and regulates various key neuronal processes Chang et al 2021 Wang and Mandelkow 2016 To investigate ADrelevant taudependent neurodegeneration we recently developed a cellular tauopathy model by overexpressing human tau hTau in mouse primary neurons Li et al 2024 This system allowed us to comprehensively assess neuronalintrinsic responses to wildtype hTau and enabled a direct comparison with frontotemporal lobar degeneration FTLDassociated mutant form Remarkably we observed heightened neurotoxicity triggered by wildtype hTau and revealed joined MAPKDLK signaling and DNA damage response in the degenerative process pertinent to AD Li et al 2024 Given the cellular complexity of the central nervous system CNS it is imperative to recapitulate the neurotoxic phenotype associated with nonmutated hTau in vivo In the brain glial cells especially microglia have been critically implicated in the pathogenesis of tauopathy as a result of mutant MAPT transgene overexpression Johnson and Lukens 2023 Parra Bravo et al 2024 Shi et al 2017 At this time the contribution of nonneuronal cells or factors to ADrelevant neurodegeneration instigated by wildtype hTau is unknown In this study we established a murine tauopathy with the AAV vectors used in our in vitro study to express human wildtype or P301L tau selectively in neurons in vivo We systemically characterized the histological structural cellular and molecular changes that occurred in the brains expressing these hTau forms Furthermore we assessed the functional requirement of microglia in wildtype hTauinduced neurodegeneration by applying this tauopathy model to Csf1rFIRE mice a transgenic mouse strain devoid of microglia Rojo et al 2019 This investigation confirmed a greater neurotoxic effect of wildtype over P301L hTau to the brain and demonstrated an essential role of microglia in the progression of ADrelevant taumediated neurodegeneration 3 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Results AAVmediated human tau expression in the mouse brain To establish a model of tau pathology in vivo we inoculated neonatal C57BL6J mice with AAV vectors containing different forms of human MAPT one with an early STOP codon preventing translation of tau protein AAVSTOP fulllength wildtype 2N4R form AAVTau and FTLDassociated P301L 2N4R mutant AAVP301L Tau Fig 1A At multiple timepoints positive expression of transgenic hTau was detected throughout the hippocampal formation as well as in some surrounding regions such as the cortex and subcortical regions like the thalamus Fig 1B Driven by the human SYN1 promoter Li et al 2024 hTau expression was confined to neurons Fig 1C Given the moderate dose of AAV inoculated between 1020 of hippocampal neurons expressed hTau whereas cortical neurons did so at a lower percentage Fig 1C Within neurons hTau was localized mostly to the soma with some expression in dendrites and axons as well Fig 1C Human tau protein undergoes posttranslational modifications at various sites to aggregate and form toxic species while eventually assembling into NFTs Dujardin et al 2020 Goedert and Jakes 2005 Guo et al 2017 Tracy and Gan 2018 Wesseling et al 2020 To gain understanding of pathological tau formation we assessed multiple histological markers of hyperphosphorylated tau ptau including pT205 AT8 which detects both pS202 and pT205 and MC1 which detects a conformational epitope within amino acids 312322 Robust expression of these markers was detected in multiple subregions of the hippocampal formation especially in the dentate gyrus Fig 1D the CA1 and the CA3 with both wildtype and P301L mutant tau and at all the time points assessed Taken together these results demonstrate a robust persistent and pathological tau expression from both wildtype and mutated MAPT sequences in multiple brain regions Brain pathologies induced by human tau To assess how wildtype and mutated tau affect the mouse brain on the macroscopic scale we first gathered brain weight data on a large cohort of animals harvested at different time points While no significant difference was noticed at 3 weeks there was a significant decrease in brain weight 67 brought by wildtype AAVTau at 6 weeks Fig 2A By contrast animals expressing P301L tau did not show brain weight changes at 3 weeks and only a very small 31 decrease at 6 weeks Fig S1A suggesting a less pathogenic impact by mutant tau protein despite comparable expression levels consistent with our findings in vitro Li et al 2024 Of note wildtype hTau expression in CNS had no impact on the body weight of the animals Fig S1B Because nonmutated tau has direct biological relevance to AD we decided to focus primarily on wildtype tau referred to throughout as Tau for the remainder of this study To examine the overall changes in brain structure brought by Tau we performed a nonbiased analysis via restingstate volumetric MRI on a cohort of mice 12 weeks after AAV inoculation 3D reconstruction of structural volumes revealed a significant increase 134 in total lateral ventricle volume and a concomitant decrease 122 in total hippocampal volume Fig 2B Ventricular enlargement is a prominent biomarker of AD progression and most neurodegenerative disorders Apostolova et al 2012 The hippocampus represents the utmost damaged brain region in AD and its dysfunction underlies the core feature of cognitive impairment SerranoPozo et al 2011 Therefore these findings signify a gross degenerative effect of wildtype human tau on the murine brain that is highly relevant to AD 4 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license We next examined cellular and molecular changes in tauexpressing animals at the histological level Using NeuN as a panneuronal marker we measured the density of neurons in the hippocampus specifically in CA1 and CA3 areas and other brain regions including layer V of the cortex While the cortex did not show a taudependent decrease in neuronal density at any age the CA1 and CA3 displayed progressive Taudependent neuron loss beginning at 6 weeks Fig 2C This observation is consistent with the abundant hTau and ptau expression in the hippocampus region and in line with the structural changes observed with brain weight and volumetric MRI We previously identified a functional synergy between DNA damage response and the DLKMAPK pathway in Tauinduced neurotoxicity on cultured primary neurons Li et al 2024 Phosphorylated histone variant H2AX \\u03b3H2AX is a core molecular marker of doublestrand DNA damage and repair Mah et al 2010 Staining for \\u03b3H2AX revealed neuronal nuclear foci indicating genomic DNA damage at a higher frequency in AAVTau animals compared to control in both the CA3 and cortex Fig 2D Phosphorylated by cJun Nterminal kinases JNKs cJun protein acts as a potent transcriptional factor downstream of MAP kinase signaling Bohmann et al 1987 In a similar manner CA1 CA3 and cortical neurons in AAVTau animals expressed a higher frequency of nuclear pcJun indicating activation of the DLKMAPK injury signaling Fig 2E Interestingly these pathways were elevated at 6 weeks but not at 3 weeks Fig S1C suggesting a delayed molecular response to early Tau expression in the brain Taken together these results demonstrate the toxic effect of wildtype human tau in mouse brains which potently infringes on brain structure reduces neuronal density in the hippocampus and activates intrinsic pathways involved in genomic stress and injury response Molecular alterations in hippocampal neurons brought on by nonmutated hTau To investigate specific molecular changes in neuronal populations during pathology induced by Tau we performed singlenucleus RNA sequencing snRNAseq on pooled hippocampi from animals receiving AAVSTOP or AAVTau at 6 weeks of age n3 per group A total of 39861 cells were sequenced After preprocessing steps including quality control and normalization see Methods 39568 cells with 22374 genes were kept for the downstream analysis Clustering with Seurat we detected 15 distinct cell clusters visualized by Uniform Manifold Approximation and Projection UMAP Fig S2A Using established marker genes Koutsodendris et al 2023 Wang et al 2024 six major cell types were identified in the tissue the most prominent among them by cell counts being neurons Other cell types in the dataset included oligodendrocytes oligodendrocyte precursor cells OPCs astrocytes microglia and vascular cells Fig 3A Remarkably AAVTau hippocampus tissue displayed a significant reduction in the neuron cell population by percent of total cells when compared with AAVSTOP Fig 3B a finding consistent with our structural and histological analyses Fig 2 We further interrogated the neuronal cells and came up with 10 subclusters Fig 3C Based on marker gene profiles they fell into four subtypes excitatory neurons from CA1 Ex_CA1 excitatory neurons from CA23 excitatory neurons from the dentate gyrus Ex_DG and inhibitory neurons Fig S2B Populational analysis revealed selective loss of Cluster 0 and Cluster 1 neurons corresponding to Ex_DG and Ex_CA1 respectively Fig 3D Pathway analysis on the differentially expressed genes between these neurons showed remarkable upregulation of multiple diseaserelated pathways such as Parkinsons Disease Alzheimers Disease and Pathways of neurodegeneration as well as cell death process such as Necroptosis in the affected neuronal subsets Fig 3EF In addition several calmodulin genes such as Calm1 Calm2 and CamK1d were differentially affected by wildtype tau in these hippocampal neurons implicating a profound effect of tau on neuronal calcium signaling Fig S2CD Thus snRNAseq analysis confirmed a 5 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license severe loss of hippocampal neurons by wildtype tau and identified molecular processes relevant to neurodegeneration in the neuronal populations Glial responses to nonmutated hTau It is well known that tau pathology is associated with a neuroinflammatory response manifesting in the brain as reactive gliosis Johnson and Lukens 2023 Parra Bravo et al 2024 GFAP astrocytes showed subtle increases most significantly in the CA1 field of the hippocampus as early as 3 weeks postinoculation with AAVTau Fig 4A While the complement pathway is activated in various neurological diseases the central component C3 a product of reactive astrocytes has been functionally implicated in the pathogenesis of tauopathy models overexpressing mutant hTau Litvinchuk et al 2018 Wu et al 2019 We found that hippocampal astrocytes displayed higher C3 expression in Tauexpressing brain at 6 weeks Fig 4B Microglia are brainresident immune phagocytes that fulfill a multitude of critical roles in the CNS Paolicelli et al 2022 Prinz et al 2019 Fairly subtle increases in Iba1 microglia were detected at 3 weeks of tau expression but more dramatic increases were evident by 6 weeks Fig 4C Activated microglia are a feature of the brains of tauopathy models overexpressing mutant hTau Johnson and Lukens 2023 Parra Bravo et al 2024 Likewise we observed elevated expression of microglial activation markers namely Clec7a Fig 4D and CD68 Fig 4E in the hippocampus by 6 weeks We also found examples of AT8 ptau localized within CD68 microglial vesicles Fig 4F indicating a continuous engulfment of Tau by microglia Our examination thus suggests an early astrocyte reaction followed by microglial activation in response to wildtype human tau expression in the rodent brain Resistance to hTauinduced hippocampal neurodegeneration in mice lacking microglia Depending on specific conditions microglia activation may be reactive protective restorative or pathogenic in the brain Paolicelli et al 2022 To examine the functional role of microglia in ADrelevant tauopathy we adopted the Csf1rFIRE line referred to here as FIRE which completely lacks microglia throughout the lifespan due to the ablation of a superenhancer element within the Csf1r gene Fig S3ARojo et al 2019 After inoculating AAVTau into FIRE mice we observed a significant rescue of brain weight loss in FIRE mice Fig 5A implying that microglia may be involved in neuronal deficits caused by Tau Indeed the neuronal density decreases seen in Tauexpressing wildtype animals especially in the CA1 were abrogated in the brains of FIRE mice Fig 5B These findings point to an essential role of microglia in mediating neurodegeneration induced by Tau To assess the impact of microglial processes on tauinduced alterations we examined a few other markers of neuronal processes namely pcJun which is a key molecule in the DLK MAPK stress pathway and Mef2c a master regulator of neuronal function that is associated with cognitive resilience in AD Barker et al 2021 Zhang and Zhao 2022 While increased pcJun was observed elevated in B6 animals expressing tau Fig 2E despite having no microglia FIRE mice expressing tau displayed similar levels of neuronal pcJun Fig 5C On the other hand we observed a trend of mild reduction of hippocampal Mef2c neuron density in B6 animals expressing Tau Fig 5D Fig S3B Maintained in a mixed C57BL6CBA background Rojo et al 2019 young FIRE mice held somewhat lower Mef2c neuronal densities in the hippocampus than their agematched B6 counterparts Fig 5D However Tau expression did not affect Mef2c neuron density in FIRE mice Fig 5D Taken altogether these data suggest that microglia play an essential role in the hippocampal neurodegenerative process prompted by wildtype hTau 6 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Tau and microgliamodulated neurodegeneration in the thalamus During examination we noticed a particularly concentrated expression of transgenic Tau in the thalamus Fig 1B In fact whereas the percentage of neurons in other areas that expressed the transgene were normally under 20 Fig 1C thalamic neurons expressed Tau at a level twice as frequently Fig S3C Within the thalamus Tau appeared to be expressed almost exclusively in excitatory neurons marked by CAMKII\\u03b1 whereas inhibitory neurons marked by PV were devoid of human tau Fig S3D Consistent with greater Tau expression the frequency of neurons displaying DNA damage in the form of \\u03b3H2AX expression and those with elevated pcJun were both significantly elevated Fig 5E surpassing other regions Figs 2DE In addition GFAP astrocytes were far more drastically induced in the thalamus while the level of Iba1 microglia was largely comparable to other regions Fig 5F Figs 4AC However no significant change of neuronal density was detected in the thalamus Figs 5G S3E a contrast to the hippocampal regions Fig 2C Thus thalamic neurons abundantly express Tau and display heightened stress response amidst significant gliosis yet without undergoing neurodegeneration in wildtype mice Given the profound ongoing gliosis we sought to determine the effects of microglia on Tauinduced cellular changes in the thalamus of FIRE mice Surprisingly thalamic neuronal cell density was significantly reduced in the absence of microglia Fig 5H Accompanying this the neuronal stress and injury marker pcJun was elevated among the thalamic neurons in FIRE 25 Fig 5I compared to wildtype animals 15 Fig 5E Additionally the overall population of Tauexpressing neurons was significantly increased in thalamus without microglia Fig 5J Altogether we have detected a prominent wildtype hTau expression in the thalamic neurons and uncovered an unexpected protective role of microglia in restraining Taumediated neurodegeneration in the thalamus 7 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Discussion By comparing neuronal expression of nonmutated versus FTLDrelated human tau in the mouse brain we have demonstrated a superior capacity of wildtype tau to induce neurodegeneration in vivo The findings align with our previous observations from primary neurons and highlight an ADrelevant taumediated pathogenesis that has not been sufficiently recognized and investigated Beyond neuronal intrinsic changes our results further demonstrated that glial responses accompanied the course of tauopathy with wildtype hTau and revealed contrasting roles of microglia in mediating or restraining neurodegenerative processes from different brain regions Unlike primary tauopathies AD patients possess higher levels of tau proteins in their brains without genetic mutations in the MAPT gene However rodents overexpressing FTLD related tau mutations are commonly used to model clinical AD tau pathology Qian et al 2024 Our finding that wildtype hTau induces severe degenerative sequelae over mutant tau on the brain especially the hippocampal region is consistent with recent reports Middleaged mice expressing AAVmediated wildtype hTau exhibited more profound brain atrophy than those expressing P301L mutant tau despite the latter accumulating higher tau protein aggregation Tetlow et al 2023 Further a direct comparison of transgenic mice genetically matched in overexpressing wildtype versus P301L hTau has revealed a greater pathogenicity of wildtype hTau which was accompanied by exaggerated tau hyperphosphorylation and early cognitive impairment Gamache et al 2020 Altogether these studies highlight the importance to establish an ADrelevant tauopathy model and delineate the underlying mechanism that is likely disease specific AD and other tauopathies affect distinct brain regions which results in diverging clinical presentations In AD tau pathology is commonly believed to initiate in the entorhinal cortex spread to limbic regions which includes the hippocampus and then migrate to the neocortex Arnsten et al 2021 Braak and Braak 1991 Our wildtype hTau model displays not only neuronal tau expression in the hippocampus but also together with signs of brain atrophy selective neuronal loss in the hippocampal areas Beyond the brain regions mentioned above thalamic neuropathology has been implicated in early AD R\\u00fcb et al 2016 Yadav et al 2024 Most recently S\\u00e1rk\\u00e1ny et al reported that tau filaments accumulated early and progressively inside the glutamatergic neurons at the anterodorsal thalamus of AD patients Aggleton et al 2016 Here we have uncovered abundant hTau expression enhanced stress response and elevated gliosis in the thalamus a regional pathology not present in transgenic models As increasingly recognized the thalamus critically participates in memory and cognitive functions via various network connections such as the Papez circuit Roy et al 2022 Yadav et al 2024 Therefore our hTau model offers a unique opportunity to dissect various aspects of ADrelevant tau pathology In primary neuronal cultures nonmutated hTau triggers neurotoxicity via synergistic MAPKDLK signaling and DNA damage response Li et al 2024 Yet characterization of in vivo neuronal wildtype hTau expression has revealed intriguing complex molecular and cellular events both neuronintrinsic and neuronextrinsic Wildtype hTau expression was sufficient to cause the accumulation of phosphorylated tau together with MAPKDLK signaling and DNA damage response in hippocampal neurons Our snRNAseq analysis validated the selective hippocampal neuronal loss and revealed the enrichment of pathways related to neurodegenerative diseases in the mostly affected excitatory neuron populations Tau upregulated the necroptosis pathway in both Ex_DG and Ex_CA1 neurons that were significantly diminished in numbers due to wildtype hTau expression Of note necroptosis was recently shown to play a central role in mediating the loss of human tangle neurons in an AD xenograft 8 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license model Balusu et al 2023 Moreover dysregulated neuronal calcium signaling by hTau is consistent with earlier findings that wildtype hTau induces memory deficits by calcineurin mediated inactivation of nuclear CaMKIVCREB signaling Yin et al 2016 Glia cells are increasingly recognized to play crucial roles in a wide range of neurological diseases especially neurodegeneration In the hippocampus expressing wildtype hTau we have detected an early astrocyte response followed by a subsequent microglial activation Moreover a robust glial reaction to wildtype hTau manifested in the thalamus These findings echo the early and persistent glial responses in transgenic mouse models expressing mutant tau Yoshiyama et al 2007 By examining FIRE mice we discovered that microglia seemingly exert contrasting regional functional influences while wildtype hTaumediated hippocampal neuronal loss decreased in the FIRE brain neuronal loss only incurred in the thalamus in the absence of microglia This process in part is comparable to mutant hTaumediated hippocampal degeneration fostered by aberrantly activated microglia Johnson and Lukens 2023 Shi et al 2017 Udeochu et al 2023 However microglias role in brain pathophysiology is highly complex In the lifelong absence of microglia FIRE mice offer a novel and valuable tool to investigate the function of these brain immune cells Intriguingly spontaneous agerelated thalamic degeneration such as atrophy and neuronal loss has been a prominent feature of aged FIRE mice Munro et al 2024 Crossed with a xenotolerant strain adult FIRE mice also display a selective pathology in the thalamus Chadarevian et al 2024 Comparatively the FIRE mice we examined were fairly young up to 6 weeks old Given the high Tau load and stress response in our model these observations indicate a key protective function of thalamic microglia in maintaining the viability of resident neurons which otherwise would be particularly vulnerable to neuropathological changes during brain aging or AD Taken together we have established an ADrelevant tauopathy model in young mice and uncovered neuronintrinsic and extrinsic responses associated with wildtype hTaumediated neurodegeneration These findings may inspire further research on the regional functions of microglia and the delineation of protective versus pathogenic roles of brain glia cells 9 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Acknowledgments This research was funded by the National Institute on Aging National Institutes of Health grant numbers AG057587 and AG074283 National Heart Lung and Blood Institute National Institutes of Health grant number HL15472003S1 National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health grant number DK12270803S1 BrightFocus ADR A20183775 Brown Foundation 2020 Healthy Aging Initiative and Pilot Grant support from UTHealth McGovern Medical School WC The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health We extend our gratitude to Dr Mathew BlurtonJones from the University of California Irvine for generously providing live FIRE mice Mingyi Lv for assistance with RNAseq analysis and Dr Michael Beierlein at UTHealth for advising thalamus biology We thank the technical support from the Cancer Prevention and Research Institute of Texas CPRIT RP240610 esp the work by Dr Xian Chen The schematic was created with BioRender Author contributions Conceptualization ERR and WC Methodology ERR QW SL and SH Formal analysis ERR QW KH ML and EE Resources JJH WL CP and XZ Writing original draft ERR and WC Writing review editing ERR and WC Visualization ERR QW and KH Validation YF and CJ Supervision WC Project administration WC Funding acquisition WC All authors have read and agreed to the manuscript Competing interests Nothing to declare 10 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Figure Legends Figure 1 A Schematic showing AAVmediated overexpression of transgenic human MAPT forms in neurons in vivo B Fluorescence microscopy images of brain sections from animals 6 weeks of age overexpressing transgenic human tau HT7 persisting into adulthood Scale bar 15 mm CTX cortex HPC hippocampus TH thalamus C Representative confocal image of HT7 total transgenic human tau expression in the CA1 of B6 mice scale bar 50 \\u00b5m with quantification of frequency of hTau neurons in multiple brain regions D Panel of antibodies targeting tau forms including total transgenic tau HT7 phosphotau pT205 AT8 and a conformational epitope MC1 expressed by either wildtype or P301L mutant tau constructs Representative images were taken from the dentate gyrus of animals from different time points Scale bars 50 \\u00b5m Figure 2 A Quantification of brain weight at various time points in animals overexpressing wildtype tau AAVTau compared to noncoding control vector AAVSTOP B 3D volumetric renderings of lateral ventricles top and hippocampi bottom from AAVTau and AAVSTOP animals at 3 months of age based on MRI images Quantification of these volumes is shown C Representative confocal images of NeuN neurons in three brain subregions at three time points after neonatal inoculation Scale bar 50 \\u00b5m Quantification of relative neuronal density in AAVTau compared to AAVSTOP animals by region and age D Representative confocal images of DNA damage in hippocampal neurons CA3 marked by nuclear \\u03b3H2AX foci Quantification of \\u03b3H2AX neurons in brain subregions at 6 weeks of age E Representative confocal images of DLK stress pathway in hippocampal neurons CA3 marked by nuclear pcJun signal Quantification of pcJun neurons in brain subregions at 6 weeks of age Figure 3 A UMAP plot of single nuclei isolated from hippocampi of AAVinoculated animals Cells clustered into six groups based on genome wide expression patterns B Cell counts expressed as a proportion in hippocampi of 6weekold animals injected with AAVSTOP and AAVTau C UMAP plot of single neuronal nuclei isolated from hippocampi of AAVinoculated animals showing 10 clusters of neurons 11 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license D Cell counts of neuronal subtypes expressed as a proportion among the 10 neuron clusters identified in hippocampi of 6weekold animals injected with AAVSTOP and AAVTau E Top 10 pathways KEGG most significantly regulated in cluster 0 neurons from AAVTau animals compared to AAVSTOP F Top 10 pathways KEGG most significantly regulated in cluster 1 neurons from AAVTau animals compared to AAVSTOP Figure 4 A Representative confocal images and quantification of GFAP astrocytes in brain subregions at 3 and 6 weeks of age in AAVTau compared to AAVSTOP animals Scale bar 100 \\u00b5m B Confocal images showing colocalized C3 signal within GFAP astrocytes at 6 weeks of tau expression Insets show isolated C3 channel Scale bar 10 \\u00b5m C Representative confocal images and quantification of Iba1 microglia in brain subregions at 3 and 6 weeks of age in AAVTau compared to AAVSTOP animals Scale bar 100 \\u00b5m D Confocal images showing colocalized Clec7a signal within Iba1 astrocytes at 6 weeks of tau expression Scale bar 10 \\u00b5m E Confocal images showing colocalized CD68 signal within Iba1 astrocytes at 6 weeks of tau expression Scale bar 10 \\u00b5m F A representative confocal image of several CA1 microglia expressing CD68 lysosomal vesicles AT8 tau aggregates can be seen within these vesicles arrowhead inside inset The highlighted vesicle is further enlarged and presented as an orthogonal projection at the right All scale bars 10 \\u00b5m Figure 5 A Quantification of brain weight at various time points in B6 and FIRE animals overexpressing wildtype tau compared to noncoding control vector B Quantification of relative neuronal density in B6 and FIRE animals overexpressing wildtype tau compared to noncoding control vector animals by region and age C Quantification of pcJun neurons in brain subregions at 6 weeks of age in both B6 and FIRE mice expressing Tau or control vector D Quantification of the frequency of Mef2cNeuN nuclei at 6 weeks of age in multiple regions from both B6 and FIRE mice expressing Tau or control vector See Fig S3B for representative images E Quantification of \\u03b3H2AX and pcJun neurons in the B6 thalamus at 6 weeks of age in AAV Tau compared to AAVSTOP animals F Quantification of GFAP astrocytes and Iba1 microglia in the B6 thalamus at 3 and 6 weeks of age in AAVTau compared to AAVSTOP animals 12 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license G Quantification of relative thalamic neuronal density under AAVTau compared to AAVSTOP expression in B6 animals by age See Fig S3E for representative images HI Quantification of relative thalamic neuronal density H and pcJun neurons I at 6 weeks in FIRE animals expressing AAVTau compared to AAVSTOP J Quantification of HT7 neuron percentage in thalamus of B6 and FIRE mice expressing AAV Tau Figure S1 A Quantification of brain weight at 3 and 6weeks postinoculation in animals overexpressing P301L mutant tau compared to noncoding control vector B Quantification of body weight at 3 6 and 12weeks postinoculation in animals overexpressing wildtype hTau compared to noncoding control vector C Quantification of pcJun neurons in brain subregions at 3 weeks of age in AAVTau compared to AAVSTOP animals Figure S2 A UMAP plots showing annotation of neuronal clusters with neuron type markers B Classification of major neuronal types including excitatory cells from CA1 CA23 and DG and inhibitory cells CD Volcano plot of gene expression changes in cluster 0 C and cluster 1 D neurons in 6 weekold AAVTau animals compared to AAVSTOP animals with significant DEGs colored Figure S3 A Representative confocal images of Iba1 staining in the dentate gyrus of B6 wildtype mice and FIRE mice Scale bar 50 \\u00b5m B Representative confocal images of dentate gyrus expression of Mef2c in neuronal nuclei Scale bar 50 \\u00b5m C Representative confocal images of thalamus in AAVTau and AAVSTOP animals at 6 weeks of age Scale bar 50 \\u00b5m Quantification of HT7 neurons in the thalamus of 6weekold AAV Tau animals D Distribution of transgenic human tau HT7 among neuronal subtypes including excitatory CamKII\\u03b1 and inhibitory PV neurons in the cortex and thalamus Scale bar 30 \\u00b5m E Representative confocal images of NeuN neurons in thalamus at two time points after neonatal inoculation with AAVSTOP or AAVTau Scale bar 50 \\u00b5m 13 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice C57BL6J mice were obtained from the National Institute on Aging NIA FIRE mice in a mixed C57B6CBA background were generated by Clare Pridans Rojo et al 2019 Mice with ad libitum access to food and water and were housed in mixedgenotype groups of 35 per cage under specific pathogenfree conditions and standard lightdark cycle Both male and female mice were used in experiments Mice were analyzed at specific timepoints as noted in the study and precise ages of all animals used in experiments are listed in respective figure legends All animal procedures were performed in accordance with NIH guidelines and with the approval of the Institutional Animal Care and Use Committee at University of Texas Health Science Center Houston AAV delivery The generation and preparation of all AAV vectors used in this study were described previouslyLi et al 2024 For in vivo inoculation frozen stock solutions of AAV particles were thawed and diluted with vehicle composed of sterile PBS with 10 trypan blue for visual confirmation of correct injection to the appropriate concentration and kept on ice Neonatal mouse pups were chilled on an icecold aluminum block until fully anesthetized AAVs were delivered into the intracerebroventricular spaces of neonatal mouse pups on p0 the day of birth using a Hamilton Gastight syringe Hamilton Company Reno NV fitted with a steel 32gauge needle point style 4 with a 12 bevel We used a dose of 5 x 109 gc in 2 \\u00b5L vehicle into each hemisphere of the brain for a total dose of 1 x 1010 gc in 4 \\u00b5L vehicle per animal Injected neonates were allowed to regain body temperature on a heating pad before being placed back into parent cages Volumetric MRI procedure In vivo MRI was performed on a 7T Bruker BioSpec MRI system Bruker BioSpin Billerica MA at the MRI core facility of UTHealth Houston Specifically T weighted images were acquired 2 using the RARE sequence with the following imaging parameters TRTE 600060 ms inplane resolution 100 x 100 \\u00b5m2 slice thickness 05 mm and a total of 30 slices to cover the whole brain Brain structures of interest were manually segmented using ITKSNAP software version 380 Yushkevich et al 2006 Briefly appropriate structures were delineated on each 2D image slice in which the structure appeared and 3D volumes were calculated based on this segmentation which yielded a total 3D volume in mm3 for each structure METHOD DETAILS Singlenuclei RNA sequencing The mouse hippocampus was dissected and snapfrozen at 80C Tissue 100 mg was powdered on dry ice using a scalpel and transferred to a 15 mL microtube Homogenization was performed by adding 05 mL of freshly prepared Homogenization Buffer 320 mM Sucrose 5 mM CaCl 3 mM MgAc 10 mM Tris pH 78 01 mM EDTA 01 NP40 01 mM Protease inhibitor 2 2 1 mM Betamercaptoethanol 1 U\\u03bcL RNase inhibitor followed by gentle pipetting and incubation on ice for 10 min The homogenate was passed through a 30 \\u03bcm strainer and centrifuged at 300 g for 3 min at 4C The pellet was resuspended in 05 mL Homogenization Buffer and mixed with 05 mL Upper Gradient Centrifugation Buffer 50 OptiPrep Gradient 5 mM CaCl 3 mM 2 MgAc 10 mM Tris pH 78 01 mM Protease inhibitor 1 mM Betamercaptoethanol 1 U\\u03bcL 2 14 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license RNase inhibitor The mixture was gently layered on top of 1 mL of Lower Gradient Centrifugation Buffer 29 OptiPrep Gradient 1 U\\u03bcL RNase inhibitor in a 2 mL microtube The gradient was centrifuged at 7200 g for 15 min at 4C The supernatant was carefully discarded The nuclei pellet was resuspended in the PBS containing 004 BSA and 1 U\\u03bcL RNase inhibitor to achieve a concentration of 7001200 nuclei\\u03bcL Nuclei 20000 per sample were loaded onto a 10x Genomics Next GEM chip G Libraries were prepared using the Chromium Next GEM Single Cell 3\\u02b9 Library and Gel Bead kit v31 10x Genomics following the manufacturers protocol and sequenced on an Illumina NovaSeq 6000 The sequencing data was generated by the UTHealth Houston Cancer Genomics Core Singlecell RNA preprocessing and cell type annotation The raw scRNAseq data were processed using CellRanger v40 which performed initial data alignment filtering and UMI counting The mouse reference genome mm10 was utilized for accurate mapping of sequencing reads to genes After preprocessing with CellRanger the resulting genebarcode matrices were imported into R for downstream analyses The quality control and preprocessing steps were performed using Seurat v440 and batch effect removal was performed using HarmonyButler et al 2018 Korsunsky et al 2019 To preprocess the scRNAseq data we applied stringent quality control thresholds to ensure the reliability and biological relevance of the downstream analysis Cells were filtered based on the following criteria a minimum of 200 detected genes nFeature_RNA 200 to exclude lowquality or empty droplets and a total RNA count between 1000 and 20000 1000 nCount_RNA 20000 to eliminate cells with extremely low or high RNA content which could indicate technical artifacts or doublets Additionally cells with a mitochondrial gene percentage exceeding 5 percentmt 5 were excluded to remove cells with potential stress or apoptosis signals Cell clustering for the scRNAseq data was performed using the Seurat package in R utilizing normalized gene expression profiles to identify distinct cell populations The resolution was set as 01 for the clustering Cell type annotation was carried out using the UCell package which computes gene set enrichment scores based on marker genes curated from established literature and databases Andreatta and Carmona 2021 Each cluster was assigned to a corresponding cell type based on the highest enrichment score Differential gene expression analysis and enrichment analysis for each cell type We performed differential expression analysis to identify agingrelated genes across different mouse types ie AAVTau vs AAVSTOP using the FindMarkers function in the Seurat package for each cell type Differentially expressed genes DEGs were defined as those with an adjusted pvalue 005 and logFC greater than the threshold calculated as meanabslogFC 2 sdabslogFC To investigate the potential biological roles of these DEGs we performed KEGG pathway enrichment analysis using the clusterProfiler v4101 packageYu et al 2012 Separate analyses were conducted for upregulated and downregulated DEGs within each cell type Only pathways with an adjusted pvalue 005 were considered significant Identification of subpopulation for major cell types After the cell type annotation for the major cell types we extract the certain cell type for the subpopulation analysis Similarly with the major cell type annotation Seurat and UCell packages were used in this stepAndreatta and Carmona 2021 Butler et al 2018 15 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Singlecell trajectory reconstruction and analysis Singlecell pseudotime trajectories were constructed with Monocle version 2301 Qiu et al 2017 Briefly we first selected the cell type and the subpopulations with their gene expression matrix Monocle applies reversed graph embedding a machine learning approach to construct a parsimonious principal graph that reduces highdimensional expression profiles into a low dimensional space Each cell is projected onto this space and organized into a trajectory with distinct branch points with a pseudotime value Immunofluorescence Mice were perfused with icecold saline 09 NaCl after deep anesthesia with ketaminexylazine and brains were extracted fixed overnight at 4C in 4 paraformaldehyde Santa Cruz cat sc281692 and dehydrated in 30 sucrose until sectioning Brains were sectioned into 30 \\u03bcm tissue sections using a freezing microtome and tissue was stored in cryoprotectant at 20C For staining floating sections were washed in phosphatebuffered saline PBS and blocked for 1 h at RT in a blocking buffer of 10 normal donkey serum Millipore cat S30100ML and 1 Triton X100 in TBS Primary antibodies were diluted in blocking buffer and applied to sections overnight at 4C Tissues were washed with PBST PBS with 01 Tween 20 three times then incubated with fluorescent secondary antibodies diluted in blocking buffer for 1 h at RT After final washing in PBST sections were mounted on glass slides allowed to dry and coverslipped with ProLong Glass Antifade mountant Life Technologies cat P36982 Image quantification All imaging in this study was performed with a Leica SP8 system For all quantitative analyses in this study multiple images were used as technical replicates from each animal For counting of neurons NeuN antibody was applied to tissues to visualize individual neuronal nuclei In some experiments other markers were colabelled with NeuN such as pcJun or Mef2c Singleplane confocal images from regions of interest were subjected to manual counting in the Leica confocal software and data were recorded for total NeuN cells per field and those with and without co expression of markers pertinent to the experiment For area fraction calculation Zstacks were converted to maximum intensity projections and loaded into ImageJ NIH for analysis Images were thresholded manually to overlap fluorescence signals and percent area was measured For assessment of hippocampal layer thickness confocal images of NeuN cell layers CA1 and CA3 were acquired using a 20X lens For each field of view the thickness of the layer at three to five points was collected and averaged and multiple sections were imaged per animal Transmission electron microscopy TEM Hippocampal tissue was imaged following standard electron microscopy procedures using a Ted Pella Bio Wave processing microwave with vacuum attachments Mice were perfused using a saline flush followed by Modified Karnovskis fixative in sodium cacodylate buffer for 40 minutes per animal Whole heads were dissected and brains were sectioned at 1mm thickness followed by microdissection of hippocampal tissues The tissue was covered in 2 paraformaldehyde 25 glutaraldehyde in 01 M sodium cacodylate buffer at pH 74 After dissection the tissues were incubated in the fixative in a cold room rotator for three days The prefixed tissue sections were then fixed again followed by 3x Millipore water rinses postfixed with 1 aqueous osmium tetroxide and rinsed again 3x with Millipore water Concentrations from 25100 of ethanol were used for the initial dehydration series followed with propylene oxide as the final dehydrant Samples were gradually infiltrated with 3 ratios of propylene oxide and Embed 812 finally going 16 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license into 3 changes of pure resin under vacuum Samples were allowed to infiltrate in pure resin overnight on a rotator The samples were embedded into appropriate molds and cured in the oven at 62C for five days The polymerized samples were thinly sectioned at 4850 nm in a Leica UC7 Ultramicrotome The grids were stained with 1 uranyl acetate for ten minutes followed by lead citrate for two minutes before TEM examination Grids were viewed in a JEOL JEM 1400 Plus transmission electron microscope at 80kV Images were captured using an AMT XR16 mid mount 16 megapixel digital camera QUANTIFICATION AND STATISTICAL ANALYSIS All data in bar plots are presented as means sem GraphPad Prism v1000 was used for all statistical analyses and graph plotting All data was tested for normality using the ShapiroWilk test For normally distributed data differences between two groups were analyzed by twotailed Students ttests with Holm\\u0160\\u00edd\\u00e1ks posthoc multiple comparisons tests where applicable and differences between three or more groups were analyzed by oneway ANOVA with \\u0160\\u00edd\\u00e1ks post hoc multiplecomparisons tests For comparisons including nonnormally distributed data differences between two groups were analyzed by MannWhitney U Tests with Holm\\u0160\\u00edd\\u00e1ks posthoc multiple comparisons tests where applicable and differences between three or more groups were analyzed by KruskalWallis tests with Dunns posthoc multiplecomparisons tests P or P values less than 005 were considered significant and those over 005 were considered adj nonsignificant All exact P values are listed within plots Female and male mice were used for all experiments All micrographs shown are images representative of multiple replicates as noted in legends No statistical methods were used to predetermine sample sizes but similar publications were used as guidelines Biorendercom was used to generate schematics within the figures 17 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license References Aggleton JP A Pralus AJ Nelson and M Hornberger 2016 Thalamic pathology and memory loss in early Alzheimers disease moving the focus from the medial temporal lobe to Papez circuit Brain 13918771890 Andreatta M and SJ Carmona 2021 UCell Robust and scalable singlecell gene signature scoring Computational and structural biotechnology journal 1937963798 Apostolova LG AE Green S Babakchanian KS Hwang YY Chou AW Toga and PM Thompson 2012 Hippocampal atrophy and ventricular enlargement in normal aging mild cognitive impairment MCI and Alzheimer Disease Alzheimer Dis Assoc Disord 261727 Arnsten AFT D Datta K Del Tredici and H Braak 2021 Hypothesis Tau pathology is an initiating factor in sporadic Alzheimers disease Alzheimers dementia the journal of the Alzheimers Association 17115124 Balusu S K Horr\\u00e9 N Thrupp K Craessaerts A Snellinx L Serneels D TSyen I Chrysidou AM Arranz A Sierksma J Simr\\u00e9n TK Karikari H Zetterberg WT Chen DR Thal E Salta M Fiers and B De Strooper 2023 MEG3 activates necroptosis in human neuron xenografts modeling Alzheimers disease Science 38111761182 Barker SJ RM Raju NEP Milman J Wang J DavilaVelderrain F GunterRahman CC Parro PL Bozzelli F Abdurrob K Abdelaal DA Bennett M Kellis and LH Tsai 2021 MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration Sci Transl Med 13eabd7695 Bohmann D TJ Bos A Admon T Nishimura PK Vogt and R Tjian 1987 Human protooncogene c jun encodes a DNA binding protein with structural and functional properties of transcription factor AP1 Science 23813861392 Braak H and E Braak 1991 Neuropathological stageing of Alzheimerrelated changes Acta Neuropathol 82239259 Butler A P Hoffman P Smibert E Papalexi and R Satija 2018 Integrating singlecell transcriptomic data across different conditions technologies and species Nature biotechnology 36411420 Chadarevian JP J Hasselmann A Lahian JK Capocchi A Escobar TE Lim L Le C Tu J Nguyen S Kiani Shabestari W CarlenJones S Gandhi G Bu DA Hume C Pridans ZK Wszolek RC Spitale H Davtyan and M BlurtonJones 2024 Therapeutic potential of human microglia transplantation in a chimeric model of CSF1Rrelated leukoencephalopathy Neuron 1122686 2707 e2688 Chang CW E Shao and L Mucke 2021 Tau Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies Science 371eabb8255 Dujardin S C Commins A Lathuiliere P Beerepoot AR Fernandes TV Kamath MB De Los Santos N Klickstein DL Corjuc BT Corjuc PM Dooley A Viode DH Oakley BD Moore K Mullin 18 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license D JeanGilles R Clark K Atchison R Moore LB Chibnik RE Tanzi MP Frosch A Serrano Pozo F Elwood JA Steen ME Kennedy and BT Hyman 2020 Tau molecular diversity contributes to clinical heterogeneity in Alzheimers disease Nat Med 2612561263 Gamache JE L Kemper E Steuer K LeinonenWright JM Choquette C Hlynialuk K Benzow KA Vossel W Xia MD Koob and KH Ashe 2020 Developmental Pathogenicity of 4Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched TauTransgenic Mice J Neurosci 40220236 Goedert M and R Jakes 2005 Mutations causing neurodegenerative tauopathies Biochim Biophys Acta 1739240250 Guo T W Noble and DP Hanger 2017 Roles of tau protein in health and disease Acta Neuropathol 133665704 Hu YY SS He X Wang QH Duan I GrundkeIqbal K Iqbal and J Wang 2002 Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimers disease patients an ultrasensitive bienzymesubstraterecycle enzymelinked immunosorbent assay Am J Pathol 16012691278 Johnson AM and JR Lukens 2023 The innate immune response in tauopathies Eur J Immunol 53e2250266 Khatoon S I GrundkeIqbal and K Iqbal 1992 Brain levels of microtubuleassociated protein tau are elevated in Alzheimers disease a radioimmunoslotblot assay for nanograms of the protein J Neurochem 59750753 Knopman DS H Amieva RC Petersen G Chetelat DM Holtzman BT Hyman RA Nixon and DT Jones 2021 Alzheimer disease Nat Rev Dis Primers 733 Korsunsky I N Millard J Fan K Slowikowski F Zhang K Wei Y Baglaenko M Brenner Pr Loh and S Raychaudhuri 2019 Fast sensitive and accurate integration of singlecell data with Harmony Nature methods 1612891296 Koutsodendris N J Blumenfeld A Agrawal M Traglia O Yip A Rao MJ Kim MR Nelson YH Wang and B Grone 2023 APOE4promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release Cell reports 42 Li S ER Roy Y Wang T Watkins and W Cao 2024 DLKMAPK Signaling Coupled with DNA Damage Promotes Intrinsic Neurotoxicity Associated with NonMutated Tau Mol Neurobiol 612978 2995 Litvinchuk A YW Wan DB Swartzlander F Chen A Cole NE Propson Q Wang B Zhang Z Liu and H Zheng 2018 Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimers Disease Neuron 1001337 1353 e1335 Mah LJ A ElOsta and TC Karagiannis 2010 gammaH2AX a sensitive molecular marker of DNA damage and repair Leukemia 24679686 19 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Munro DAD N BestardCuche C McQuaid A Chagnot SK Shabestari JP Chadarevian U Maheshwari S Szymkowiak K Morris M Mohammad A Corsinotti B Bradford N Mabbott RJ Lennen MA Jansen C Pridans BW McColl A Keller M BlurtonJones A Montagne A Williams and J Priller 2024 Microglia protect against ageassociated brain pathologies Neuron 11227322748 e2738 Paolicelli RC A Sierra B Stevens ME Tremblay A Aguzzi B Ajami I Amit E Audinat I Bechmann M Bennett F Bennett A Bessis K Biber S Bilbo M BlurtonJones E Boddeke D Brites B Brone GC Brown O Butovsky MJ Carson B Castellano M Colonna SA Cowley C Cunningham D Davalos PL De Jager B de Strooper A Denes BJL Eggen U Eyo E Galea S Garel F Ginhoux CK Glass O Gokce D GomezNicola B Gonzalez S Gordon MB Graeber AD Greenhalgh P Gressens M Greter DH Gutmann C Haass MT Heneka FL Heppner S Hong DA Hume S Jung H Kettenmann J Kipnis R Koyama G Lemke M Lynch A Majewska M Malcangio T Malm R Mancuso T Masuda M Matteoli BW McColl VE Miron AV Molofsky M Monje E Mracsko A Nadjar JJ Neher U Neniskyte H Neumann M Noda B Peng F Peri VH Perry PG Popovich C Pridans J Priller M Prinz D Ragozzino RM Ransohoff MW Salter A Schaefer DP Schafer M Schwartz M Simons CJ Smith WJ Streit TL Tay LH Tsai A Verkhratsky R von Bernhardi H Wake V Wittamer SA Wolf LJ Wu and T WyssCoray 2022 Microglia states and nomenclature A field at its crossroads Neuron 11034583483 Parra Bravo C SA Naguib and L Gan 2024 Cellular and pathological functions of tau Nat Rev Mol Cell Biol Prinz M S Jung and J Priller 2019 Microglia Biology One Century of Evolving Concepts Cell 179292 311 Qian Z Y Li and K Ye 2024 Advancements and challenges in mouse models of Alzheimers disease Trends Mol Med Qiu X A Hill J Packer D Lin YA Ma and C Trapnell 2017 Singlecell mRNA quantification and differential analysis with Census Nature methods 14309315 Rojo R A Raper DD Ozdemir L Lefevre K Grabert E WollscheidLengeling B Bradford M Caruso I Gazova A Sanchez ZM Lisowski J Alves I MolinaGonzalez H Davtyan RJ Lodge JD Glover R Wallace DAD Munro E David I Amit VE Miron J Priller SJ Jenkins GE Hardingham M BlurtonJones NA Mabbott KM Summers P Hohenstein DA Hume and C Pridans 2019 Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations Nat Commun 103215 Roy DS Y Zhang MM Halassa and G Feng 2022 Thalamic subnetworks as units of function Nat Neurosci 25140153 R\\u00fcb U K Stratmann H Heinsen D Del Turco E Ghebremedhin K Seidel W den Dunnen and HW Korf 2016 Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimers Disease Patients Journal of Alzheimers disease JAD 49905915 Scheltens P B De Strooper M Kivipelto H Holstege G Chetelat CE Teunissen J Cummings and WM van der Flier 2021 Alzheimers disease Lancet 39715771590 20 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license SerranoPozo A MP Frosch E Masliah and BT Hyman 2011 Neuropathological alterations in Alzheimer disease Cold Spring Harb Perspect Med 1a006189 Shi Y K Yamada SA Liddelow ST Smith L Zhao W Luo RM Tsai S Spina LT Grinberg JC Rojas G Gallardo K Wang J Roh G Robinson MB Finn H Jiang PM Sullivan C Baufeld MW Wood C Sutphen L McCue C Xiong JL DelAguila JC Morris C Cruchaga I Alzheimers Disease Neuroimaging AM Fagan BL Miller AL Boxer WW Seeley O Butovsky BA Barres SM Paul and DM Holtzman 2017 ApoE4 markedly exacerbates taumediated neurodegeneration in a mouse model of tauopathy Nature 549523527 Tetlow AM BM Jackman MM Alhadidy P Muskus DG Morgan and MN Gordon 2023 Neural atrophy produced by AAV tau injections into hippocampus and anterior cortex of middleaged mice Neurobiol Aging 1243950 Tracy TE and L Gan 2018 Taumediated synaptic and neuronal dysfunction in neurodegenerative disease Curr Opin Neurobiol 51134138 Udeochu JC S Amin Y Huang L Fan ERS Torres GK Carling B Liu H McGurran G Coronas Samano G Kauwe GA Mousa MY Wong P Ye RK Nagiri I Lo J Holtzman C Corona A Yarahmady MT Gill RM Raju SA Mok S Gong W Luo M Zhao TE Tracy RR Ratan LH Tsai SC Sinha and L Gan 2023 Tau activation of microglial cGASIFN reduces MEF2C mediated cognitive resilience Nat Neurosci 26737750 Wang B H MartiniStoica C Qi TC Lu S Wang W Xiong Y Qi Y Xu M Sardiello and H Li 2024 TFEBvacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy Nature neuroscience 274862 Wang Y and E Mandelkow 2016 Tau in physiology and pathology Nat Rev Neurosci 17521 Wesseling H W Mair M Kumar CN Schlaffner S Tang P Beerepoot B Fatou AJ Guise L Cheng S Takeda J Muntel MS Rotunno S Dujardin P Davies KS Kosik BL Miller S Berretta JC Hedreen LT Grinberg WW Seeley BT Hyman H Steen and JA Steen 2020 Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimers Disease Cell 18316991713 e1613 Wu T B Dejanovic VD Gandham A Gogineni R Edmonds S Schauer K Srinivasan MA Huntley Y Wang TM Wang M Hedehus KH Barck M Stark H Ngu O Foreman WJ Meilandt J Elstrott MC Chang DV Hansen RAD Carano M Sheng and JE Hanson 2019 Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy Cell Rep 2821112123 e2116 Yadav N A Toader and P Rajasethupathy 2024 Beyond hippocampus Thalamic and prefrontal contributions to an evolving memory Neuron 11210451059 Yamamori H S Khatoon I GrundkeIqbal K Blennow M Ewers H Hampel and K Iqbal 2007 Tau in cerebrospinal fluid a sensitive sandwich enzymelinked immunosorbent assay using tyramide signal amplification Neurosci Lett 418186189 21 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Yin Y D Gao Y Wang ZH Wang X Wang J Ye D Wu L Fang G Pi Y Yang XC Wang C Lu K Ye and JZ Wang 2016 Tau accumulation induces synaptic impairment and memory deficit by calcineurinmediated inactivation of nuclear CaMKIVCREB signaling Proc Natl Acad Sci U S A 113E37733781 Yoshiyama Y M Higuchi B Zhang SM Huang N Iwata TC Saido J Maeda T Suhara JQ Trojanowski and VM Lee 2007 Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model Neuron 53337351 Yu G LG Wang Y Han and QY He 2012 clusterProfiler an R package for comparing biological themes among gene clusters Omics a journal of integrative biology 16284287 Yushkevich PA J Piven HC Hazlett RG Smith S Ho JC Gee and G Gerig 2006 Userguided 3D active contour segmentation of anatomical structures significantly improved efficiency and reliability NeuroImage 3111161128 Zhang Z and Y Zhao 2022 Progress on the roles of MEF2C in neuropsychiatric diseases Mol Brain 158 22 Figure 1 A C Human tau expression HT7NeuN by region 60 40 20 0 NueN latot fo 7TH B CA1 CA3 CTX POTSVAA uaT TWVAA uaT L103PVAA D 3w 6w 12w HT7 HT7 pT205 HT7 CTX HPC TH CTX HPC TH CTX HPC TH POTSVAA uaT TWVAA uaT L103PVAA which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license NeuN AT8 MC1 HT7 pT205 AT8 MC1 Figure 2 A B Brain weight 800 600 400 200 0 C gm 3wk 6wk 12wk PP 0 62774 PP 0 001001 PP 0 200146 Lateral ventricles 10 5 0 AAVSTOP AAVTau ST O P VTau A V A A A 3mm Hippocampus 30 P 018 20 10 0 ST O P VTau A V A A A 3mm P 009 NeuN cell density 150 100 50 0 dleif rep sllec fo leR CA1 CA3 CTX PP 0 85681 PP 000011 PP 000011 PP 0 98663 PP 0 11706 PP 000011 PP 0 99989 PP 0 71359 PP 0 99999 3 wk 6 wk 12 wk 3 wk 6 wk 12 wk 3 wk 6 wk 12 wk AAVSTOP AAVTau D AAVSTOP AAVTau E XA2H\\u03b3NueN XA2H\\u03b3 AAVSTOP AAVTau nuJcpNueN nuJcp Frequency of \\u03b3H2AXneurons by region 60 40 20 0 CA1 CA3 CTX ielcun NueN fo Frequency of pcJunneurons by region 30 PP 0 142886 PP 0 000140 PP 0 000193 AAVSTOP AAVTau 20 10 0 CA1 CA3 CTX ielcun NueN fo which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license NeuN P P 0 4 01 8 0 3 PP 0 004713 PP 0 000012 AAVSTOP AAVTau Figure 3 A B UMAP1 Cluster 1 neurons Fluid shear stress and atherosclerosis Salmonella infection Estrogen signaling pathway Gastric acid secretion Lipid and atherosclerosis Oxytocin signaling pathway Necroptosis Rap1 signaling pathway Antigen processing and presentation Parkinson disease 0 2 4 6 log10padj value 2PAMU AAVSTOP AAVTau Neuronal clusters Cluster Cluster noitroporp lleC Cell type clusters Cell types UMAP1 C D E F 2PAMU AAVSTOP AAVTau Cell types noitroporp epyt lleC which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Cluster 0 neurons Parkinson disease Fluid shear stress and atherosclerosis Estrogen signaling pathway Gastric acid secretion Pathways of neurodegeneration Salmonella infection Alzheimer disease Necroptosis Oocyte meiosis Lipid and atherosclerosis 0 2 4 6 log10padj value Figure 4 A 3 weeks 6 weeks AAVSTOP AAVWT tau AAVSTOP AAVWT tau CA1 CA3 B AAVSTOP AAVWT tau CTX 3CPAFG C 3 weeks 6 weeks AAVSTOP AAVWT tau AAVSTOP AAVWT tau CA1 CA3 D AAVSTOP AAVWT tau CTX a7celC1abI E 86DC1abI GFAP astrocytes 80 60 40 20 2 1 0 GFAP AAVSTOP AAVWT tau Iba1 F AT8Iba1CD68 aera PP 000011 PP 000243 PP 101051 PP 100511 PP 099952 PP 99998 3 wk 6 wk 3 wk 6 wk 3 wk 6 wk AAVSTOP AAVWT tau Iba1 microglia 10 5 0 aera which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license PP 001701 PP 000011 PP 329968 PP 000011 PP 999995 PP 000031 3 wk 6 wk 3 wk 6 wk 3 wk 6 wk AAVSTOP AAVWT tau NeuN cell density 150 100 50 0 dleif rep sllec fo leR Brain weight 800 600 400 200 0 Thalamus P 059 P 143 3 wk 6 wk gm Figure 5 A B 6 wk 12 wk PP 001050 PP 897668 PP 441243 PP 455709 B6 FIRE B6 FIRE C D F E \\u03b3H2AXneurons 80 60 40 20 0 P u S T O V T a A V A A A G H I J ielcun NueN fo pcJunneurons 50 Thalamus P 018 40 30 20 10 0 P u S T O V T a A V A A A ielcun NueN fo Iba1 microglia Thalamus 10 P 001 5 0 aera GFAP astrocytes 40 Thalamus P 088 P 001 30 20 10 0 3 wk 6 wk aera Thalamus P 016 P 001 3 wk 6 wk NeuN cell density 150 AAVSTOP 100 AAVTau 50 0 lortnoc fo sllec NueN fo ytisneD CA1 CA3 CTX P 001 P 784 P 007 P 058 P 277 P 999 B6 FIRE B6 FIRE B6 FIRE Frequency of pcJun neurons by region 60 40 20 6 4 2 0 ielcun NueN fo Mef2cNeuN hippocampal neurons CA1 CA3 CTX 20 PP 062444 PP 259049 PP 014631 PP 278832 PP 002088 PP 108269 15 10 05 00 B6 FIRE B6 FIRE B6 FIRE dleif rep sllec fo leR CA1 CA3 DG PP 220961 PP 969199 PP 353132 PP 997978 PP 004360 PP 896802 B6 FIRE B6 FIRE B6 FIRE AAVSTOP AAVTau AAVSTOP AAVTau Human tau expression 100 50 0 6 E B R FI NueN latot fo 7TH NeuN cell density Thalamus P 001 150 100 50 0 dleif rep sllec fo leR pcJunneurons Thalamus 60 P 004 40 20 0 FIRE ielcun NueN fo Thalamus P 001 FIRE which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license AAVSTOP AAVTau Figure S1 A B AAVTauSTOP AAVP301LTau Frequency of pcJun neurons by region 3 weeks 40 30 20 10 0 CA1 CA3 CTX ielcun NueN fo Body weight 40 30 20 10 0 3 wk 6 wk 12 wk AAVSTOP PP 0 959683 PP 0 945195 PP 561128 AAVTau g Brain weight 800 P 877 P 172 P 937 AAVSTOP 600 AAVTau 400 200 0 C gm which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license P 024 P 072 3wk 6wk Figure S2 Grin2bpanneuronal B Slc17a7excitatory Gad2GABAergic UMAP1 Mpped1CA1 pyramidal Prox1DG granule Cdh24CA3 pyramidal Map3k15CA2 pyramidal C 2PAMU A Neuronal type classification D Cluster 0 neurons 200 150 100 50 0 15 10 05 00 05 10 15 Fold change log 2 gol eulav P 01 Cluster 1 neurons 100 80 Calm1 60 Calm2 40 Camk1d 20 0 15 10 05 00 05 10 15 Fold change log 2 gol eulav P 01 which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made available under aCCBYNCND 40 International license Calm1 Calm2 Camk1d B6 FIRE AAVSTOP AAVTau Iba1 NeuN C 60 40 20 0 NueN latot fo 7TH which was not certified by peer review is the authorfunder who has granted bioRxiv a license to display the preprint in perpetuity It is made Figure S3 available under aCCBYNCND 40 International license A B D CamKII\\u03b1HT7 PVHT7 E\",\n          \"INTRODUCTION Alzheimers disease AD a leading cause of dementia worldwide is a progressive neurodegenerative disorder that gradually impairs memory cognition behavior and executive functions13 AD is defined by two primary pathological hallmarks the accumulation of extracellular amyloid\\u03b2 A\\u03b2 plaques and intracellular neurofibrillary tau tangles accompanied by gliosis and neuronal loss Despite substantial advances in understanding AD pathology the complex interplay of genetic cellular and environmental factors makes the mechanisms of the disease progression an enigma Among genetic risk factors carrying the \\u03b54 allele of apolipoprotein E APOE4 represents the strongest contributor to lateonset AD45 Accumulating evidence from epidemiological and genomewide association studies GWAS has shown that APOE4 heterozygotes are two to three times more likely and homozygotes up to 12 to 15 times more likely to develop AD compared with APOE3 populations468 In this study we analyzed positron emission tomography PET imaging data from nondemented preclinical individuals in the Alzheimers Disease Neuroimaging Initiative ADNI cohort and found that even among cognitively normal control participants both APOE4 heterozygotes and homozygotes show significantly increased amyloid\\u03b2 and tau burden compared with noncarriers demonstrating that APOE4 drives early pathological changes well before clinical symptoms emerge Figure 1 Furthermore APOE4 increases the risk of amyloidrelated imaging abnormalities during treatment with secondgeneration antiamyloid monoclonal antibodies and diminishes therapeutic efficacy 911 Despite its central role in AD pathogenesis the mechanisms by which APOE4 potentiates pathological amyloid and tau burden exacerbates disease severity and confers treatment resistance remain elusive Progress in understanding AD and APOE4 has been limited by the lack of models that accurately capture human pathophysiology While animal models have provided critical insights into amyloid processing tau aggregation and neuroinflammation speciesspecific differences prevent full recapitulation of the human brain and the complex interplay of AD pathologies This limitation is particularly pronounced for APOE4 as APOE exhibits speciesspecific differences in its evolution structure and posttranslational modifications between rodents and humans1213 Rodent models even those expressing humanized APOE encounter difficulty in reproducing the phenotypes observed in human populations1416 Human induced pluripotent stem cell hiPSC based models have emerged as powerful tools to overcome these limitations1720 By 4 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission reprogramming patientderived cells into neurons astrocytes and other brain cell types hiPSC models allow the study of AD mechanisms in a human genetic context21 Advances in stem cell engineering have further enabled the generation of threedimensional 3D brain organoids or assembloids selforganizing multicellular structures that recapitulate aspects of human brain development cellular diversity and architecture2226 Organoids and assembloids provide unique opportunities to investigate cellular interactions and disease processes in a physiologically relevant environment that is difficult to achieve in conventional 2D cultures2732 However most current organoid systems remain limited in cellular composition often lacking or exhibiting delayed development of key nonneuronal cell types and rarely incorporate diseaserelevant stressors in a controlled and systematic manner3336 To overcome the challenges in understanding the pathophysiology of AD and recapitulate human heterogeneity we built on our previously published Asteroid model37 to develop Masteroids 3D cultures composed of hiPSCderived neurons astrocytes microglia and endogenously generated oligodendrocytes In this study we established Masteroid models using hiPSCs carrying APOE4 and their isogenic APOE3 controls combining tau and amyloid pathologies to more comprehensively model AD progression Our Masteroid system was specifically designed to capture both the proteopathic and genetic contributors to AD Neurons were initially seeded with tau oligomers to prime the system for pathological tau aggregation and then combined with astrocytes and microglia to form mature multicellular 3D Masteroids The cultures were subsequently exposed to extracellular amyloid\\u03b2 oligomers creating a comprehensive environment that models intermediate and advanced stages of neurodegeneration After four weeks ADMasteroids faithfully recapitulated multiple hallmark features of AD pathology including A\\u03b2 deposition tau aggregation widespread neurodegeneration astrogliosis and robust microglial activation Notably the presence of APOE4 markedly exacerbated all of these pathological phenotypes highlighting its critical role in disease progression Electron microscopy revealed that Masteroids recapitulated ultrastructural features of the human brain including neuronal synaptic structures neuronglial interactions glial phagocytic activity and early myelination development Electrophysiological recordings confirmed Masteroid neurons had excitation ability action potentials in response to current injection and synaptic events Leveraging singlecell RNA sequencing we identified IGFBPs as distinct mediators and highlighted signaling pathways involved in amyloid\\u03b2 and tauassociated cellular dysfunction 5 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission providing new mechanistic insights Strikingly treatment of ADMasteroids with IGFBP inhibitor NBI 31772 significantly reduced neurodegeneration astrogliosis and microglial activation demonstrating a direct role for IGFBP signaling in driving AD pathogenesis Together these results establish Masteroids as a powerful tool for highthroughput evaluation of therapeutic interventions bridging a critical gap between conventional cell cultures and in vivo models and enabling the study of complex genotypepathology interactions in AD under a controlled environment RESULTS DoseDependent Impact of APOE4 on A\\u03b2 Deposition and Tau Accumulation from Preclinical to Prodromal Stages AD is composed of three primary stages preclinical prodromal and clinical38 In the preclinical stage patients are primarily asymptomatic and cognitively normal while bearing some pathological markers of AD In the prodromal stage patients experience mild cognitive impairment MCI ranging from early to late MCI with varying levels of AD pathology The clinical stage is characterized by extensive AD pathology alongside severe cognitive impairment38 Using the ADNI dataset3942 we analyzed the impact of APOE4 status on amyloid and tau burden in human patients during the preclinical and prodromal stages of AD The ADNI study is composed of three cohorts of varying severities determined by diagnostic criteria of both cognitive and pathological scores the Cognitively Unimpaired CU cohort the Mild Cognitive Impairment MCI cohort and the EarlyStage Alzheimers Disease DEM cohort4344 The CU cohort consists of both normal control participants with little to no positive AD pathology as well as cognitively normal participants with some AD pathological markers but little to no cognitive impairment For our analysis we considered the CU cohort to be in the preclinical stage the MCI cohort to be in the prodromal stage and the DEM cohort to be in the clinical stage We began by analyzing the difference in amyloid burden in the preclinical and prodromal stages of AD between APOE33 APOE34 and APOE44 individuals The amyloid burden was determined by the proportion of a given population with a positive whole brain PET scan which was defined by a normalized Standardized Uptake Value Ratio SUVR 111 Figure 1A Even one APOE4 allele markedly increased amyloid positivity in preclinical and prodromal patients with homozygotes showing the highest rates indicating a dosedependent effect of APOE4 on 6 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission disease progression Figure 1B APOE34 in the CU group showed significantly higher amyloid positivity than noncarriers though no difference was observed between APOE34 and APOE44 carriers Figure S1A By MCI stage the APOE44 individuals had a significantly greater proportion of amyloid positive scans than the APOE34 though this difference is not significant in the DEM cohort as nearly all APOE34 and APOE44 patients had positive amyloid scans In both the MCI and DEM cohorts any instance of APOE4 APOE44 vs APOE43 vs APOE33 led to a significantly greater proportion of amyloid positive scans than in noncarriers Figures S1B and S1C Across all genotypes each additional APOE4 allele was associated with higher amyloid positivity with APOE44 carriers showing the greatest amyloid burden Figure S1D Amyloid accumulation typically marks early AD pathology while tau burden increases in parallel with cognitive decline45 We therefore analyzed tau PET data in the same ADNI cohort by APOE status across disease stages focusing on the entorhinal cortex which is among the first regions to show tau pathology4647 Tau burden was determined by the actual SUVR value instead of a binary cutoff of positive or negative scan like amyloid prevalence Figure 1C Similarly to observations with amyloid burden APOE4 heterozygotes and homozygotes had significantly greater tau burden than noncarriers in both the left and right entorhinal cortex as early as in the preclinical and prodromal stages of AD with APOE4 homozygotes exhibiting greater tau burden than APOE4 heterozygotes Figures 1D and 1E In the CU cohort tau burden in the left entorhinal cortex did not differ significantly by APOE4 status though a strong trend was seen between APOE33 and APOE44 In the right entorhinal cortex tau burden was significantly higher in APOE44 than APOE33 individuals with no difference between APOE33 and APOE34 Figure S1E By the prodromal stage of MCI APOE4 heterozygotes and homozygotes showed significantly greater tau burden in both the left and right entorhinal cortices compared to noncarriers Figure S1F Across all genotypes each additional APOE4 allele was linked to higher tau burden in both entorhinal cortices with APOE4 homozygotes showing the greatest levels Figure S1G Altogether our analysis demonstrated a dosedependent effect of the APOE4 allele on disease progression influencing both A\\u03b2 deposition and tau accumulation from the earliest preclinical and prodromal stages 7 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 8 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 1 DoseDependent Impact of APOE4 on A\\u03b2 Deposition and Tau Accumulation from Preclinical to Prodromal Stages A Examples of a negative top and positive bottom amyloid PET scan visualized sagittally left coronally center and axially right A positive scan is defined by a normalized SUVR 111 see methods B Quantification of proportion of population with positive amyloid PET scan by APOE genotype in preclinical and prodromal populations CU and MCI n 565 341 and 76 for APOE33 APOE34 and APOE44 respectively C Mean tau PET burden by brain region in the full cohort shown by APOE genotypes D Quantification of normalized Tau PET SUVR in left entorhinal cortex by APOE genotypes in preclinical and prodromal populations CU and MCI n 339 196 and 38 for APOE33 APOE34 and APOE44 respectively E Quantification of normalized Tau PET SUVR in right entorhinal cortex by APOE genotype in preclinical and prodromal populations CU and MCI n 339 196 and 38 for APOE33 APOE34 and APOE44 respectively p 0001 p 00001 Amyloid PET statistical analysis was done by Chisquare Test with Yates correction B and Tau PET statistical analysis was done with KruskalWallis test D and E with p values shown See also Figure S1 3D Masteroid culture system recapitulates human brain cell types and ultrastructure To establish a 3D neuronglial assembloid model that recapitulates the coordinated origin and emergence of neurons astrocytes and microglia similar to human brain development we developed a 3D coculture system termed Masteroid for modeling neurodegenerative diseases following a modified neuronastrocyte AstTau assembloid protocol developed in our previous work 3748 In brief human iPSCs with a normal APOE33 genotype were initially differentiated into hematopoietic progenitor cells and neural progenitor cells hiNPCs where hiNPCs were also further differentiated into astrocyte progenitor cells All three types of progenitor cells were subsequently differentiated into neuronal astrocytic and microglial lineages to generate human iPSCderived neurons hiNeurons astrocytes hiAstrocytes and microglia hiMicroglia These cells were then combined into a 3D spherical culture termed Masteroids and allowed to mature over the course of 5 weeks Figure 2A We also maintained individual hiNeurons hiAstrocytes and hiMicroglia in 2D culture for 1 week alongside the creation of Masteroids to confirm proper cell morphology and identity through immunolabeling Figure 2B Mature Masteroids exhibited extensive neuronal and astrocytic processes with microglia distributed throughout the Masteroid Figure 2C 9 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission The final Masteroid cellular phenotypes were characterized using singlecell RNA sequencing scRNAseq profiling 8000 cells per sample at a sequencing depth of 50000 read pairs per cell Visualization by uniform manifold approximation and projection UMAP demonstrated the separation of cells into trajectory guided clusters The clusters were identified as astrocytes ASC excitatory neurons EX_NEU inhibitory neurons IN_NEU microglia Microglial oligodendrocytes Oligo and various progenitor and panneuronal cells Figure 2D Analysis of scRNAseq clustering revealed an oligodendrocyte cluster which was confirmed by immunolabeling for Myelin Basic Protein MBPpositive myelinating oligodendrocytes in Masteroids Figures 2D S2A and S2B To determine the origin of the oligodendrocytes the astrocyte oligodendrocyte and progenitor clusters were isolated and redefined on a UMAP followed by a pseudotime subclustering and trajectory analysis Figure S2C4951 This analysis traced gene expression trajectories and indicated that oligodendrocytes in Masteroids likely originate from astrocyte progenitor cells Previous studies showed that astrocytes and oligodendrocytes share a common glial precursor5254 and astrocytes can be reprogrammed into oligodendrocytes5556 Together with our pseudotime analysis this supports that the endogenously generated oligodendrocytes within our Masteroids originate from astrocyte progenitor cells To determine the number and probability of intercellular interactions between cell types we did CellChat scRNAseq analysis which identified the differentially overexpressed ligands and receptors in each cluster57 Significant receptorligand interactions were present between all cell types in the Masteroids noting the presence of extensive intercellular communication with the strongest interaction probability occurring between the neuronal clusters Figure 2E scRNAseq profiling of voltagegated channel expression in hiNeurons confirmed Masteroid functionality showing expression of hyperpolarization cyclicnucleotide gated HCN subunits for I currents h voltagegated sodium and potassium channels for action potentials and calcium channel subunits required for synaptic neurotransmitter release Figures S2D S2E S2F and S2G5860 To further validate that Masteroids recapitulate the ultrastructure of human brain tissue we performed transmission electron microscopy EM Synapses were identified Figure 2F with presynaptic terminals containing numerous vesicles adjacent to the synaptic cleft and a prominent postsynaptic density features indicative of active synapses and supporting the biophysical functionality of the Masteroid model 6162 EM also revealed the proper ultrastructural morphology of mature neuronal and glial cells within Masteroids Figures S2H S2I and S2J Masteroid 10 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission neurons have abundant perinuclear cytoplasm with mitochondria endoplasmic reticulum Golgi and numerous ribosomes and large round nuclei with lowcontrast unclustered chromatin and distinct nucleoli Figure S2H6364 Masteroid neurons often extend large neurites from the cell body Figure S2H64 Masteroid glial cells display irregularlyshaped and darker nuclei composed of dense clumped chromatin with smaller and darker cytoplasm Figure S2I Cells with intracellular space containing a full ensemble of cytoskeletal elements including microtubules and neurofilaments were also found Figure S2J6165 Myelin whirls concentric membrane stacks lacking a neuropil core were observed confirming myelinating oligodendrocyte development in Masteroids Figure 2G63 Moreover wholecell patchclamp recordings further validated the electrophysiological functionality of whole Masteroids at day 35 of culture Figure S2K Masteroid hiNeurons exhibited a resting membrane potential and action potentials were evoked by current injection Figures S2L and 2H66 The hiNeurons also showed synaptic transmission with relatively infrequent but consistent and spontaneous excitatory postsynaptic currents EPSCs observed indicating the formation of synapses between hiNeurons within the Masteroids as was also observed by EM Figures S2M and 2F Together scRNAseq profiling EM ultrastructural analysis and electrophysiological recordings demonstrate the overall biophysical functionality cellular health and intercellular connectivity of Masteroids 11 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 12 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 2 3D Masteroid culture system recapitulates human brain cell types and ultrastructure A Schematic illustrating experimental Masteroid culture system Created with BioRendercom B Representative immunofluorescence images of iPSCderived neurons TUJ1 magenta astrocytes GFAP green and microglia CD11b green P2RY12 red and IBA1 magenta with dsDNA stain Dapi blue Scale bar 50\\u00b5m C Representative tile scanned and zstacked immunofluorescence images of 3D Masteroid with cell type markers for astrocytes GFAP cyan microglia IBA1 red and neurons TUJ1 magenta Scale bar 100\\u00b5m D UMAP of singlecell transcriptomic profiles by scRNAseq after filtration and cell type identification The following cell types were identified astrocytes ASC red excitatory neurons EX_NEU lime green inhibitory neurons IN_NEU teal microglia Microglial blue oligodendrocytes Oligo pink and various progenitor and panneuronal cells ASC_P orange Cycling olive EX_NEU_P green IN_NEU_P cyan NEU_P purple NEU_X light pink E Number and weight of significant ligandreceptor interactions between five major cell types Circle sizes are proportional to the number of cells within a given cluster and line width is proportional to the indicated number or strength of interactions Cell types included are excitatory neurons EX_NEU blue inhibitory neurons IN_NEU green astrocytes ASC red microglia Microglial purple and oligodendrocytes Oligo orange F Electron microscopy EM image of a synapse within a Masteroid Green arrows point to microtubules purple arrow points to synaptic vesicles blue arrows point to ribosomes and indicates postsynaptic density Scale bar 05\\u00b5m G EM image of a myelin whirl within a Masteroid Scale bar 1\\u00b5m H Single cell patchclamp Iclamp recording of an action potential in a Masteroid in response to current injection 20 pA per step FG m mitochondria t synaptic terminal d dendrite er endoplasmic reticulum and r ribosomes See also Figure S2 Propagation of oTau and A\\u03b2 oligomers in Masteroids mirrors key features of AD We next used our Masteroid system to build a model of sporadic AD by selectively propagating human oligomeric tau oTau andor A\\u03b2 oligomers Figure S3A Oligomeric tau was extracted from postmortem human brain tissue by centrifugation using a wellestablished extraction method6770 Human oTau fractions were isolated from diseased Alzheimers brains AD oTau and age matched control brains NC and identified by Western blot with antiTau antibodies total by Tau5 and PhosphoTau by pThr217 Figures S3B and S3C The dose response of oTau toxicity was determined using LDH analysis at 24 and 96 hours after addition of oTau in 2D hiNeurons Figure S3D Based on the doseresponse 004mgmL of human oTau was seeded to hiNeurons 24 hours prior to their combination with hiAstrocytes and hiMicroglia 13 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission for all ADMasteroids while the controls were treated with the same volume of NC fraction Purified A\\u03b2 oligomers 05\\u00b5MmL were spiked in at one week after the Masteroids were transferred to 96 well plates The proper size 10 kDa and identity of the purified A\\u03b2 oligomers was confirmed by western blot with antiA\\u03b2 antibody 6E10 Figure S3E To dissect the contributions of amyloid and tau pathology to AD pathogenesis we established four Masteroid conditions NC NC A\\u03b2 AD oTau and AD A\\u03b2 by selectively introducing NC or AD oTau together with either A\\u03b2 oligomers or a DMSO vehicle Figure 3A Subsequent analysis of these Masteroids revealed significant development of ADassociated pathology in all diseased conditions with the most pronounced effects observed in Masteroids treated with both AD oTau and A\\u03b2 oligomers Figure 3 The reactive astrogliosis marker GFAP showed significant increases in astrocytic reactivity in both AD oTau and AD A\\u03b2 Masteroids with a more significant increase in the AD A\\u03b2 condition compared to AD oTau alone Figure 3B While AD oTau Masteroids exhibited some microglial activation as indicated by IBA1 only AD A\\u03b2 Masteroids showed significant increase Figure 3C Both A\\u03b2 and AD oTau treatments led to a significant decrease in neuronal TUJ1 immunolabeling compared to NC Masteroids with A\\u03b2 conditions showing greater neuronal loss than AD oTau alone and the most severe loss observed in AD A\\u03b2 Masteroids Figure 3D Immunolabeling by 6E10 in whole Masteroids revealed that both NC A\\u03b2 and AD A\\u03b2 conditions formed A\\u03b2 plaques Figures 3E and 3F While some plaques were more diffuse others exhibited the classic star shape morphology with a dense core71 No A\\u03b2 plaques were observed in the NC or AD oTau conditions In identifying the tau pathology we found that the AD oTau and AD A\\u03b2 Masteroids showed significant tau misfolding MC1 antibody with the AD A\\u03b2 Masteroids containing significantly more misfolded tau than the AD oTau only condition Figures 3G and 3H This is consistent with the most pronounced glial activation and neuronal loss occurring in the AD A\\u03b2 condition highlighting the deleterious synergistic interaction between tauopathy and A\\u03b2 in AD7273 Interestingly there were no significant differences in neuronal loss or A\\u03b2 burden between NC A\\u03b2 and AD A\\u03b2 Masteroids Figures 3D 3E and 3F suggesting that tau may not directly induce or enhance amyloid pathology EM imaging also revealed extensive neurodegenerative and AD pathology in NC A\\u03b2 AD oTau and AD A\\u03b2 Masteroids including abundant dystrophic neurites degenerating myelin membrane sheath disintegration glial engulfment and lipofuscin accumulation Figures 3I S3F S3G S3H S3I and S3J7476 14 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission To further delineate cell typespecific responses to amyloid and tau pathology we compared scRNAseq profiles from NC AD oTau NC A\\u03b2 and AD A\\u03b2 Masteroids uncovering both shared and distinct transcriptional alterations induced by oTau and A\\u03b2 UMAP projections demonstrated successful integration of all scRNAseq datasets and visualized changes in the relative proportions of cell types across conditions Figures S4A S4B S4C and S4D Differential gene expression analysis of the IN_NEU and EX_NEU clusters revealed an overall reduction in synaptic gene expression in AD A\\u03b2 Masteroids compared to NC Masteroids Figures S3K and S3L and ASC clusters exhibited diseaseassociated astrocyte features such as extensive upregulation of PLCG2 in AD A\\u03b2 Masteroids Figure S3M7778 Additionally the predicted interaction probability between EX_NEU and IN_NEU clusters was notably decreased in NC A\\u03b2 and AD A\\u03b2 Masteroids relative to NC consistent with observed neuronal loss by immunolabeling and the reduction in synaptic markers Figures S4I S4J S4K S4L S4Q S4R S4S and S4T Functional gene set enrichment analysis GSEA further revealed that AD A\\u03b2 Masteroids robustly recapitulate ADrelated pathway alterations Figure 3J They showed strong enrichment in respirasomal spliceosomal ribosomal neurodegenerative and stressresponse pathways alongside marked dysregulation of histone and immune signaling79 Conversely pathways linked to neuronal and glial morphology synaptic formation and function were substantially downregulated consistent with neuronal loss and impaired communication7980 Overall these results highlight the strong modeling of ADassociated cellular dysfunction in AD A\\u03b2 Masteroids 15 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 16 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 3 Propagation of oTau and A\\u03b2 oligomers in Masteroids mirrors key features of AD A Tiled and zstacked immunofluorescence images of control NC A\\ua7b5 oligomers only NC A\\ua7b5 oTau only AD and A\\ua7b5 oligomers and oTau AD A\\ua7b5 Masteroids with dsDNA nuclei stain DAPI cyan astrocytes GFAP green microglia IBA1 red and neurons TUJ1 magenta Scale bar 100\\u00b5m B Quantification of astrogliosis by GFAP raw integrated density normalized to Masteroid area C Quantification of microglia activation by IBA1 raw integrated density normalized to TUJ1 D Quantification of neuronal loss by TUJ1 raw integrated density normalized to Masteroid area E Immunofluorescence images of A\\ua7b5 plaques 6E10 yellow Scale bar 50\\u00b5m F Quantification of A\\ua7b5 burden by 6E10 raw integrated density normalized to Masteroid area G DAB staining images of misfolded tau MC1 H Quantification of misfolded tau by MC1 DAB staining normalized to Masteroid area I Electron microscopic view of neurodegenerative pathology in AD oTau Masteroid dystrophic neurite containing degenerated mitochondria red arrow multilamellar whorls and electron dense granules green arrow Scale bar 1\\u00b5m J Heatmap showing normalized enrichment scores NES of pathways in APOE3 AD A\\u03b2 Masteroids versus APOE3 NC Masteroids by scRNAseq Positive NES indicates upregulation in APOE3 AD A\\u03b2 Pathways include oxidative phosphorylation dark orange histone modifications pink ribosomal light orange spliceosomal yellow neurodegenerative green stress response teal immune signaling blue synaptic purple and neuronalglial morphology burgundy Error bars indicate 95 of the standard error of the mean p 005 p 001 p 0001 p 00001 Statistical analysis was done using oneway ANOVA with Fishers LSD B C D F and Tukeys multiple comparison test H See also Figures S3 and S4 oTau and A\\u03b2 Oligomer Seeding in APOE44 Masteroids Reveals APOE4Genotypic AD Pathology APOE4 Masteroids were generated using hiNeurons hiAstrocytes and hiMicroglia derived from homozygous APOE4 iPSCs and treated with the same selective seeding of oTau and A\\u03b2 oligomers as APOE33 Masteroids as described in Figure 3 Cell morphology and identity were confirmed through individual 2D cultures and immunostaining of whole Masteroids Figures 4A and 4B Proper neuronal and glial ultrastructure within APOE4 Masteroids was validated by EM imaging Figures S5A and S5B which revealed synaptic vesicles extensive cytoskeletal organization with microtubules neurofilaments and dendritic branching Figures S5C S5D S5E Extensive processes were also observed by both IF and EM imaging Figures 4B and S5F Cellular phenotypes of APOE4 Masteroids were further characterized by scRNAseq with UMAP 17 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission projections demonstrating integration across experimental conditions and visualizing relative proportional shifts in cell types between groups Figures S4E S4F S4G and S4H Pathological analyses were performed on APOE4 Masteroids to determine the impact of oTau and A\\u03b2 in this deleterious genotype The reactive astrocyte marker GFAP showed a significant increase in astrogliosis between APOE4 NC and APOE4 AD A\\u03b2 Masteroids confirmed by both immunofluorescence labeling and immunoblotting Figures 4C S5G and S5I scRNAseq analysis revealed elevated reactive astrocyte gene expression in the APOE4 AD A\\u03b2 ASC population compared to APOE4 NC ASC with significant upregulation of AD risk genes PLCG2 and CLU and enrichment of postmortem AD astrocyte signatures Figure S5M and S5N 8185 Significant microglial activation was observed across all noncontrol APOE4 Masteroid conditions with the strongest activation in APOE4 AD A\\u03b2 Masteroids Figures 4D S5H and S5J scRNAseq analysis demonstrated robust enrichment of diseaseassociated microglial DAM signatures with key genes including NEAT1 PICALM APOE MAPT CD44 PSEN1 SORL1 and GRN markedly upregulated in APOE4 AD A\\u03b2 Masteroids closely mirroring post mortem AD brain profiles Figures S5O and S5P8487 Notably PLCG2 showed striking upregulation and IGF1R emerged as one of the most prominently elevated transcripts in APOE4 AD A\\u03b2 Masteroids Figure S5O Neuronal analyses revealed significant loss in APOE4 NC A\\u03b2 and AD A\\u03b2 Masteroids compared to both APOE4 NC and AD oTau conditions Figures 4E S5H and S5K scRNAseq profiling further showed an increase in both inhibitory and excitatory neurons carrying ADassociated transcriptional signatures in APOE4 AD A\\u03b2 Masteroids compared to APOE4 NC Figures S5Q S5R S5S and S5T82 Interestingly no differences were detected between APOE4 NC and AD oTau or between APOE4 NC A\\u03b2 and AD A\\u03b2 groups in neuronal loss as indicated by TUJ1 intensity Figure 4E Wholeorganoid immunolabeling of APOE4 Masteroids with the 6E10 antibody revealed extensive A\\u03b2 plaque accumulation in both NC A\\u03b2 and AD A\\u03b2 conditions Figures 4F and 4G Notably despite the absence of exogenous A\\u03b2 oligomers 6E10positive plaques were detected in nonA\\u03b2 APOE4 Masteroids Although plaques were observed only in the APOE4 NC condition and not in the APOE4 AD oTau condition by wholeorganoid labeling both NC and AD oTau conditions exhibited plaque formation in 14\\u03bcm cryosections Figures S5U and S5V indicating that the APOE4 genotype alone is sufficient to drive endogenous plaque formation APOE4 Masteroids also developed extensive tau pathology with significant increases in 18 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission hyperphosphorylated labeled by pThr217 pSer202 oligomeric labeled by TOMA2 and misfolded tau MC1 in AD oTau and AD A\\u03b2 conditions Figures 4H 4I S5G S5L S5W S5X S5Y and S5Z The presence of A\\u03b2 did not further affect tau hyperphosphorylation on site pThr217 as NC and NC A\\u03b2 and AD oTau and AD A\\u03b2 groups showed comparable levels within each category Figures S5G S5L S5W and S5X However tau oligomerization and misfolding assessed with TOMA2 and MC1 antibodies followed a more severe pattern AD oTau and AD A\\u03b2 Masteroids developed significantly greater pathology than NC and NC A\\u03b2 groups and the addition of A\\u03b2 oligomers exacerbated these effects APOE4 AD A\\u03b2 Masteroids developed the highest burden of oligomeric and misfolded tau surpassing AD oTau Masteroids Figures 4I S5Y and S5Z Moreover ultrastructural analyses by EM revealed extensive neurodegenerative pathology Dystrophic neurites lipofuscin and degenerating myelin were detected across all conditions including APOE4 NC Masteroids Figures 4K S5AA S5BB and S5CC Morphologically abnormal mitochondria and pronounced vacuole accumulation were particularly evident in AD and AD A\\u03b2 Masteroids Figures 4K S5CC and S5DD In addition APOE4 AD A\\u03b2 Masteroids displayed striking glial engulfment with cytoplasmic inclusions containing phagocytosed material ranging from loose chromatin to dystrophic neurite fragments Figures 4J and S5EE Altogether APOE4 Masteroids alone developed A\\u03b2 plaques mild gliosis and neuronal dystrophy whereas addition of oTau and A\\u03b2 oligomers induced robust ADlike pathology including reactive astrocyte and microglial activation neuronal loss A\\u03b2 plaques tau hyperphosphorylation oligomerization and misfolding and ultrastructural neurodegeneration with the greatest severity observed in APOE4 AD A\\u03b2 Masteroids 19 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 20 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 4 oTau and A\\u03b2 Oligomer Seeding in APOE44 Masteroids Reveals APOE4 Genotypic AD Pathology A Immunofluorescence images of APOE4 iPSC induced neurons TUJ1 magenta astrocytes GFAP cyan and Microglia CD11b green P2RY12 red and IBA1 magenta with dsDNA stain DAPI Scale bar 50\\u00b5m B Tile scanned and zstacked immunofluorescence images of control NC A\\ua7b5 oligomer only NC A\\ua7b5 oTau only AD and A\\ua7b5 oligomer and oTau AD A\\ua7b5 APOE4 Masteroids with astrocytes GFAP green microglia IBA1 red and neurons TUJ1 magenta Scale bar 100\\u00b5m C Quantification of astrogliosis by GFAP labeling raw integrated density normalized to Masteroid area D Quantification of microglial activation by IBA1 labeling raw integrated density normalized to Masteroid area E Quantification of neuronal loss by TUJ1 labeling raw integrated density normalized to Masteroid area F Immunofluorescence images of amyloid plaques 6E10 yellow within Masteroids Scale bar 50\\u00b5m G Quantification of amyloid burden by 6E10 labeling raw integrated density normalized to Masteroid area H Immunofluorescence images of NC and AD A\\ua7b5 APOE4 Masteroids with astrocytes GFAP cyan microglia IBA1 red neurons TUJ1 magenta and oligomeric tau TOMA2 green Scale bar 50\\u00b5m I Quantitation of oligomeric tau labeled by TOMA2 antibody raw integrated density normalized to neuronal area J Electron microscopy EM image of glial engulfment in an APOE4 AD A\\ua7b5 Masteroid Green arrow points to loose chromatin engulfed while the red arrow points to engulfed dystrophic neurites Scale bar 2\\u00b5m K EM images of neurodegeneration in APOE4 AD left and APOE4 AD A\\ua7b5 right Masteroids Red arrow points to dystrophic neurites and degenerating myelin m depicts deformed and enlarged mitochondria cyan arrows depict lysosomes and magenta arrow points to filament bundles Scale bars 1\\u00b5m JK n nucleus m mitochondria Error bars indicate 95 standard error of the mean p 005 p 001 p 0001 p 00001 Statistical analysis was done using one way ANOVA with Fishers LSD C D E G and Tukeys multiple comparisons test I See also Figures S4 and S5 APOE44 significantly exacerbates AD pathology compared to APOE33 Having determined the impact of AD pathology within genotypes we wanted to examine the impact of the APOE4 genotype on AD pathology in comparison to the APOE3 isogenic control Notably APOE4 NC Masteroids develop A\\u03b2 plaques even in the absence of A\\u03b2 oligomer or AD oTau challenge which differs from APOE3 Masteroids Figures S5U and S5V In APOE4 21 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Masteroids neuronal loss did not differ significantly between NC and AD oTau conditions whereas APOE3 AD oTau Masteroids exhibited a significant reduction relative to APOE3 NC Figures 3D and 4E However when directly comparing between the genotypes APOE4 Masteroids exhibited significantly more neuronal loss compared to their APOE3 isogenic control with the most profound difference observed in the basal NC conditions Figures 5A and 5B This suggested that the lack of significant difference observed across the intermediate APOE4 conditions was due to an increase in severity at the basal level of APOE4 rather than a lack of neuronal loss in APOE4 AD oTau Masteroids This is further evidenced by the significant increase in neuronal loss in APOE4 AD oTau and AD A\\u03b2 Masteroids when directly compared to their respective APOE3 counterparts Figure 5B Additionally APOE4 A\\u03b2 Masteroids had significantly greater A\\u03b2 burdens than APOE3 A\\u03b2 Masteroids and the plaques in APOE4 A\\u03b2 Masteroids were generally larger and denser than those in APOE3 A\\u03b2 Masteroids Figures 5A and 5C There was also a remarkable increase in misfolded tau in APOE4 Masteroids compared to APOE3 Masteroids particularly in the NC and NC A\\u03b2 conditions Figures 5D and 5E Comparison of glial pathology between APOE4 and APOE3 Masteroids revealed that APOE4 Masteroids exhibit a more severe pathological baseline In APOE3 Masteroids significant astrogliosis was observed under intermediate conditions and reached its peak in the AD A\\u03b2 condition By contrast in APOE4 Masteroids only the AD A\\u03b2 condition showed significantly greater astrogliosis relative to the APOE4 baseline Figures 3B and 4C This was further supported by scRNAseq profiling of several top DEGs LFC 3 between APOE3 NC and APOE4 NC astrocytic clusters Figure 5F APOE4 NC astrocytes showed reduced expression of protective and amyloidclearance genes NTRK2 C1QL2 GAD2 NMU LRP2 HAP1 and upregulation of genes linked to A\\u03b2 accumulation and neuroinflammation CDH23 IFI168894 indicating a transcriptomic shift toward a more pathogenic state Figure 5F Notably many of the top 20 up and downregulated DEGs across major cell types in APOE3 NC versus APOE4 NC Masteroids were linked to AD indicating widespread dysregulation of ADassociated genes driven by the APOE4 genotype alone Figures S6A S6B S6C S6D and S6E84 In APOE3 Masteroids only the most severe condition combining AD oTau and A\\u03b2 oligomers induced significant microglial inflammation However all noncontrol APOE4 conditions exhibited significant microglial activation with the strongest response observed in the AD A\\u03b2 condition Figures 3C and 4D This trend suggests that microglial activation required less pathology in APOE4 22 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Masteroids than in APOE3 Masteroids indicating that APOE4 itself primes the Masteroids for an amplified inflammatory response scRNAseq profiling further highlighted genotype and cell typespecific dysregulation of ADassociated genes PLCG2 expression was elevated at baseline in APOE4 NC and remained higher across all cell types under AD A\\u03b2 challenge consistent with a primed inflammatory state in APOE4 Masteroids Figure S6F CLU expression also diverged by genotype APOE3 astrocytes and microglia upregulated CLU under AD A\\u03b2 whereas APOE4 microglia downregulated CLU and APOE4 neurons aberrantly increased it indicating a dysregulated Clusterin response in APOE4 Masteroids Figure S6G9596 To further determine the impact of APOE4 in pathologically challenged conditions we narrowed the scRNAseq analysis to compare between APOE4 AD A\\u03b2 and APOE3 AD A\\u03b2 which revealed widespread genotype and cell typespecific dysregulation of ADassociated genes Figures 5G 5H 5I 5J and S6H In excitatory EX_NEU and inhibitory IN_NEU neurons APOE4 Masteroids showed strong upregulation of APP MAPT PICALM TMEM106B CLU BACE1 and SORT1 while astrocytes ASC and microglia MG exhibited selective increases in MAPT CLU APOE PSEN1 and PLCG2 and oligodendrocytes Oligo showed similar trends for PICALM MAPT PLCG2 and SORT1 Figures 5K 5L 5M 5N and 5O CellChat network analysis revealed enhanced neuronalglial interaction probabilities in APOE4 compared to APOE3 Figure S6I indicating a more reactive and pathologically engaged cellular network By cross referencing a scRNAseq atlas of the entorhinal cortex from AD brains our clusterlevel analyses revealed stronger ADassociated neuronal and microglial signatures in APOE4 AD A\\u03b2 Masteroids accompanied by downregulation of protective A2 astrocyte signatures Figures S6J S6K S6L and S6M8297 Collectively these results demonstrate that APOE4 amplifies ADrelevant transcriptional dysregulation and intercellular network alterations under A\\u03b2 and oTauinduced stress producing a more severe genotypedependent pathology APOE4 drives stronger networked AD pathology than APOE3 underscoring its central role in genotypedependent disease progression 23 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 24 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 5 APOE44 significantly exacerbates AD pathology compared to APOE33 A Immunofluorescence images of amyloid plaques 6E10 yellow within A\\u03b2 Masteroid conditions Scale bar 50\\u00b5m B Quantification of neuronal loss by TUJ1 labeling raw integrated density normalized to Masteroid area C Quantification of A\\u03b2 plaques by 6E10 labeling raw integrated density normalized to Masteroid area D Representative images of MC1 in 14\\u00b5m thin sections of APOE3 and APOE4 Masteroids Scale bar 50\\u00b5m E Quantification of misfolded tau in APOE3 and APOE4 Masteroids by MC1 raw integrated density normalized to Masteroid area F Expression of top DEGs LFC 3 of ADassociated genes in APOE3 NC and APOE4 NC astrocytes ASC by scRNAseq Genes are colorcoded as follows downregulated in AD red protective against AD yellow involved in A\\u03b2 clearance green contributing to A\\u03b2 burden blue or upregulated in AD purple GJ Red dots indicate genes upregulated in APOE4 and those in blue are downregulated in APOE4 Log foldchange cutoffs are y 2 and 2 with a p value cutoff of 005 log10P 2 G Volcano plot of DEGs between APOE3 AD A\\ua7b5 and APOE4 AD A\\ua7b5 excitatory neurons EX_NEU H Volcano plot of DEGs between APOE3 AD A\\ua7b5 and APOE4 AD A\\ua7b5 inhibitory neurons IN_NEU I Volcano plot of DEGs between APOE3 AD A\\ua7b5 and APOE4 AD A\\ua7b5 astrocytes ASC J Volcano plot of DEGs between APOE3 AD A\\ua7b5 and APOE4 AD A\\ua7b5 microglia Microglial K Expression of differentially expressed ADassociated genes in APOE3 AD A\\u03b2 and APOE4 AD A\\u03b2 excitatory neurons by scRNA EX_NEU L Expression of differentially expressed ADassociated genes in APOE3 AD A\\u03b2 and APOE4 AD A\\u03b2 inhibitory neurons by scRNA IN_NEU M Expression of differentially expressed ADassociated genes in APOE3 AD A\\u03b2 and APOE4 AD A\\u03b2 astrocytes by scRNA ASC N Expression of differentially expressed ADassociated genes in APOE3 AD A\\u03b2 and APOE4 AD A\\u03b2 microglia by scRNA Microglial O Expression of differentially expressed ADassociated genes in APOE3 AD A\\u03b2 and APOE4 AD A\\u03b2 oligodendrocytes by scRNA Oligo Error bars indicate 95 standard error of the mean p 005 p 001 p 0001 p 00001 Statistical analysis was done using twoway ANOVA with Fishers LSD B C and E Blue bars are APOE3 conditions burgundy bars are APOE4 conditions See also Figures S4 and S6 APOE4 A\\u03b2 oligomers and oTau synergistically activate ADrelated pathways highlighting IGF signaling as a key mediator To delineate how APOE4 interacts with A\\u03b2 and oTau to influence AD pathogenesis we 25 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission performed Cytoscape STRING network analysis of differentially expressed genes DEGs across all major cell types in APOE4 AD A\\u03b2 Masteroids relative to APOE3 NC Network analysis revealed extensive transcriptional reprogramming across cell types Excitatory neurons EX_NEU and inhibitory neurons IN_NEU exhibited dysregulation of translational and ribosomal stress metabolic pathways synaptic activity chaperonemediated protein folding and cytoskeletal signaling RHO GTPase in EX_NEU ubiquitination and proteolysis in IN_NEU Figures 6A and 6B Inhibitory neurons IN_NEU showed further dysregulation in neurogenesis and cholesterol biosynthesis Figures 6A Astrocytes ASC showed enrichment for translational and ribosomal stress mitochondrial dysfunction neurodegenerationrelated pathways metabolism neurogenesis and development cellmatrix interactions and synaptic activity and immuneinflammatory responses Figures 6C Microglia Microglial exhibited transcriptional changes in translation immune and inflammatory responses proteolysis migration axon guidance and Wnt signaling Figures 6D9899 Oligodendrocytes Oligo were enriched for ribosome and translation transcriptional signaling cell adhesion and synapse formation oxidative phosphorylation and neurodegeneration pathways development and DNA damage responses Figures 6E Next analysis of top differentially expressed transcripts in APOE4 AD A\\u03b2 versus APOE3 NC highlights APOE4s broad impact on multicellular ADrelevant networks with IGFBP2 IGFBP5 and IGF1R key components of the IGF signaling pathway among the most significantly altered genes Figures 6F and S6N Across all cell types DEGs implicated in the IGF signaling axis were prominently altered suggesting APOE4 modulates neurotrophic and metabolic networks in response to A\\u03b2 and oTau stress Figures 6G S6O S6P S6Q S6R and S6S100 Collectively these results demonstrate that APOE4 synergizes with A\\u03b2 and oTau to drive widespread cell type specific transcriptional networks that converge on protein homeostasis synaptic function metabolism and neuroinflammation reinforcing its central role in exacerbating AD pathology 26 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 27 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 6 APOE4 A\\u03b2 oligomers and oTau synergistically activate ADrelated pathways highlighting IGF signaling as a key mediator AE MCL clustering of DEGs between APOE3 NC and APOE4 AD A\\u03b2 cell types see Methods p 005 with additive gene annotations Genes upregulated in APOE4 AD A\\u03b2 are shown in red and those downregulated are shown in blue A Gene interaction network of significant DEGs in inhibitory neurons IN_NEU B Gene interaction network of significant DEGs in excitatory neurons EX_NEU C Gene interaction network of significant DEGs in astrocytes ASC D Gene interaction network of significant DEGs in microglia Microglial E Gene interaction network of significant DEGs in oligodendrocytes Oligo F scRNAseq heatmap of log fold changes of ADassociated genes between APOE3 NC and APOE4 AD A\\u03b2 Genes upregulated in APOE4 AD A\\u03b2 are shown in red and those downregulated are shown in blue G scRNAseq comparison of IGF signaling gene expression in astrocytes ASC excitatory neurons EX_NEU inhibitory neurons IN_NEU microglia Microglial and oligodendrocytes Oligo between APOE3 NC and APOE4 AD A\\u03b2 Masteroids p 005 p 001 Statistical analysis was done using paired onesided Wilcoxon signedrank test G See also Figure S6 IGFBP inhibitor NBI 31772 ameliorates AD associated neuroinflammation Our scRNAseq data suggested that Insulinlike Growth Factor Binding Proteins IGFBPs and the Insulinlike Growth Factor IGF signaling pathway play a crucial role in the propagation of AD pathology in the Masteroid model Figures 5G 5H 5I 5J S6H 6F and 6G The IGF axis is a complex signaling pathway increasingly implicated in AD pathogenesis100108 IGFBPs particularly IGFBP2 and IGFBP5 have been shown to modulate IGF availability neuronal survival and synaptic function101102109 To test the involvement of IGFBPs and the IGF axis in AD pathological development we treated Masteroids with an IGFBP inhibitor a small molecule named NBI 31772 that has been successfully applied in retinal organoids previously109 All eight Masteroid conditions APOE4 oTau A\\u03b2 oligomers were treated with NBI 31772 at 05\\u00b5M for 4 days to assess the role of IGF signaling in AD pathology Treatment markedly reduced reactive astrogliosis neuronal loss and microglial inflammation in diseased Masteroids Figures 7 and S7 In APOE3 NC A\\u03b2 Masteroids NBI 31772 decreased astrogliosis but did not restore neuronal loss whereas APOE3 AD oTau Masteroids showed no change in astrogliosis but exhibited increased TUJ1 labeling indicating reduced neuronal loss Figures 7A 7B and 7C In the severe APOE3 AD A\\u03b2 condition NBI 31772 ameliorated both astrogliosis and neuronal loss 28 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figures 7B and 7C Similar effects were observed in APOE4 Masteroids treated NC A\\u03b2 AD oTau and AD A\\u03b2 Masteroids all showed significantly less neuronal loss than untreated controls though improvements in astrogliosis and microglial inflammation were limited to the severe APOE4 AD A\\u03b2 condition with intermediate conditions largely unaffected Figures 7B 7D 7E 7F S7A S7B S7C S7D S7E S7G and S7H While more APOE4 conditions showed partial neuronal recovery upon NBI 31772 treatment the effect was more pronounced in APOE3 Masteroids Figure 7B This likely reflects the higher baseline neuronal loss in APOE4 NC APOE4 AD oTau and APOE4 AD A\\u03b2 Masteroids where immunolabeling was already substantially reduced compared to APOE3 counterparts Figure 5B Nevertheless in all conditions exhibiting neuronal recovery NBI 31772 restored neurons to the baseline levels typical of their respective genotypes indicating that treatment effectively normalized neuronal capacity relative to the intrinsic genotypespecific baseline Figure 7B Surprisingly despite the pronounced reduction in glial activation and neuronal loss NBI 31772 treatment led to an increase in tau phosphorylation and misfolding Figures 7G 7H S7F S7H S7I and S7J Tau misfolding MC1 increased markedly in all APOE3 conditions following treatment whereas only APOE4 NC and NC A\\u03b2 Masteroids showed significant increases Consistent with the less pronounced neuronal recovery the increase in tau misfolding was less substantial in APOE4 Masteroids compared to APOE3 Masteroids Figures 7G and 7H Moreover NBI 31772 treated APOE4 NC and NC A\\u03b2 Masteroids exhibited higher tau hyperphosphorylation at pThr217 in 14\\u00b5m sections while APOE4 NC and AD A\\u03b2 Masteroids showed increased pSer202 phosphorylation by immunoblot Figures S7F S7H S7I and S7J Overall NBI 31772mediated inhibition of IGFBPs mitigates ADassociated neuroinflammation and neuronal loss across APOE3 and APOE4 Masteroids while paradoxically increasing tau phosphorylation and misfolding highlighting a complex genotypedependent role of IGF signaling in AD pathology 29 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 30 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Figure 7 IGFBP inhibitor NBI 31772 ameliorates ADassociated neuroinflammation A Immunofluorescence images of APOE3 Masteroids NBI 31772 treatment Neurons TUJ1 magenta astrocytes GFAP cyan and microglia IBA1 red are shown Scale bar 50\\u00b5m B Quantification of neuronal loss in all conditions by TUJ1 raw integrated density normalized to Masteroid area C Quantification of astrogliosis in APOE3 Masteroids by GFAP raw integrated density normalized by Masteroid area D Quantification of astrogliosis in APOE4 Masteroids by GFAP raw integrated density normalized by Masteroid area E Western blot band of IBA1 and corresponding \\u03b2actin F Quantification of microglial activation in APOE4 Masteroids by IBA1 Western blot raw integrated density with background subtraction normalized by \\u03b2actin G DAB images of MC1 in 14\\u00b5m thin APOE3 and APOE4 Masteroid sections NBI 31772 treatment Scale bar 50\\u00b5m H Quantification of misfolded tau burden in Masteroids NBI 31772 treatment by MC1 raw integrated density normalized to Masteroid area Error bars indicate 95 standard error of the mean p 005 p 001 p 0001 p 00001 Statistical analysis was done using twoway ANOVA with Fishers LSD B C D E and G Bars with stripes represent NBI 31772 treatment See also Figure S7 DISCUSSION Alzheimers disease AD is a complex neurodegenerative disorder in which the interplay between genetic risk factors and pathological hallmarks such as amyloidbeta A\\u03b2 and tau drives disease progression1110 Modeling these interactions in a humanrelevant system has remained challenging particularly in the preclinical and prodromal stages of AD Our APOE3 and APOE4 Masteroid model provides a robust platform to interrogate both individual components and their synergistic effects on AD pathology while also enabling functional studies of genotypespecific contributions and therapeutic interventions Consistent with clinical observations our analysis with the pan ADNI PET scan imaging dataset revealed that APOE4 markedly exacerbates amyloid deposition and tau pathology in preclinical and prodromal stages with severity increasing with allele dosage111 Notably in our Masteroid model APOE4 NC organoids developed A\\u03b2 plaques and tau hyperphosphorylation even in the absence of exogenous seeding of A\\u03b2 oligomers or oTau highlighting the intrinsic pathogenic influence of the APOE4 genotype These findings recapitulate the early genotype driven disease processes that are nearly impossible to study in living humans By incorporating 31 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission excitatory and inhibitory neurons astrocytes microglia and oligodendrocytes our Masteroid brain organoid system matures rapidly within five weeks while maintaining functional synapses proper membrane potential action potential propagation and active ligandreceptor interactions The endogenously generated oligodendrocytes in the Masteroids further provides the potential to study myelin dynamics neurodegeneration and other CNS disorders including multiple sclerosis in a versatile and reproducible humanrelevant system112 The functional robustness of our Masteroids is extensively underscored by electrophysiological recordings which demonstrate healthy wellformed neuronal networks capable of patchclamp analysis This confirms both the biophysical integrity and the intercellular connectivity necessary for modeling complex AD pathology Compared to traditional cerebral organoids or rodent models15282933 our system achieves functional maturity and multilineage composition in a fraction of the time bridging a critical gap in translational research At the molecular level scRNAseq reveals that APOE4 significantly amplifies ADassociated transcriptional programs across neurons and glia By combining oTau and A\\u03b2 in our assembloids a feature largely absent in previous APOE4 organoid or spheroid models we provide the first system capable of dissecting the combined impact of multiple pathological components in a human genotypespecific context Importantly our data demonstrates that APOE4 not only exacerbates neurodegeneration and glial activation but also modulates critical pathways including the IGF signaling axis105 highlighting mechanisms that may underlie genotypespecific vulnerability The utility of this model extends to translational applications Treatment with the IGFBP inhibitor NBI 31772 reduced astrogliosis microglial activation and neuronal loss particularly in APOE3 Masteroids but paradoxically increased tau phosphorylation and misfolding These results mirror the differential efficacy and resistance observed among specific genotypic populations in human clinical trials underscoring the predictive value of the Masteroid system for evaluating genotypedependent therapeutic responses By capturing both the protective and deleterious effects of interventions our model provides a platform for optimizing drug candidates before clinical testing Overall the Masteroid system demonstrates remarkable versatility allowing for the study of individual AD components genotypespecific effects and complex interactions between A\\u03b2 tau and APOE4 It faithfully recapitulates key features of human AD including amyloid plaque 32 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission formation tau pathology neuroinflammation and neuronal loss while providing a rapid and reproducible platform for mechanistic studies and therapeutic testing By bridging the gap between in vitro and in vivo models Masteroids hold significant promise for advancing our understanding of AD pathogenesis and for accelerating the development of genotypetailored therapies Limitations of the study While Masteroids capture key neuronal and glial components and recapitulate AD pathology they lack full cellular diversity vascularization and longrange brain connectivity Electrophysiological and network properties may not fully reflect the adult human brain and the accelerated in vitro disease timeline may not model slow chronic processes Systemic factors and peripheral immune interactions are absent and therapeutic responses may not fully predict clinical outcomes Despite these limitations Masteroids provide a reproducible manipulable human relevant platform for studying genotypespecific mechanisms and testing candidate interventions Resource availability Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact Lulu Jiang jiangluluvirginiaedu Materials availability This study did not generate new unique reagents Data and code availability Single cell RNAseq data generated in this study will be deposited in the NCBI Gene Expression Omnibus GEO and made publicly available upon publication This paper used existing R and STRING code packages and does not report original code Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request Acknowledgments Postmortem human brain tissues were provided by the Emory University Goizueta Alzheimers Disease Research Center P30 AG066511 We thank Dr Rakez Kayed and his lab 33 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission for their generous support in providing the TOMA2 antibody We also acknowledge the late Dr Peter Davies NorthwellHofstra and the Feinstein Institutes for Medical Research for providing the CP13 and MC1 antibodies Electron Microscopy sample preparation was performed using the Leica UC7 at the Molecular Electron Microscopy Core supported by the University of Virginia School of Medicine RRID SCR_019031 The RNA sequencing was conducted at the Genome Analysis and Bioinformatics Core at UVA RRIDSCR_018883 We are grateful for the following funding support to LJ UVA Provost Award UVA Health System Virginia Alzheimers disease Center 2023 Pitch and Catch funding UVA Brain Institute Transformative Neuroscience Pilot Grant Jim and Bruce Eck Fund Strang Neuroscience Research Award NIHNIA R01AG091577 Commonwealth Health Research Board Award Cure Alzheimers Fund Data collection and sharing for Figure 1 of this project was funded by the Alzheimers Disease Neuroimaging Initiative ADNI National Institutes of Health Grant U01 AG024904 and DOD ADNI Department of Defense award number W81XWH1220012 ADNI is funded by the National Institute on Aging the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following AbbVie Alzheimers Association Alzheimers Drug Discovery Foundation Araclon Biotech BioClinica Inc Biogen Bristol Myers Squibb Company CereSpir Inc Cogstate Eisai Inc Elan Pharmaceuticals Inc Eli Lilly and Company EuroImmun F HoffmannLa Roche Ltd and its affiliated company Genentech Inc Fujirebio GE Healthcare IXICO Ltd Janssen Alzheimer Immunotherapy Research Development LLC Johnson Johnson Pharmaceutical Research Development LLC Lumosity Lundbeck Merck Co Inc Meso Scale Diagnostics LLC NeuroRx Research Neurotrack Technologies Novartis Pharmaceuticals Corporation Pfizer Inc Piramal Imaging Servier Takeda Pharmaceutical Company and Transition Therapeutics The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada Private sector contributions are facilitated by the Foundation for the National Institutes of Health wwwfnihorg The grantee organization is the Northern California Institute for Research and Education and the study is coordinated by the Alzheimers Therapeutic Research Institute at the University of Southern California ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California Author contributions 34 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Conceptualization LJ Investigation ES KQ RR AZ AE LJ LS SL HS LI WG KS Visualization ES KQ RR LS HS AZ AE LJ Data analysis ES KQ LS SL AZ Writing Editing ES LJ KQ RR LS SL HS AT AZ AE JK JS Supervision LJ Declaration of interests LJ and ES have filed a patent application related to the technology described in this manuscript The authors declare no other competing interests 35 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission STAR METHODS KEY RESOURCES TABLE in the supplemental material LEAD CONTACT AND MATERIALS AVAILABILITY Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact Lulu Jiang jiangluluvirginiaedu EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell Culture Cell maintenance All cell cultures were maintained at 37C with 5 CO2 All cell counts were performed in duplicates using the C100 Automated Cell Counter RWD with trypan blue Human induced pluripotent stem cells iPSC Human iPSCs were obtained from Jackson Laboratory JIPSC001150 JIPSC001162 and maintained as a monolayer culture in StemFlex medium Thermo Fisher Scientific cat A3349401 with 1 PenicillinStreptomycin Thermo Fisher Scientific cat 15070063 on Corning Matrigel hESCqualified Matrix Corning cat 354277 coated tissue culture plates 1X RevitaCell Supplement Thermo Fisher Scientific cat A2644501 was added to the medium when thawing iPSCs were passaged at 80 confluency by Accutase Stemcell Technologies cat 07920 dissociation as necessary A full media change was performed every other day iPSCs were cryopreserved in CryoStor CS10 Stemcell Technologies cat 07959 All iPSCs used for experimentation were maintained at passage 10 iPSC neuronal progenitor cell hiNPC Human iPSCs were passaged and plated at 50000 cellscm2 in STEMdiff SMADi Neural Induction medium Stemcell Technologies cat 08581 with 10\\u00b5M ROCK inhibitor Y27632 Stemcell Technologies cat 72304 and 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture plates hiNPCs were maintained in monoculture and passaged at 90 confluency by Accutase dissociation as necessary A full media change was performed every other day hiNPCs were cryopreserved STEMdiff Neural Progenitor Freezing Medium Stemcell Technologies cat 05838 36 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission iPSC neuronal cell hiNeuron After 18 days in STEMdiff SMADi Neural Induction medium hiNPCs were passaged and plated at 50000 cellscm2 in STEMdiff Forebrain Neuron Differentiation Medium Stemcell Technologies cat 08600 with 10\\u00b5M ROCK inhibitor Y27632 and 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture plates and transduced with a NEUROG2 lentivirus GeneCopoeia cat CLPHPRM50462LvPF02A00 at MOI 2 to induce iPSCderived neuronal cells hiNeurons After 48 hours the cells were again transduced using the same NEUROG2 lentivirus to ensure complete transduction A full media change was performed 24 hours after each transduction iPSC astrocytic cell hiAstrocyte iPSCderived astrocyte progenitor cells hiAPCs were differentiated from hiNPCs After 19 days in STEMdiff SMADi Neural Induction Medium NPCs were passaged and plated at 50000 cellscm2 in STEMdiff Astrocyte Differentiation Medium Stemcell Technologies cat 100 0013 with 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture plates A full media change was performed daily for 5 days then every other day for 15 days passaging as needed with Accutase dissociation The differentiated hiAPCs were cryopreserved in CryoStor CS10 At the time of experimentation hiAPCs were thawed in STEMdiff Astrocyte Maturation Medium Stemcell Technologies cat 1000016 with 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture plates A full media change was performed every other day for 5 days with one passage by Accutase at 90 confluency as necessary iPSC hematopoietic progenitor cell hiHPC iPSC derived hematopoietic progenitor cells hiHPCs were differentiated from iPSCs Human iPSCs were plated in StemFlex medium with 1 PenicillinStreptomycin as small aggregates on Corning Matrigel hESCqualified Matrix coated tissue culture plates The next day the StemFlex medium was removed and replaced with STEMdiff Hematopoietic Basal Medium containing Supplement A Stemcell Technologies cat 05310 and 1 Penicillin Streptomycin After two days a half media change was performed The following day considered day 3 the medium was changed to STEMdiff Hematopoietic Basal Medium containing Supplement B and 1 PenicillinStreptomycin A half media change was performed on days 5 7 37 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission and 10 hiHPCs were harvested at day 12 and either directly differentiated into microglia or cryopreserved in CryoStor CS10 iPSC microglial cell hiMicroglia iPSC derived microglia hiMicroglia were derived from hiHPCs hiHPCs were plated in STEMdiff Microglia Differentiation Medium Stemcell Technologies cat 1000019 and 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture plates 1mL of medium was added every 23 days After 12 days the cell suspension was collected and replated in the same medium After 24 days in differentiation medium the hiMicroglia were cryopreserved in CryoStor CS10 Four days prior to experimentation hiMicroglia were thawed in STEMdiff Microglia Maturation Medium Stemcell Technologies cat 1000020 with 1 PenicillinStreptomycin on Corning Matrigel hESCqualified Matrix coated tissue culture plates 1mL of medium was added every other day Masterioid generation and maintenance A single cell suspension of hiNeurons and hiAstrocytes was prepared by Accutase dissociation and washed once with DMEMF12 Stemcell Technologies cat 36254 to remove debris as described before37 A single cell suspension of hiMicroglia was prepared by collecting the floating cells and washing once with DMEMF12 hiNeurons hiAstrocytes and hiMicroglia were combined in a 454510 ratio in Masteroid medium DMEMF12 Stemcell Technologies cat 36254 1 Glutamax Thermo Fisher Scientific cat 35050061 1 sodium pyruvate Thermo Fisher Scientific cat 11360070 1 N2 Supplement Thermo Fisher Scientific cat 17502048 1 B27 Supplement Thermo Fisher Scientific 17504044 10\\u00b5M Y276321 PenicillinStreptomycin 1mgmL Heparin SigmaAldrich cat H3149250KU and 10 STEMdiff Microglia Maturation Medium passed through a 40\\u00b5m cell strainer and plated at 2000 cellsmicrowell in AggreWell800 microwells Stemcell Technologies cat 34815 coated in AntiAdherence Rinsing Solution Stemcell Technologies cat 07010 The Aggrewell plate was immediately centrifuged at 100g for 3 minutes to capture the cells in the microwells and incubated for 24 hours A halfmedia change was performed at 24 hours and then every other day for 1 week At 1 week when the spheroids displayed a smooth bright edge under the cell culture microscope cultures were transferred to ultralowattachment roundbottom 96well plates 38 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Thermo Fisher Scientific cat 174929 and maintained in 200\\u00b5L Masteroid media rotating at 65rpm For the generation of Masteroids with AD oTau seeding hiNeurons were exposed to 40ngmL oTau fraction extracted from postmortem AD brain tissues or agematched normal control by direct admission into cell culture media for 24 hours prior to their incorporation into Masteroid The concentration of oTau fraction to be added into the iNeurons was determined by doseresponse test For the Masteroids with A\\u03b2 oligomers conditions Masteroids were exposed to 05\\u00b5M A\\ua7b5 oligomers or vehicle control DMSO after 1 week when the Masteroids were transferred to 96 well plates Anaspec cat AS6412905 The dose of A\\u03b2 oligomers were determined by a dose response test in hiNeurons and hiAstrocyte For NBI 31772 treatment Masteroids were exposed to 05\\u00b5M of NBI 31772 MedChemExpress cat HY110135 or vehicle control DMSO at 5 days before collection Half media change was performed daily with 1\\u00b5M NBI 31772 to maintain the 05\\u00b5M concentration 2D neuron and glial culture treatment At the time point of creating the Masteroids individual cultures of hiNeurons hiAstrocytes and hiMicroglia were passaged and plated in Masteroid media onto Corning Matrigel hESC qualified Matrix coated tissue culture 8 well chambers Half media changes were performed every other day Oligomer processing Generation of S1p oTau fraction The anonymous postmortem human brain tissues used in this study were sourced from the brain bank of the Emory Goizueta Alzheimers Disease Research Center ADRC funded by NIH P30AG066511 All fresh frozen tissue samples 8 agematched control and 8 AD were de identified and obtained from the human prefrontal cortex tissues Brodmann Area 10 within the same patient cohort These brain regions were selected due to their consistent availability in the brain bank and previous research indicating high positive correlations between altered gene expression and disease severity measures regardless of the classification scheme for disease severity113 The generation of S1p oTau fractions was consistent with previous publications6870 In brief frozen sections were weighed 100250mg and put into polycarbonate thick wall 15mL 39 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission tubes Beckman Coulter cat 357448 A 10x volume of homogenization buffer Hsaio TBS buffer 50mM Tris pH 80 274mM NaCl 5mM KCl supplemented with cOmplete Protease Inhibitor Cocktail Roche cat 05892791001 and the phosphatase inhibitor cocktail PhosSTOP Roche cat 04906837001 was used to homogenize brain tissue The homogenate was centrifuged at 29800 x g for 20 minutes at 4C The supernatant was then centrifuged a second time at 150000 x g at 4C for 40 minutes The TBSextractable pellet S1p fraction was resuspended with 50uL TE buffer 10mM Tris pH 80 1mM EDTA 5mM KCl supplemented with cOmplete Protease Inhibitor Cocktail and PhosSTOP relative to the starting weight of the tissue homogenized aliquoted and frozen at 80C Tau oligomerization was confirmed through running a western blot and visualizing total misfolded and oligomerized tau with AntiTau Antibody clone Tau5 Millipore Sigma cat MAB361 and PhosphoTau Thr217 Polyclonal Antibody Thermo Fisher Scientific cat 44744 The human brain tissue samples used in this study were all deidentified All studies included both sexes and results were integrated by covariate analysis as described below Primary Neuropathologic Braak Age at Age at Duration Diagnosis Stage Onset DeathBx years APOE Race Sex Alzheimers disease AD VI 49 59 10 E33 w m AD VI 59 69 10 E34 w m AD VI 53 71 18 E34 w m AD VI 65 80 15 E34 b f AD V 77 83 6 NA w f AD V 86 92 6 E34 w f AD V 82 92 10 E33 w m AD VI 80 93 13 E34 w f Normal Control NC I NA 59 NA E23 b m NC I NA 70 NA E33 b m NC I NA 72 NA E33 w m NC II NA 78 NA E33 w f NC IV NA 84 NA E23 b f NC III NA 91 NA E33 w f NC III NA 92 NA E33 w f NC II NA 94 NA E33 w m Preparation of A\\ua7b5 oligomers 40 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 05mg of human betaAmyloid 142 Anaspec cat AS6412905 was dissolved in 50\\u00b5L of filtered DMSO then transferred to a 15mL Protein LoBind Eppendorf tube Eppendorf cat 022 431081 The dissolved A\\u03b2 was sonicated at a high power 550 Sonic Dismembrator machine output power 550W output frequency 20KHz on ice for 2 minutes then resuspended with 60\\u00b5L of neurobasal medium Thermo Fisher Scientific cat 21103049 for a final concentration of 1mM The resuspension was rotated at 4C for 24 hours to promote oligomerization Oligomerization was confirmed through running a nativepage gel and visualizing with Purified anti\\u03b2Amyloid 116 Antibody BioLegend cat 803001 A\\ua7b5 oligomers were aliquoted and stored at 80C Sample collection Masteroid fixation for immunofluorescence At the time of collection Masteroids were transferred to a 15mL Protein LoBind Eppendorf tube Eppendorf cat 022431081 and allowed to settle The supernatant was discarded and the Masteroids were fixed in 4 PFA in 1x PBS for 15 minutes After fixation Masteroids were washed 3 times for 10 minutes each in 1x PBS Samples were stored in 1x PBS at 4C Masteroid fixation for electron microscopy At the time of collection Masteriods were transferred to a 15mL tube and allowed to settle The supernatant was discarded and the Masteroids were fixed with 4 PFA and 25 glutaraldehyde Electron microscopy sciences cat 16316 in 1x PBS for 20 minutes After fixation Masteroids were washed 2 times for 10 minutes each in 1x PBS Samples were stored in 4 PFA in 1x PBS at 4C 2D individual culture fixation for immunofluorescence After 1 week in culture the individual cell types were washed once with 1x PBS then fixed in 4 PFA in 1x PBS for 15 minutes After fixation chambers were washed 3 times for 10 minutes each in 1x PBS Samples were stored in 1x PBS at 4C Protein lysate At the time of collection 16 pooled Masteroids per condition were transferred to a 15mL Protein LoBind Eppendorf tube and allowed to settle The supernatant was discarded and the Masteroids were washed once with PBS The PBS was discarded and the samples were flash 41 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission frozen and stored at 80C Samples were subsequently lysed by mechanical homogenization in 40\\u00b5L of Hsiao TBS buffer 50mM Tris pH 80 274mM NaCl 5mM KCl supplemented with cOmplete Protease Inhibitor Cocktail Roche cat 05892791001 and the phosphatase inhibitor cocktail PhosSTOP Roche cat 04906837001 200U of Benzonase SigmaAldrich cat E101425KU with 1mM MgCl2 was added for removal of nucleic acids Lysate concentration was quantified by the Pierce BCA assay according to the manufacturers protocol Thermo Fisher Scientific cat 23225 14\\u00b5m thin sectioning of Masteroids Masteroids were pooled per condition and fixed in a freshly prepared solution of 4 paraformaldehyde and 01 glutaraldehyde in PBS for 5 minutes at room temperature After fixation samples were washed three times in PBS for 10 minutes each A thin layer of a 3 agar solution maintained at 55C was poured into a 35mm petri dish Masteroids were carefully transferred to the petri dish and positioned on the same layer no more than 1cm apart and additional 3 agar solution was used to fully embed the Masteroids then cooled for 15 minutes to solidify The block containing the Masteroids was separated using a razor blade then carefully extracted with a spatula To prevent freezing artifacts during cryosectioning Masteroids were equilibrated in 30 sucrose for 24 hours at 4C Embedded samples were sectioned at 14\\u00b5m thickness using a lowprofile blade in a cryochamber at 30C and collected onto positively charged glass slides Slides with Masteroid sections were stored at 4C Conditioned media collection 60\\u00b5L of conditioned cell culture media from replicate Masteroid wells were collected in flat bottomed 96well plates and frozen at 20C Sample processing Immunofluorescence labeling Selected Masteroids from each condition were washed in 150\\u00b5L PBS for 10 minutes in a U bottom 96well plate and then permeabilized in 150\\u00b5L PBS025 Triton X100 PBST for 30 minutes The Masteroids were blocked with 150\\u00b5L PBST with 5 Bovine Serum Albumin BSA and 5 Normal Goat Serum NGS for 1 hour at room temperature RT After blocking the Masteroids were incubated in primary antibodies diluted in 5 BSA in PBST overnight at 4C 42 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Plates were wrapped with parafilm and photobleached by an LED lamp The following day the Masteroids were washed 3 times with PBST for 10 minutes each before being incubated in secondary antibodies diluted 11000 of Alexaconjugated antibodies made from goat purchased from Thermo Fisher Scientific in PBST with 5 BSA for two hours The Masteroids were protected from light and washed 3 times with PBST for 10 minutes each followed by one 10 minute wash with PBS For Masteroids stained with DAPI Nucleic Acid Stain Thermo Fisher Scientific cat 62248 15000 of 1mgmL stock was diluted in PBST and incubated with asteroids for 15 minutes followed by 2 washes with PBST then 1 with PBS 10 minutes each Masteroids were then mounted onto microscope glass slides in Prolong Gold Antifade Mountant Thermo Fisher Scientific cat P36934 and protected from light All washing and incubated steps were done with agitation Primary antibodies used for Masteroid immunofluorescent labeling were as follows Tuj1Anti BetaTubulin 3 Antibody chicken Aves Labs cat TUJ 1500 GFAP Monoclonal Antibody rat Thermo Fisher Scientific cat 130300 1500 Anti Iba1 rabbit FUJIFILM Wako Pure Chemical Corporation cat 01919741 1300 Anti Iba1 goat FUJIFILM Wako Pure Chemical Corporation cat 01127991 1300 Monoclonal antiTOMA2 mouse provided by Dr Rakez Kayed 1500 Myelin Basic Protein rabbit Cell Signaling Technology cat 78896 1500 6E10Purified anti\\u03b2Amyloid 116 Antibody mouse BioLegend cat 803001 1500 CD11b Antibody clone 5C6 rat BioRad cat MCA711G 1300 AntiP2Y12 Antibody rabbit Abcam cat ab300141 1500 and AntiMicrotubuleAssociated Protein Antibody chicken Antibodies Incorporated cat MAP 1500 Secondary antibodies used for Masteroid immunofluorescent labeling were as follows Goat antiRat IgG HL Alexa Fluor 405 Thermo Fisher Scientific cat A48261 Goat antiRat IgG HL Alexa Fluor 488 Thermo Fisher Scientific cat A11006 Goat antiRabbit IgG HL Alexa Fluor 488 Thermo Fisher Scientific cat A11008 Goat antiRabbit IgG HL Alexa Fluor 594 Thermo Fisher Scientific cat A11012 Goat antiMouse IgG HL Alexa Fluor 405 Thermo Fisher Scientific cat A48255 Goat antiMouse IgG HL Alexa Fluor 488 Thermo Fisher Scientific cat A28175 Donkey antiGoat IgG HL Alexa Fluor 647 Thermo Fisher Scientific cat A21447 and Goat antiChicken IgG HL Alexa Fluor 647 Thermo Fisher Scientific cat A32933 More details are available from the Key Research Table in the supplemental materials Immunofluorescence staining of 14\\u00b5m thin sections of Masteroids 43 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Masteroids were sliced and collected onto slides as described in the 14\\u00b5m thin sectioning of Masteroids protocol Sections were outlined with a hydrophobic barrier using a PAP pen and air dried before staining Immunofluorescence staining was performed as described in the Immunofluorescence Staining protocol with the modification of using 01 Triton X100 in PBS instead of 025 Immunohistochemistry single stain with DAB 33diaminobenzidine of 14\\u00b5m thin sections of Masteroids Masteroids were sliced and collected onto slides as described in the 14\\u00b5m thin sectioning of Masteroids protocol All subsequent steps were performed at room temperature unless otherwise specified Sections were outlined with a hydrophobic barrier using a PAP pen and airdried before staining Sections were washed in PBS for 10 minutes then treated with 1 H O diluted in dH2O 2 2 for 15 minutes Sections were rinsed twice in PBS for 15 minutes each then blocked with 04 Triton X100 with 1 BSA and 4 NGS in PBS for 30 minutes After blocking sections were incubated overnight in 1 antibody diluted in DAKO antibody diluent 5 BSA in 025 TritonX 100PBS at 4C with photobleaching The following day sections were rinsed twice in PBS for 15 minutes then incubated for one hour in BTA solution 044 Biotinylated goat antirabbit mouse depending on 1 antibody IgG diluted in 03 Triton X100PBS Sections were rinsed twice in PBS then treated with Avidin Biotin Complex ABC 088 Avidin 088 Biotin diluted in 03 Triton X100PBS prepared 30 minutes prior to use Vector Laboratories cat PK6101 After ABC incubation sections were washed three times in PBS for 10 minutes each DAB solution was prepared by adding 1 tablet DAB Millipore Sigma cat D42935SET and 1 tablet Urea SigmaAldrich cat D4193 to 5mL dH O and vortexed until fully dissolved DAB 2 solution was added to sections individually for one to three minutes until section turned medium brown in color then were immediately placed in PBS Sections were washed twice with PBS for five minutes each then dried overnight at 37C The following day sections were dehydrated by washing in 70 EtOH 85 EtOH 95 EtOH and 100 EtOH for two minutes each followed by washing in 100 EtOH for five minutes Slides were then cleared by washing twice in Xylene for five minutes followed by immediately dropping 50\\u00b5L of Permount Mounting Medium Thermo Fisher Scientific cat SP15500 and covering with glass coverslips Slides were dried overnight in the fume hood and stored at 4C for long term storage All washing and incubated steps were done with agitation Primary antibodies used for Masteroid DAB labeling were as 44 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission follows MC1 mouse Dr Peter Davies and the Feinstein Institutes for Medical Research 1300 and PhosphoTau Thr217 Polyclonal Antibody rabbit Thermo Fisher Scientific cat 44744 1500 Secondary antibodies used for Masteroid DAB labeling were as follows Goat antiRabbit IgG Antibody HL Biotinylated Vector Laboratories cat BA1000 and Goat antiMouse IgG Antibody HL Biotinylated Vector Laboratories cat BA9200 More details are available from the Key Research Table in the supplemental materials Electron microscopy The protocol for sample preparation is consistent with previous publications114 In brief Resin embedding for electron microscopy followed standard protocols Masteroids fixed with 4 PFA and 25 glutaraldehyde EMS cat 16316 were transferred to Beem Capsules EMS cat 70010B in 01M phosphate buffer PB and allowed to settle All subsequent steps were carried out in the same Beem Capsules About half of the buffer was removed and replaced with 1 osmium tetroxide in 01M PB then once the Masteroids were visible all the buffer was removed and replaced with the 1 osmium tetroxide solution for one hour The Masteroids were then transferred into 50 EM grade ethanol EMS cat 15055 for three minutes and counterstained with filtered 4 uranyl acetate in 70 ethanol overnight in the refrigerator The sections were dehydrated through a series of ethanol and EM grade acetone EMS cat 10015 solutions and infiltrated with a 11 ratio of EPON EMbed 812 resin EMS cat 14121 and acetone overnight They were then transferred to 100 EPON resin overnight Capsules were then placed in a 60C oven for 48 hours until hardened the resin block is removed from the capsules the block face was trimmed to 1x2mm that contains multiple Masteroids and then cut into ultrathin 6070nm sections using an ultramicrotome Leica Ultracut UCT7 The ultrathin sections were collected on 200 mesh copper grids EMS cat Cu G200TTCu and slot copper grids EMS cat FCF2010 Cu50 in ultrapure water and allowed to dry before imaging Immunoblot Western blot 10\\u00b5g of Masteroid lysate was separated by denaturing gel electrophoresis SDSpage and transferred onto a nitrocellulose membrane The membrane was blocked for an hour in 5 non fat milk in 01 Tween20 in 1x PBS PBST and incubated in primary antibody dilution antibody dependent in 5 BSA PBST overnight at 4C The following day the membrane was washed with PBST for 3 times for 10 minutes each then incubated with secondary antibody 45 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 15000 conjugated with horseradish peroxidase Thermo Fisher Scientific cat G21040 cat A16054 cat G21234 cat A16054 in 5 BSA PBST for 2 hours at RT The membrane was washed with PBST 3 times for 10 minutes before briefly being washed with PBS prior to visualization Antibody staining was visualized using SuperSignal West Pico PLUS Chemiluminescent Substrate Thermo Fisher Scientific cat 34578 and imaged by ChemiDoc Imaging System BioRad For reprobing membranes were incubated in Restore PLUS Western Blot Stripping Buffer Thermo Fisher Scientific cat 46430 for 15 minutes at RT Band intensities were quantified using ImageJ Protein abundance was normalized to total Beta Actin with background subtraction Primary antibodies used for immunoblotting were as follows IBA1 Polyclonal Antibody rabbit Proteintech cat 109041AP 11000 GFAP Monoclonal Antibody rat Thermo Fisher Scientific cat 130300 11000 6E10Purified anti\\u03b2Amyloid 116 Antibody mouse BioLegend cat SIG39320 11000 Beta Actin Monoclonal Antibody mouse Proteintech cat 660091Ig 12000 NeuN Polyclonal Antibody rabbit Thermo Fisher Scientific cat PA578499 11000 and CP13 mouse Dr Peter Davies and the Feinstein Institutes for Medical Research 11000 Secondary antibodies used for immunoblotting were as follows Goat antiRabbit IgG HL HRP Thermo Fisher Scientific cat G21234 12000 Goat antiMouse IgG HL HRP Thermo Fisher Scientific cat G21040 12000 and Goat antiRat IgG HL HRP Thermo Fisher Scientific cat A18865 12000 More details are available from the Key Research Table in the supplemental materials LDH cytotoxicity assay The CyQUANT LDH Cytotoxicity Assay was performed as per manufacturers instructions using 50\\u00b5L conditioned media replicates to measure lactate dehydrogenase LDH release Thermo Fisher Scientific cat C20301 The assay 490nm and 680nm absorbance readings were taken on an Epoch microplate spectrophotometer BioTek Singlecell RNAsequencing sample preparation The protocol for Singlecell RNAsequencing sample preparation was consistent from our previous publication37 In brief for each condition 30 Masteroids were pooled in a 15mL Protein LoBind Eppendorf tube and allowed to settle The supernatant was discarded and a singlecell suspension was produced by incubation in 500\\u00b5L of digestion buffer Accutase with 80 UmL Protector RNase Inhibitor Sigma Aldrich cat 3335399001 for 1 hour at 37C with gentle 46 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission pipette mixing every 10 minutes At the end of the incubation the singlecell suspension was washed with 500\\u03bcL wash buffer 002 BSA in 1X PBS with 80 UmL Protector RNase Inhibitor and passed through a 20\\u03bcM filter Miltenyi Biotec cat 130101812 to a fresh 2mL Protein LoBind Eppendorf After another centrifugation the supernatant was discarded and the single cell pellet gently resuspended in 50\\u03bcL of wash buffer Cells were counted in triplicate on the Nexcelom Cellometer Auto 2000 with trypan blue and processed through the singlecell RNA sequencing pipeline from 10X Genomics 3 Version 3 10X Genomic Chromium Singlecell RNAsequencing library preparation and sequencing The singlecell RNA library preparation and sequencing was done by the University of Virginia School of Medicines Genome Analysis and Technology Core GATC RRIDSCR_018883 cDNA library creation RNA samples were processed for singlecell sequencing according to manufacturers instructions using the kit according to validated standard operating procedures established by the GATC cDNA quality assessment cDNA quality was assessed by the MiSeq Reagent Nano Kit v2 Illumina cat MS1022001 Singlecell libraries were sequenced using a p4100 kit Chromium Next GEM Single Cell 3 GEM Library Gel Bead Kit v31 16 rxns Illumina cat PN1000121 on the NextSeq2000 Sequencing System Illumina Wholecell recording of Masteroids Neuronal activity in whole neuronglial brain assembloid was recorded using a wholecell patch clamp technique as described previously115 Wholecell patchclamp recordings were performed under infrared differential interference contrast microscopy Olympus a 40 water immersion objective was used to visually identify neurons in the brain assembloid The Masteroids were continuously perfused with ACSF solution that was saturated with 95 O2 and 5 CO2 at room temperature Patch electrodes final resistances 35 M\\u03a9 were pulled from borosilicate glass Sutter Instruments Novato CA USA on a horizontal FlamingBrown microelectrode puller Model P97 Sutter Instruments For voltageclamp recordings the electrode tips were filled with a filtered internal recording solution that consisted of the following components in mM 100 Cs gluconate 10 Hepes 06 EGTA 4 MgATP and 03 NaGTP 5 QX314 the pH was 73 with CsOH and the osmolarity was 310 mosmol l1 For currentclamp recording the pipette solution contained the following in mm 135 potassium gluconate 25 NaCl 10 Hepes 05 EGTA 40 47 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission MgATP 04 NaGTP 01 CaCl2 the pH was 73 and the osmolarity was 310 mosmol l1 Neurons were voltage clamped at 60mV using a PC505B amplifier Warner Instruments Hamden CT USA Electrode capacitance was electronically compensated Access resistance was continuously monitored and if the series resistance increased by 20 at any time the recording was terminated Currents were filtered at 2 kHz digitized using a Digidata 1322 digitizer Molecular Devices Sunnyvale CA USA and acquired using Clampex 102 software Molecular Devices Spontaneous excitatory postsynaptic currents sEPSCs were recorded from neurons after blocking the GABA A receptors with the antagonist picrotoxin 50\\u03bcm Quantification and statistical analysis Fluorescent image analysis Fluorescent images were captured by STELLARIS 5 Confocal Microscope Leica Microsystems Stellaris 5 and LP8 Confocal Microscope Leica Microsystems SP8 using LAS X Life Science Microscope Software Platform Leica Microsystems The staining intensities in immunofluorescencelabeled Masteroids were measured by ImageJ116 Brightfield image analysis Brightfield images DAB were captured by Keyence BZX810 Microscope Keyence BZ X810 using BZX800 Viewer Software Keyence The staining intensities in DABlabelled Masteroids were measured by ImageJ116 Electron microscopy analysis Electron microscopy EM images were captured on a JEOL 1010 EM with a 16megapixel CCD camera SIA at magnifications ranging from 4kx to 20kx yielding nmpixel resolution Adobe Photoshop was used to balance and annotate EM images Crosssections of dendrites were identified by the presence of microtubules and lack of neurotransmitter vesicles Axon terminals may display presynaptic zones and contain vesicles Glial and neuronal cells were identified based on established accepted criteria6165117118 Schematics Schematics were created with BioRendercom Data analysis 48 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Statistical analysis Statistical analyses and figures artwork were performed using GraphPad Prism version 1000 for Windows Pairwise data was compared using onetailed Wilcoxon matchedpairs signed rank test All group data are expressed as mean SEM Column means were compared using oneway ANOVA with treatment as the independent variable Group means were compared using twoway ANOVA using factors of genotype and fraction treatment respectively When ANOVA showed a significant difference pairwise comparisons between group means were examined by Tukeys Dunnett or uncorrected Fishers LSD multiple comparison test Significance was defined when p 005 Gene networks were visualized using the Cytoscape StringApp 220 STRING protein query through Cytoscape 3103 Singlecell RNAsequencing analysis CellRanger pipeline CellRanger version 310 10X Genomics was used to combine and process the raw Illumina NextSeq 500 RNA and NOVAseq sequencing files First each sequencing library was demultiplexed by sample index to generate FASTQ files for pairedend reads using the CellRanger mkfastq pipeline FASTQ files were then passed to the CellRanger count pipeline which used STAR aligner version 2 to align reads to the human reference genome GRCh38119 Genecell barcode matrices of each sample were further processed in R version 403 Seurat object filtration Datasets were loaded into Seurat v503 for filtering normalization and data scaling120 Cells containing fewer than 2000 and greater than 20000 RNA counts and greater than 25 mitochondrial RNA were filtered out using Seurats subset function Datasets were processed using SCTransform and integrated using Seurats CCA integration121 Clusters were determined from the uniform manifold approximation and projection UMAP dimensional reduction graph via SLM algorithm using Seurats native FindClusters function at 15 resolution122 Cluster celltype identification Identities of each cluster were labeled manually using the APOE3 NC condition through various methods including comparing cluster marker genes to known human neuronalglial cell types scoring each cluster enrichment of marker genes from our previous singlecell organoid 49 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission datasets using AddModuleScore37123 Clusters otherwise not found in APOE3 NC were matched to the nearest normal cluster by querying the dataset containing all clusters to the annotated APOE3 NConly dataset Significantly upregulated genes in disease conditions were obtained using Wilcoxon rankedsum testing Differential expression analysis Differential expression analysis was performed within each cell type between different conditions using the Wilcoxon ranksum test implemented in Seurat with a minpct of 01 a logfcthreshold of 025 and a pseudocount of 1 default A multiplecomparison correction was performed using the Benjamin Hochberg FDR method to produce an adjusted p value124 Differentially expressed genes were evaluated according to their log fold change greater than log225 and adjusted p values 005 Functional enrichment analysis Functional enrichment analysis of the significantly differentially expressed genes between different conditions was performed using the R implemented GProfiler version 023125 The enrichment analysis was run as an ordered query ordered by log2FC using an \\u03b1 threshold of 005 and using Benjamin Hochberg FDR for multiple testing correction124 Only genes in the Seurat dataset were considered by using a custom domain scope A custom source GMT gp__zSEF_sD9Q_d1M was used It includes all Hallmark gene sets curated gene sets and ontology gene sets from the Molecular Signatures Database MsigDB v72126127 Gene set enrichment analysis To generate NES scoresassess pathwaylevel changes in gene expression across conditions we performed GSEA within each cell type cluster and condition comparison126 DE analysis was conducted as previously described and all expressed genes were ranked by average log fold change between the two conditions This ranked list was used as input to the fgseaMultiLevel function from the fgsea R package which implements an adaptive multilevel approach for improved accuracy in estimating enrichment p values We used the same custom MSigDB gene set collection as previously described filtered to include only gene sets with at least one gene expressed in the given cluster The analysis output included normalized enrichment scores and adjusted p values for each pathway 50 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission CellChat analysis To infer intercellular signaling networks we used CellChat R package version 220 to analyze ligandreceptor mediated communication between cell types57 For each condition we subsetted the Seurat object to include only cells from the selected condition and 5 major cell types CellChat objects for each condition were then initialized using the RNA assay and grouped by cell type identity The secreted signaling subset of the human CellChatDB was used for this analysis The general CellChat pipeline included SubsetDatta to retain only signalingrelated genes identifyOverExpressedGenes and identifyOverExpressedInteractions to identify potential ligands and receptors computeCommunProb to infer the probability of communication between cell types computeCommunProbPathway to summarize interactions at the signaling pathway level aggregateNet to construct a global signaling network for each condition We extracted both counts total number of significant ligandreceptor interactions between each senderreceiver cell type pair and weights summed communication probabilities representing strength of signaling between cell pairs Circle plots were generated for visualization of count and weights Cytoscape analysis A STRING network of the significant p value 005 differentially expressed genes DEGs in a given cell cluster was created using the Cytoscape StringApp 220 STRING protein query through Cytoscape 3103128129 The network was then clustered by Markov clustering MCL with a granularity inflation of 4 to create gene nodes using clusterMaker2130 Functional enrichment was run on individual nodes using STRING enrichment to determine the enriched pathways and nodes that were associated with similar pathways were grouped together For visualization manual annotations were assigned based on the most abundant or relevant pathways per node The color gradient was applied using Continuous Mapping with the log2FC value of each gene The most enriched 610 clusters were presented in the figure PET analysis Tau PET analysis T1weighted T1w MRI and 18Fflortaucipir AV1451 PET images were downloaded from the ADNI repository For T1w images crosssectional image processing was performed using FreeSurfer version 7131134 Six fiveminute frames were acquired 75 to 105 51 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission minutes postinjection Individual frames were extracted from the image files and coregistered to the first extracted frame of the raw image file The base frame and coregistered frames were recombined into a dynamic image set The images were further processed using PETSurfer131132 utilizing segmentation results from FreeSurfer We applied partial volume correction PVC with a 6mm extent using geometric transfer matrix GTM methods After segmentation and registration PETSurfer calculates SUVR using the pons as the reference region Average SUVR measures were calculated using the DKT135136 and ASAG137 atlases for cortical and subcortical ROIs Amyloid PET analysis Preprocessed \\u00b9\\u2078Fflorbetapir AV45 amyloid PET data were provided by the ADNI database Specifically we used amyloid positivity status based on the cutoff value of 111 to the global cortical AV45 SUVR normalized by the whole cerebellum These SUVR values were preprocessed using the ADNI UC Berkeley AV45 pipeline138 where PET frames acquired 5070 minutes postinjection were motioncorrected averaged coregistered to corresponding T1 weighted MRI scans and spatially normalized Subject selection Since ADNI is a longitudinal study that includes individuals who are cognitively unimpaired CU have mild cognitive impairment MCI or have dementiaAlzheimers disease DEM we selected subjects whose APOE genotype was APOE33 APOE34 or APOE44 and used their earliest available PET imaging data for analysis Summarization of the distribution of subjects by APOE genotype and diagnostic group can be found in the Source Data ADNI Data Acquisition PET imaging data used in the preparation of Figure 1 of this article were obtained from the Alzheimers Disease Neuroimaging Initiative ADNI database adniloniuscedu ADNI was launched in 2003 as a publicprivate partnership led by Principal Investigator Michael W Weiner MD The primary goal of ADNI has been to test whether serial magnetic resonance imaging MRI positron emission tomography PET other biological markers and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment MCI and early Alzheimers disease AD 52 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission Reference 1 Knopman DS Amieva H Petersen RC Chetelat G Holtzman DM Hyman BT Nixon RA and Jones DT 2021 Alzheimer disease Nat Rev Dis Primers 7 33 101038s4157202100269y 2 Cataldi R Sachdev PS Chowdhary N Seeher K Bentvelzen A Moorthy V and Dua T 2023 A WHO blueprint for action to reshape dementia research Nat Aging 3 469471 101038s43587023003816 3 Tahami Monfared AA Byrnes MJ White LA and Zhang Q 2022 Alzheimers Disease Epidemiology and Clinical Progression Neurol Ther 11 553569 101007s40120022003388 4 Fortea J Pegueroles J Alcolea D Belbin O DolsIcardo O VaqueAlcazar L Videla L Gispert JD SuarezCalvet M Johnson SC et al 2024 APOE4 homozygozity represents a distinct genetic form of Alzheimers disease Nat Med 30 12841291 101038s4159102402931w 5 Vance JM Farrer LA Huang Y Cruchaga C Hyman BT PericakVance MA Goate AM Greicius MD Griswold AJ Haines JL et al 2024 Report of the APOE4 National Institute on AgingAlzheimer Disease Sequencing Project Consortium Working Group Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimers Disease Ann Neurol 95 625634 101002ana26864 6 Blanchard JW Akay LA DavilaVelderrain J von Maydell D Mathys H Davidson SM Effenberger A Chen CY ManerSmith K Hajjar I et al 2022 APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes Nature 611 769779 101038s4158602205439w 7 van der Lee SJ Wolters FJ Ikram MK Hofman A Ikram MA Amin N and van Duijn CM 2018 The effect of APOE and other common genetic variants on the onset of Alzheimers disease and dementia a communitybased cohort study Lancet Neurol 17 434444 101016S147444221830053X 8 Kim JP Cho M Kim C Lee H Jang B Jung SH Kim Y Koh IG Kim S Shin D et al 2025 Wholegenome sequencing analyses suggest novel genetic factors associated with Alzheimers disease and a cumulative effects model for risk liability Nat Commun 16 4870 101038s4146702559949y 9 Withington CG and Turner RS 2022 AmyloidRelated Imaging Abnormalities With Antiamyloid Antibodies for the Treatment of Dementia Due to Alzheimers Disease Front Neurol 13 862369 103389fneur2022862369 10 Honig LS Sabbagh MN van Dyck CH Sperling RA Hersch S Matta A Giorgi L Gee M Kanekiyo M Li D et al 2024 Updated safety results from phase 3 lecanemab study in early Alzheimers disease Alzheimers Res Ther 16 105 101186s13195024014418 11 Honig LS Sabbagh MN van Dyck CH Sperling RA Hersch S Matta A Giorgi L Gee M Kanekiyo M Li D et al 2024 Correction Updated safety results from phase 3 lecanemab study in early Alzheimers disease Alzheimers Res Ther 16 159 101186s13195024015077 12 Riddell DR Zhou H Atchison K Warwick HK Atkinson PJ Jefferson J Xu L Aschmies S Kirksey Y Hu Y et al 2008 Impact of apolipoprotein E ApoE polymorphism on brain ApoE levels J Neurosci 28 1144511453 101523JNEUROSCI1972082008 13 Raulin AC Doss SV Trottier ZA Ikezu TC Bu G and Liu CC 2022 ApoE in Alzheimers disease pathophysiology and therapeutic strategies Mol Neurodegener 17 72 101186s13024022005744 53 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 14 Lau F Binacchi R Brugnara S CumplidoMayoral A Savino SD Khan I Orso A Sartori S Bellosta P Carl M et al 2025 Using SingleCell RNA sequencing with Drosophila Zebrafish and mouse models for studying Alzheimers and Parkinsons disease Neuroscience 573 505517 101016jneuroscience202503042 15 Gotz J Bodea LG and Goedert M 2018 Rodent models for Alzheimer disease Nat Rev Neurosci 19 583598 101038s4158301800548 16 King A 2018 The search for better animal models of Alzheimers disease Nature 559 S13S15 101038d41586018057229 17 Lin YT Seo J Gao F Feldman HM Wen HL Penney J Cam HP Gjoneska E Raja WK Cheng J et al 2018 APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimers Disease Phenotypes in Human iPSC Derived Brain Cell Types Neuron 98 1294 101016jneuron201806011 18 GarciaReitboeck P Phillips A Piers TM VillegasLlerena C Butler M Mallach A Rodrigues C Arber CE Heslegrave A Zetterberg H et al 2018 Human Induced Pluripotent Stem CellDerived MicrogliaLike Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis Cell Rep 24 23002311 101016jcelrep201807094 19 Frederiksen HR Holst B Ramakrishna S Muddashetty R Schmid B and Freude K 2019 Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670671NL mutation in the APP gene Stem Cell Res 34 101368 101016jscr2018101368 20 Gonzalez C Armijo E BravoAlegria J BecerraCalixto A Mays CE and Soto C 2018 Modeling amyloid beta and tau pathology in human cerebral organoids Mol Psychiatry 23 23632374 101038s4138001802298 21 Tcw J Qian L Pipalia NH Chao MJ Liang SA Shi Y Jain BR Bertelsen SE Kapoor M Marcora E et al 2022 Cholesterol and matrisome pathways dysregulated in astrocytes and microglia Cell 185 22132233 e2225 101016jcell202205017 22 Popova G Soliman SS Kim CN Keefe MG Hennick KM Jain S Li T Tejera D Shin D Chhun BB et al 2021 Human microglia states are conserved across experimental models and regulate neural stem cell responses in chimeric organoids Cell Stem Cell 28 21532166 e2156 101016jstem202108015 23 SabateSoler S Nickels SL Saraiva C Berger E Dubonyte U Barmpa K Lan YJ Kouno T Jarazo J Robertson G et al 2022 Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality Glia 70 12671288 101002glia24167 24 Wenzel TJ Desjarlais JD and Mousseau DD 2024 Human brain organoids containing microglia that have arisen innately adapt to a betaamyloid challenge better than those in which microglia are integrated by coculture Stem Cell Res Ther 15 258 101186s13287024038760 25 Kim JI Imaizumi K Jurjut O Kelley KW Wang D Thete MV Hudacova Z Amin ND Levy RJ Scherrer G and Pasca SP 2025 Human assembloid model of the ascending neural sensory pathway Nature 642 143153 101038s41586025 088083 26 Lancaster MA Renner M Martin CA Wenzel D Bicknell LS Hurles ME Homfray T Penninger JM Jackson AP and Knoblich JA 2013 Cerebral organoids model human brain development and microcephaly Nature 501 373379 101038nature12517 27 Park DS Kozaki T Tiwari SK Moreira M Khalilnezhad A Torta F Olivie N Thiam CH Liani O Silvin A et al 2023 iPScellderived microglia promote brain 54 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission organoid maturation via cholesterol transfer Nature 623 397405 101038s41586023 067131 28 Ji Y Chen X Wang Z Meek CJ McLean JL Yang Y Yuan C Rochet JC Liu F and Xu R 2025 Alzheimers disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery Mol Psychiatry 30 45584575 101038s4138002503041w 29 Chen X Sun G Tian E Zhang M Davtyan H Beach TG Reiman EM Blurton Jones M Holtzman DM and Shi Y 2021 Modeling Sporadic Alzheimers Disease in Human Brain Organoids under Serum Exposure Adv Sci Weinh 8 e2101462 101002advs202101462 30 Miura Y Li MY Revah O Yoon SJ Narazaki G and Pasca SP 2022 Engineering brain assembloids to interrogate human neural circuits Nat Protoc 17 15 35 101038s4159602100632z 31 Li E Benitez C Boggess SC Koontz M Rose IVL Martinez D Drager N Teter OM Samelson AJ Pierce N et al 2025 CRISPRibased screens in iAssembloids to elucidate neuronglia interactions Neuron 113 701718 e708 101016jneuron202412016 32 Xu R Boreland AJ Li X Erickson C Jin M Atkins C Pang ZP Daniels BP and Jiang P 2021 Developing human pluripotent stem cellbased cerebral organoids with a controllable microglia ratio for modeling brain development and pathology Stem Cell Reports 16 19231937 101016jstemcr202106011 33 Cerneckis J Bu G and Shi Y 2023 Pushing the boundaries of brain organoids to study Alzheimers disease Trends Mol Med 29 659672 101016jmolmed202305007 34 Bubnys A and Tsai LH 2022 Harnessing cerebral organoids for Alzheimers disease research Curr Opin Neurobiol 72 120130 101016jconb202110003 35 Onesto MM Kim JI and Pasca SP 2024 Assembloid models of cellcell interaction to study tissue and disease biology Cell Stem Cell 31 15631573 101016jstem202409017 36 Penney J Ralvenius WT and Tsai LH 2020 Modeling Alzheimers disease with iPSCderived brain cells Mol Psychiatry 25 148167 101038s4138001904683 37 Rickner HD Jiang L Hong R ONeill NK Mojica CA Snyder BJ Zhang L Shaw D Medalla M Wolozin B and Cheng CS 2022 Single cell transcriptomic profiling of a neuronastrocyte assembloid tauopathy model Nat Commun 13 6275 101038s41467022340051 38 Vermunt L Sikkes SAM van den Hout A Handels R Bos I van der Flier WM Kern S Ousset PJ Maruff P Skoog I et al 2019 Duration of preclinical prodromal and dementia stages of Alzheimers disease in relation to age sex and APOE genotype Alzheimers Dement 15 888898 101016jjalz201904001 39 Huckvale ED Hodgman MW Greenwood BB Stucki DO Ward KM Ebbert MTW Kauwe JSK The Alzheimers Disease Neuroimaging I The Alzheimers Disease Metabolomics C and Miller JB 2021 Pairwise Correlation Analysis of the Alzheimers Disease Neuroimaging Initiative ADNI Dataset Reveals Significant Feature Correlation Genes Basel 12 103390genes12111661 40 Aisen PS Donohue MC Raman R Rafii MS Petersen RC and Alzheimers Disease Neuroimaging I 2024 The Alzheimers Disease Neuroimaging Initiative Clinical Core Alzheimers Dement 20 73617368 101002alz14167 41 Carrillo MC Sanders CA and Katz RG 2009 Maximizing the Alzheimers Disease Neuroimaging Initiative II Alzheimers Dement 5 271275 101016jjalz200902005 55 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 42 Mueller SG Weiner MW Thal LJ Petersen RC Jack C Jagust W Trojanowski JQ Toga AW and Beckett L 2005 The Alzheimers disease neuroimaging initiative Neuroimaging Clin N Am 15 869877 xixii 101016jnic200509008 43 Petersen RC Aisen PS Beckett LA Donohue MC Gamst AC Harvey DJ Jack CR Jr Jagust WJ Shaw LM Toga AW et al 2010 Alzheimers Disease Neuroimaging Initiative ADNI clinical characterization Neurology 74 201209 101212WNL0b013e3181cb3e25 44 Jagust WJ Bandy D Chen K Foster NL Landau SM Mathis CA Price JC Reiman EM Skovronsky D Koeppe RA and Alzheimers Disease Neuroimaging I 2010 The Alzheimers Disease Neuroimaging Initiative positron emission tomography core Alzheimers Dement 6 221229 101016jjalz201003003 45 Long JM and Holtzman DM 2019 Alzheimer Disease An Update on Pathobiology and Treatment Strategies Cell 179 312339 101016jcell201909001 46 Khan UA Liu L Provenzano FA Berman DE Profaci CP Sloan R Mayeux R Duff KE and Small SA 2014 Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimers disease Nat Neurosci 17 304 311 101038nn3606 47 Igarashi KM 2023 Entorhinal cortex dysfunction in Alzheimers disease Trends Neurosci 46 124136 101016jtins202211006 48 Jiang L Chakraborty P Zhang L Wong M Hill SE Webber CJ Libera J Blair LJ Wolozin B and Zweckstetter M 2023 Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress Sci Adv 9 eadd9789 101126sciadvadd9789 49 Tong M Tu Q Wang L Chen H Wan X and Xu Z 2025 Joint analysis of singlecell RNA sequencing and bulk transcriptome reveals the heterogeneity of the urea cycle of astrocytes in glioblastoma Neurobiol Dis 208 106835 101016jnbd2025106835 50 Trapnell C Cacchiarelli D Grimsby J Pokharel P Li S Morse M Lennon NJ Livak KJ Mikkelsen TS and Rinn JL 2014 The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells Nat Biotechnol 32 381386 101038nbt2859 51 Cheng J Smyth GK and Chen Y 2023 Unraveling the timeline of gene expression A pseudotemporal trajectory analysis of singlecell RNA sequencing data F1000Res 12 684 1012688f1000research1340782 52 Suzuki N Sekimoto K Hayashi C Mabuchi Y Nakamura T and Akazawa C 2017 Differentiation of Oligodendrocyte Precursor Cells from Sox10Venus Mice to Oligodendrocytes and Astrocytes Sci Rep 7 14133 101038s41598017142070 53 Carmen J Magnus T CassianiIngoni R Sherman L Rao MS and Mattson MP 2007 Revisiting the astrocyteoligodendrocyte relationship in the adult CNS Prog Neurobiol 82 151162 101016jpneurobio200703001 54 Huang H Rubenstein JL and Qiu M 2021 Cracking the Codes of Cortical Glial Progenitors Evidence for the Common Lineage of Astrocytes and Oligodendrocytes Neurosci Bull 37 437439 101007s1226402100675y 55 Sadick JS ODea MR Hasel P Dykstra T Faustin A and Liddelow SA 2022 Astrocytes and oligodendrocytes undergo subtypespecific transcriptional changes in Alzheimers disease Neuron 110 17881805 e1710 101016jneuron202203008 56 Farhangi S Dehghan S Totonchi M and Javan M 2019 In vivo conversion of astrocytes to oligodendrocyte lineage cells in adult mice demyelinated brains by Sox2 Mult Scler Relat Disord 28 263272 101016jmsard201812041 56 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 57 Jin S GuerreroJuarez CF Zhang L Chang I Ramos R Kuan CH Myung P Plikus MV and Nie Q 2021 Inference and analysis of cellcell communication using CellChat Nat Commun 12 1088 101038s41467021212469 58 He C Chen F Li B and Hu Z 2014 Neurophysiology of HCN channels from cellular functions to multiple regulations Prog Neurobiol 112 123 101016jpneurobio201310001 59 Armstrong CM and Hille B 1998 Voltagegated ion channels and electrical excitability Neuron 20 371380 101016s0896627300809812 60 Cooper D and Dimri M 2025 Biochemistry Calcium Channels In StatPearls 61 Nahirney PC and Tremblay ME 2021 Brain Ultrastructure Putting the Pieces Together Front Cell Dev Biol 9 629503 103389fcell2021629503 62 Harris KM 2020 Synaptic Odyssey J Neurosci 40 6180 101523JNEUROSCI0735192019 63 ShapsonCoe A Januszewski M Berger DR Pope A Wu Y Blakely T Schalek RL Li PH Wang S MaitinShepard J et al 2024 A petavoxel fragment of human cerebral cortex reconstructed at nanoscale resolution Science 384 eadk4858 101126scienceadk4858 64 Knott G Marchman H Wall D and Lich B 2008 Serial section scanning electron microscopy of adult brain tissue using focused ion beam milling J Neurosci 28 2959 2964 101523JNEUROSCI3189072008 65 Peters A and Folger C 2013 A website entitled The fine structure of the aging brain J Comp Neurol 521 12031206 101002cne23280 66 Burnsed J Matysik W Yang L Sun H Joshi S and Kapur J 2023 Increased glutamatergic synaptic transmission during development in layer IIIII mouse motor cortex pyramidal neurons Cereb Cortex 33 46454653 101093cercorbhac368 67 Apicco DJ Ash PEA Maziuk B LeBlang C Medalla M Al Abdullatif A Ferragud A Botelho E Ballance HI Dhawan U et al 2018 Reducing the RNA binding protein TIA1 protects against taumediated neurodegeneration in vivo Nat Neurosci 21 7280 101038s415930170022z 68 Jiang L Ash PEA Maziuk BF Ballance HI Boudeau S Abdullatif AA Orlando M Petrucelli L Ikezu T and Wolozin B 2019 TIA1 regulates the generation and response to toxic tau oligomers Acta Neuropathol 137 259277 101007s0040101819375 69 Jiang L Zhao J Cheng JX and Wolozin B 2020 Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association With RNA Binding Proteins Front Neurol 11 579434 103389fneur2020579434 70 Jiang L Lin W Zhang C Ash PEA Verma M Kwan J van Vliet E Yang Z Cruz AL Boudeau S et al 2021 Interaction of tau with HNRNPA2B1 and N6 methyladenosine RNA mediates the progression of tauopathy Mol Cell 81 42094227 e4212 101016jmolcel202107038 71 Koutarapu S Ge J Dulewicz M Srikrishna M Szadziewska A Wood J Blennow K Zetterberg H Michno W Ryan NS et al 2025 Chemical imaging delineates Abeta plaque polymorphism across the Alzheimers disease spectrum Nat Commun 16 3889 101038s41467025590857 72 Busche MA and Hyman BT 2020 Synergy between amyloidbeta and tau in Alzheimers disease Nat Neurosci 23 11831193 101038s4159302006876 73 Bloom GS 2014 Amyloidbeta and tau the trigger and bullet in Alzheimer disease pathogenesis JAMA Neurol 71 505508 101001jamaneurol20135847 74 StPierre MK Carrier M Gonzalez Ibanez F Simoncicova E Wallman MJ Vallieres L Parent M and Tremblay ME 2022 Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimers disease pathology and in 57 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission human postmortem brain samples J Neuroinflammation 19 235 101186s12974022 025958 75 El Hajj H Savage JC Bisht K Parent M Vallieres L Rivest S and Tremblay ME 2019 Ultrastructural evidence of microglial heterogeneity in Alzheimers disease amyloid pathology J Neuroinflammation 16 87 101186s1297401914739 76 DominguezAlvaro M MonteroCrespo M BlazquezLlorca L DeFelipe J and AlonsoNanclares L 2019 3D Electron Microscopy Study of Synaptic Organization of the Normal Human Transentorhinal Cortex and Its Possible Alterations in Alzheimers Disease eNeuro 6 101523ENEURO0140192019 77 Leng K Rose IVL Kim H Xia W RomeroFernandez W Rooney B Koontz M Li E Ao Y Wang S et al 2022 CRISPRi screens in human iPSCderived astrocytes elucidate regulators of distinct inflammatory reactive states Nat Neurosci 25 15281542 101038s41593022011809 78 Matusova Z Hol EM Pekny M Kubista M and Valihrach L 2023 Reactive astrogliosis in the era of singlecell transcriptomics Front Cell Neurosci 17 1173200 103389fncel20231173200 79 Miyoshi E Morabito S Henningfield CM Das S Rahimzadeh N Shabestari SK Michael N Emerson N Reese F Shi Z et al 2024 Spatial and singlenucleus transcriptomic analysis of genetic and sporadic forms of Alzheimers disease Nat Genet 56 27042717 101038s4158802401961x 80 Neff RA Wang M Vatansever S Guo L Ming C Wang Q Wang E HorgusluogluMoloch E Song WM Li A et al 2021 Molecular subtyping of Alzheimers disease using RNA sequencing data reveals novel mechanisms and targets Sci Adv 7 101126sciadvabb5398 81 Tsai AP Dong C Lin PB Messenger EJ Casali BT Moutinho M Liu Y Oblak AL Lamb BT Landreth GE et al 2022 PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimers disease Genome Med 14 17 101186s13073022010220 82 Grubman A Chew G Ouyang JF Sun G Choo XY McLean C Simmons RK Buckberry S VargasLandin DB Poppe D et al 2019 A singlecell atlas of entorhinal cortex from individuals with Alzheimers disease reveals celltypespecific gene expression regulation Nat Neurosci 22 20872097 101038s4159301905394 83 Habib N McCabe C Medina S Varshavsky M Kitsberg D DvirSzternfeld R Green G Dionne D Nguyen L Marshall JL et al 2020 Diseaseassociated astrocytes in Alzheimers disease and aging Nat Neurosci 23 701706 101038s4159302006248 84 Bellenguez C Kucukali F Jansen IE Kleineidam L MorenoGrau S Amin N Naj AC CamposMartin R GrenierBoley B Andrade V et al 2022 New insights into the genetic etiology of Alzheimers disease and related dementias Nat Genet 54 412436 101038s4158802201024z 85 Wightman DP Jansen IE Savage JE Shadrin AA Bahrami S Holland D Rongve A Borte S Winsvold BS Drange OK et al 2021 A genomewide association study with 1126563 individuals identifies new risk loci for Alzheimers disease Nat Genet 53 12761282 101038s4158802100921z 86 Andrews SJ Renton AE FultonHoward B PodlesnyDrabiniok A Marcora E and Goate AM 2023 The complex genetic architecture of Alzheimers disease novel insights and future directions EBioMedicine 90 104511 101016jebiom2023104511 87 Kozlova A Zhang S Sudwarts A Zhang H Smirnou S Byeon SK Thapa C Sun X Stephenson K Zhao X et al 2025 PICALM Alzheimers risk allele causes aberrant lipid droplets in microglia Nature 101038s4158602509486x 58 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 88 Lee SI Yu J Lee H Kim B Jang MJ Jo H Kim NY Pak ME Kim JK Cho S et al 2025 Astrocyte priming enhances microglial Abeta clearance and is compromised by APOE4 Nat Commun 16 7551 101038s41467025629951 89 Kim S Chun H Kim Y Kim Y Park U Chu J Bhalla M Choi SH Yousefian Jazi A Kim S et al 2024 Astrocytic autophagy plasticity modulates Abeta clearance and cognitive function in Alzheimers disease Mol Neurodegener 19 55 101186s1302402400740w 90 Avey DR Ng B Vialle RA Kearns NA de Paiva Lopes K Iatrou A De Tissera S Vyas H Saunders DM Flood DJ et al 2025 Uncovering plaqueglia niches in human Alzheimers disease brains using spatial transcriptomics Mol Neurodegener Adv 1 2 101186s4447702500002z 91 Chen Z Simmons MS Perry RT Wiener HW Harrell LE and Go RC 2008 Genetic association of neurotrophic tyrosine kinase receptor type 2 NTRK2 With Alzheimers disease Am J Med Genet B Neuropsychiatr Genet 147 363369 101002ajmgb30607 92 SasakiHamada S Funane T Nakao Y Sasaki R Nagai M Ueta Y Yoshizawa K Horiguchi M Yamashita C and Oka JI 2018 Intranasal administration of neuromedin U derivatives containing cellpenetrating peptides and a penetration accelerating sequence induced memory improvements in mice Peptides 99 241246 101016jpeptides201710010 93 Roy ER Wang B Wan YW Chiu G Cole A Yin Z Propson NE Xu Y Jankowsky JL Liu Z et al 2020 Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease J Clin Invest 130 1912 1930 101172JCI133737 94 De Jager PL Srivastava G Lunnon K Burgess J Schalkwyk LC Yu L Eaton ML Keenan BT Ernst J McCabe C et al 2014 Alzheimers disease early alterations in brain DNA methylation at ANK1 BIN1 RHBDF2 and other loci Nat Neurosci 17 11561163 101038nn3786 95 Lee H Aylward AJ Pearse RV 2nd Lish AM Hsieh YC Augur ZM Benoit CR Chou V Knupp A Pan C et al 2023 Celltypespecific regulation of APOE and CLU levels in human neurons by the Alzheimers disease risk gene SORL1 Cell Rep 42 112994 101016jcelrep2023112994 96 Lish AM Grogan EFL Benoit CR Pearse RV 2nd Heuer SE Luquez T Orme GA Galle PC Milinkeviciute G Green KN et al 2025 CLU alleviates Alzheimers diseaserelevant processes by modulating astrocyte reactivity and microglia dependent synaptic density Neuron 113 19251946 e1911 101016jneuron202503034 97 Zamanian JL Xu L Foo LC Nouri N Zhou L Giffard RG and Barres BA 2012 Genomic analysis of reactive astrogliosis J Neurosci 32 63916410 101523JNEUROSCI6221112012 98 Yang Y and Zhang Z 2020 Microglia and Wnt Pathways Prospects for Inflammation in Alzheimers Disease Front Aging Neurosci 12 110 103389fnagi202000110 99 Faust TE Lee YH OConnor CD Boyle MA Gunner G Badimon A Ayata P Schaefer A and Schafer DP 2024 Microgliaastrocyte crosstalk regulates synapse remodeling via Wnt signaling bioRxiv 10110120240208579178 100 Cohen E Paulsson JF Blinder P BurstynCohen T Du D Estepa G Adame A Pham HM Holzenberger M Kelly JW et al 2009 Reduced IGF1 signaling delays ageassociated proteotoxicity in mice Cell 139 11571169 101016jcell200911014 59 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 101 Kiani L 2024 IGFBP2 levels associated with Alzheimer disease Nat Rev Neurol 20 1 101038s41582023009111 102 Rauskolb S Andreska T Fries S von Collenberg CR Blum R Monoranu CM Villmann C and Sendtner M 2022 Insulinlike growth factor 5 associates with human Ass plaques and promotes cognitive impairment Acta Neuropathol Commun 10 68 101186s40478022013525 103 Quesnel MJ Labonte A Picard C Zetterberg H Blennow K Brinkmalm A Villeneuve S Poirier J Alzheimers Disease Neuroimaging I and Group PAR 2024 Insulinlike growth factor binding protein2 in atrisk adults and autopsy confirmed Alzheimer brains Brain 147 16801695 101093brainawad398 104 Baxter RC 2023 Signaling Pathways of the Insulinlike Growth Factor Binding Proteins Endocr Rev 44 753778 101210endrevbnad008 105 Miao J Zhang Y Su C Zheng Q and Guo J 2025 InsulinLike Growth Factor Signaling in Alzheimers Disease Pathophysiology and Therapeutic Strategies Mol Neurobiol 62 31953225 101007s12035024044571 106 ZegarraValdivia J AranaNombera H PerezFernandez L Del Rocio Casimiro M GallegosManayay V Del Rosario OlivaPiscoya M AlamoMedina R Abanto Saldana E CruzOrdinola MC ParedesManrique C and ChinoVilca B 2025 Insulinlike Growth Factor 1 Impact on Alzheimers Disease Role in Inflammation Stress and Cognition Curr Issues Mol Biol 47 103390cimb47040233 107 Hou X Jin Y Chen J Hong Y Luo D Yin Q and Liu X 2017 IGF1 protects against Abeta2535induced neuronal cell death via inhibition of PUMA expression and Bax activation Neurosci Lett 637 188194 101016jneulet201611012 108 Freude S Hettich MM Schumann C Stohr O Koch L Kohler C Udelhoven M Leeser U Muller M Kubota N et al 2009 Neuronal IGF1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimers disease FASEB J 23 33153324 101096fj09132043 109 Zerti D Molina MM Dorgau B Mearns S Bauer R AlAama J and Lako M 2021 IGFBPs mediate IGF1s functions in retinal lamination and photoreceptor development during pluripotent stem cell differentiation to retinal organoids Stem Cells 39 458466 101002stem3331 110 Migliore L and Coppede F 2022 Geneenvironment interactions in Alzheimer disease the emerging role of epigenetics Nat Rev Neurol 18 643660 101038s4158202200714w 111 Liu CC Liu CC Kanekiyo T Xu H and Bu G 2013 Apolipoprotein E and Alzheimer disease risk mechanisms and therapy Nat Rev Neurol 9 106118 101038nrneurol2012263 112 Fagiani F Pedrini E Taverna S Brambilla E Murtaj V Podini P Ruffini F Butti E Braccia C Andolfo A et al 2024 A gliaenriched stem cell 3D model of the human brain mimics the glialimmune neurodegenerative phenotypes of multiple sclerosis Cell Rep Med 5 101680 101016jxcrm2024101680 113 Haroutunian V Katsel P and Schmeidler J 2009 Transcriptional vulnerability of brain regions in Alzheimers disease and dementia Neurobiol Aging 30 561573 101016jneurobiolaging200707021 114 Ramos EN Jiron GM Danoff JS Anderson Z Carter CS Perkeybile AM Connelly JJ and Erisir A 2024 The central oxytocinergic system of the prairie vole Brain Struct Funct 229 17371756 101007s00429024028321 115 Sun J and Kapur J 2012 Mtype potassium channels modulate Schaffer collateral CA1 glutamatergic synaptic transmission J Physiol 590 39533964 101113jphysiol2012235820 60 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 116 Schneider CA Rasband WS and Eliceiri KW 2012 NIH Image to ImageJ 25 years of image analysis Nat Methods 9 671675 101038nmeth2089 117 Berg DA Su Y JimenezCyrus D Patel A Huang N Morizet D Lee S Shah R Ringeling FR Jain R et al 2019 A Common Embryonic Origin of Stem Cells Drives Developmental and Adult Neurogenesis Cell 177 654668 e615 101016jcell201902010 118 Aten S Kiyoshi CM Arzola EP Patterson JA Taylor AT Du Y Guiher AM Philip M Camacho EG Mediratta D et al 2022 Ultrastructural view of astrocyte arborization astrocyteastrocyte and astrocytesynapse contacts intracellular vesicle like structures and mitochondrial network Prog Neurobiol 213 102264 101016jpneurobio2022102264 119 Dobin A Davis CA Schlesinger F Drenkow J Zaleski C Jha S Batut P Chaisson M and Gingeras TR 2013 STAR ultrafast universal RNAseq aligner Bioinformatics 29 1521 101093bioinformaticsbts635 120 Hao Y Hao S AndersenNissen E Mauck WM 3rd Zheng S Butler A Lee MJ Wilk AJ Darby C Zager M et al 2021 Integrated analysis of multimodal singlecell data Cell 184 35733587 e3529 101016jcell202104048 121 Hafemeister C and Satija R 2019 Normalization and variance stabilization of single cell RNAseq data using regularized negative binomial regression Genome Biol 20 296 101186s1305901918741 122 McInnes LA JohnASaul NathanielAGro\\u00dfberger LukasBJournal Name Journal of Open Source Software 3 JV and 29 JI 2018 UMAP Uniform Manifold Approximation and Projection Journal Name Journal of Open Source Software Journal Volume 3 Journal Issue 29 Medium X 123 Tian W Zhou J Bartlett A Zeng Q Liu H Castanon RG Kenworthy M Altshul J Valadon C Aldridge A et al 2023 Singlecell DNA methylation and 3D genome architecture in the human brain Science 382 eadf5357 101126scienceadf5357 124 Benjamini Y Drai D Elmer G Kafkafi N and Golani I 2001 Controlling the false discovery rate in behavior genetics research Behav Brain Res 125 279284 101016s0166432801002972 125 Raudvere U Kolberg L Kuzmin I Arak T Adler P Peterson H and Vilo J 2019 gProfiler a web server for functional enrichment analysis and conversions of gene lists 2019 update Nucleic Acids Res 47 W191W198 101093nargkz369 126 Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA Paulovich A Pomeroy SL Golub TR Lander ES and Mesirov JP 2005 Gene set enrichment analysis a knowledgebased approach for interpreting genomewide expression profiles Proc Natl Acad Sci U S A 102 1554515550 101073pnas0506580102 127 Liberzon A Birger C Thorvaldsdottir H Ghandi M Mesirov JP and Tamayo P 2015 The Molecular Signatures Database MSigDB hallmark gene set collection Cell Syst 1 417425 101016jcels201512004 128 Szklarczyk D Morris JH Cook H Kuhn M Wyder S Simonovic M Santos A Doncheva NT Roth A Bork P et al 2017 The STRING database in 2017 quality controlled proteinprotein association networks made broadly accessible Nucleic Acids Res 45 D362D368 101093nargkw937 129 Shannon P Markiel A Ozier O Baliga NS Wang JT Ramage D Amin N Schwikowski B and Ideker T 2003 Cytoscape a software environment for integrated models of biomolecular interaction networks Genome Res 13 24982504 101101gr1239303 61 which was not certified by peer review is the authorfunder All rights reserved No reuse allowed without permission 130 Utriainen M and Morris JH 2023 clusterMaker2 a major update to clusterMaker a multialgorithm clustering app for Cytoscape BMC Bioinformatics 24 134 101186s1285902305225z 131 Greve DN Svarer C Fisher PM Feng L Hansen AE Baare W Rosen B Fischl B and Knudsen GM 2014 Cortical surfacebased analysis reduces bias and variance in kinetic modeling of brain PET data Neuroimage 92 225236 101016jneuroimage201312021 132 Greve DN Salat DH Bowen SL IzquierdoGarcia D Schultz AP Catana C Becker JA Svarer C Knudsen GM Sperling RA and Johnson KA 2016 Different partial volume correction methods lead to different conclusions An 18FFDG PET study of aging Neuroimage 132 334343 101016jneuroimage201602042 133 Vahermaa V Aydogan DB Raij T Armio RL Laurikainen H Saramaki J and Suvisaari J 2023 FreeSurfer 7 quality control Key problem areas and importance of manual corrections Neuroimage 279 120306 101016jneuroimage2023120306 134 Fischl B 2012 FreeSurfer Neuroimage 62 774781 101016jneuroimage201201021 135 Alexander B Loh WY Matthews LG Murray AL Adamson C Beare R Chen J Kelly CE Anderson PJ Doyle LW et al 2019 DesikanKillianyTourville Atlas Compatible Version of MCRIB Neonatal Parcellated Whole Brain Atlas The MCRIB 20 Front Neurosci 13 34 103389fnins201900034 136 Desikan RS Segonne F Fischl B Quinn BT Dickerson BC Blacker D Buckner RL Dale AM Maguire RP Hyman BT et al 2006 An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest Neuroimage 31 968980 101016jneuroimage200601021 137 Fischl B Salat DH Busa E Albert M Dieterich M Haselgrove C van der Kouwe A Killiany R Kennedy D Klaveness S et al 2002 Whole brain segmentation automated labeling of neuroanatomical structures in the human brain Neuron 33 341355 101016s089662730200569x 138 Landau SM Breault C Joshi AD Pontecorvo M Mathis CA Jagust WJ Mintun MA and Alzheimers Disease Neuroimaging I 2013 Amyloidbeta imaging with Pittsburgh compound B and florbetapir comparing radiotracers and quantification methods J Nucl Med 54 7077 102967jnumed112109009 62\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-ef2185aa-0197-4d4f-a598-76f734a22e20\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>pdf</th>\n",
              "      <th>abstract</th>\n",
              "      <th>introduction</th>\n",
              "      <th>conclusion</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2025.10.17.683162v1.full.pdf</td>\n",
              "      <td>which was not certified by peer review is the ...</td>\n",
              "      <td>Alzheimers disease AD a leading cause of demen...</td>\n",
              "      <td>INTRODUCTION Alzheimers disease AD a leading c...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2023.06.05.543662v1.full.pdf</td>\n",
              "      <td>20 Progressive Tau deposition in neurofibrilla...</td>\n",
              "      <td>None</td>\n",
              "      <td>1 Introduction 36 Tau pathology is the hallmar...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2025.11.07.687156v1.full.pdf</td>\n",
              "      <td>Lightning has been proposed as a pivotal energ...</td>\n",
              "      <td>Alzheimers disease AD is a progressive neurode...</td>\n",
              "      <td>This study provides compelling evidence that C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2023.04.20.537649v1.full.pdf</td>\n",
              "      <td>The recent massive improvements in transcripto...</td>\n",
              "      <td>Singlecell RNA sequencing scRNAseq generates h...</td>\n",
              "      <td>Singlecell RNA sequencing generates high volum...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>2025.10.16.682926v1.full.pdf</td>\n",
              "      <td>21 Introduction Alzheimers disease AD is a com...</td>\n",
              "      <td>Alzheimers disease AD is a complex neurodegene...</td>\n",
              "      <td>Indeed the results from some targets imply tha...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ef2185aa-0197-4d4f-a598-76f734a22e20')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ef2185aa-0197-4d4f-a598-76f734a22e20 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ef2185aa-0197-4d4f-a598-76f734a22e20');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-240a6a9f-6619-4241-8bf3-c8924887417c\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-240a6a9f-6619-4241-8bf3-c8924887417c')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-240a6a9f-6619-4241-8bf3-c8924887417c button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                            pdf  \\\n",
              "0  2025.10.17.683162v1.full.pdf   \n",
              "1  2023.06.05.543662v1.full.pdf   \n",
              "2  2025.11.07.687156v1.full.pdf   \n",
              "3  2023.04.20.537649v1.full.pdf   \n",
              "4  2025.10.16.682926v1.full.pdf   \n",
              "\n",
              "                                            abstract  \\\n",
              "0  which was not certified by peer review is the ...   \n",
              "1  20 Progressive Tau deposition in neurofibrilla...   \n",
              "2  Lightning has been proposed as a pivotal energ...   \n",
              "3  The recent massive improvements in transcripto...   \n",
              "4  21 Introduction Alzheimers disease AD is a com...   \n",
              "\n",
              "                                        introduction  \\\n",
              "0  Alzheimers disease AD a leading cause of demen...   \n",
              "1                                               None   \n",
              "2  Alzheimers disease AD is a progressive neurode...   \n",
              "3  Singlecell RNA sequencing scRNAseq generates h...   \n",
              "4  Alzheimers disease AD is a complex neurodegene...   \n",
              "\n",
              "                                          conclusion  \n",
              "0  INTRODUCTION Alzheimers disease AD a leading c...  \n",
              "1  1 Introduction 36 Tau pathology is the hallmar...  \n",
              "2  This study provides compelling evidence that C...  \n",
              "3  Singlecell RNA sequencing generates high volum...  \n",
              "4  Indeed the results from some targets imply tha...  "
            ]
          },
          "execution_count": 37,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df.head()"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "BhwVmiuavGqo"
      },
      "source": [
        "По информации о датасете видно что у нас есть 27 статей, 25 из них имеют введение, 26 заключение"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AfDjCOX1Aq0M",
        "outputId": "05f4a54f-a48b-4566-b935-c56f76639575"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "<class 'pandas.core.frame.DataFrame'>\n",
            "RangeIndex: 27 entries, 0 to 26\n",
            "Data columns (total 4 columns):\n",
            " #   Column        Non-Null Count  Dtype \n",
            "---  ------        --------------  ----- \n",
            " 0   pdf           27 non-null     object\n",
            " 1   abstract      27 non-null     object\n",
            " 2   introduction  25 non-null     object\n",
            " 3   conclusion    26 non-null     object\n",
            "dtypes: object(4)\n",
            "memory usage: 996.0+ bytes\n"
          ]
        }
      ],
      "source": [
        "df.info()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 209
        },
        "id": "2dOzwv5HAvHr",
        "outputId": "701b73b2-d7ff-41be-b6d7-3a293e2e8ce4"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>0</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>pdf</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>abstract</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>introduction</th>\n",
              "      <td>7.407407</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>conclusion</th>\n",
              "      <td>3.703704</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div><br><label><b>dtype:</b> float64</label>"
            ],
            "text/plain": [
              "pdf             0.000000\n",
              "abstract        0.000000\n",
              "introduction    7.407407\n",
              "conclusion      3.703704\n",
              "dtype: float64"
            ]
          },
          "execution_count": 20,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df.isna().mean() * 100"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "IEqkbk22A7f1"
      },
      "source": [
        "Длины текстов"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "WVEQvcgqA9GX"
      },
      "outputs": [],
      "source": [
        "for col in [\"abstract\", \"introduction\", \"conclusion\"]:\n",
        "    df[f\"{col}_len\"] = df[col].fillna(\"\").str.len()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 300
        },
        "id": "6r2KsjMCA_Bh",
        "outputId": "dabc61de-2be9-4d13-918a-418ab7041952"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"df[[c for c in df\",\n  \"rows\": 8,\n  \"fields\": [\n    {\n      \"column\": \"abstract_len\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 20011.251280338536,\n        \"min\": 27.0,\n        \"max\": 58778.0,\n        \"num_unique_values\": 8,\n        \"samples\": [\n          5005.0,\n          1591.0,\n          27.0\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"introduction_len\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 18089.037024344314,\n        \"min\": 0.0,\n        \"max\": 54714.0,\n        \"num_unique_values\": 8,\n        \"samples\": [\n          8000.740740740741,\n          4627.0,\n          27.0\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"conclusion_len\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 46124.28504905791,\n        \"min\": 0.0,\n        \"max\": 134455.0,\n        \"num_unique_values\": 8,\n        \"samples\": [\n          55624.40740740741,\n          63551.0,\n          27.0\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-7fbb1105-49f3-4507-899e-970684d7907e\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>abstract_len</th>\n",
              "      <th>introduction_len</th>\n",
              "      <th>conclusion_len</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>count</th>\n",
              "      <td>27.000000</td>\n",
              "      <td>27.000000</td>\n",
              "      <td>27.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>mean</th>\n",
              "      <td>5005.000000</td>\n",
              "      <td>8000.740741</td>\n",
              "      <td>55624.407407</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>std</th>\n",
              "      <td>11889.435456</td>\n",
              "      <td>11461.654524</td>\n",
              "      <td>41691.126028</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>min</th>\n",
              "      <td>232.000000</td>\n",
              "      <td>0.000000</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>25%</th>\n",
              "      <td>1457.500000</td>\n",
              "      <td>2747.500000</td>\n",
              "      <td>11142.500000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>50%</th>\n",
              "      <td>1591.000000</td>\n",
              "      <td>4627.000000</td>\n",
              "      <td>63551.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>75%</th>\n",
              "      <td>2448.000000</td>\n",
              "      <td>6500.500000</td>\n",
              "      <td>81405.500000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>max</th>\n",
              "      <td>58778.000000</td>\n",
              "      <td>54714.000000</td>\n",
              "      <td>134455.000000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-7fbb1105-49f3-4507-899e-970684d7907e')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-7fbb1105-49f3-4507-899e-970684d7907e button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-7fbb1105-49f3-4507-899e-970684d7907e');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-f37e12ad-58fa-415e-b9c6-850c7f72a812\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f37e12ad-58fa-415e-b9c6-850c7f72a812')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-f37e12ad-58fa-415e-b9c6-850c7f72a812 button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "       abstract_len  introduction_len  conclusion_len\n",
              "count     27.000000         27.000000       27.000000\n",
              "mean    5005.000000       8000.740741    55624.407407\n",
              "std    11889.435456      11461.654524    41691.126028\n",
              "min      232.000000          0.000000        0.000000\n",
              "25%     1457.500000       2747.500000    11142.500000\n",
              "50%     1591.000000       4627.000000    63551.000000\n",
              "75%     2448.000000       6500.500000    81405.500000\n",
              "max    58778.000000      54714.000000   134455.000000"
            ]
          },
          "execution_count": 40,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df[[c for c in df.columns if c.endswith(\"_len\")]].describe()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 147
        },
        "id": "MqGMbrTWBeg4",
        "outputId": "f0a3a569-d727-46b8-9d6b-78449b8fdcba"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>0</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>abstract_dup</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>intro_dup</th>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div><br><label><b>dtype:</b> int64</label>"
            ],
            "text/plain": [
              "abstract_dup    0\n",
              "intro_dup       1\n",
              "dtype: int64"
            ]
          },
          "execution_count": 23,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df[\"abstract_dup\"] = df[\"abstract\"].duplicated()\n",
        "df[\"intro_dup\"] = df[\"introduction\"].duplicated()\n",
        "\n",
        "df[[\"abstract_dup\", \"intro_dup\"]].sum()\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "EUN4rKW0vki8"
      },
      "source": [
        "Построим график распределения длин статей по abstract, introduction и conclusion"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 447
        },
        "id": "7kBAr5baBnDy",
        "outputId": "37667962-28ec-4a4c-8630-29b5ea72ae68"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "<Axes: >"
            ]
          },
          "execution_count": 41,
          "metadata": {},
          "output_type": "execute_result"
        },
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "df[\"abstract_len\"].hist(bins=50)\n",
        "df[\"introduction_len\"].hist(bins=50)\n",
        "df[\"conclusion_len\"].hist(bins=50)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 557
        },
        "id": "c80_shqZCKEY",
        "outputId": "b687ea78-8032-4c9a-e74e-a9e7348a8067"
      },
      "outputs": [
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1200x600 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import matplotlib.pyplot as plt\n",
        "\n",
        "plt.figure(figsize=(12, 6))\n",
        "\n",
        "plt.scatter(df.index, df[\"abstract_len\"], label=\"Abstract\", alpha=0.7)\n",
        "plt.scatter(df.index, df[\"introduction_len\"], label=\"Introduction\", alpha=0.7)\n",
        "plt.scatter(df.index, df[\"conclusion_len\"], label=\"Conclusion\", alpha=0.7)\n",
        "\n",
        "plt.xlabel(\"Article index\")\n",
        "plt.ylabel(\"Text length (characters)\")\n",
        "plt.title(\"Lengths of Abstract / Introduction / Conclusion\")\n",
        "plt.legend()\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 634
        },
        "id": "GpAYDXaWhUwl",
        "outputId": "8e9a8d1e-0b6f-4c7d-c532-a247e8df0cd5"
      },
      "outputs": [
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1200x800 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "plt.figure(figsize=(12, 8))\n",
        "\n",
        "plt.scatter(\n",
        "    df[\"introduction_len\"],\n",
        "    df[\"conclusion_len\"],\n",
        "    s=df[\"abstract_len\"] / 10,  # размер точки = длина abstract\n",
        "    alpha=0.7\n",
        ")\n",
        "\n",
        "for _, row in df.iterrows():\n",
        "    plt.text(\n",
        "        row[\"introduction_len\"],\n",
        "        row[\"conclusion_len\"],\n",
        "        row[\"pdf\"],\n",
        "        fontsize=8,\n",
        "        alpha=0.7\n",
        "    )\n",
        "\n",
        "plt.xlabel(\"Introduction length\")\n",
        "plt.ylabel(\"Conclusion length\")\n",
        "plt.title(\"Section lengths (point size = abstract length)\")\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "yBgLYcYPjoEX"
      },
      "source": [
        "### Подготовка данных для моделирования\n",
        "\n",
        "Собираем корпус данных abstract + introduction + conclusion"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "4vZwBXoWkMVg"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "\n",
        "df[\"text\"] = (\n",
        "    df[\"abstract\"].fillna(\"\") + \"\\n\\n\" +\n",
        "    df[\"introduction\"].fillna(\"\") + \"\\n\\n\" +\n",
        "    df[\"conclusion\"].fillna(\"\")\n",
        ").str.strip()\n",
        "\n",
        "df = df[df[\"text\"].str.len() > 200].reset_index(drop=True)  # убрать совсем пустое/короткое\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "3u76KrgwkaO-"
      },
      "source": [
        "Чанкинг (разбиение на куски)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "5YptzFE_kbNn"
      },
      "outputs": [],
      "source": [
        "def chunk_text(text: str, chunk_size=1200, overlap=200):\n",
        "    # chunk_size/overlap — в символах (просто и работает)\n",
        "    chunks = []\n",
        "    start = 0\n",
        "    n = len(text)\n",
        "    while start < n:\n",
        "        end = min(start + chunk_size, n)\n",
        "        chunks.append(text[start:end])\n",
        "        start = end - overlap\n",
        "        if start < 0:\n",
        "            start = 0\n",
        "        if end == n:\n",
        "            break\n",
        "    return chunks\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "hiQXE8Wykd7r",
        "outputId": "ec6a7e52-a379-4688-f92a-6a5914d9092b"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "   doc_id  chunk_id                           pdf  \\\n",
            "0       0         0  2025.10.17.683162v1.full.pdf   \n",
            "1       0         1  2025.10.17.683162v1.full.pdf   \n",
            "2       0         2  2025.10.17.683162v1.full.pdf   \n",
            "3       0         3  2025.10.17.683162v1.full.pdf   \n",
            "4       0         4  2025.10.17.683162v1.full.pdf   \n",
            "\n",
            "                                               chunk  \n",
            "0  which was not certified by peer review is the ...  \n",
            "1   and their affiliations appears at how_to_appl...  \n",
            "2  e Brain Assembloid Tau oligomers Amyloid Plaqu...  \n",
            "3  Neuroimaging Initiative 3 which was not certif...  \n",
            "4  ohort and found that even among cognitively no...  \n"
          ]
        }
      ],
      "source": [
        "rows = []\n",
        "for i, row in df.iterrows():\n",
        "    chunks = chunk_text(row[\"text\"], chunk_size=1500, overlap=250)\n",
        "    for j, ch in enumerate(chunks):\n",
        "        rows.append({\n",
        "            \"doc_id\": i,\n",
        "            \"chunk_id\": j,\n",
        "            \"pdf\": row[\"pdf\"],\n",
        "            \"chunk\": ch\n",
        "        })\n",
        "\n",
        "chunks_df = pd.DataFrame(rows)\n",
        "print(chunks_df.head())\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "d5cd7XGmklns"
      },
      "source": [
        "Векторизация (эмбеддинги) + индексация"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 542,
          "referenced_widgets": [
            "d752997a225047b39e138874816042f4",
            "ab0d9835d28342129e3c99aee5c52aff",
            "cd79fba6a0264bd48b790bf34223d943",
            "b7952aab57c949f7a23ac221a132af4d",
            "2d498f9bc5e640f9b69e87968164b626",
            "128646c4c27f49a2b31b584214a5fc15",
            "83043d31416d4ca190938d8b01e16d30",
            "930f8db8847b455ba3702bda45c3196e",
            "57952eb7d34d4f1499585ce0d36a2dad",
            "f4ee10be5c144ac48c1afce928b1e624",
            "a7e20c6dcc494922bb59a53dbc9b4585",
            "30c5f252b85b4728bf2baab6f3ffe6b0",
            "c80c1f8b273846928e39b384ed84509d",
            "568f9c84f37d4285853079bc94337b30",
            "5700f24bcf584030bb34f3a975a9f63f",
            "740eefb9e7684c168e04fe71fb7ce176",
            "94da805e3da24182b3a7c18aea7ec692",
            "af1c73f1227042e1b12d2ec855d886bd",
            "1ff0e37e952044a9898686ad76b3eb0b",
            "c25b361ba2af4b95809d6ab40b74af82",
            "8c447f60df294fc78fa32c262ba1d3a5",
            "ccc389b0e9724100a4085a98aecb71bf",
            "afb71a53f6424a5b95043fac5b6f5cd4",
            "592a82e4ad7a493fa2b0e65f6e84470a",
            "6a3b9872081040a79a20ff19d8b1bddf",
            "c71c21cc0c6e4fe59c3afb1b0f75fb05",
            "81bb70b4bf0c41e0876e8d2f7acb4cab",
            "ea81f616ee4b48c18458fb6c939299e3",
            "a4f6b802d8424cad9c463ff6b4cc2dee",
            "6878c66b7703415b874556f7bc9ea2c0",
            "106768647d0745cab9ffef4e67acbf71",
            "ebd596dd2cd746f59c12f36b9265ecfc",
            "14815b3cb54d43c9a12383c6697b2596",
            "59a24c819f074c0bb9856c78282e4f45",
            "a54e342699cd41f2a4d7ce04f74a3234",
            "5d40571baf7c4ad0983af26e9d17206f",
            "51d96f42eeb74a79a3bdc60ba76bb9a0",
            "6af6994120f1414a89379143db5c6f40",
            "bfc2dd902e9547c5887f286d9833f60c",
            "d2f42864613d4671a81fa84cddcbec5a",
            "024814ceb3bc4a6b9b1190e58f539b75",
            "1fbeaa08608b4cdc9b51bd89ad3a6795",
            "924e4a3fcb9f480bac1a20e9cc029108",
            "b9626908fb9b4b538584c9b9b5d2383b",
            "0c52649527694298ad506551506f5198",
            "e94f2c52709f4230b49129ac377d3bdc",
            "7cdee95a51744520b785363c66493935",
            "97016bc8b701476ba15b53a3fa0915a4",
            "604f8d291a914ccc921efeafcf8a2447",
            "d0708c18c44247738df0bf3f15290e6c",
            "652c6f62eb044782b374b6439f520753",
            "30d362aa13b442ee89555fc03cd8b530",
            "09f7b13970344f769c17e6b2732ae1dd",
            "0fc4112606b6447db2ba2532495d3f69",
            "f88613c7f0a24b7287b37353baa3c688",
            "8676cf4b9b9543b0a2612072a4252d54",
            "069ed3cb1de04d65b739ac4c6af02b6c",
            "89f8c63f3312482d821b8b5848461d8d",
            "2285542384fc4c88b2a8dffc33c1322d",
            "eca951b58fe244d2a59cff0297f41795",
            "234ccc2a10904a75ad1e039435efc408",
            "b6889f9fc1924d69baa8ba4326b9b0c3",
            "2b04d6d98a4d473b94f34342022e9702",
            "c0bfb52eecf942fcb8b73f5762104f2b",
            "ce439611bb914d6cadc24e03be26c242",
            "3bb102d70c644a42a32090b86a4ff3ba",
            "988d0cd1965142398f447f50cfe818dc",
            "be59d2601fee4e2eb643724b2937ca25",
            "bf0afcbc3a4b4e9195fcca2ad3041440",
            "7b852a7bf0194a398c955e7ab1cd6650",
            "26ad98e97918406aabf0456f31d7d309",
            "4c27e1864a2a4a0eb2ab4ac2d4603552",
            "0b03084413fd4c86bcf52f49dc064eb5",
            "95f4dd927d5344179adace93bd74e61c",
            "f818d2442ac64554af2101482dc8fbe0",
            "a9053a1366e946bb90eac8d6f321fbc8",
            "3d93fe90882a4b929ab77173bdc7bf1f",
            "dd3dc5b53a294dd0ab4295d264648910",
            "be5fb25dce6040cb8de49904874cfa7f",
            "fd8f1a10633044fc85ca9812bf6500ff",
            "9561407302564151bffe0a27059ec6a5",
            "910116f8336641e5bfa48e5beaf839fb",
            "89caccc27c2e4b3dad3f90edb6b35467",
            "acbd6ff5a0ac46d5a3b8a12cc4f98f65",
            "e71cdc9b3d9c47aaae272286e2ad755f",
            "7f663b5b7eca4f30a79b3001093fde1d",
            "f743b7152f7440c3bc0d80d29cf44e79",
            "fda0131974b04cfe8b665c8838322c4b",
            "08fcd675bcfc459d801d0e20646a5d44",
            "2d92be8022c74b2380b2062dce157681",
            "7c403a5122cb4938be243c2382df47ca",
            "6831b3d7a1c9464f96b27d2d3a9e104e",
            "ea4f974644914ccc95e92e102847b232",
            "fd63a2322d2b4e6fbae757a479dec683",
            "75d0b35caef64ffdb2b449b39887b9c3",
            "dfe4ffb30d434ad49121806bcd26de46",
            "a4ac5254d30b4524910e0621f9f8d02e",
            "648d06612518495b8e2bdd4c97034804",
            "67d71b0fd3824b42ba057ec06c13cad6",
            "616684c3ffac46f9987f9cf65243b730",
            "afef3571b1a34097a5822d49bb783d92",
            "56a544cdcb2e487ab153152d24349181",
            "fdee49242d98472a8c675bed021084bc",
            "08bce8da439c449599c6f2730490d361",
            "781dfca0fa874d749f3ac12b96a7b2ff",
            "c362163c755340eeb73566c3d3544006",
            "aa69f206242f4032bcf3ceee1a55f129",
            "dd49a057d299494fb7b465a8e9c7e624",
            "634d146a3f7d4d11b6f9e2187919ad91",
            "b96123ed6e56419a8a111046d8787d60",
            "e3b4760da6bb4ede8903cd0b7c0761a2",
            "1ebacd1310614bbebe0b3b2a9cda9057",
            "2d1693f3fa3742af9b1d1a8c0723d18a",
            "6229bbdac6034957b0f93f3e2ef9dbfb",
            "3fba5cb2d7634e7398bbd944c9f69dcd",
            "b7e925503f4b4cf98c437720f1f6c078",
            "6376506ceb51454bb88fdc033e6b6806",
            "ade94385c1734a3383788d03d955fa40",
            "ee4d40d0e301441b883e00bb31f82c66",
            "2902f3211d2249e9bc3ed4fd43eaf219",
            "9ba80a7b69434635a98ac2448671ba9b",
            "c2effa887aff4f5b922099dfed7dd281",
            "a6ce5d8a9bdd4198bd4a4571ca35545f",
            "7c531b1552b2416d814ef2a42478cdd9",
            "6f2721155fa74fc5a1931b7df707ebef",
            "8735af8dd8e34fdba1368d6dc2fa91c2",
            "7c68742ee1f5494f847d1da2172b5b45",
            "e0f39cea384c4c7e9bb12d40dbc8e98d",
            "c79c6899f0c448df83f287fb5b478d0d",
            "4f9306dca79248bb82d2240a65c78d98",
            "0615dc945fb54d22bb83c065a509a524",
            "d35eedec036d4c10b9488b62c70ed7bc"
          ]
        },
        "id": "XSu8A6pcof52",
        "outputId": "3ac13824-1c13-44ce-d5c3-93c3b100797f"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "WARNING:torchao.kernel.intmm:Warning: Detected no triton, on systems without Triton certain kernels will not work\n",
            "/usr/local/lib/python3.12/dist-packages/huggingface_hub/utils/_auth.py:94: UserWarning: \n",
            "The secret `HF_TOKEN` does not exist in your Colab secrets.\n",
            "To authenticate with the Hugging Face Hub, create a token in your settings tab (https://huggingface.co/settings/tokens), set it as secret in your Google Colab and restart your session.\n",
            "You will be able to reuse this secret in all of your notebooks.\n",
            "Please note that authentication is recommended but still optional to access public models or datasets.\n",
            "  warnings.warn(\n"
          ]
        }
      ],
      "source": [
        "model = SentenceTransformer(\"sentence-transformers/all-MiniLM-L6-v2\")\n",
        "\n",
        "emb = model.encode(\n",
        "    chunks_df[\"chunk\"].tolist(),\n",
        "    batch_size=64,\n",
        "    show_progress_bar=True,\n",
        "    normalize_embeddings=True\n",
        ").astype(\"float32\")\n",
        "\n",
        "index = faiss.IndexFlatIP(emb.shape[1])  # cosine similarity если normalize=True\n",
        "index.add(emb)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "1DeBYl1tqaNR"
      },
      "outputs": [],
      "source": [
        "def retrieve(query: str, top_k=10):\n",
        "    q_emb = model.encode([query], normalize_embeddings=True).astype(\"float32\")\n",
        "    scores, ids = index.search(q_emb, top_k)\n",
        "\n",
        "    results = chunks_df.iloc[ids[0]].copy()\n",
        "    results[\"score\"] = scores[0]\n",
        "    return results\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "oUcdXW0lqcX4",
        "outputId": "fa2754c0-1a2a-4f0f-e1a6-2832eea4182e"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"res[[\\\"pdf\\\", \\\"chunk_id\\\", \\\"score\\\"]]\",\n  \"rows\": 5,\n  \"fields\": [\n    {\n      \"column\": \"pdf\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"2025.01.10.632400v1.full.pdf\",\n          \"2023.06.15.545187v1.full.pdf\",\n          \"2025.07.11.659973v2.full.pdf\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"chunk_id\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 17,\n        \"min\": 12,\n        \"max\": 55,\n        \"num_unique_values\": 5,\n        \"samples\": [\n          55,\n          43,\n          39\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"score\",\n      \"properties\": {\n        \"dtype\": \"float32\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          0.637049674987793,\n          0.6131195425987244,\n          0.6334171295166016\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-168df8ae-5ecc-4315-a383-fc6826d3038a\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>pdf</th>\n",
              "      <th>chunk_id</th>\n",
              "      <th>score</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>961</th>\n",
              "      <td>2025.01.10.632400v1.full.pdf</td>\n",
              "      <td>22</td>\n",
              "      <td>0.670759</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1135</th>\n",
              "      <td>2023.06.15.545187v1.full.pdf</td>\n",
              "      <td>55</td>\n",
              "      <td>0.637050</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1119</th>\n",
              "      <td>2023.06.15.545187v1.full.pdf</td>\n",
              "      <td>39</td>\n",
              "      <td>0.633417</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>775</th>\n",
              "      <td>2025.07.11.659973v2.full.pdf</td>\n",
              "      <td>12</td>\n",
              "      <td>0.615496</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1123</th>\n",
              "      <td>2023.06.15.545187v1.full.pdf</td>\n",
              "      <td>43</td>\n",
              "      <td>0.613120</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-168df8ae-5ecc-4315-a383-fc6826d3038a')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-168df8ae-5ecc-4315-a383-fc6826d3038a button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-168df8ae-5ecc-4315-a383-fc6826d3038a');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-f3fdb6a3-5604-4eac-99a1-f9fa59c0fa3f\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f3fdb6a3-5604-4eac-99a1-f9fa59c0fa3f')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-f3fdb6a3-5604-4eac-99a1-f9fa59c0fa3f button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                               pdf  chunk_id     score\n",
              "961   2025.01.10.632400v1.full.pdf        22  0.670759\n",
              "1135  2023.06.15.545187v1.full.pdf        55  0.637050\n",
              "1119  2023.06.15.545187v1.full.pdf        39  0.633417\n",
              "775   2025.07.11.659973v2.full.pdf        12  0.615496\n",
              "1123  2023.06.15.545187v1.full.pdf        43  0.613120"
            ]
          },
          "execution_count": 83,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "res = retrieve(\"microglia mitochondrial function knockdown\", top_k=5)\n",
        "res[[\"pdf\", \"chunk_id\", \"score\"]]\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "4Nad-aBEqfto"
      },
      "source": [
        "### Generation: строим RAG pipeline"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "91OFf4wbh6PR"
      },
      "source": [
        "Настраиваем доступ по API к модели"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "NZjTgZ8Isur0"
      },
      "outputs": [],
      "source": [
        "load_dotenv(\"/content/drive/MyDrive/TestTask/.env\")\n",
        "API_KEY = os.environ[\"API_KEY\"]\n",
        "BASE_URL = \"https://foundation-models.api.cloud.ru/v1\"\n",
        "\n",
        "lector_llm = ChatOpenAI(\n",
        "    model=\"openai/gpt-oss-120b\",\n",
        "    base_url=BASE_URL,\n",
        "    api_key=API_KEY,\n",
        "    temperature=0.4,\n",
        "    max_tokens=2500\n",
        ")\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "XL_sRD6jOPNb"
      },
      "source": [
        "## Пайплайн"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "BEzGGL4-qiCl"
      },
      "outputs": [],
      "source": [
        "from langchain_community.embeddings import HuggingFaceEmbeddings\n",
        "from langchain_community.vectorstores import FAISS\n",
        "from langchain_core.documents import Document\n",
        "from langchain_core.prompts import ChatPromptTemplate\n",
        "from langchain_core.runnables import RunnablePassthrough\n",
        "from langchain_core.output_parsers import StrOutputParser\n",
        "\n",
        "embeddings = HuggingFaceEmbeddings(model_name=\"sentence-transformers/all-MiniLM-L6-v2\")\n",
        "\n",
        "docs = []\n",
        "for _, r in chunks_df.iterrows():\n",
        "    docs.append(\n",
        "        Document(\n",
        "            page_content=r[\"chunk\"],\n",
        "            metadata={\"pdf\": r[\"pdf\"], \"doc_id\": int(r[\"doc_id\"]), \"chunk_id\": int(r[\"chunk_id\"])}\n",
        "        )\n",
        "    )\n",
        "\n",
        "vectorstore = FAISS.from_documents(docs, embeddings)\n",
        "retriever = vectorstore.as_retriever(search_kwargs={\"k\": 10})\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "DqhW_v1SsVrO"
      },
      "outputs": [],
      "source": [
        "rag_prompt = ChatPromptTemplate.from_messages([\n",
        "    (\"system\",\n",
        "     \"You are a scientific assistant. Answer ONLY using the provided context. \"\n",
        "     \"If the context is insufficient, say you don't know. \"\n",
        "     \"Always mention which PDF(s) you used in 1 short line at the end: 'Sources: ...'.\"),\n",
        "    (\"human\",\n",
        "     \"Question:\\n{question}\\n\\nContext:\\n{context}\\n\\nAnswer:\")\n",
        "])\n",
        "\n",
        "def format_docs(docs):\n",
        "    parts = []\n",
        "    for d in docs:\n",
        "        pdf = d.metadata.get(\"pdf\", \"unknown.pdf\")\n",
        "        cid = d.metadata.get(\"chunk_id\", \"?\")\n",
        "        parts.append(f\"[{pdf} | chunk {cid}]\\n{d.page_content}\")\n",
        "    return \"\\n\\n---\\n\\n\".join(parts)\n",
        "\n",
        "rag_chain = (\n",
        "    {\"context\": retriever | format_docs, \"question\": RunnablePassthrough()}\n",
        "    | rag_prompt\n",
        "    | lector_llm\n",
        "    | StrOutputParser()\n",
        ")\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "sOSd6IYMtuh_",
        "outputId": "3c119200-61b1-4d1a-d60c-467194bec7dc"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "The study’s primary contribution is the discovery and systematic characterization of **372 circulating micro‑RNAs that are dysregulated in Alzheimer’s disease**. By integrating data from multiple source studies, the authors show that these miRNAs not only reproduce the majority of pathways already known to be involved in AD but also reveal several previously unrecognized pathways, thereby offering a new molecular basis for both biomarker development and therapeutic targeting.\n",
            "\n",
            "**Evidence supporting this contribution**  \n",
            "- The meta‑analysis identified a novel set of 372 circulating miRNAs altered in AD.  \n",
            "- Functional enrichment of these miRNAs demonstrated that they recapitulate most established AD‑related pathways while also uncovering additional, unaccounted‑for pathways.  \n",
            "- The authors argue that these findings provide an “unprecedented opportunity” to create next‑generation biomarkers and to explore novel therapeutic avenues.  \n",
            "\n",
            "**Source:** 2025.11.27.690929v1.full.pdf (chunk 22).\n"
          ]
        }
      ],
      "source": [
        "question = \"What is the main contribution of the work and what evidence supports it?\"\n",
        "answer = rag_chain.invoke(question)\n",
        "print(answer)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "9xO5c-FHt5yk"
      },
      "source": [
        "## Оценка"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "EU4x1N2KFFgx"
      },
      "source": [
        "### Для оценки RAG - системы создаем eval_questions"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ilaRY2QAt7pR"
      },
      "outputs": [],
      "source": [
        "eval_questions = [\n",
        "    {\n",
        "        \"question\": \"What role do microglial cells play in tau seeding and spreading in Alzheimer's disease?\",\n",
        "        \"gold_pdfs\": [\"2023.03.28.534418v2.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How do oligomeric and fibrillar tau differ in their ability to induce glial responses in vivo?\",\n",
        "        \"gold_pdfs\": [\"2023.03.28.534418v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What is the main purpose of the CSSG algorithm in single-cell RNA-seq analysis?\",\n",
        "        \"gold_pdfs\": [\"2023.04.20.537649v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How does the CSSG/JSEQ pipeline improve the detection of rare cell populations?\",\n",
        "        \"gold_pdfs\": [\"2023.04.20.537649v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does tau depletion affect PRC2 activity and cellular senescence?\",\n",
        "        \"gold_pdfs\": [\"2023.06.05.543662v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"What molecular mechanism links Tau loss to increased IGFBP3 expression?\",\n",
        "        \"gold_pdfs\": [\"2023.06.05.543662v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Which protein biomarkers differentiate microglial activation states in Alzheimer's disease?\",\n",
        "        \"gold_pdfs\": [\"2023.06.15.545187v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How are TREM2 and GRN knockout models used to define microglial activity states?\",\n",
        "        \"gold_pdfs\": [\"2023.06.15.545187v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What is the functional role of PSENEN within the gamma-secretase complex?\",\n",
        "        \"gold_pdfs\": [\"2023.07.28.550932v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How does PSENEN loss affect Notch and APP processing?\",\n",
        "        \"gold_pdfs\": [\"2023.07.28.550932v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What pharmacodynamic biomarkers change in response to CT1812 treatment in Alzheimer's patients?\",\n",
        "        \"gold_pdfs\": [\"2024.02.16.578765v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"Which biological pathways are impacted by CT1812 according to CSF proteomics?\",\n",
        "        \"gold_pdfs\": [\"2024.02.16.578765v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What epigenomic abnormalities persist in iPSCs derived from Alzheimer's disease patients?\",\n",
        "        \"gold_pdfs\": [\"2024.08.29.610372v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How does reduced BMI1 expression contribute to Alzheimer's-related epigenomic changes?\",\n",
        "        \"gold_pdfs\": [\"2024.08.29.610372v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does semantic analysis help identify COVID-19 related genetic variants?\",\n",
        "        \"gold_pdfs\": [\"2022.09.16.508278v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"What population-level genetic data are integrated to study COVID-19 susceptibility?\",\n",
        "        \"gold_pdfs\": [\"2022.09.16.508278v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How do age-related changes in neuronal GTP levels affect endocytosis and autophagy in Alzheimer’s disease models?\",\n",
        "        \"gold_pdfs\": [\"2020.12.10.419598v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What experimental evidence links NAD+ precursors and Nrf2 modulation to restoration of autophagy in aged neurons?\",\n",
        "        \"gold_pdfs\": [\"2022.05.14.491965v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does Regulation Flow Analysis generate mechanistic hypotheses from large molecular knowledge graphs?\",\n",
        "        \"gold_pdfs\": [\"2022.09.16.508278v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What are the core mathematical assumptions behind the Regulation Flow model and its convergence guarantees?\",\n",
        "        \"gold_pdfs\": [\"2023.03.28.534418v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does context-dependent regulatory variation contribute to Alzheimer’s disease risk across immune and neural cell types?\",\n",
        "        \"gold_pdfs\": [\"2023.04.20.537649v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What role do microglial and macrophage enhancer variants play in late-onset Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2023.06.05.543662v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How do massively parallel reporter assays reveal opposite regulatory effects of the same variants across cell states?\",\n",
        "        \"gold_pdfs\": [\"2023.06.15.545187v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How are graph neural networks used to identify EEG frequency-band biomarkers for dementia?\",\n",
        "        \"gold_pdfs\": [\"2023.07.28.550932v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Which brain regions and EEG frequency bands are most informative for frontotemporal dementia classification?\",\n",
        "        \"gold_pdfs\": [\"2024.02.16.578765v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does Alzheimer’s disease impair bone marrow myelopoiesis and monocyte differentiation?\",\n",
        "        \"gold_pdfs\": [\"2024.08.29.610372v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What is the role of type I interferon signaling in bone marrow dysfunction during Alzheimer’s disease progression?\",\n",
        "        \"gold_pdfs\": [\"2025.01.10.632400v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does blocking IFN-I signaling restore myeloid cell function in Alzheimer’s disease models?\",\n",
        "        \"gold_pdfs\": [\"2025.01.17.633633v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Which molecular pathways are implicated in disrupted hematopoietic stem cell quiescence in Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2025.01.26.634937v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does integrated phenotypic and proteomic screening prioritize therapeutic targets in Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2025.06.09.658689v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Which candidate genes show the strongest phenotypic rescue effects in microglial Alzheimer’s disease models?\",\n",
        "        \"gold_pdfs\": [\"2025.06.15.659785v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How do noncoding regulatory variants exert opposite effects depending on immune versus neural contexts in Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2025.07.11.659973v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How do EEG connectivity patterns differ between frontotemporal dementia patients and healthy controls?\",\n",
        "        \"gold_pdfs\": [\"2025.08.18.670945v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What evidence supports bone marrow dysfunction as a systemic contributor to Alzheimer’s disease pathology?\",\n",
        "        \"gold_pdfs\": [\"2025.10.06.680030v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Which therapeutic targets reverse Alzheimer’s-associated proteomic signatures in microglial models?\",\n",
        "        \"gold_pdfs\": [\"2025.10.16.682926v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How do APOE4 neuron–glia assembloids reveal IGFBP signaling as a therapeutic target in Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2025.10.17.683162v1.full.pdf\"]\n",
        "    },\n",
        "    {\n",
        "        \"question\": \"How do age-related changes in neuronal GTP levels impair endocytosis and autophagy in Alzheimer’s disease models?\",\n",
        "        \"gold_pdfs\": [\"2020.12.10.419598v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does BrainBridge integrate atlas-scale single-cell RNA-seq data with phenotypic information to model Alzheimer’s disease and aging?\",\n",
        "        \"gold_pdfs\": [\"2025.12.03.692255v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Why does astrocyte-specific deletion of monoacylglycerol lipase reduce amyloid pathology and improve cognition in Alzheimer’s disease models?\",\n",
        "        \"gold_pdfs\": [\"2025.12.04.692105v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does astrocytic soluble epoxide hydrolase contribute to neurovascular dysfunction and vascular amyloid deposition in Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2025.12.09.692941v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does IL-17A–STAT1–CEBPB signaling drive neuroinflammation in HIV-1–infected human cerebral organoids despite cART treatment?\",\n",
        "        \"gold_pdfs\": [\"2025.12.30.697044v2.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What molecular mechanisms link astrocytic lipid metabolism to synaptic dysfunction in neurodegenerative disease models?\",\n",
        "        \"gold_pdfs\": [\"2025.11.04.686626v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How does cell-type–specific immune signaling alter disease progression in Alzheimer’s disease mouse models?\",\n",
        "        \"gold_pdfs\": [\"2025.11.07.687156v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"Which transcriptomic signatures distinguish pathogenic versus protective astrocyte states in neurodegeneration?\",\n",
        "        \"gold_pdfs\": [\"2025.11.27.690929v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"How do multimodal single-cell approaches uncover gene programs associated with Alzheimer’s disease phenotypes?\",\n",
        "        \"gold_pdfs\": [\"2025.12.03.692255v1.full.pdf\"]\n",
        "    },\n",
        "\n",
        "    {\n",
        "        \"question\": \"What evidence supports targeting astrocyte-specific metabolic enzymes as a therapeutic strategy for Alzheimer’s disease?\",\n",
        "        \"gold_pdfs\": [\"2025.10.17.683162v1.full.pdf\"]\n",
        "    }\n",
        "]\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "r6mGNl-Q2XxW",
        "outputId": "a8d51fe5-c815-4514-b8e2-72297a258d7d"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "What role do microglial cells play in tau seeding and spreading in Alzheimer's disease?\n",
            "Gold: ['2023.03.28.534418v2.full.pdf']\n",
            "How do oligomeric and fibrillar tau differ in their ability to induce glial responses in vivo?\n",
            "Gold: ['2023.03.28.534418v2.full.pdf']\n",
            "What is the main purpose of the CSSG algorithm in single-cell RNA-seq analysis?\n",
            "Gold: ['2023.04.20.537649v1.full.pdf']\n",
            "How does the CSSG/JSEQ pipeline improve the detection of rare cell populations?\n",
            "Gold: ['2023.04.20.537649v1.full.pdf']\n",
            "How does tau depletion affect PRC2 activity and cellular senescence?\n",
            "Gold: ['2023.06.05.543662v1.full.pdf']\n"
          ]
        }
      ],
      "source": [
        "for q in eval_questions[:5]:\n",
        "    print(q[\"question\"])\n",
        "    print(\"Gold:\", q[\"gold_pdfs\"])\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VGXunl_92rpv",
        "outputId": "1d2807b0-52e2-4118-90d5-9ddb4df3feb3"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "2023.03.28.534418v2.full.pdf 34\n",
            "2023.03.28.534418v2.full.pdf 46\n",
            "2023.03.28.534418v2.full.pdf 53\n",
            "2023.03.28.534418v2.full.pdf 51\n",
            "2023.03.28.534418v2.full.pdf 58\n",
            "2023.03.28.534418v2.full.pdf 35\n",
            "2023.03.28.534418v2.full.pdf 43\n",
            "2025.01.10.632400v1.full.pdf 13\n",
            "2025.01.10.632400v1.full.pdf 3\n",
            "2023.03.28.534418v2.full.pdf 45\n"
          ]
        }
      ],
      "source": [
        "test_q = eval_questions[0][\"question\"]\n",
        "docs = retriever.invoke(test_q)\n",
        "\n",
        "for d in docs:\n",
        "    print(d.metadata[\"pdf\"], d.metadata[\"chunk_id\"])\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "5LykSbV8FQVW"
      },
      "source": [
        "### Функции оценки"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "CC_ICMvi3QZa"
      },
      "outputs": [],
      "source": [
        "def unique_keep_order(seq):\n",
        "    seen = set()\n",
        "    out = []\n",
        "    for x in seq:\n",
        "        if x not in seen:\n",
        "            seen.add(x)\n",
        "            out.append(x)\n",
        "    return out\n",
        "\n",
        "\n",
        "def recall_at_k(retrieved_pdfs, gold_pdfs, k):\n",
        "    retrieved_pdfs = unique_keep_order(retrieved_pdfs)[:k]\n",
        "    return int(len(set(retrieved_pdfs) & set(gold_pdfs)) > 0)\n",
        "\n",
        "\n",
        "def mrr_at_k(retrieved_pdfs, gold_pdfs, k):\n",
        "    retrieved_pdfs = unique_keep_order(retrieved_pdfs)[:k]\n",
        "    gold = set(gold_pdfs)\n",
        "    for i, pdf in enumerate(retrieved_pdfs, start=1):\n",
        "        if pdf in gold:\n",
        "            return 1.0 / i\n",
        "    return 0.0\n",
        "\n",
        "\n",
        "def eval_retrieval(eval_questions, k=10):\n",
        "    recalls = []\n",
        "    mrrs = []\n",
        "\n",
        "    retriever.search_kwargs[\"k\"] = k\n",
        "\n",
        "    for item in eval_questions:\n",
        "        q = item[\"question\"]\n",
        "        gold = item[\"gold_pdfs\"]\n",
        "\n",
        "        docs = retriever.invoke(q)\n",
        "\n",
        "        retrieved_pdfs = [d.metadata.get(\"pdf\") for d in docs if d.metadata.get(\"pdf\")]\n",
        "\n",
        "        recalls.append(recall_at_k(retrieved_pdfs, gold, k))\n",
        "        mrrs.append(mrr_at_k(retrieved_pdfs, gold, k))\n",
        "\n",
        "    return {\n",
        "        f\"Recall@{k}\": sum(recalls) / len(recalls),\n",
        "        f\"MRR@{k}\": sum(mrrs) / len(mrrs)\n",
        "    }\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wULFnlU69mM-",
        "outputId": "466ed4d6-9cc0-4d08-d39d-5b4710a96ae0"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "{'Recall@5': 0.5434782608695652, 'MRR@5': 0.532608695652174} {'Recall@10': 0.5434782608695652, 'MRR@10': 0.532608695652174}\n"
          ]
        }
      ],
      "source": [
        "metrics_5 = eval_retrieval(eval_questions, k=5)\n",
        "metrics_10 = eval_retrieval(eval_questions, k=10)\n",
        "print(metrics_5, metrics_10)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Jz4DzGo36Ls2",
        "outputId": "e9239b19-f490-4696-8ce4-c569031456b4"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "docs returned: 10\n",
            "['2023.03.28.534418v2.full.pdf', '2023.03.28.534418v2.full.pdf', '2023.03.28.534418v2.full.pdf', '2023.03.28.534418v2.full.pdf', '2023.03.28.534418v2.full.pdf', '2023.03.28.534418v2.full.pdf', '2023.03.28.534418v2.full.pdf', '2025.01.10.632400v1.full.pdf', '2025.01.10.632400v1.full.pdf', '2023.03.28.534418v2.full.pdf']\n",
            "unique pdfs: 2\n"
          ]
        }
      ],
      "source": [
        "q0 = eval_questions[0][\"question\"]\n",
        "retriever.search_kwargs[\"k\"] = 10\n",
        "docs10 = retriever.invoke(q0)\n",
        "print(\"docs returned:\", len(docs10))\n",
        "print([d.metadata[\"pdf\"] for d in docs10])\n",
        "print(\"unique pdfs:\", len(set(d.metadata[\"pdf\"] for d in docs10)))\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "a0wsAUeZLSyA"
      },
      "outputs": [],
      "source": [
        "def eval_retrieval_unique(eval_questions, k=10, k_chunks=50):\n",
        "    recalls, mrrs = [], []\n",
        "\n",
        "    for item in eval_questions:\n",
        "        q = item[\"question\"]\n",
        "        gold = item[\"gold_pdfs\"]\n",
        "\n",
        "        docs = retrieve_unique_pdfs(q, k_pdfs=k, k_chunks=k_chunks)\n",
        "        retrieved_pdfs = [d.metadata.get(\"pdf\") for d in docs if d.metadata.get(\"pdf\")]\n",
        "\n",
        "        recalls.append(recall_at_k(retrieved_pdfs, gold, k))\n",
        "        mrrs.append(mrr_at_k(retrieved_pdfs, gold, k))\n",
        "\n",
        "    return {\n",
        "        f\"Recall@{k}\": sum(recalls) / len(recalls),\n",
        "        f\"MRR@{k}\": sum(mrrs) / len(mrrs)\n",
        "    }\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "rDF7auks6ihi",
        "outputId": "ed7ab2bb-4df4-48bc-ada1-2822bdbac467"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Unique PDFs:\n",
            "{'Recall@5': 0.6086956521739131, 'MRR@5': 0.5456521739130435}\n",
            "{'Recall@10': 0.7391304347826086, 'MRR@10': 0.5636991028295376}\n"
          ]
        }
      ],
      "source": [
        "print(\"Unique PDFs:\")\n",
        "print(eval_retrieval_unique(eval_questions, k=5, k_chunks=50))\n",
        "print(eval_retrieval_unique(eval_questions, k=10, k_chunks=50))\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "cBi1pJr2LwGn"
      },
      "source": [
        "### Вывод\n",
        "В результате оценки retrieval-компоненты RAG-системы на уровне документов было получено значение Recall для 5 = 0.61 и Recall для 10 = 0.74. Это означает, что релевантный документ попадает в топ-5 источников примерно в 61% случаев, а при расширении выдачи до 10 документов — уже в 74% случаев. Рост Recall при увеличении k указывает на адекватную способность системы находить релевантные статьи при увеличении охвата. Значения MRR@k (≈0.55–0.56) показывают, что при успешном поиске релевантные документы, как правило, располагаются в верхней части ранжирования."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "zu-qsJIUCUM_"
      },
      "source": [
        "## Интерфейс"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "kB17Cc3sDeuP"
      },
      "outputs": [],
      "source": [
        "import ipywidgets as widgets\n",
        "from IPython.display import display, Markdown, clear_output\n",
        "import textwrap\n",
        "from langchain_core.output_parsers import StrOutputParser"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Xxu3qyoFDnIW"
      },
      "outputs": [],
      "source": [
        "def retrieve_unique_pdfs_with_scores(query: str, k_pdfs=5, k_chunks=50):\n",
        "    docs_scores = vectorstore.similarity_search_with_score(query, k=k_chunks)\n",
        "\n",
        "    uniq = []\n",
        "    seen = set()\n",
        "    for d, score in docs_scores:\n",
        "        pdf = d.metadata.get(\"pdf\")\n",
        "        if pdf and pdf not in seen:\n",
        "            seen.add(pdf)\n",
        "            uniq.append((d, score))\n",
        "        if len(uniq) >= k_pdfs:\n",
        "            break\n",
        "    return uniq\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "eKAVs98wDq3E"
      },
      "outputs": [],
      "source": [
        "def generate_rag_answer(question: str, docs):\n",
        "    \"\"\"\n",
        "    docs: list[Document]\n",
        "    \"\"\"\n",
        "    context = format_docs(docs)\n",
        "    chain = rag_prompt | lector_llm | StrOutputParser()\n",
        "    answer = chain.invoke({\"question\": question, \"context\": context})\n",
        "\n",
        "    pdfs = []\n",
        "    seen = set()\n",
        "    for d in docs:\n",
        "        pdf = d.metadata.get(\"pdf\")\n",
        "        if pdf and pdf not in seen:\n",
        "            seen.add(pdf)\n",
        "            pdfs.append(pdf)\n",
        "\n",
        "    if \"Sources:\" not in answer:\n",
        "        answer = answer.strip() + \"\\n\\nSources: \" + \", \".join(pdfs) if pdfs else \"\\n\\nSources: (none)\"\n",
        "    return answer, pdfs\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "aJlNIJJdDu0K"
      },
      "outputs": [],
      "source": [
        "example_questions = [\n",
        "    \"What are potential targets for Alzheimer's disease treatment?\",\n",
        "    \"Are the targets druggable with small molecules, biologics, or other modalities?\",\n",
        "    \"What additional studies are needed to advance these targets?\"\n",
        "]\n",
        "\n",
        "query_box = widgets.Textarea(\n",
        "    value=example_questions[0],\n",
        "    placeholder=\"Type your research question here...\",\n",
        "    description=\"Query:\",\n",
        "    layout=widgets.Layout(width=\"100%\", height=\"90px\")\n",
        ")\n",
        "\n",
        "examples_dropdown = widgets.Dropdown(\n",
        "    options=example_questions,\n",
        "    description=\"Examples:\",\n",
        "    layout=widgets.Layout(width=\"100%\")\n",
        ")\n",
        "\n",
        "k_slider = widgets.IntSlider(\n",
        "    value=5, min=1, max=15, step=1,\n",
        "    description=\"Top PDFs:\",\n",
        "    continuous_update=False\n",
        ")\n",
        "\n",
        "k_chunks_slider = widgets.IntSlider(\n",
        "    value=50, min=10, max=200, step=10,\n",
        "    description=\"Scan chunks:\",\n",
        "    continuous_update=False\n",
        ")\n",
        "\n",
        "run_btn = widgets.Button(\n",
        "    description=\"Run RAG\",\n",
        "    button_style=\"primary\",\n",
        "    icon=\"search\"\n",
        ")\n",
        "\n",
        "sources_out = widgets.Output()\n",
        "answer_out = widgets.Output()\n",
        "\n",
        "\n",
        "def on_example_change(change):\n",
        "    if change[\"name\"] == \"value\":\n",
        "        query_box.value = change[\"new\"]\n",
        "\n",
        "examples_dropdown.observe(on_example_change)\n",
        "\n",
        "\n",
        "def render_sources(docs_scores):\n",
        "    \"\"\"\n",
        "    docs_scores: list[(Document, score)]\n",
        "    \"\"\"\n",
        "    with sources_out:\n",
        "        clear_output()\n",
        "        if not docs_scores:\n",
        "            display(Markdown(\"### Sources\\nNo sources found.\"))\n",
        "            return\n",
        "\n",
        "        display(Markdown(\"### Sources (retrieved)\"))\n",
        "        for idx, (d, score) in enumerate(docs_scores, start=1):\n",
        "            pdf = d.metadata.get(\"pdf\", \"unknown.pdf\")\n",
        "            chunk_id = d.metadata.get(\"chunk_id\", \"?\")\n",
        "            doc_id = d.metadata.get(\"doc_id\", \"?\")\n",
        "\n",
        "            snippet = d.page_content.strip().replace(\"\\n\", \" \")\n",
        "            snippet = textwrap.shorten(snippet, width=320, placeholder=\"...\")\n",
        "\n",
        "            display(Markdown(\n",
        "                f\"**{idx}. {pdf}** (doc_id={doc_id}, chunk_id={chunk_id}, score={score:.4f})\\n\\n\"\n",
        "                f\"> {snippet}\\n\"\n",
        "            ))\n",
        "\n",
        "\n",
        "def on_run_clicked(_):\n",
        "    question = query_box.value.strip()\n",
        "    if not question:\n",
        "        with answer_out:\n",
        "            clear_output()\n",
        "            display(Markdown(\"Please enter a question.\"))\n",
        "        return\n",
        "\n",
        "    # 1) retrieve\n",
        "    docs_scores = retrieve_unique_pdfs_with_scores(\n",
        "        question,\n",
        "        k_pdfs=int(k_slider.value),\n",
        "        k_chunks=int(k_chunks_slider.value)\n",
        "    )\n",
        "    docs = [d for d, _ in docs_scores]\n",
        "\n",
        "    # render sources\n",
        "    render_sources(docs_scores)\n",
        "\n",
        "    # generate answer\n",
        "    with answer_out:\n",
        "        clear_output()\n",
        "        display(Markdown(\"### Answer\"))\n",
        "        answer, _pdfs = generate_rag_answer(question, docs)\n",
        "        display(Markdown(answer))\n",
        "\n",
        "\n",
        "run_btn.on_click(on_run_clicked)\n",
        "\n",
        "ui = widgets.VBox([\n",
        "    widgets.HTML(\"<h3>RAG demo interface</h3>\"),\n",
        "    examples_dropdown,\n",
        "    query_box,\n",
        "    widgets.HBox([k_slider, k_chunks_slider, run_btn]),\n",
        "    sources_out,\n",
        "    answer_out\n",
        "])\n",
        "\n",
        "display(ui)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Jvyq9R2sMPKY"
      },
      "source": [
        "## Вопросы"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Qnh1jPWAM5TM"
      },
      "source": [
        "### На какие модальности данных можно расширить решение?\n",
        "\n",
        "Расширением модальности данной RAG-системы может являться переход к мультимодальному подходу, объединяющему текстовые и визуальные данные. В качестве дополнительной модальности могут использоваться изображения, извлекаемые из научных статей, такие как графики, схемы, диаграммы и иллюстрации. В этом случае система будет формировать ответы не только на основе текстовых источников, но и подкреплять выводы визуальными материалами, повышая интерпретируемость и наглядность результатов для пользователя.\n",
        "Реализация подобного расширения возможна в виде мультиагентной архитектуры, где один агент отвечает за генерацию текстового ответа на основе retrieval-механизма, а второй агент осуществляет поиск и отбор релевантных изображений из статей, соответствующих контексту запроса. Совместная работа агентов позволит формировать более информативные и обоснованные ответы, что особенно актуально для научных и исследовательских задач."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "tCH3KNsuNpu2"
      },
      "source": [
        "### Как это можно сделать?\n",
        "\n",
        "Реализация мультимодального расширения RAG-системы может быть выполнена в виде двухагентной архитектуры. В рамках данного подхода используется несколько моделей с открытым API, как и в реализованном решении, где применялась LLM-модель класса GPT-oss.\n",
        "Первый агент выполняет роль генератора текстового контекста и отвечает за retrieval релевантных фрагментов документов, а также за формирование связного текстового ответа на запрос пользователя. Второй агент ориентирован на работу с визуальной модальностью и осуществляет поиск, отбор или генерацию изображений, соответствующих контексту запроса и извлечённым текстовым данным, например графиков, схем или иллюстраций из научных статей.\n",
        "Взаимодействие агентов может быть реализовано в виде последовательного пайплайна, где результат работы текстового агента используется в качестве входных данных для визуального агента. Для построения подобного пайплайна можно использовать фреймворк LangChain, который предоставляет инструменты для организации цепочек вызовов моделей и отлично подходит для RAG-ситсем.\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "vAdFpXfePE9b"
      },
      "source": [
        "### Какие модели и почему вы выбрали для решения?\n",
        "\n",
        "В рамках данной работы основное внимание уделялось обработке и анализу англоязычных научных текстов, что обусловило выбор модели, ориентированной на работу с английским языком. Для решения поставленной задачи была выбрана LLM-модель класса GPT-oss, которая демонстрирует высокое качество генерации и понимания англоязычного научного текста.\n",
        "\n",
        "Так же важную роль играет доступность, модель можно получить по API на платформе cloud.ru. Модели семейства GPT хорошо подходят для задач компоновки и обобщения информации, а также для проведения исследовательского анализа научных статей, что делает их эффективным инструментом в рамках реализации RAG-системы."
      ]
    }
  ],
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3 (ipykernel)",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.12.4"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}